Lenalidomide, a analog of thalidomide, is TNF-α secretion inhibitor with IC50 of 13 nM.
There will be a HazMat fee per item when shipping a dangerous goods. The HazMat fee will be charged to your UPS/DHL/FedEx collect account or added to the invoice unless the package is shipped via Ground service. Ship by air in Excepted Quantity (each bottle), which is up to 1g/1mL for class 6.1 packing group I or II, and up to 25g/25ml for all other HazMat items.
Type | HazMat fee for 500 gram (Estimated) |
Excepted Quantity | USD 0.00 |
Limited Quantity | USD 15-60 |
Inaccessible (Haz class 6.1), Domestic | USD 80+ |
Inaccessible (Haz class 6.1), International | USD 150+ |
Accessible (Haz class 3, 4, 5 or 8), Domestic | USD 100+ |
Accessible (Haz class 3, 4, 5 or 8), International | USD 200+ |
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_am, item.pr_size) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_am, item.pr_size) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
产品名称 | TNF-α ↓ ↑ | 其他靶点 | 纯度 | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Thalidomide | ✔ | E3 Ligase | 98% | ||||||||||||||||
GSK2982772 |
++
human RIP1, IC50: 16 nM |
99%+ | |||||||||||||||||
QNZ |
++++
TNF-α, IC50: 7 nM |
NF-κB | 99%+ | ||||||||||||||||
Lenalidomide |
+++
TNF-α, IC50: 13 nM |
98% | |||||||||||||||||
Pomalidomide |
+++
TNF-α, IC50: 13 nM |
98% | |||||||||||||||||
GSK481 | ✔ | 99%+ | |||||||||||||||||
Apremilast |
++
TNF-α, IC50: 77 nM |
98% | |||||||||||||||||
Necrostatin-1 |
+
RIP1, EC50: 490 nM |
99%+ | |||||||||||||||||
Acetylcysteine | ✔ | 98% | |||||||||||||||||
Adalimumab | ✔ | 98% | |||||||||||||||||
1. 鼠标悬停在“+”上可以显示相关IC50的具体数值。"+"越多,抑制作用越强。2. "✔"表示该化合物对相应的亚型有抑制作用,但抑制强度暂时没有相关数据。 |
靶点 |
|
描述 | Cereblon, encoded by CRBN gene, is the substrate recognition component of a DCX (DDB1-CUL4-X-box) E3 protein ligase complex that mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Cereblon, or the E3 ligase complex mediated normal degradation of key regulatory proteins is required for normal limb outgrowth and expression of the fibroblast growth factor FGF8. They may play a role in memory and learning by regulating the assembly and neuronal surface expression of large-conductance calcium-activated potassium channels in brain regions involved in memory and learning via its interaction with KCNT1. It was well reported that binding of thalidomide-related drugs, such as Lenalidomide, changed the substrate specificity of the E3 ligase complex, leading to decreased degradation of MEIS2 and other target proteins and increased degradation of MYC, IRF4, IKZF1 and IKZF3[3]. Lenalidomide is an analogue of thalidomide with immunomodulatory, antiangiogenic, and antineoplastic properties. The cellular target of lenalidomide is cereblon. Another experiment revealed that Lenalidomide down regulated IKZF1 and IKZF3 and this was cereblon-dependent[4]. Lenalidomide treatment for 4 days was toxic to most ABC DLBCL cell lines[5]. 2 μM Lenalidomide led to down regulation of IKZF1, IKZF3 and IRF4 in MM1S, KMS34 and RPMI8226 cells[3]. In a MM1S xenograft model in CB17-SCID mice, Lenalidomide was administrated at the dose of 15 mg/kg i.p. 5days weekly as a single agent or in combination. The results were Lenalidomide was marginally effective as a single agent and the combination of Lenalidomide with dexamethasone or the triple combination of Lenalidomide, dexamethasone and panobinostat[6]. In an OCI-Ly10 xenograft model, daily i.p. treatment with lenalidomide at the dose of 10 mg/kg for 20 days resulted in little effect as a single agent but effective in combination with ibrutinib[5]. |
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
697 | Growth Inhibition Assay | IC50=50.3545 μM | SANGER | ||
A2058 | Growth Inhibition Assay | IC50=13.8199 μM | SANGER | ||
A2780 | Growth Inhibition Assay | IC50=35.3601 μM | SANGER | ||
A388 | Growth Inhibition Assay | IC50=60.449 μM | SANGER | ||
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT01002703 | Multiple Myeloma | Phase 1 Phase 2 | Unknown | October 2014 | Germany ... 展开 >> University of Leipzig Recruiting Leipzig, Germany, 04103 Contact: Dietger Niederwieser +4934197 ext 13050 dietger@medizin.uni-leipzig.de Sub-Investigator: Wolfram Pönisch 收起 << |
NCT01718743 | Myeloma | Phase 2 | Active, not recruiting | December 2020 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00923234 | Myelodysplastic Syndromes ... 展开 >> Acute Myelogenous Leukemia 收起 << | Phase 1 | Terminated(The primary objecti... 展开 >>ve has already been answered with the number of recruited patients.) 收起 << | - | Germany ... 展开 >> Medizinische Klinik und Poliklinik I, Uniklinik Dresden, Germany Universitätsklinikum Düsseldorf, Klinik für Hämatologie/Onkologie/klinische Immunologie Düsseldorf, Germany, 40225 Klinikum der J.W. Goethe-Universität, Medizinische Klink II Frankfurt, Germany, 60590 Technische Universität München, Klinikum Rechts der Isar München, Germany, 81675 收起 << |
计算器 | ||||
存储液制备 | 1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
3.86mL 0.77mL 0.39mL |
19.29mL 3.86mL 1.93mL |
38.57mL 7.71mL 3.86mL |
CAS号 | 191732-72-6 |
分子式 | C13H13N3O3 |
分子量 | 259.261 |
别名 | CC-5013 |
运输 | 蓝冰 |
存储条件 |
液体 -20°C:3-6个月-80°C:12个月 粉末 Keep in dark place,Inert atmosphere,2-8°C |
溶解度 |
DMSO: 105 mg/mL(405 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
动物实验配方 |
IP 2% DMSO+2% Tween80+40% PEG300+water 9 mg/mL clear PO 0.5% CMC-Na 40 mg/mL suspension |
Tags: Lenalidomide | CC-5013 | Apoptosis Inducer | Apoptosis | TNF-alpha | CRBN Ligand | AmBeed-信号通路专用抑制剂 | Lenalidomide 纯度/质量文件 | Lenalidomide 亚型比较 | Lenalidomide 生物活性 | Lenalidomide 细胞研究 | Lenalidomide 临床数据 | Lenalidomide 参考文献 | Lenalidomide 实验方案 | Lenalidomide 技术信息
请填写此表格索取QC报告。我们很快就会发送到您的邮箱。您的信息在我们这里是安全的。*是必填项.
靶点 | 数值 |
TNF-α |
TNF-α, IC50:13 nM |
CRBN |
需要的总药量: mg
您需要配制的工作液浓度为:mg/mL
细胞系 | 浓度 | 检测类型 | 检测时间 | 活动说明 | 数据源 |
697 | Growth Inhibition Assay | IC50=50.3545 μM | SANGER | ||
A2058 | Growth Inhibition Assay | IC50=13.8199 μM | SANGER | ||
A2780 | Growth Inhibition Assay | IC50=35.3601 μM | SANGER | ||
A388 | Growth Inhibition Assay | IC50=60.449 μM | SANGER | ||
A3-KAW | Growth Inhibition Assay | IC50=59.2809 μM | SANGER | ||
A498 | Growth Inhibition Assay | IC50=74.9308 μM | SANGER | ||
ABC-1 | Growth Inhibition Assay | IC50=29.6974 μM | SANGER | ||
ACN | Growth Inhibition Assay | IC50=16.5297 μM | SANGER | ||
ATN-1 | Growth Inhibition Assay | IC50=81.1187 μM | SANGER | ||
BCPAP | Growth Inhibition Assay | IC50=43.7917 μM | SANGER | ||
Becker | Growth Inhibition Assay | IC50=73.1489 μM | SANGER | ||
BHT-101 | Growth Inhibition Assay | IC50=93.1 μM | SANGER | ||
BT-549 | Growth Inhibition Assay | IC50=6.21849 μM | SANGER | ||
BV-173 | Growth Inhibition Assay | IC50=8.67585 μM | SANGER | ||
C8166 | Growth Inhibition Assay | IC50=31.2274 μM | SANGER | ||
CAL-33 | Growth Inhibition Assay | IC50=78.9939 μM | SANGER | ||
CAL-72 | Growth Inhibition Assay | IC50=92.0219 μM | SANGER | ||
CAL-85-1 | Growth Inhibition Assay | IC50=58.8643 μM | SANGER | ||
ChaGo-K-1 | Growth Inhibition Assay | IC50=74.7486 μM | SANGER | ||
CHP-212 | Growth Inhibition Assay | IC50=71.965 μM | SANGER | ||
COLO-680N | Growth Inhibition Assay | IC50=79.1007 μM | SANGER | ||
COLO-684 | Growth Inhibition Assay | IC50=15.3979 μM | SANGER | ||
COLO-829 | Growth Inhibition Assay | IC50=85.4912 μM | SANGER | ||
COR-L105 | Growth Inhibition Assay | IC50=40.4746 μM | SANGER | ||
CTB-1 | Growth Inhibition Assay | IC50=39.7789 μM | SANGER | ||
CTV-1 | Growth Inhibition Assay | IC50=25.0149 μM | SANGER | ||
D-283MED | Growth Inhibition Assay | IC50=79.812 μM | SANGER | ||
Daoy | Growth Inhibition Assay | IC50=56.3204 μM | SANGER | ||
DEL | Growth Inhibition Assay | IC50=15.499 μM | SANGER | ||
DOK | Growth Inhibition Assay | IC50=67.4948 μM | SANGER | ||
ECC10 | Growth Inhibition Assay | IC50=34.7443 μM | SANGER | ||
EKVX | Growth Inhibition Assay | IC50=37.4212 μM | SANGER | ||
EM-2 | Growth Inhibition Assay | IC50=17.143 μM | SANGER | ||
EoL-1-cell | Growth Inhibition Assay | IC50=4.10515 μM | SANGER | ||
ES3 | Growth Inhibition Assay | IC50=22.6963 μM | SANGER | ||
EW-11 | Growth Inhibition Assay | IC50=86.4336 μM | SANGER | ||
EW-16 | Growth Inhibition Assay | IC50=38.3885 μM | SANGER | ||
EW-18 | Growth Inhibition Assay | IC50=93.8462 μM | SANGER | ||
EW-3 | Growth Inhibition Assay | IC50=86.2032 μM | SANGER | ||
G-402 | Growth Inhibition Assay | IC50=70.9395 μM | SANGER | ||
GCT | Growth Inhibition Assay | IC50=61.0786 μM | SANGER | ||
GR-ST | Growth Inhibition Assay | IC50=71.172 μM | SANGER | ||
H9 | Growth Inhibition Assay | IC50=16.626 μM | SANGER | ||
HAL-01 | Growth Inhibition Assay | IC50=14.5796 μM | SANGER | ||
HCC1419 | Growth Inhibition Assay | IC50=91.6374 μM | SANGER | ||
HCC1806 | Growth Inhibition Assay | IC50=11.4467 μM | SANGER | ||
HCC2218 | Growth Inhibition Assay | IC50=25.5407 μM | SANGER | ||
HCC70 | Growth Inhibition Assay | IC50=30.7346 μM | SANGER | ||
HCE-T | Growth Inhibition Assay | IC50=67.0798 μM | SANGER | ||
HDLM-2 | Growth Inhibition Assay | IC50=28.2026 μM | SANGER | ||
HEL | Growth Inhibition Assay | IC50=82.4134 μM | SANGER | ||
H-EMC-SS | Growth Inhibition Assay | IC50=48.3224 μM | SANGER | ||
HMV-II | Growth Inhibition Assay | IC50=10.0172 μM | SANGER | ||
HOP-62 | Growth Inhibition Assay | IC50=13.48 μM | SANGER | ||
HSC-4 | Growth Inhibition Assay | IC50=17.6601 μM | SANGER | ||
HT-1376 | Growth Inhibition Assay | IC50=69.8314 μM | SANGER | ||
HuP-T3 | Growth Inhibition Assay | IC50=25.4009 μM | SANGER | ||
HuP-T4 | Growth Inhibition Assay | IC50=91.0405 μM | SANGER | ||
IGROV-1 | Growth Inhibition Assay | IC50=17.783 μM | SANGER | ||
JAR | Growth Inhibition Assay | IC50=2.97001 μM | SANGER | ||
JEG-3 | Growth Inhibition Assay | IC50=31.1614 μM | SANGER | ||
K5 | Growth Inhibition Assay | IC50=16.1486 μM | SANGER | ||
K-562 | Growth Inhibition Assay | IC50=61.5333 μM | SANGER | ||
KARPAS-45 | Growth Inhibition Assay | IC50=44.2776 μM | SANGER | ||
KASUMI-1 | Growth Inhibition Assay | IC50=11.571 μM | SANGER | ||
KMOE-2 | Growth Inhibition Assay | IC50=56.2893 μM | SANGER | ||
KNS-62 | Growth Inhibition Assay | IC50=57.0142 μM | SANGER | ||
KP-N-YS | Growth Inhibition Assay | IC50=52.3142 μM | SANGER | ||
KU812 | Growth Inhibition Assay | IC50=72.9702 μM | SANGER | ||
KY821 | Growth Inhibition Assay | IC50=35.7681 μM | SANGER | ||
KYSE-270 | Growth Inhibition Assay | IC50=53.6364 μM | SANGER | ||
KYSE-520 | Growth Inhibition Assay | IC50=30.8839 μM | SANGER | ||
L-363 | Growth Inhibition Assay | IC50=2.92212 μM | SANGER | ||
LAMA-84 | Growth Inhibition Assay | IC50=60.9905 μM | SANGER | ||
LB771-HNC | Growth Inhibition Assay | IC50=2.15038 μM | SANGER | ||
LCLC-103H | Growth Inhibition Assay | IC50=14.4892 μM | SANGER | ||
LN-405 | Growth Inhibition Assay | IC50=19.9076 μM | SANGER | ||
LU-135 | Growth Inhibition Assay | IC50=55.1853 μM | SANGER | ||
LU-139 | Growth Inhibition Assay | IC50=58.826 μM | SANGER | ||
MDA-MB-361 | Growth Inhibition Assay | IC50=96.0516 μM | SANGER | ||
Mewo | Growth Inhibition Assay | IC50=41.9871 μM | SANGER | ||
MHH-NB-11 | Growth Inhibition Assay | IC50=81.8849 μM | SANGER | ||
MKN1 | Growth Inhibition Assay | IC50=36.2137 μM | SANGER | ||
ML-2 | Growth Inhibition Assay | IC50=55.9489 μM | SANGER | ||
MLMA | Growth Inhibition Assay | IC50=59.091 μM | SANGER | ||
MOLT-13 | Growth Inhibition Assay | IC50=87.2243 μM | SANGER | ||
MOLT-4 | Growth Inhibition Assay | IC50=20.5759 μM | SANGER | ||
Mo-T | Growth Inhibition Assay | IC50=92.7697 μM | SANGER | ||
MPP-89 | Growth Inhibition Assay | IC50=83.2575 μM | SANGER | ||
MSTO-211H | Growth Inhibition Assay | IC50=20.3573 μM | SANGER | ||
MV-4-11 | Growth Inhibition Assay | IC50=29.7317 μM | SANGER | ||
NB6 | Growth Inhibition Assay | IC50=65.988 μM | SANGER | ||
NB69 | Growth Inhibition Assay | IC50=83.0033 μM | SANGER | ||
NBsusSR | Growth Inhibition Assay | IC50=57.5705 μM | SANGER | ||
NCI-H1304 | Growth Inhibition Assay | IC50=52.7024 μM | SANGER | ||
NCI-H1666 | Growth Inhibition Assay | IC50=61.875 μM | SANGER | ||
NCI-H1693 | Growth Inhibition Assay | IC50=46.6986 μM | SANGER | ||
NCI-H1993 | Growth Inhibition Assay | IC50=63.4043 μM | SANGER | ||
NCI-H209 | Growth Inhibition Assay | IC50=78.6147 μM | SANGER | ||
NCI-H2342 | Growth Inhibition Assay | IC50=53.0508 μM | SANGER | ||
NCI-H358 | Growth Inhibition Assay | IC50=65.0121 μM | SANGER | ||
NCI-H526 | Growth Inhibition Assay | IC50=32.683 μM | SANGER | ||
NCI-H69 | Growth Inhibition Assay | IC50=75.7663 μM | SANGER | ||
NCI-H720 | Growth Inhibition Assay | IC50=58.8942 μM | SANGER | ||
NCI-N87 | Growth Inhibition Assay | IC50=81.7296 μM | SANGER | ||
NCI-SNU-5 | Growth Inhibition Assay | IC50=41.2069 μM | SANGER | ||
NEC8 | Growth Inhibition Assay | IC50=70.1243 μM | SANGER | ||
NKM-1 | Growth Inhibition Assay | IC50=32.9568 μM | SANGER | ||
NOS-1 | Growth Inhibition Assay | IC50=52.8559 μM | SANGER | ||
OC-314 | Growth Inhibition Assay | IC50=92.8821 μM | SANGER | ||
OE33 | Growth Inhibition Assay | IC50=55.818 μM | SANGER | ||
ONS-76 | Growth Inhibition Assay | IC50=85.7908 μM | SANGER | ||
PANC-08-13 | Growth Inhibition Assay | IC50=14.9108 μM | SANGER | ||
QIMR-WIL | Growth Inhibition Assay | IC50=71.4434 μM | SANGER | ||
Ramos-2G6-4C10 | Growth Inhibition Assay | IC50=59.6287 μM | SANGER | ||
RPMI-8226 | Growth Inhibition Assay | IC50=12.6241 μM | SANGER | ||
RS4-11 | Growth Inhibition Assay | IC50=22.1563 μM | SANGER | ||
SBC-1 | Growth Inhibition Assay | IC50=23.8696 μM | SANGER | ||
SK-MEL-24 | Growth Inhibition Assay | IC50=16.4652 μM | SANGER | ||
SK-MEL-28 | Growth Inhibition Assay | IC50=11.9764 μM | SANGER | ||
SK-NEP-1 | Growth Inhibition Assay | IC50=7.89512 μM | SANGER | ||
SK-OV-3 | Growth Inhibition Assay | IC50=31.6755 μM | SANGER | ||
SW1990 | Growth Inhibition Assay | IC50=30.33 μM | SANGER | ||
SW620 | Growth Inhibition Assay | IC50=14.2473 μM | SANGER | ||
SW900 | Growth Inhibition Assay | IC50=87.2053 μM | SANGER | ||
T47D | Growth Inhibition Assay | IC50=13.2099 μM | SANGER | ||
TE-1 | Growth Inhibition Assay | IC50=17.9968 μM | SANGER | ||
TE-12 | Growth Inhibition Assay | IC50=94.3055 μM | SANGER | ||
UACC-257 | Growth Inhibition Assay | IC50=58.6264 μM | SANGER | ||
WM-115 | Growth Inhibition Assay | IC50=30.3099 μM | SANGER |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT01002703 | Multiple Myeloma | Phase 1 Phase 2 | Unknown | October 2014 | Germany ... 展开 >> University of Leipzig Recruiting Leipzig, Germany, 04103 Contact: Dietger Niederwieser +4934197 ext 13050 dietger@medizin.uni-leipzig.de Sub-Investigator: Wolfram Pönisch 收起 << |
NCT01718743 | Myeloma | Phase 2 | Active, not recruiting | December 2020 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00923234 | Myelodysplastic Syndromes ... 展开 >> Acute Myelogenous Leukemia 收起 << | Phase 1 | Terminated(The primary objecti... 展开 >>ve has already been answered with the number of recruited patients.) 收起 << | - | Germany ... 展开 >> Medizinische Klinik und Poliklinik I, Uniklinik Dresden, Germany Universitätsklinikum Düsseldorf, Klinik für Hämatologie/Onkologie/klinische Immunologie Düsseldorf, Germany, 40225 Klinikum der J.W. Goethe-Universität, Medizinische Klink II Frankfurt, Germany, 60590 Technische Universität München, Klinikum Rechts der Isar München, Germany, 81675 收起 << |
NCT01011894 | Chronic Lymphocytic Leukemia ... 展开 >> Leukemia 收起 << | Phase 2 | Completed | - | United States, New York ... 展开 >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 收起 << |
NCT02038153 | Acute Myeloid Leukemia Arising... 展开 >> From Previous Myelodysplastic Syndrome Adult Acute Megakaryoblastic Leukemia Adult Acute Monoblastic Leukemia Adult Acute Monocytic Leukemia Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With Maturation Adult Acute Myeloid Leukemia With Minimal Differentiation Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL Adult Acute Myeloid Leukemia Without Maturation Adult Acute Myelomonocytic Leukemia Adult Erythroleukemia Adult Pure Erythroid Leukemia Alkylating Agent-Related Acute Myeloid Leukemia Recurrent Adult Acute Myeloid Leukemia 收起 << | Phase 1 Phase 2 | Unknown | January 2017 | United States, New York ... 展开 >> Albert Einstein College of Medicine Recruiting Bronx, New York, United States, 10461 Contact: Ira Braunschweig 718-920-4826 ibraunsc@montefiore.org Principal Investigator: Ira Braunschweig Montefiore Medical Center - Moses Campus Recruiting Bronx, New York, United States, 10467-2490 Contact: Ira Braunschweig 718-920-4826 ibraunsc@montefiore.org Principal Investigator: Ira Braunschweig 收起 << |
NCT00933426 | Prostate Cancer | Phase 1 | Terminated(Terminated early du... 展开 >>e to slow accrual as Phase I dose escalation study.) 收起 << | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01011894 | - | Completed | - | - | |
NCT02041325 | Plasma Cell Disorder | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> VA Boston Healthcare System Boston, Massachusetts, United States, 02130 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 收起 << |
NCT02041325 | - | Completed | - | - | |
NCT01133275 | Myelodysplastic Syndrome ... 展开 >> MDS 收起 << | Phase 2 | Active, not recruiting | June 2019 | United States, Florida ... 展开 >> University of Florida Shands Cancer Center Gainesville, Florida, United States, 32610 H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 收起 << |
NCT01241734 | Diffuse Large B-cell Lymphoma. | Phase 1 Phase 2 | Unknown | December 2014 | United States, New Jersey ... 展开 >> John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 收起 << |
NCT01373294 | - | Active, not recruiting | - | - | |
NCT01133275 | - | Active, not recruiting | - | - | |
NCT01243476 | Myelodysplastic Syndrome | Phase 3 | Active, not recruiting | January 2022 | Spain ... 展开 >> Hospital de Cabueñes Gijón, Asturias, Spain, 33394 Hospital Central de Asturias Oviedo, Asturias, Spain, 33006 Hospital Universitari Germans Trias i Pujol (ICO Badalona) Badalona, Barcelona, Spain, 08916 Hospital Son Llàtzer Palma de Mallorca, Islas Baleares, Spain, 07198 Hospital de Cruces Barakaldo, Vizcaya, Spain, 48930 Hospital Clínic i Provincial Barcelona, Spain, 08036 Hospital Universitario Reina Sofía Córdoba, Spain, 14004 Hospital Infanta Leonor Madrid, Spain, 28031 Hospital Clínico San Carlos Madrid, Spain, 28040 Hospital Universitario La Paz Madrid, Spain, 28046 Hospital General Universitario José Maria Morales Meseguer Murcia, Spain, 30008 Hospital Clínico Universitario de Salamanca Salamanca, Spain, 37007 Hospital Universitario Virgen del Rocío Sevilla, Spain, 41013 Hospital Universitario La Fe Valencia, Spain, 46009 收起 << |
NCT00923663 | MALT Lymphoma | Phase 2 | Unknown | June 2011 | Austria ... 展开 >> Dept of Internal Medicine Recruiting Vienna, Austria, A-1090 Contact: Markus Raderer, MD +43-1-40400 ext 2296 markus.raderer@meduniwien.ac.at Principal Investigator: Markus Raderer, MD 收起 << |
NCT01316523 | Non Hodgkin's Lymphoma | Phase 2 | Active, not recruiting | July 2019 | United States, California ... 展开 >> University of California Davis Cancer Center Sacramento, California, United States, 95817 Sutter Pacific Medical Foundation Santa Rosa, California, United States, 95403 收起 << |
NCT01254578 | Adult Acute Myeloid Leukemia i... 展开 >>n Remission Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A Adult Acute Promyelocytic Leukemia With PML-RARA Adult Grade III Lymphomatoid Granulomatosis Adult Nasal Type Extranodal NK/T-Cell Lymphoma Alkylating Agent-Related Acute Myeloid Leukemia Anaplastic Large Cell Lymphoma Angioimmunoblastic T-Cell Lymphoma Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue Hepatosplenic T-Cell Lymphoma Intraocular Lymphoma Lymphomatous Involvement of Non-Cutaneous Extranodal Site Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma Nodal Marginal Zone Lymphoma Post-Transplant Lymphoproliferative Disorder Primary Cutaneous B-Cell Non-Hodgkin Lymphoma Prolymphocytic Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Immunoblastic Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-Cell Leukemia/Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides and Sezary Syndrome Recurrent Non-Hodgkin Lymphoma Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Richter Syndrome Small Intestinal Lymphoma Splenic Marginal Zone Lymphoma T-Cell Large Granular Lymphocyte Leukemia Testicular Lymphoma Waldenstrom Macroglobulinemia 收起 << | Phase 1 | Completed | - | United States, Ohio ... 展开 >> Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 收起 << |
NCT01373294 | Bladder Cancer | Phase 2 | Active, not recruiting | December 2019 | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 收起 << |
NCT00675441 | - | Terminated(Terminated due to s... 展开 >>low accrual.) 收起 << | - | - | |
NCT00675441 | Graft-versus-Host Disease | Phase 2 | Terminated(Terminated due to s... 展开 >>low accrual.) 收起 << | - | United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01463670 | Multiple Myeloma | Phase 2 | Active, not recruiting | October 2019 | United States, Connecticut ... 展开 >> Stamford Hospital Stamford, Connecticut, United States, 06902 United States, New Jersey Memorial Sloan Kettering at Basking Ridge Basking Ridge, New Jersey, United States, 07920 Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Montefiore Medical Center Bronx, New York, United States, 10467 SUNY Downstate Medical Center Brooklyn, New York, United States North Shore LIJ New Hyde Park, New York, United States, 11040 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Weill Cornell Medical Center New York, New York, United States, 10065 University of Rochester Medical Center Rochester, New York, United States Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States Memoral Sloan Kettering Cancer Center at Phelps Sleepy Hollow, New York, United States, 10591 收起 << |
NCT00704691 | Peripheral T-cell Lymphomas ... 展开 >> Adult T-cell Leukemia Adult T-cell Lymphoma Peripheral T-cell Lymphoma Unspecified Angioimmunoblastic T-cell Lymphoma Anaplastic Large Cell Lymphoma T/Null Cell Systemic Type Cutaneous t-Cell Lymphoma With Nodal/Visceral Disease 收起 << | Early Phase 1 | Terminated(Closed due to futil... 展开 >>ity with only 1 patient accrued) 收起 << | - | United States, Alabama ... 展开 >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 - 0104 收起 << |
NCT00901615 | Lymphoma, Large B-Cell, Diffus... 展开 >>e Follicular Lymphoma Mantle Cell Lymphoma Marginal Zone Lymphoma 收起 << | Phase 1 Phase 2 | Completed | - | France ... 展开 >> CHU de Dijon Dijon, France, 21034 CHRU Lille Lille, France, 59037 CHU Lyon Sud Pierre Benite, France, 69310 Centre Henri Becquerel Rouen, France, 76038 CHU Brabois Vandoeuvre les Nancy, France, 54511 收起 << |
NCT00981708 | Amyloidosis | Phase 1 Phase 2 | Unknown | February 2015 | Greece ... 展开 >> Alexandra Hospital , Department of Clinical Therapeutics Athens, Attica, Greece, 115 28 收起 << |
NCT03283046 | Malignant Neoplasms Stated as ... 展开 >>Primary Lymphoid Haematopoietic Multiple Myeloma 收起 << | Phase 1 | Withdrawn(Similar to another s... 展开 >>tudy.) 收起 << | October 2020 | - |
NCT01207921 | Hodgkin Disease | Phase 1 | Active, not recruiting | September 30, 2026 | United States, Missouri ... 展开 >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, North Carolina Wake Forest University Winston-Salem, North Carolina, United States, 27106 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 收起 << |
NCT00655668 | T-cell Non-Hodgkin's Lymphoma | Phase 2 | Terminated(Decision not to pur... 展开 >>sue as single agent in the study population.) 收起 << | - | - |
NCT03106324 | - | Recruiting | March 31, 2025 | - | |
NCT00655668 | - | Terminated(Decision not to pur... 展开 >>sue as single agent in the study population.) 收起 << | - | - | |
NCT00761449 | MDS AML | Phase 2 | Completed | - | Denmark ... 展开 >> Department of Hematology, Aalborg Hospital Aalborg, Denmark, 9000 Department of Hematology, Aarhus University Hospital Aarhus, Denmark, 8000 Department of Hematology, Rigshospitalet Copenhagen, Denmark, 2100 Department of Hematology, Herlev Hospital Herlev, Denmark, 2730 Department of Hematology, Odense University Hospital Odense, Denmark, 5000 Department of Hematology, Vejle Hospital Vejle, Denmark, 7100 Norway Department of Hematology, Rikshospitalet University Hospital Oslo, Norway, 0027 Department of Medicine, Ullevål Hospital Oslo, Norway, 0407 Department of Hematology, Trondheim University Hospital Trondheim, Norway, 7006 Sweden Department of Hematology and Coagulation, Sahlgrenska University hospital Gothenburg, Sweden, 413 45 Department of Hematology, Lund University Hospital Lund, Sweden, 221 85 Department of Hematology, Malmö University Hospital Malmö, Sweden, 205 02 Hematology Center, Karolinska University Hospital Huddinge Stockholm, Sweden, 141 86 Hematology Center, Karolinska University Hospital Solna Stockholm, Sweden, 171 76 Department of Medicine, Sundsvall Hospital Sundsvall, Sweden, 851 86 Department of Medicine, Umeå University Hospital Umeå, Sweden, 901 85 Department of Hematology, Akademiska University Hospital Uppsala, Sweden, 751 85 Department of Medicine, Örebro University Hospital Örebro, Sweden, 701 85 收起 << |
NCT00874978 | Myelodysplastic Syndromes | Phase 2 | Unknown | December 2015 | United Kingdom ... 展开 >> King's College Hospital NHS Foundation Trust London, United Kingdom, SE5 9RS 收起 << |
NCT00478959 | Hodgkin Disease | Phase 2 | Completed | - | - |
NCT00799513 | Diffuse Large B-cell Lymphoma | Phase 2 | Unknown | November 2013 | Italy ... 展开 >> San Raffaele Scientific Institute Recruiting Milan, Italy, 20132 Sub-Investigator: Roberto Crocchiolo, MD Sub-Investigator: Silvia Govi, MD 收起 << |
NCT01433965 | Acute Myeloid Leukemia ... 展开 >> Myelodysplastic Syndrome 收起 << | Phase 1 | Recruiting | December 2019 | United States, California ... 展开 >> University of California Davis Recruiting Sacramento, California, United States, 95817 Contact: Corinne Turrell 916-734-3089 Principal Investigator: Mehrdad Abedi, MD 收起 << |
NCT01995669 | Lymphoma | Phase 1 Phase 2 | Recruiting | May 2019 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 收起 << |
NCT01038635 | Leukemia | Phase 1 Phase 2 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT03411031 | Multiple Myeloma | Phase 2 | Recruiting | April 2022 | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Mark Melody 813-745-3420 mark.melody@moffitt.org Contact: Melissa Alsina, M.D. 813-745-7202 melissa.messina@moffitt.org 收起 << |
NCT01553786 | T-cell Lymphoma | Phase 2 | Active, not recruiting | March 2020 | Belgium ... 展开 >> Université Catholique de Louvain Saint Luc Bruxelles, Belgium, 1200 Universitair Ziekenhuis Gent Gent, Belgium, 9000 Université Catholique de Louvain Mont Godinne Yvoir, Belgium, 5530 France CHU d'Amiens - Hôpital Sud Amiens, France, 80054 CHU Angers Angers, France, 49033 CH d'Avignon - Hôpital Henri Duffaut Avignon, France, 84902 CHU Jean Minjoz Besançon, France, 25030 Institut Bergonié Bordeaux, France, 33076 Polyclinique Bordeaux Nord Aquitaine Bordeaux, France, 33077 Centre hospitalier Chalon sur Saone William Morey Châlon sur saône, France, 71100 CHU Estaing Clermont Ferrand, France, 63000 CH Sud Francilien de Corbeil Corbeil Essonnes, France, 91106 Hôpital Henri Mondor Créteil, France, 94010 CHU de Dijon Dijon, France, 21000 CHU de Grenoble Grenoble, France, 38043 CH Départemental La roche sur Yon, France, 85925 CHRU de Lille Lille, France, 59037 Institut Paoli Calmette Marseille, France, 13273 Centre Hospitalier de Meaux Meaux, France, 77104 CHU Saint-Eloi Montpellier, France, 34295 CHU Hôtel Dieu Nantes, France, 44093 Hôpital Saint Louis Paris, France, 75475 Hôpital Necker Paris, France, 75743 Centre Francois Magendie Pessac, France, 33604 CHU Lyon Sud Pierre Bénite, France Centre Hospitalier de la Région d'Annecy Pringy, France, 74370 CHU Robert Debré Reims, France, 51092 CHU Pontchaillou Rennes, France, 35003 Centre Henri Becquerel Rouen, France, 76038 CHU Brabois Vandoeuvre les Nancy, France, 54511 收起 << |
NCT02589145 | Lymphoma | Phase 1 Phase 2 | Active, not recruiting | June 2021 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01032291 | Colorectal Cancer | Phase 2 | Terminated(A business decision... 展开 >> not to continue with Phase 2b based on non-safety observations during proof of concept phase.) 收起 << | - | Australia, South Australia ... 展开 >> Flinders Medical Centre, Dept. of Oncology Bedford Park, South Australia, Australia Belgium UZ Antwerpen Dept. of Medical Oncology Antwerp, Belgium ULB Erasme Service de Gastroenterologie Brussels, Belgium Grand hôpital de Charleroi, Oncologie Charleroi, Belgium Algemeen Ziekenhuis Maria Middelares Gent, Belgium Universitaire Ziekenhuis Gasthuisberg K.U. Leuven Gastroenterologie, Oncologie Leuven, Belgium Centre Hospitalier Universitaire Sart Tilman Liège Liège, Belgium Germany Klinikum Oldenburg gGmbH Klinik für Innere Medizin II Oldenburg, Niedersachsen, Germany Italy Azienda Osperdaliero Universitaria Riuniti Umberto I-GM Lancisi-G. Salesi di Ancona Clinica di Oncologia Medica Ancona, Italy Azienda Ospedaliera Universitaria San Martino Unità Operativa Oncologia Medica Genova, Italy Azienda Ospedaliera Niguarda Ca' Grande, Oncologia Medica Falck Milano, Italy Spain Hospital Vall D'Hebron Servicio de Oncología. Unidad de ensayos clínicos Barcelona, Spain Hospital Universitario Marques de Valdecilla Servicio de Oncología Santander, Spain Hospital Clinico Universitario de Valencia Servicio de Oncologia Valencia, Spain Sweden Östra Sjukhuset Kirurgkliniken Gothenburg, Sweden Karolinska University Hospital, Solna, Karolinska Institutet Dept of Oncology Stockholm, Sweden Akademiska Sjukhuset Onkologkliniken Uppsala, Sweden 收起 << |
NCT01038635 | - | Completed | - | - | |
NCT01421927 | Multiple Myeloma | Phase 1 | Completed | - | France ... 展开 >> CHU Bordeaux - Hôpital Haut-Lévêque Pessac, France, 33600 收起 << |
NCT00783367 | Follicular Lymphoma ... 展开 >> Marginal Zone B-Cell Lymphoma MALT Lymphoma Lymphoma of Mucosa-Associated Lymphoid Tissue Lymphoma, Small Lymphocytic Waldenstrom Macroglobulinemia Mantle-Cell Lymphoma 收起 << | Phase 2 | Active, not recruiting | - | United States, Pennsylvania ... 展开 >> University of Pennsylvania; Abramson Cancer Center; Lymphoma Program Philadelphia, Pennsylvania, United States, 19104 收起 << |
NCT01111903 | Ovarian Cancer Recurrent | Phase 1 Phase 2 | Completed | - | France ... 展开 >> Hopital Tenon Paris, France, 75020 收起 << |
NCT01032291 | - | Terminated(A business decision... 展开 >> not to continue with Phase 2b based on non-safety observations during proof of concept phase.) 收起 << | - | - | |
NCT00812968 | Myelodysplastic Syndromes | Phase 2 | Completed | - | Japan ... 展开 >> Celgene Clinical Site Shimono, Tochigi, Japan, 329-0498 Celgene Clinical Site Shibuya-ku, Tokyo, Japan, 150-8935 Celgene Clinical Site Hiroshima, Japan, 734-8551 Celgene Clinical Site Kyoto, Japan, 601-1495 Celgene Clinical Site Osaka, Japan, 543-8555 Celgene Clinical Site Shizuoka, Japan, 420-8527 收起 << |
NCT03232307 | Hematopoietic/Lymphoid Cancer ... 展开 >> Mantle Cell Lymphoma 收起 << | Phase 2 | Not yet recruiting | January 2023 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact miwang@mdanderson.org 收起 << |
NCT01919619 | Blood And Marrow Transplantati... 展开 >>on Leukemia Lymphoma 收起 << | Early Phase 1 | Recruiting | November 2019 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact ikhouri@mdanderson.org 收起 << |
NCT00812968 | - | Completed | - | - | |
NCT00699842 | Myelodysplastic Syndrome ... 展开 >> MDS Low to Intermediate-1 MDS Non-deletion 5q 收起 << | Phase 1 Phase 2 | Terminated(Administratively te... 展开 >>rminated per FDA recommendation) 收起 << | - | United States, Pennsylvania ... 展开 >> Associates in Hematology-Oncology, PC Chester, Pennsylvania, United States, 19130 Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 收起 << |
NCT01956695 | Lymphoma Rela... 展开 >>pse 收起 << | Phase 2 | Active, not recruiting | January 2019 | France ... 展开 >> CHU Estaing Clermont-Ferrand, Auvergne, France, 63003 CHU Bretonneau - Centre Henry Kaplan Tours, Centre, France, 37044 Institut Bergonié Bordeaux, Gironde, France, 33076 Hôpital de la Pitié Salpétrière Paris, Ile De France, France, 75013 Institut curie - Hôpital René Huguenin Saint-Cloud, Ile De France, France, 92210 Chu Michallon Grenoble, Isère, France, 38043 Hôpital Central Nancy, Lorraine, France, 54036 CHRU Lille - Hôpital Claude Huriez Lille, Nord, France, 59037 Centre Léon Bérard Lyon, Rhône-Alpes, France, 39373 Centre Henri Becquerel Rouen, Seine Maritime, France, 76038 CHU Amiens -Hôpital Sud Amiens, Somme, France, 80054 Chu La Timone Marseille, France, 13005 收起 << |
NCT00699842 | - | Terminated(Administratively te... 展开 >>rminated per FDA recommendation) 收起 << | - | - | |
NCT02255162 | Acute Myeloid Leukemia (AML) ... 展开 >> Acute Myelocytic Leukemia Acute Myelogenous Leukemia Acute Granulocytic Leukemia Acute Non-Lymphocytic Leukemia 收起 << | Phase 1 | Terminated(Slow Accrual) | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 收起 << |
NCT02875067 | Relapsed Hodgkin Lymphoma ... 展开 >> Relapsed Non-Hodgkin Lymphoma 收起 << | Phase 1 Phase 2 | Active, not recruiting | August 2023 | United States, Georgia ... 展开 >> Emory University Hospital Atlanta, Georgia, United States, 30322 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, New York NYU Perlmutter Cancer Center New York, New York, United States, 10016 收起 << |
NCT02322320 | Multiple Myeloma | Phase 3 | Active, not recruiting | December 2018 | - |
NCT01816620 | POEMS Syndrome | Phase 2 | Completed | - | China, Beijing ... 展开 >> Peking Union Medical College Hospital Beijing, Beijing, China, 100005 收起 << |
NCT01752075 | - | Completed | - | Taiwan ... 展开 >> NTUH Taipei, Taiwan 收起 << | |
NCT02523040 | Langerhans Cell Histiocytosis ... 展开 >>(LCH) Histiocytoses Erdheim-chester Disease Histiocytic Sarcoma (HS) 收起 << | Phase 2 | Active, not recruiting | August 2022 | United States, Massachusetts ... 展开 >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 << |
NCT01274533 | Adult T Cell Leukemia/Lymphoma | Phase 2 | Completed | - | United States, New York ... 展开 >> Columbia University Medical Center New York, New York, United States, 10032 收起 << |
NCT01274533 | - | Completed | - | - | |
NCT01996865 | Lymphoma, Non-Hodgkin | Phase 3 | Recruiting | July 8, 2024 | - |
NCT01615042 | Acute Leukemia | Phase 1 | Terminated(Lack of enrollment) | - | United States, California ... 展开 >> University of California Comprehensive Cancer Center Sacramento, California, United States, 95817 收起 << |
NCT02354313 | MANTLE CELL LYMPHOMA | Phase 3 | Active, not recruiting | January 2019 | - |
NCT02312102 | Myelodysplastic Syndrome ... 展开 >> Acute Myeloid Leukemia 收起 << | Phase 1 | Active, not recruiting | August 2019 | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 收起 << |
NCT01593410 | Multiple Myeloma | Phase 2 | Completed | - | China ... 展开 >> 307 Hospital of Chinese PLA Beijing, China, 100071 Peking University Third Hospital Beijing, China, 100081 Peking Union Medical College Hospital Beijing, China, 100730 Chinese PLA General Hospital Beijing, China, 300200 Xiangya Hospital of Central- South University Changsha, China, 410008 Guangdong General Hospital Guangzhou, China, 510080 Nanfang Hospital of Southern Medical University Guangzhou, China, 510515 The First Hospital Affiliated of College Medicine, Zhejiang University Hangzhou, China, 310003 The First Hospital Affiliated of College Medicine, Zhejiang University Hangzhou, China, 310009 Shanghai Changzheng Hospital Shanghai, China, 200003 Shanghai 6th People's Hospital Shanghai, China, 200233 Changhai Hospital Shanghai, China, 200433 The First Affiliated Hospital of Soochow University Suzhou, China, 215006 收起 << |
NCT00439231 | Chronic Lymphocytic Leukemia (... 展开 >>CLL) Small Lymphocytic Lymphoma 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT01703364 | CLL Chronic L... 展开 >>ymphocytic Leukemia 收起 << | Phase 1 Phase 2 | Completed | - | Austria ... 展开 >> Universitätsklinik für Innere Medizin Innsbruck, Klinische Abteilung für Hämatologie und Onkologie Innsbruck, Tirol, Austria, 6020 Universitätsklinik der PMU Salzburg, Univ-Klinik für Innere Medizin III Salzburg, Austria, 5020 收起 << |
NCT01180569 | Lymphoma Foll... 展开 >>icular Lymphoma 收起 << | Phase 1 Phase 2 | Withdrawn | - | - |
NCT00439231 | - | Completed | - | - | |
NCT03110822 | Multiple Myeloma | Phase 1 | Recruiting | May 2020 | United States, California ... 展开 >> Comprehensive Blood and Cancer Center Recruiting Bakersfield, California, United States, 93309-0633 Contact: Nicole Henry 661-862-8548 nhenry@cbccusa.com Principal Investigator: Ravindranath Patel, MD California Cancer Associates for Research & Excellence (cCARE) Recruiting Encinitas, California, United States, 92024 Contact: Daniela Slavin, PhD 760-452-3909 dslavin@ccare.com Principal Investigator: Alberto Bessudo, MD Robert A. Moss, M.D., F.A.C.P., Inc. Recruiting Fountain Valley, California, United States, 92708 Contact: Helen Tam 714-641-1128 helen.tam@sbcglobal.net Principal Investigator: Robert A Moss, MD Pacific Cancer Care Recruiting Monterey, California, United States, 93940 Contact: Dorothy Tenney 831-375-4105 dtenney@pacificcancercare.com Principal Investigator: Laura Stampleman, MD Sansum Clinic- Ridley-Tree Cancer Center Recruiting Santa Barbara, California, United States, 93105 Contact: Heidi Heitkamp, PhD 805-879-5091 hheitkam@ridleytreecc.org Principal Investigator: Daniel R Greenwald, MD James R. Berenson M.D. Inc. Recruiting West Hollywood, California, United States, 90069 Contact: Regina Swift, R.N 310-623-1227 rswift@berensononcology.com Principal Investigator: James R Berenson, MD United States, Florida Millennium Oncology Research Clinic Recruiting Pembroke Pines, Florida, United States, 33024 Contact: Maria Contreras, MD 954-266-7885 mcontreras@millenniumoncologyfl.com Principal Investigator: Isaac Levy, MD United States, Maryland Regional Cancer Care Associates (RCCA) MD, LLC Recruiting Bethesda, Maryland, United States, 20817 Contact: Natalie Bongiorno, RN 301-571-2016 nbongiorno@regionalcancercare.org Principal Investigator: Ralph Boccia, MD 收起 << |
NCT01698801 | Multiple Myeloma | Phase 2 | Completed | - | Japan ... 展开 >> Nagoya Daini Red Cross Hospital Nagoya, Aichi, Japan, 466-8650 Nagoya City University Hospital Nagoya, Aichi, Japan, 467-8602 Kameda Medical Center Kamogawa, Chiba, Japan, 296-8602 Japanese Red Cross Narita Hospital Narita, Chiba, Japan, 286-8523 Ehime University Hospital Touon, Ehime, Japan, 791-0295 Nishigunma National Hospital Shibukawa, Gunma, Japan, 377-8511 Kobe City Medical Center General Hospital Kobe, Hyogo, Japan, 650-0047 Hitachi General Hospital Hitachi, Ibaraki, Japan, 317-0077 Iwate Medical University Morioka, Iwate, Japan, 020-8505 Tokai University Hospital Isehara, Kanagawa, Japan, 259-1193 Tohoku University Hospital Sendai, Miyagi, Japan, 980-8574 Kurashiki Central Hospital Kurashiki, Okayama, Japan, 710-8602 Kinki University Hospital, Faculty of Medicine Osakasayama, Osaka, Japan, 589-8511 Shizuoka Cancer Center Sunto, Shizuoka, Japan, 411-8777 National Disaster Medical Center Tachikawa, Tokyo, Japan, 190-0014 Kagoshima Medical Center Kagoshima, Japan, 892-0853 University Hospital, Kyoto Prefectural University of Medicine Kyoto, Japan, 602-8566 Niigata Cancer Center Hospital Niigata, Japan, 951-8566 Okayama Medical Center Okayama, Japan, 701-1192 Osaka Red Cross Hospital Osaka, Japan, 543-8555 National Cancer Center Hospital Tokyo, Japan, 104-0045 The Cancer Institute Hospital of Japanese Foundation for Cancer Research Tokyo, Japan, 135-8550 Japanese Red Cross Medical Center Tokyo, Japan, 150-8935 Keio University Hospital Tokyo, Japan, 160-8582 收起 << |
NCT02225275 | Leukemia | Phase 2 | Recruiting | March 1, 2024 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 收起 << |
NCT01379274 | MDS | Phase 2 | Terminated(Loss of funding.) | - | United States, Illinois ... 展开 >> Rush University Medical Center Chicago, Illinois, United States, 60612 收起 << |
NCT03376477 | Multiple Myeloma | Phase 2 | Recruiting | October 16, 2023 | United States, Maryland ... 展开 >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21287 Contact: Syed A Ali, MD 443-287-7104 sali35@jhmi.edu 收起 << |
NCT01698801 | - | Completed | - | - | |
NCT00751296 | - | Terminated(Seven years of foll... 展开 >>ow-up & final analysis done in Dec 2012.) 收起 << | - | - | |
NCT01947309 | - | Terminated(Business Decision) | - | China ... 展开 >> Peking Chao-Yang Hospital Beijing, China, 100020 Peking University People's Hospital Beijing, China, 100044 People's Liberation Army Hospital 307 Beijing, China, 100071 Beijing Hospital Beijing, China, 100730 The Fisrt Hospital Of Jilin University Changchun, China, 130031 Xiangya Hospital Central-South University Changsha, China, 410008 Xinqiao Hospital, 3rd Military Medical University Chongqing, China, 410008 NanFang Hospital of China Southern Medical University Guangzhou, China, 510515 The First Affliated Hospital of Anhui Medical University Hefei, China, 230032 Qilu Hospital of Shandong University Jinan, China, 250012 The Affiliated Hospital of Mecical College Qingdao University Qingdao, China, 266003 Shanghai Changzhen Hospital Shanghai, China, 200003 The Second Affiliated Hospital Of China Medical University Shenyang, China, 110004 The First Affiliated Hospital of Suzhou University Suzhou, China, 215006 People's Hospital of Xinjiang Uygur Autonomous Region Urumqi, China, 830001 Wuhan Union Hospital of Tongji Medical College of Huazhong University of Science & Technology Wuhan, China, 430000 Tongji Medical College Huazhong University of Science & Technology Wuhan, China, 430030 收起 << | |
NCT01342172 | - | Terminated(low accrual) | - | - | |
NCT00751296 | Chronic Lymphocytic Leukaemia | Phase 2 | Terminated(Seven years of foll... 展开 >>ow-up & final analysis done in Dec 2012.) 收起 << | - | Canada, Ontario ... 展开 >> University Health Network - Princess Margaret Cancer Centre Toronto, Ontario, Canada, M5G 2M9 收起 << |
NCT01342172 | Urinary Bladder Neoplasms | Phase 1 Phase 2 | Terminated(low accrual) | - | United States, Maryland ... 展开 >> National Cancer Institute Bethesda, Maryland, United States, 20892 United States, New York Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 收起 << |
NCT02692339 | - | Recruiting | September 29, 2023 | Portugal ... 展开 >> Hospital Garcia Orta, E.P.E. Not yet recruiting Almada, Portugal, 2805-267 Almada Hospital Professor Doutor Fernando Fonseca, E.P.E. Not yet recruiting Amadora, Portugal, 2720-276 Amadora Hospital Central de Faro Not yet recruiting Faro, Portugal, 8000-386 Faro Instituto Português de Oncologia de Lisboa Francisco Gentil, EPE Not yet recruiting Lisboa, Portugal, 1099-023 Lisboa Centro Hospitalar Lisboa Central, EPE - Hospital de Sto. Ant. Capuchos Not yet recruiting Lisboa, Portugal, 1169-050 Lisboa Fundação Champalimaud Recruiting Lisboa, Portugal, 1400-038 Lisboa Centro Hospitalar Lisboa Norte, EPE - Hospital Santa Maria Recruiting Lisboa, Portugal, 1649-035 Lisboa Centro Hospitalar do Porto - Hospital de Santo António Recruiting Porto, Portugal, 4099-001 Porto Instituto Português de Oncologia do Porto Francisco Gentil, EPE Not yet recruiting Porto, Portugal, 4200-072 Porto Centro Hospitalar de São João, EPE - Hospital de São João Recruiting Porto, Portugal, 4200-319 Porto Centro Hospitalar de Vila Nova de Gaia Not yet recruiting Vila Nova de Gaia, Portugal, 4430-502 Vila Nova de Gaia Hospital de São Teotónio, E.P.E. Not yet recruiting Viseu, Portugal, 3504-509 Viseu 收起 << | |
NCT01582776 | Follicular Lymphoma Patients (... 展开 >>Phase IB) Follicular and Agressive (DLBCL&MCL) B-cell Lymphoma Patients (Phase II) 收起 << | Phase 1 Phase 2 | Active, not recruiting | March 2022 | Belgium ... 展开 >> ZNA Stuivenberg Antwerpen, Belgium, 2060 A.Z. Sint Jan AV Bruges, Belgium, 8000 institut Jules Bordet Bruxelles, Belgium, 1000 Université Catholique de Louvain Saint Luc Bruxelles, Belgium, 1200 AZ Groeninge - Campus Maria's Voorzienigheid Kortrijk, Belgium, 8500 CHU de Liège Liège, Belgium, 4000 Université Catholique de Louvain Mont Godinne Yvoir, Belgium, 5530 France CHU d'Amiens Amiens, France, 80054 Institut Bergonié Bordeaux, France, 33076 Institut d'Hématologie de Basse Normandie Caen, France, 14076 CHU d'Estaing Clermont-Ferrand, France, 63000 Hôpital Henri Mondor Créteil, France, 94010 CHU de Dijon Dijon, France, 21034 CHU de Grenoble Grenoble, France, 38043 CHRU de Lille Lille, France, 59037 Centre Léon Bérard Lyon, France, 69373 Institut Paoli Calmette Marseille, France, 13273 CHU St Eloi Montpellier, France, 34295 CHU Brabois Nancy, France, 54511 CHU Hôtel Dieu Nantes, France, 44093 Hôpital St Louis Paris, France, 75475 Centre François Magendie Pessac, France, 33604 CH Lyon Sud Pierre Bénite, France, 69495 CHU Pontchaillou Rennes, France, 35003 Centre henri Becquerel Rouen, France, 76038 收起 << |
NCT01723839 | Chronic Lymphocytic Leukemia (... 展开 >>CLL) 收起 << | Phase 2 | Active, not recruiting | August 2018 | United States, New Jersey ... 展开 >> John Theurer Cancer Center at HackensackUMC Hackensack, New Jersey, United States, 07601 收起 << |
NCT01861340 | Myeloma | Early Phase 1 | Completed | - | United States, Maryland ... 展开 >> The Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21287 收起 << |
NCT01750983 | Advanced Cancers | Phase 1 | Active, not recruiting | March 2019 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01766583 | Relapsed/Refractory B-cell Lym... 展开 >>phoma 收起 << | Phase 1 | Completed | - | France ... 展开 >> Hopital henri mondor Créteil, France, 94010 CHU de Lille Lille, France, 59037 Institut Paoli Calmette Marseille, France, 13273 CHU de Nantes Nantes, France, 44093 CHU Lyon Sud Pierre Bénite, France, 69495 CHU de Toulouse Toulouse, France, 31059 收起 << |
NCT01460940 | Adult Lymphocyte Depletion Hod... 展开 >>gkin Lymphoma Adult Lymphocyte Predominant Hodgkin Lymphoma Adult Mixed Cellularity Hodgkin Lymphoma Adult Nodular Lymphocyte Predominant Hodgkin Lymphoma Adult Nodular Sclerosis Hodgkin Lymphoma Recurrent Adult Hodgkin Lymphoma 收起 << | Phase 2 | Completed | - | United States, Missouri ... 展开 >> Washington University Saint Louis, Missouri, United States, 63110 United States, Ohio The Ohio State University Medical Center Columbus, Ohio, United States, 43210 收起 << |
NCT01270932 | Renal Failure ... 展开 >> Multiple Myeloma 收起 << | Phase 2 | Completed | - | Canada, Ontario ... 展开 >> University Health Network- Princess Margaret Hosptial Toronto, Ontario, Canada, M5G2M9 收起 << |
NCT02898259 | B Cell Lymphoma ... 展开 >> Lymphoma 收起 << | Phase 1 Phase 2 | Recruiting | June 2024 | United States, Ohio ... 展开 >> University Hospitals, Seidman Cancer Center, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44106 Contact: Paolo Caimi, MD 800-641-2422 Paolo.Caimi@uhhospitals.org Principal Investigator: Paolo Caimi, MD Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44195 Contact: Brian Hill, MD, PhD 216-444-9451 Hillb2@ccf.org Principal Investigator: Brian Hill, MD, PhD 收起 << |
NCT01460940 | - | Completed | - | - | |
NCT01169298 | Adult T-cell Leukemia-Lymphoma... 展开 >> Peripheral T-cell Lymphoma 收起 << | Phase 1 | Completed | - | Japan ... 展开 >> National Kyusyu Cancer Center Fukuoka, Japan, 811-1395 Imamura Bun-in Hospital Kagoshima, Japan, 890-0064 Kumamoto University Hospital Kumamoto, Japan, 860-8556 Nagasaki University Hospital Nagasaki, Japan, 852-8501 Nagoya Daini Red Cross Hospital Nagoya, Japan, 466-8650 National Cancer Center Hospital Tokyo, Japan, 104-0045 收起 << |
NCT01057121 | - | Completed | - | - | |
NCT01718379 | Myelodysplastic Syndromes | Phase 2 | Completed | - | - |
NCT01352338 | Multiple Myeloma | Phase 1 Phase 2 | Completed | - | Netherlands ... 展开 >> Antonius Ziekenhuis Nieuwegein Nieuwegein, Utrecht, Netherlands, 3435 CM VU Medical Center Amsterdam, Netherlands UMC Utrecht Utrecht, Netherlands, 3584CX 收起 << |
NCT02371590 | Chronic Lymphocytic Leukemia | Phase 2 | Withdrawn(Study Not Activated ... 展开 >>Due to Contract Issues) 收起 << | December 2022 | United States, California ... 展开 >> UC San Diego Moores Cancer Center La Jolla, California, United States, 92093 收起 << |
NCT01264315 | Multiple Myeloma | Phase 2 | Active, not recruiting | December 2021 | Italy ... 展开 >> A.O.U. San Giovanni Battista Torino, Italy, 10126 收起 << |
NCT01057121 | AIDS-Related Kaposi Sarcoma ... 展开 >> Recurrent Kaposi Sarcoma 收起 << | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> UCLA Center for Clinical AIDS Research and Education Los Angeles, California, United States, 90035 University of California San Diego San Diego, California, United States, 92103 San Francisco General Hospital San Francisco, California, United States, 94110 United States, Florida University of Miami Miller School of Medicine-Sylvester Cancer Center Miami, Florida, United States, 33136 United States, Hawaii Cancer Center of Hawaii-Hawaii AIDS Clinical Research Program Honolulu, Hawaii, United States, 96816 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital Baltimore, Maryland, United States, 21231 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, Ohio Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 United States, Pennsylvania Pennsylvania Oncology Hematology Associates Philadelphia, Pennsylvania, United States, 19106 United States, Texas Thomas Street Clinic Houston, Texas, United States, 77009 United States, Washington Virginia Mason Medical Center Seattle, Washington, United States, 98101 Harborview Medical Center Seattle, Washington, United States, 98104 收起 << |
NCT01611259 | Lymphoma of the Mucosa Associa... 展开 >>ted Lymphoid Tissue (MALT) 收起 << | Phase 2 | Completed | - | Austria ... 展开 >> AKH Linz Linz, Oberösterreich, Austria, 4021 Klin.Abt.f. Hämatologie; Med.Univ.Graz Graz, Austria, A-8036 Univ.-Klinik f. Innere Medizin V Innsbruck, Austria, A-6020 PMU Salzburg Salzburg, Austria, 5020 Universitätsklinik f. Innere Medizin I Vienna, Austria, 1190 收起 << |
NCT00910858 | Low- or Intermediate-1-risk My... 展开 >>elodysplastic Syndrome (MDS) 收起 << | Phase 1 Phase 2 | Completed | - | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 收起 << |
NCT00847639 | Multiple Myeloma | Phase 2 | Completed | - | United States, California ... 展开 >> City of Hope National Medical Center Duarte, California, United States, 91010 United States, Florida H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 United States, Minnesota University of Minnesota Medical Center Minneapolis, Minnesota, United States, 55455 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, Pennsylvania University of Pennsylvania Hospital Center Philadelphia, Pennsylvania, United States, 19104 United States, Texas The University of Texas, M.D. Anderson Cancer Center Houston, Texas, United States, 77030 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98195 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 收起 << |
NCT02155634 | Multiple Myeloma ... 展开 >> Neoplasms Plasma Cells Paraproteinemias Blood Protein Disorders Hematologic Diseases Therapeutic Uses 收起 << | Phase 3 | Withdrawn(The study was termin... 展开 >>ated due to poor feasibility and lack of interest at the participating sites.) 收起 << | March 2021 | - |
NCT01380106 | Multiple Myeloma | Phase 2 | Unknown | December 2016 | United States, Arkansas ... 展开 >> Central Arkansas Veterans Healthcare System Little Rock, Arkansas, United States, 72205 United States, California West Los Angeles VA Medical Center Los Angeles, California, United States, 90073 United States, Illinois Edward Hines Jr VA Hospital Hines, Illinois, United States, 60141 United States, Massachusetts VA Boston Healthcare System Jamaica Plain, Massachusetts, United States, 02130 United States, Missouri Kansas City VA Medical Center Kansas City, Missouri, United States, 64128 United States, Pennsylvania Pittsburgh VA Medical Center Pittsburgh, Pennsylvania, United States, 15240 United States, Texas Houston VA Medical Center Houston, Texas, United States, 77030 收起 << |
NCT03208218 | Healthy, Male | Phase 1 | Completed | - | - |
NCT01724177 | Adult T-Cell Leukemia-Lymphoma | Phase 2 | Completed | - | Japan ... 展开 >> Nagoya City University Hospital Nagoya, Aichi, Japan, 467-8602 National Cancer Center Hospital East Kashiwa, Chiba, Japan, 277-8577 Ehime University Hospital Toon, Ehime, Japan, 791-0295 Iwate Medical University Hospital Morioka, Iwate, Japan, 020-8505 Tohoku University Hospital Sendai, Miyagi, Japan, 980-8574 Sasebo City General Hospital Sasebo, Nagasaki, Japan, 857-8511 Heart Life Hospital Nakagami, Okinawa, Japan, 901-2492 Shimane University Hospital Izumo, Shimane, Japan, 693-8501 National Hospital Organization Kyushu Cancer Center Fukuoka, Japan, 811-1395 Kyushu University Hospital Fukuoka, Japan, 812-8582 Imamura Bunin Hospital Kagoshima, Japan, 890-0064 Kagoshima University Medical and Dental Hospital Kagoshima, Japan, 890-8520 National Hospital Organization Kagoshima Medical Center Kagoshima, Japan, 892-0853 Kumamoto University Hospital Kumamoto, Japan, 860-8556 Nagasaki University Hospital Nagasaki, Japan, 852-8501 The Japanese Red Cross Nagasaki Genbaku Hospital Nagasaki, Japan, 852-8511 Oita Prefectual Hospital Oita, Japan, 870-8511 National Cancer Center Hospital Tokyo, Japan, 104-0045 收起 << |
NCT02126553 | Leukemia | Phase 2 | Recruiting | November 2023 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 收起 << |
NCT02963610 | Relapsed or Refractory Solid T... 展开 >>umors Nonsmall Cell Lung Cancer 收起 << | Phase 1 Phase 2 | Terminated(Per recommendation ... 展开 >>of the PI) 收起 << | - | United States, Pennsylvania ... 展开 >> Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 收起 << |
NCT00910858 | - | Completed | - | - | |
NCT03302728 | Lymphoma, T-Cell, Cutaneous ... 展开 >> Lymphoma, T-Cell, Peripheral Hodgkin Lymphoma 收起 << | Phase 1 | Not yet recruiting | August 15, 2021 | Australia, Victoria ... 展开 >> Peter MacCallum Cancer Centre Not yet recruiting Melbourne, Victoria, Australia, 3000 Contact: Maria Farrell, Ms 收起 << |
NCT01611259 | - | Completed | - | - | |
NCT01724177 | - | Completed | - | - | |
NCT01750762 | Multiple Myeloma ... 展开 >> Lymphoma 收起 << | Phase 1 | Terminated | - | United States, Massachusetts ... 展开 >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 收起 << |
NCT01198054 | AML | Phase 4 | Terminated | - | Spain ... 展开 >> Hospital General de Alicante. Alicante, Spain Hospital Germans Trias I Pujol Badalona, Spain Hospital Clínico y Provincial de Barcelona Barcelona, Spain Hospital Juan Canalejo. La Coruña, Spain Hospital 12 de Octubre Madrid, Spain Hospital Clínico San Carlos de Madrid Madrid, Spain Hospital Ramón y Cajal. Madrid Madrid, Spain H. Carlos Haya Málaga, Spain Hospital Central de Asturias. Oviedo, Spain Hospital Clínico Universitario de Salamanca. Salamanca, Spain Hospital Universitario Virgen del Rocío. Sevilla, Spain Hospital La Fe de Valencia Valencia, Spain 收起 << |
NCT02018523 | Carcinoma, Non-Small-Cell Lung | Phase 1 | Terminated(Study did not enrol... 展开 >>l enough subjects to make a statistically sound conclusion.) 收起 << | - | United States, Texas ... 展开 >> Baylor College of Medicine Houston, Texas, United States, 77030 收起 << |
NCT02279654 | - | Recruiting | December 31, 2022 | - | |
NCT02302469 | Waldenstrom Macroglobulinemia | Phase 1 Phase 2 | Completed | - | France ... 展开 >> Centre Hospitalier de la côte basque Bayonne, France, 64109 Ch Clermond Ferrand Clermond Ferrand, France, 63000 CH LENS Lens, France, 62307 Chru Lille Lille, France, 59037 Ch Nantes Nantes, France, 44 093 Groupe hospitalier Pitié Salpétrière Paris, France, 75651 Centre Hospitalier Lyon Sud Pierre Benite, France, 69495 收起 << |
NCT02538965 | - | Active, not recruiting | - | - | |
NCT02538965 | Leukemia, Myeloid | Phase 2 | Active, not recruiting | July 13, 2022 | - |
NCT02370888 | Leukemia, Myeloid ... 展开 >> Myelodysplastic Syndromes 收起 << | Phase 1 | Active, not recruiting | May 2019 | United States, Florida ... 展开 >> University of Florida Shands Cancer Center Gainesville, Florida, United States, 32608 收起 << |
NCT03701711 | Demyelinating Sensorimotor Neu... 展开 >>ropathy 收起 << | Phase 1 | Recruiting | September 30, 2020 | United States, Ohio ... 展开 >> The Ohio State University Medical Center Recruiting Columbus, Ohio, United States, 43210 Contact: Carson Reider, PhD 614-293-9274 carson.reider@osumc.edu 收起 << |
NCT02371577 | Chronic Lymphocytic Leukemia (... 展开 >>CLL) 收起 << | Phase 2 | Withdrawn(withdrawn) | December 2020 | United States, California ... 展开 >> UC San Diego Moores Cancer Center La Jolla, California, United States, 92093 收起 << |
NCT03647124 | - | Not yet recruiting | December 31, 2026 | - | |
NCT02232516 | Adult Nasal Type Extranodal NK... 展开 >>/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Hepatosplenic T-cell Lymphoma Peripheral T-cell Lymphoma Stage I Cutaneous T-cell Non-Hodgkin Lymphoma Stage IA Mycosis Fungoides/Sezary Syndrome Stage IB Mycosis Fungoides/Sezary Syndrome Stage II Cutaneous T-cell Non-Hodgkin Lymphoma Stage IIA Mycosis Fungoides/Sezary Syndrome Stage IIB Mycosis Fungoides/Sezary Syndrome Stage III Cutaneous T-cell Non-Hodgkin Lymphoma Stage IIIA Mycosis Fungoides/Sezary Syndrome Stage IIIB Mycosis Fungoides/Sezary Syndrome Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma Stage IVA Mycosis Fungoides/Sezary Syndrome Stage IVB Mycosis Fungoides/Sezary Syndrome 收起 << | Phase 2 | Recruiting | August 2020 | United States, California ... 展开 >> City of Hope Recruiting Duarte, California, United States, 91010 Contact: Jasmine Zain, MD 626-256-4673 Principal Investigator: Jasmine Zain, MD United States, Connecticut Yale University Not yet recruiting New Haven, Connecticut, United States, 06520 Contact: Francine M. Foss, MD 203-200-4363 Principal Investigator: Francine M. Foss, MD United States, Illinois Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Adam M. Petrich, MD 312-695-4537 Principal Investigator: Adam M. Petrich, MD United States, New York Weill Cornell Medicine Recruiting New York, New York, United States, 10021 Contact: Jia Ruan, MD 646-962-2064 Principal Investigator: Jia Ruan, MD United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Not yet recruiting Seattle, Washington, United States, 98109 Contact: Andrei R. Shustov 206-288-6739 Principal Investigator: Andrei R. Shustov, MD 收起 << |
NCT02655458 | Multiple Myeloma | Phase 1 | Completed | - | United States, New York ... 展开 >> Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 收起 << |
NCT00348595 | Prostate Cancer | Phase 1 Phase 2 | Completed | - | United States, Maryland ... 展开 >> The Harry and Jeanette Weinberg Building Baltimore, Maryland, United States, 21230 收起 << |
NCT03409432 | Lymphomatoid Papulosis ... 展开 >> Primary Cutaneous Anaplastic Large Cell Lymphoma Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma Recurrent T-Cell Non-Hodgkin Lymphoma Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma Stage I Cutaneous T-Cell Non-Hodgkin Lymphoma Stage II Cutaneous T-Cell Non-Hodgkin Lymphoma Stage III Cutaneous T-Cell Non-Hodgkin Lymphoma Stage IV Cutaneous T-Cell Non-Hodgkin Lymphoma 收起 << | Phase 2 | Recruiting | April 30, 2020 | United States, Ohio ... 展开 >> Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Basem M. William, MD 614-688-7942 basem.william@osumc.edu Principal Investigator: Basem M. William, MD 收起 << |
NCT00738829 | Leukemia, Lymphocytic, Chronic... 展开 >>, B-Cell 收起 << | Phase 1 Phase 2 | Completed | - | Austria ... 展开 >> Medizinische Universitaet Innsbruck, Abtlg. f. Haematologie und Onkologie Innsbruck, Tirol, Austria, A-6020 Landeskrankenhaus Feldkirch Feldkirch, Austria, A-6806 Krankenhaus d. Barmherzigen Schwestern Linz Linz, Austria, A-4010 Krankenhaus der Elisabethinen Linz GmbH Linz, Austria, A-4010 Krankenhaus der Stadt Linz Linz, Austria, A-4020 Universitaetsklinik f. Innere Medizin III Salzburg, Austria, A-5020 Klinikum Wels-Grieskirchen GmbH Wels, Austria, A-4600 收起 << |
NCT00903630 | Fallopian Tube Cancer ... 展开 >> Ovarian Cancer Peritoneal Cavity Cancer 收起 << | Phase 1 Phase 2 | Terminated(lack of funding) | - | United States, Minnesota ... 展开 >> University of Minnesota Medical Center - Fairview Minneapolis, Minnesota, United States, 55455 收起 << |
NCT00064974 | Myelodysplastic Syndromes | Phase 2 | Completed | - | - |
NCT00831766 | Myelodysplastic Syndrome ... 展开 >> Acute Myeloid Leukemia 收起 << | Phase 1 Phase 2 | Active, not recruiting | February 2019 | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Ohio Cleveland Clinic - Taussig Cancer Institute Cleveland, Ohio, United States, 44195 收起 << |
NCT00903630 | - | Terminated(lack of funding) | - | - | |
NCT03333746 | Recurrent Plasma Cell Myeloma ... 展开 >> Refractory Plasma Cell Myeloma 收起 << | Phase 2 | Recruiting | December 31, 2020 | United States, Ohio ... 展开 >> Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Yvonne A. Efebera, MD 614-293-2268 yvonne.efebera@osumc.edu Contact: Misty Fleming 614-688-9498 misty.fleming@osumc.edu Principal Investigator: Yvonne A. Efebera, MD 收起 << |
NCT02005289 | Contiguous Stage II Small Lymp... 展开 >>hocytic Lymphoma Noncontiguous Stage II Small Lymphocytic Lymphoma Prolymphocytic Leukemia Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Stage I Chronic Lymphocytic Leukemia Stage I Small Lymphocytic Lymphoma Stage II Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia Stage III Small Lymphocytic Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Small Lymphocytic Lymphoma 收起 << | Phase 2 | Active, not recruiting | October 31, 2018 | United States, Ohio ... 展开 >> The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 收起 << |
NCT01939327 | Non-Hodgkin Lymphoma | Phase 2 | Recruiting | September 2020 | France ... 展开 >> Institut Paoli-Calmettes Recruiting Marseille, France, 13009 Contact: Vadim IVANOV, MD PhD Principal Investigator: Vadim IVANOV, MD 收起 << |
NCT01955499 | Recurrent Diffuse Large B-Cell... 展开 >> Lymphoma Recurrent Follicular Lymphoma Recurrent Lymphoplasmacytic Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Follicular Lymphoma Refractory Lymphoplasmacytic Lymphoma Refractory Mantle Cell Lymphoma 收起 << | Phase 1 | Active, not recruiting | - | United States, Illinois ... 展开 >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 United States, Ohio Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Canada, Ontario University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 收起 << |
NCT00831766 | - | Active, not recruiting | - | - | |
NCT00360672 | Acute Myelogenous Leukemia ... 展开 >> Myelodysplastic Syndrome 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00360672 | - | Completed | - | - | |
NCT02203643 | MULTIPLE MYELOMA (MM) | Phase 2 | Active, not recruiting | October 2020 | Italy ... 展开 >> IRCCS--CROB --CROB di Rionero in di Rionero in Vulture Rionero in Vulture, Italy, 85028 收起 << |
NCT00398515 | Refractory Multiple Myeloma ... 展开 >> Stage II Multiple Myeloma Stage III Multiple Myeloma 收起 << | Phase 1 | Completed | - | United States, Ohio ... 展开 >> Ohio State University Medical Center Columbus, Ohio, United States, 43210 收起 << |
NCT00227591 | Essential Thrombocythemia ... 展开 >> Polycythemia Vera Primary Myelofibrosis 收起 << | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 收起 << |
NCT03118466 | AML | Phase 2 | Recruiting | September 30, 2024 | United States, Massachusetts ... 展开 >> Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02062 Contact: Richard Stone, MD 617-632-2214 Richard_Stone@dfci.harvard.edu Principal Investigator: Richard Stone, MD Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Lourdes Mendez, MD 617-667-9920 Principal Investigator: Lourdes Mendez, MD Massachusetts general Hospital Recruiting Boston, Massachusetts, United States, 02215 Contact: Andrew Brunner, MD 617-724-1124 Andrew_Brunner@DFCI.HARVARD.EDU Principal Investigator: Andrew Brunner, MD 收起 << |
NCT00227591 | - | Completed | - | - | |
NCT02281279 | B-cell Adult Acute Lymphoblast... 展开 >>ic Leukemia Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Intraocular Lymphoma Nodal Marginal Zone B-cell Lymphoma Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Hairy Cell Leukemia Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Testicular Lymphoma Waldenström Macroglobulinemia 收起 << | Phase 1 Phase 2 | Withdrawn | - | - |
NCT01850524 | Multiple Myeloma | Phase 3 | Active, not recruiting | February 22, 2021 | - |
NCT02341014 | T-cell Lymphomas ... 展开 >> Relapsed or Refractory 收起 << | Phase 1 Phase 2 | Active, not recruiting | January 2019 | United States, Nebraska ... 展开 >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-7680 United States, New Jersey Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States, 07920 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Westchester Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States, 11570 收起 << |
NCT01145495 | Ann Arbor Stage II Grade 1 Con... 展开 >>tiguous Follicular Lymphoma Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma Ann Arbor Stage III Grade 1 Follicular Lymphoma Ann Arbor Stage III Grade 2 Follicular Lymphoma Ann Arbor Stage III Grade 3 Follicular Lymphoma Ann Arbor Stage IV Grade 1 Follicular Lymphoma Ann Arbor Stage IV Grade 2 Follicular Lymphoma Ann Arbor Stage IV Grade 3 Follicular Lymphoma 收起 << | Phase 2 | Completed | - | - |
NCT01145495 | - | Completed | - | - | |
NCT03729804 | Multiple Myeloma | Phase 3 | Not yet recruiting | December 24, 2023 | United States, Illinois ... 展开 >> University Of Chicago Medicine Comprehensive Cancer Center Not yet recruiting Chicago, Illinois, United States, 60637 Contact: Andrzej Jakubowiak, MD 773-834-1592 Principal Investigator: Andrzej Jakubowiak, MD 收起 << |
NCT01954784 | Refractory Multiple Myeloma ... 展开 >> Stage I Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma 收起 << | Phase 1 | Terminated(Funding unavailable... 展开 >>) 收起 << | - | United States, Ohio ... 展开 >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 收起 << |
NCT01076543 | AIDS-Related Hodgkin Lymphoma ... 展开 >> Recurrent Adult Hodgkin Lymphoma Recurrent Follicular Lymphoma Recurrent Lymphoplasmacytic Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Non-Hodgkin Lymphoma Recurrent T-Cell Non-Hodgkin Lymphoma Waldenstrom Macroglobulinemia 收起 << | Phase 1 Phase 2 | Active, not recruiting | - | United States, Illinois ... 展开 >> Northwestern University Chicago, Illinois, United States, 60611 University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 Decatur Memorial Hospital Decatur, Illinois, United States, 62526 Ingalls Memorial Hospital Harvey, Illinois, United States, 60426 Illinois CancerCare-Peoria Peoria, Illinois, United States, 61615 Central Illinois Hematology Oncology Center Springfield, Illinois, United States, 62702 Southern Illinois University School of Medicine Springfield, Illinois, United States, 62702 United States, Indiana Fort Wayne Medical Oncology and Hematology Inc-Parkview Fort Wayne, Indiana, United States, 46845 Indiana University/Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 United States, Maryland University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 United States, Missouri Mercy Hospital Saint Louis Saint Louis, Missouri, United States, 63141 收起 << |
NCT01166035 | Solid Tumors | Phase 1 Phase 2 | Unknown | December 2011 | Austria ... 展开 >> Medical University of Innsbruck, Department for Internal Medicine I Recruiting Innsbruck, Tyrol, Austria, 6020 Contact: Heinz Zwierzina, Prof. Dr. +43 (0)512 -504-81427 heinz.zwierzina@i-med.ac.at Sub-Investigator: Wolfgang Hilbe, M.D. Sub-Investigator: Wolfgang Eisterer, M.D. Sub-Investigator: Dominik Wolf, M.D. Sub-Investigator: Georg Sprinzl, M.D. Sub-Investigator: Siegfried Jank, M.D. Sub-Investigator: Matthias Zitt, M.D. Sub-Investigator: Judith Löffler-Ragg, M.D. Sub-Investigator: Gabriele Gamerith, M.D. Sub-Investigator: Thomas Auer, M.D. Sub-Investigator: Daniel Putzer, M.D. Sub-Investigator: Reto Bale, M.D. Sub-Investigator: Georg Pall, M.D. Sub-Investigator: Eva-Maria Gassner, M.D. Sub-Investigator: Volker Hans Schartinger, M.D. Sub-Investigator: Ulrich Strasser, M.D. Sub-Investigator: Jòzsef Dudàs, PhD 收起 << |
NCT01412307 | Recurrent Adult Hodgkin Lympho... 展开 >>ma 收起 << | Phase 1 Phase 2 | Unknown | July 2016 | Italy ... 展开 >> Hematology Oncology and Stem Cell Transplantation Unit , IRCCS Fondazione "G.Pascale" Naples, Italy, 80131 收起 << |
NCT01200004 | Advanced Cancers | Phase 1 | Terminated(Slow Accrual.) | - | United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT03011814 | Folliculotropic Mycosis Fungoi... 展开 >>des Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma Recurrent Mycosis Fungoides Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma Refractory Mycosis Fungoides Refractory Peripheral T-Cell Lymphoma, Not Otherwise Specified Sezary Syndrome Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma 收起 << | Phase 1 Phase 2 | Recruiting | September 2019 | United States, California ... 展开 >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Christiane Querfeld, MD 626-256-4673 cquerfeld@coh.org Principal Investigator: Christiane Querfeld, MD United States, New York Memorial Sloan-Kettering Cancer Center Not yet recruiting New York, New York, United States, 10065 Contact: Steven M. Horwitz, MD 212-639-3045 horwitzs@mskcc.org Principal Investigator: Steven M. Horwitz, MD United States, Pennsylvania Thomas Jefferson University Hospital Not yet recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Pierluigi Porcu, MD 215-955-8874 Pierluigi.Porcu@jefferson.edu Principal Investigator: Pierluigi Porcu, MD United States, Texas M D Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Michelle A. Fanale, MD 713-792-2860 mfanale@mdanderson.org Principal Investigator: Michelle A. Fanale, MD 收起 << |
NCT00729638 | Multiple Myeloma | Phase 1 | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226` 收起 << |
NCT00957385 | Acute Myeloid Leukemia | Phase 2 | Completed | - | Canada, Ontario ... 展开 >> University Health Network, Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 收起 << |
NCT00142168 | Waldenstrom's Macroglobulinemi... 展开 >>a 收起 << | Phase 2 | Terminated(Toxicity) | - | United States, Massachusetts ... 展开 >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 收起 << |
NCT00691704 | Multiple Myeloma | Phase 2 | Completed | - | United States, North Carolina ... 展开 >> Duke University Medical Center Durham, North Carolina, United States, 27710 收起 << |
NCT01686386 | Multiple Myeloma | Phase 1 Phase 2 | Unknown | October 2013 | Italy ... 展开 >> U. O. C. Ematologia - Azienda Ospedaliera Cosenza Recruiting Cosenza, Italy, 87100 Contact: Fortunato Morabito, MD +390984681329 fortunato_morabito@tin.it 收起 << |
NCT00474188 | - | Terminated(Business decision) | - | - | |
NCT00474188 | Diffuse Large B-cell Lymphoma | Phase 2 | Terminated(Business decision) | - | - |
NCT00142168 | - | Terminated(Toxicity) | - | - | |
NCT00691704 | - | Completed | - | - | |
NCT00091260 | Multiple Myeloma | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Cancer Research Center at Boston Medical Center Boston, Massachusetts, United States, 02118 收起 << |
NCT01545804 | Liver Cancer | Phase 2 | Completed | - | Taiwan ... 展开 >> National Taiwan University Hospital Taipei, Taiwan, 100 收起 << |
NCT01754870 | Chronic Lymphocytic Leukemia (... 展开 >>CLL) Small Lymphocytic Lymphoma (SLL) 收起 << | Phase 2 | Withdrawn(slow accrual) | - | United States, Wisconsin ... 展开 >> University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States, 53792 收起 << |
NCT01271283 | Chronic Lymphocytic Leukemia ... 展开 >> Stage III Chronic Lymphocytic Leukemia Stage IV Chronic Lymphocytic Leukemia 收起 << | Phase 2 | Withdrawn | - | United States, New York ... 展开 >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 收起 << |
NCT01476787 | Follicular Lymphoma | Phase 3 | Active, not recruiting | June 1, 2024 | - |
NCT02633137 | Mantle Cell Lymphoma ... 展开 >> Untreated 收起 << | Phase 2 | Active, not recruiting | December 2019 | United States, New Jersey ... 展开 >> Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States, 07920 Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States, 07748 Memorial Sloan Kettering Bergen Montvale, New Jersey, United States, 07645 United States, New York Memorial Sloan Kettering Commack Commack, New York, United States, 11725 Memorial Sloan Kettering Westchester Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering Rockville Centre Rockville Centre, New York, United States, 11570 收起 << |
NCT01711554 | Recurrent Neuroblastoma ... 展开 >> Refractory Neuroblastoma 收起 << | Phase 1 | Suspended(Scheduled interim mo... 展开 >>nitoring) 收起 << | - | United States, California ... 展开 >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States, 94304 UCSF Medical Center-Parnassus San Francisco, California, United States, 94143 United States, Colorado Children's Hospital Colorado Aurora, Colorado, United States, 80045 United States, Georgia Children's Healthcare of Atlanta - Egleston Atlanta, Georgia, United States, 30322 United States, Illinois University of Chicago Comer Children's Hospital Chicago, Illinois, United States, 60637 United States, Massachusetts Boston Children's Hospital Boston, Massachusetts, United States, 02115 United States, Michigan C S Mott Children's Hospital Ann Arbor, Michigan, United States, 48109 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 United States, Pennsylvania Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Texas Cook Children's Medical Center Fort Worth, Texas, United States, 76104 United States, Washington Seattle Children's Hospital Seattle, Washington, United States, 98105 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 收起 << |
NCT01891643 | Newly Diagnosed, Previously Un... 展开 >>treated Multiple Myeloma 收起 << | Phase 3 | Active, not recruiting | July 31, 2020 | United States, California ... 展开 >> Pacific Hematology Oncology Associates San Francisco, California, United States, 94115 United States, Florida Memorial Cancer Institute Hollywood, Florida, United States, 33021 United States, Illinois Illinois Cancercare, Pc Peoria, Illinois, United States, 61615 United States, Indiana Franciscan St. Francis Health Indianapolis, Indiana, United States, 46237 United States, Louisiana Crescent City Research Consortium, LLC Marrero, Louisiana, United States, 70072 United States, Ohio Ohio State University Medical Center Columbus, Ohio, United States, 43210 United States, South Carolina Medical University Of South Carolina Hollings Cancer Center Charleston, South Carolina, United States, 29425 United States, Tennessee Baptist Cancer Center Memphis, Tennessee, United States, 38120 United States, Utah Northern Utah Associates Ogden, Utah, United States, 84405 Greece Local Institution Athens, Greece, 11528 Italy Local Institution Genova, Italy, 16132 Local Institution Rome, Italy, 00161 Poland Local Institution Chorzow, Poland, 41-500 Local Institution Lublin, Poland, 20-081 收起 << |
NCT00091260 | - | Completed | - | - | |
NCT02215980 | Multiple Myeloma | Phase 3 | Active, not recruiting | July 2022 | Italy ... 展开 >> FO.NE.SA.Onlus Torino, Italy, 10126 收起 << |
NCT01348503 | Hepatocellular Carcinoma | Phase 1 | Terminated(Treatment was ineff... 展开 >>ective) 收起 << | - | United States, Indiana ... 展开 >> Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 收起 << |
NCT00179699 | Non-Small Cell Lung Cancer | Phase 1 | Terminated | - | United States, Florida ... 展开 >> MD Anderson - Orlando Orlando, Florida, United States, 32806 United States, Iowa University of Iowa Iowa City, Iowa, United States, 52242 United States, Kentucky Norton Healthcare Louisville, Kentucky, United States, 40202 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 United States, New York North Shore Hem/Onc Associates East Setauket, New York, United States, 11733-3456 收起 << |
NCT00843882 | Anemia Chroni... 展开 >>c Myelomonocytic Leukemia de Novo Myelodysplastic Syndrome Myelodysplastic Syndrome Previously Treated Myelodysplastic Syndrome 收起 << | Phase 3 | Active, not recruiting | - | - |
NCT03652064 | Multiple Myeloma | Phase 3 | Not yet recruiting | April 30, 2025 | - |
NCT02441686 | Multiple Myeloma | Phase 2 | Active, not recruiting | August 2022 | United States, Colorado ... 展开 >> Colorado Blood Cancer Institute Denver, Colorado, United States, 80218 United States, Maine Eastern Maine Medical Center Brewer, Maine, United States, 04412 United States, Massachusetts Massachusetts General Hosptial Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Minnesota Virginia Piper Cancer Institute Coon Rapids, Minnesota, United States, 55433 Virgina Piper Cancer Institute Minneapolis, Minnesota, United States, 55407 United States, New Jersey Hematology Oncology of Northern New Jersey Morristown, New Jersey, United States, 07962 收起 << |
NCT02309515 | Monoclonal B-Cell Lymphocytosi... 展开 >>s Stage 0 Chronic Lymphocytic Leukemia Stage I Chronic Lymphocytic Leukemia Stage I Small Lymphocytic Lymphoma 收起 << | Phase 2 | Active, not recruiting | July 10, 2020 | United States, Arizona ... 展开 >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT02389517 | Plasma Cell Myeloma ... 展开 >> Residual Disease 收起 << | Phase 2 | Recruiting | March 2, 2022 | United States, Illinois ... 展开 >> University of Chicago Recruiting Chicago, Illinois, United States, 60637 Contact: Andrzej J. Jakubowiak 773-834-1592 ajakubowiak@medicine.bsd.uchicago.edu Principal Investigator: Andrzej J. Jakubowiak 收起 << |
NCT01731886 | Multiple Myeloma | Phase 4 | Completed | - | United States, New York ... 展开 >> Columbia University New York, New York, United States, 10032 收起 << |
NCT00179725 | Ovarian Cancer | Phase 1 Phase 2 | Terminated | - | United States, California ... 展开 >> University of California at San Francisco San Francisco, California, United States, 94115 United States, Florida MD Anderson Cancer Center Orlando Orlando, Florida, United States, 32806 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Oklahoma OU Health Sciences Center Oklahoma City, Oklahoma, United States, 73104 United States, Washington Swedish Cancer Institute Seattle, Washington, United States, 98104 收起 << |
NCT01127386 | Cancer Cachexia Syndrome | Phase 1 Phase 2 | Completed | - | Switzerland ... 展开 >> Kantonsspital St.Gallen St.Gallen, Switzerland, 9000 收起 << |
NCT01348919 | Multiple Myeloma | Phase 1 Phase 2 | Terminated | - | United States, Georgia ... 展开 >> Teva Investigational Site 1 Augusta, Georgia, United States United States, Kentucky Teva Investigational Site 3 Lexington, Kentucky, United States United States, Texas Teva Investigational Site 2 Houston, Texas, United States New Zealand Teva Investigational Site 201 Auckland, New Zealand Teva Investigational Site 204 Auckland, New Zealand Teva Investigational Site 200 Christchurch, New Zealand Teva Investigational Site 206 Hamilton, New Zealand Teva Investigational Site 205 Newtown, New Zealand Teva Investigational Site 202 Palmerston North, New Zealand Teva Investigational Site 203 Takapuna, New Zealand 收起 << |
NCT02389543 | Multiple Myeloma | Phase 1 Phase 2 | Withdrawn(Terminated this tria... 展开 >>l and added a Lenalidomide arm to KCP-330-017) 收起 << | February 2018 | - |
NCT03150316 | Myeloma, Multiple | Phase 1 | Recruiting | November 19, 2019 | Korea, Republic of ... 展开 >> Samsung Hospital Recruiting Soul, Gangnam-gu, Korea, Republic of, 06351 Contact: Ki Hyun Kim, PI +82-2-3410-3456 kihyunkimk@gmail.com the catholic university of korea, Seoul ST. Mary's Hospital Enrolling by invitation Seoul, Seocho, Korea, Republic of, 06591 收起 << |
NCT02253316 | Multiple Myeloma | Phase 2 | Recruiting | January 31, 2023 | United States, California ... 展开 >> City of Hope Recruiting Duarte, California, United States, 91010 Contact: Nitya Nathwani, MD 626-256-4673 ext 65295 nnathwani@coh.org Principal Investigator: Nitya Nathwani, MD Sub-Investigator: Ahmed Aribi, MD Sub-Investigator: Ibrahim Aldoss, MD Sub-Investigator: Monzr Al-Malki, MD Sub-Investigator: Elizabeth Budde, MD Sub-Investigator: Ji-Lian Cai, MD Sub-Investigator: Thai Cao, MD Sub-Investigator: Robert Chen, MD Sub-Investigator: Leonardo Farol, MD Sub-Investigator: Stephen Forman, MD Sub-Investigator: Alex Herrera, MD Sub-Investigator: Myo Htut, MD Sub-Investigator: Chatchada Karanes, MD Sub-Investigator: Khaled Samer, MD Sub-Investigator: Amrita Krishnan, MD Sub-Investigator: Matthew Mei, MD Sub-Investigator: Auayporn Nademanee, MD Sub-Investigator: Ryotaro Nakamura, MD Sub-Investigator: Margaret O'Donnell, MD Sub-Investigator: Pablo Parker, MD Sub-Investigator: Leslie Popplewell, MD Sub-Investigator: Michael Rosenzweig, MD Sub-Investigator: Firoozeh Sahebi, MD Sub-Investigator: Amandeep Salhotra, MD Sub-Investigator: Tanya Siddiqi, MD Sub-Investigator: David Snyeder, MD Sub-Investigator: George Somlo, MD Sub-Investigator: Ricardo Spielberger, MD Sub-Investigator: Anthony Stein, MD Sub-Investigator: Jasmine Zain, MD University of California, San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Thomas G. Martin, MD 415-353-2051 tom.martin@ucsf.edu Principal Investigator: Thomas G. Martin, MD United States, Colorado Colorado Blood Cancer Institute Recruiting Denver, Colorado, United States, 80218 Contact: Tara K Gregory, M.D. 720-754-4800 Tara.Gregory@HealthONECares.com Principal Investigator: Tara K Gregory, M.D. Sub-Investigator: Alireza B Maris, M.D. Sub-Investigator: Jeffrey V Matous, M.D. Sub-Investigator: Peter A McSweeney, M.D. Sub-Investigator: Richard Nash, M.D. Sub-Investigator: Marcello Rotta, M.D. Sub-Investigator: Michael T Tees, M.D. United States, Georgia Emory University - Winship Cancer Institute Recruiting Atlanta, Georgia, United States, 30322 Contact: Jonathan L Kaufman, MD 404-778-1900 jlkaufm@emory.edu United States, Michigan Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 Contact: Jeffrey A Zonder, MD 313-576-8732 zonderj@karmanos.org Principal Investigator: Jeffrey A. Zonder, M.D. Sub-Investigator: Abhinav Deol, MD Sub-Investigator: Radhakrishnan Ramchandren, MD Sub-Investigator: Melissa Runge-Morris, MD Sub-Investigator: Charles Schiffer, MD Sub-Investigator: Jay Yang, MD Sub-Investigator: Steven Burt, MD United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Francis K Buadi, M.D. (507) 538-3270 Buadi.Francis@mayo.edu Principal Investigator: Francis K Buadi, M.D. Sub-Investigator: Angela Dispenzieri, M.D. Sub-Investigator: Matthew T Drake, M.D., Ph.D. Sub-Investigator: Amie L Fonder, PA-C Sub-Investigator: Morie Gertz, M.D. Sub-Investigator: Ronald S Go, M.D. Sub-Investigator: Wilson I Gonsalves, M.D. Sub-Investigator: Suzanne R Hayman, M.D. Sub-Investigator: Miriam A Hobbs, APRN, CNP, DNP Sub-Investigator: Yi (Lisa) L Hwa, APRN, CNP, DNP Sub-Investigator: Prashant Kapoor, M.D. Sub-Investigator: Taxiarchis Kourelis, M.D. Sub-Investigator: Shaji K Kumar, M.D. Sub-Investigator: Nelson Leung, M.D. Sub-Investigator: Yi Lin, M.D., Ph.D. Sub-Investigator: John A Lust, M.D., Ph.D. Sub-Investigator: S. Vincent Rajkumar, M.D. Sub-Investigator: Stephen J Russell, M.D., Ph.D. Sub-Investigator: Thomas E Witzig, M.D. Sub-Investigator: Steven R Zeldenrust, M.D, Ph.D. United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 62864 Contact: Ravi Vij, M.D. 314-454-8323 rvij@wustl.edu Principal Investigator: Ravi Vij, M.D. Sub-Investigator: Camille Abboud, M.D. Sub-Investigator: John DiPersio, M.D., Ph.D. Sub-Investigator: Todd Fehniger, M.D., Ph.D. Sub-Investigator: Armin Ghobadi, M.D. Sub-Investigator: Megan Jacoby, M.D., Ph.D. Sub-Investigator: Jesse Keller, M.D. Sub-Investigator: Iskra Pusic, M.D. Sub-Investigator: Rizwan Romee, M.D. Sub-Investigator: Mark Schreoder, M.D. Sub-Investigator: Keith Stockerl-Goldstein, M.D. Sub-Investigator: Michael Tomasson, M.D. Sub-Investigator: Geoffrey Uy, M.D. Sub-Investigator: Matthew Walter, M.D. Sub-Investigator: Lukas Wartman, M.D. Sub-Investigator: John Welch, M.D., Ph.D. Sub-Investigator: Peter Westervelt, M.D., Ph.D. United States, New York Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029 Contact: Ajai Chari, M.D. 212-241-7873 ajai.chari@mountsinai.org Principal Investigator: Ajai Chari, M.D. Sub-Investigator: Sundar Jagannath, M.D. Sub-Investigator: Hearn Cho, M.D. Sub-Investigator: Samir Parekh, M.D. Sub-Investigator: Deepu Madduri, M.D. United States, Ohio Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Ashley Rosko, M.D. 614-293-7807 Ashley.Rosko@osumc.edu Principal Investigator: Ashley Rosko, M.D. Sub-Investigator: Don Benson, Jr., M.D., Ph.D. Sub-Investigator: Jonathan Brammer, M.D. United States, Tennessee Tennessee Oncology, PLLC Recruiting Nashville, Tennessee, United States, 37203 Contact: Jesus Berdeja, M.D. 615-329-7274 jberdeja@tnonc.com Principal Investigator: Jesus Berdeja, M.D. 收起 << |
NCT01794039 | - | Completed | - | - | |
NCT00179738 | Prostate Cancer | Phase 2 | Terminated | - | United States, California ... 展开 >> Alta Bates Cancer Center Berkeley, California, United States, 94704 United States, Florida Moffit Cancer Center Tampa, Florida, United States, 33612 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New Jersey Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109 收起 << |
NCT02206503 | Multiple Myeloma | Phase 2 | Completed | - | Italy ... 展开 >> Policlinico Umberto I Rome, Italy, 00161 收起 << |
NCT01881789 | Multiple Myeloma | Phase 1 Phase 2 | Active, not recruiting | February 28, 2019 | United States, Alabama ... 展开 >> Clearview Cancer Institute Huntsville, Alabama, United States United States, California Providence St. Joseph's Hospital Burbank, California, United States David Geffen School of Medicine at UCLA Los Angeles, California, United States Monterey Bay Oncology Corp DBA Pacific Cancer Care Salinas, California, United States United States, Colorado Colorado Blood Cancer Institute Denver, Colorado, United States United States, Florida H. Lee Moffit Cancer Center & Research Institute Tampa, Florida, United States United States, Illinois University of Chicago Medical Center Chicago, Illinois, United States United States, Indiana Indiana University Health Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States United States, Maryland Center for Cancer & Blood Disorders Bethesda, Maryland, United States United States, North Carolina The University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States United States, Ohio Cleveland Clinic Cleveland, Ohio, United States United States, Texas University of Texas M.D. Anderson Cancer Center Houston, Texas, United States United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States United States, Wisconsin Froedtert Hospital and the Medical College of Wisconsin Milwaukee, Wisconsin, United States 收起 << |
NCT00727415 | Chronic Lymphocytic Leukemia | Phase 1 Phase 2 | Completed | - | Italy ... 展开 >> Unità Operativa Ematologia 1 - Università degli Studi di Bari Bari, Italy, 70010 Istituto di Ematologia e Oncologia Medica "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi Bologna, Italy Azienda Ospedaliera Pugliese Ciaccio Catanzaro, Italy, 88100 Sez.Ematologia e Dip. scienze Biomediche Arcispedale S. Anna Ferrara, Italy, 44100 Clinica Ematologica - Università degli Studi Genova, Italy Divisione di Ematologia Ospedale "Santa Maria Goretti" Latina, Italy Istituto Scientifico Romagnoli per lo Studio e la Cura dei Tumori- IRST Meldola, Italy Divisione di Ematologia - Azienda Ospedaliera Ospedali Riuniti "Papardo Piemonte" Messina, Italy UO Centro Trapianti di Midollo - IRCCS Ospedale Maggiore Policlinico Milano, Italy (SA) U.O. di Oncoematologia di Nocera Inferiore-plesso ospedaliero "A. Tortora" di Pagani del DEA Nocera-Pagani Nocera Inferiore, Italy Università degli Studi di Padova - Ematologia ed Immunologia Clinica Padova, Italy U.O. Ematologia Clinica - Azienda USL di Pescara Pescara, Italy Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale di Piacenza Piacenza, Italy Ospedale S. M. delle Croci Ravenna, Italy, I-48100 Azienda Ospedaliera Bianchi Melacrino Morelli Reggio Calabria, Italy, 89100 Ospedale "Infermi" Rimini, Italy Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia Roma, Italy Universita Degli Studi "La Sapeinza" Rome, Italy, 00161 Policlinico A. Gemelli - Universita Cattolica del Sacro Cuore Rome, Italy, 00168 U.O.C. Ematologia - Ospedale S.Eugenio Rome, Italy U.O. Ematologia, Azienda Ospedaliera Universitaria Senese Siena, Italy, 53100 SS.C. di Oncoematologia - Dipartimento di Medicina Clinica e Sperimentale - Azienda Ospedaliera - S. Maria Di Terni Terni, Italy Clinica Ematologica - Policlinico Universitario Udine, Italy 收起 << |
NCT01919086 | Multiple Myeloma (MM) | Phase 2 | Active, not recruiting | August 2019 | United States, Connecticut ... 展开 >> Hartford Healthcare Cancer Institute @ Hartford Hospital Hartford, Connecticut, United States, 06102 United States, New Jersey Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States, 07748 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering Westchester Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States 收起 << |
NCT01402284 | Multiple Myeloma | Phase 2 | Active, not recruiting | September 1, 2026 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT01446133 | Leukemia Lymp... 展开 >>homa 收起 << | Phase 2 | Active, not recruiting | December 2020 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01123356 | Chronic Lymphocytic Leukemia | Phase 2 | Completed | - | United States, South Carolina ... 展开 >> Medical University of South Carolina Charleston, South Carolina, United States, 29425 Greenville Hospital System Greenville, South Carolina, United States, 29605 收起 << |
NCT00153933 | Refractory Multiple Myeloma ... 展开 >> Relapsed Multiple Myeloma Multiple Myeloma 收起 << | Phase 1 | Completed | - | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Georgia Winship Cancer Center Atlanta, Georgia, United States, 30322 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Center Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, New York St. Vincent's Comprehensive Cancer Center New York City, New York, United States, 10011 收起 << |
NCT00890552 | - | Completed | - | - | |
NCT01794039 | Recurrent Plasma Cell Myeloma ... 展开 >> Refractory Plasma Cell Myeloma 收起 << | Phase 2 | Completed | - | United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT00968331 | Diffuse Large B-cell Lymphoma | Phase 2 | Terminated(The EC withdrawn th... 展开 >>e approval becuase of possible conflicts of interests between our Institute and Supporter (Celgene)) 收起 << | - | Italy ... 展开 >> Institute Of Hematology "Seràgnoli" Bologna, Italy, 40138 收起 << |
NCT01402284 | - | Active, not recruiting | - | - | |
NCT01123356 | - | Completed | - | - | |
NCT01132989 | Cutaneous T Cell Lymphoma | Phase 2 | Unknown | December 2010 | United States, Florida ... 展开 >> Florida Academic Dermatology Center Recruiting Miami, Florida, United States, 33136 Contact: Annika M Grant, RN,MBA 305-324-2110 ext 210 annika@fadcenter.com Principal Investigator: Francisco A Kerdel, M.D. 收起 << |
NCT01347944 | - | Completed | - | Italy ... 展开 >> Dipartimento Onco - Ematologico Azienda Ospedaliera SS Antonio, Biagio e Cesare Arrigo Alessandria, Italy, 15121 Unità Operativa Clinica di Ematologia Azianda Ospedaliero Universitaria Ospedali Riuniti di Ancona Ancona, Italy, 60100 Dipartimento di Oncologia Medica Ospedale Cardinale G. Massaia Asti, Italy, 14100 Ematologia Azienda Ospedaliera Universitaria Policlinico di Bari Bari, Italy, 70124 Dipartimento di Ematologia Ospedale dell'U.L.S.S. n.1 Belluno Belluno, Italy, 32100 Ematologia A.O. Ospedale Riuniti di Bergamo Bergamo, Italy, 24128 Dip. Medicina Interna Ospedale degli Infermi di Biella Biella, Italy, 13900 Dipartimento di Ematologia Spedale Civili di Brescia Brescia, Italy, 25123 Dipartimento Trapianto di Midollo Allogenico Spedale Civili di Brescia Brescia, Italy, 25123 Dipartimento di Ematologia Ospedale R. Binaghi Cagliari, Italy, 09126 Dip. Di Oncoematologia A.O. S.Anna e S. Sebastiano Caserta, Italy, 81100 Dip. Di Ematologia A.O. Istituti Ospedalieri Cremona, Italy, 26100 Dip. Di Ematologia Az. Ospedaliero-Universitaria Careggi Firenze, Italy, 50139 Dip. Di Ematologia A.O. Universitaria S. Martino Genova, Italy, 10-1632 Dip. Di Medicina Interna A.O. Universitaria S. Martino Genova, Italy, 10-1632 Struttura di Ematologia, Dip. di Oncoematologia IRCCS Casa Sollievo della Sofferenza Giovanni Rotondo, Italy, 71013 Dip. Di Ematologia Azienda Ospedaliera V. Fazzi Lecce, Italy, 73100 Centro Trapianti di Midollo Ospedale Maggiore Policlinico Milano, Italy, 20122 Dip. Di Ematologia Policlinico, Az. Ospedaliero- Universitaria Modena, Italy, 41124 Dip. Di Ematologia Azienda Ospedaliera S. Gerardo Monza, Italy, 20052 Dip. Di Oncoematologia A.O. Universitaria Federico II Napoli, Italy, 80131 Dip. Di Ematologia Presidio Ospedaliero Umberto I Nocera Inferiore, Italy, 84014 Dip. Di Ematologia Ospedale S. Francesco Nuoro, Italy, 08100 Dip. Di Ematologia Azienda Ospedaliera Padova, Italy, 35127 Dip. di Ematologia Azienda Ospedaliera Parma, Italy, 43100 Dip. Di Ematologia Azienda Ospedaliera - Osp. S. Maria della Misericordia Perugia, Italy, 06156 Dip. Di Ematologia Azienda Ospedaliera s. Salvatore Pesaro, Italy, 61100 Dip. Di Ematologia Az. Ospedaliera Regionale S. Carlo Potenza, Italy, 85100 Servizio di Ematologia - Dip. di Oncologia Az. Ospedaliera di Reggio Emilia - Arcispedale S. Maria Nuova Reggio Emilia, Italy, 42100 Dip. Di Ematologia Ospedale S. Maria delle Croci Revenna, Italy, 48100 U. O. Ematologia Az. Ospedaliero-Universitaria Policlinico Tor Vergata Roma, Italy, 00133 U.O.C Ematologia Ospedale S. Eugenio, Piazzale dell'Umanesimo Roma, Italy, 00144 Dip. di Ematologia Policlinico Umberto I Roma, Italy, 00161 U.O.C. Ematologia Policlinico Universitario Gemelli Roma, Italy, 00168 Dip. di Oncoematologia Ospedale Civile Giannettasio Rossano, Italy, 87068 Dip. di Oncoematologia Az. ULSS 18 Rovigo, Italy, 45100 Dip. di Ematologia Policlinico Universitario di Sassari Sassari, Italy, 07100 Divisione di Ematologia e Trapianti Spedali Riuniti Sienna, Italy, 53100 Dip. di Ematologia 1 A.O. Universitaria S.Giovanni Battista Torino, Italy, 10126 Dip. di Ematologia 2 A.O. Universitaria S.Giovanni Battista Torino, Italy, 10126 Dip. di Ematologia e Terapie Cellulari Ospedale Mauriziano Umberto I Torino, Italy, 10128 Unità Operativa Trasfusionale ed Immunologia Centro di riferimento per le malattie rare e centro regionale per le malattie del sangue Ospedale S. Giacomo Apostolo Treviso, Italy, 31033 Ospedale Dell'Angelo USL12 - Venezia (Mestre) Venezia, Italy, 30174 Dip. Funzionale di Terapie Cellulari e Ematologia Azienda Sanitaria ULSS 6 - Osp. di Vicenza Vicenza, Italy, 36100 Dip. Di Ematologia Ospedale di Belcolle Viterbo, Italy, 01100 收起 << | |
NCT00890552 | Leukemia Amyl... 展开 >>oidosis 收起 << | Not Applicable | Completed | - | United States, California ... 展开 >> Stanford University Cancer Institute Stanford, California, United States, 94305 收起 << |
NCT03373305 | CD30-Positive Neoplastic Cells... 展开 >> Present Folliculotropic Mycosis Fungoides Recurrent Mycosis Fungoides Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma Refractory Mycosis Fungoides Refractory Primary Cutaneous T-Cell Non-Hodgkin Lymphoma Sezary Syndrome 收起 << | Phase 1 | Not yet recruiting | December 2020 | United States, California ... 展开 >> City of Hope Medical Center Not yet recruiting Duarte, California, United States, 91010 Contact: Jasmine Zain, MD Principal Investigator: Jasmine Zain, MD 收起 << |
NCT01675141 | Multiple Myeloma | Phase 2 | Terminated(Original investigat... 展开 >>or left the NIH and the primary outcome was not reached) 收起 << | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT01675141 | - | Terminated(Original investigat... 展开 >>or left the NIH and the primary outcome was not reached) 收起 << | - | - | |
NCT01222754 | Diffuse Intrinsic Pontine Glio... 展开 >>ma Anaplastic Astrocytoma High Grade Glioma 收起 << | Phase 1 | Active, not recruiting | April 30, 2021 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT00096044 | - | Completed | - | - | |
NCT00096044 | Leukemia | Phase 2 | Completed | - | United States, New York ... 展开 >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 收起 << |
NCT01116154 | Adult Nasal Type Extranodal NK... 展开 >>/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Cutaneous B-cell Non-Hodgkin Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Nodal Marginal Zone B-cell Lymphoma Peripheral T-Cell Lymphoma Post-transplant Lymphoproliferative Disorder Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Testicular Lymphoma Waldenstrom Macroglobulinemia 收起 << | Phase 1 | Terminated(Sponsor withdrew su... 展开 >>pport for the study) 收起 << | - | United States, California ... 展开 >> City of Hope Duarte, California, United States, 91010 收起 << |
NCT01002755 | Chronic Lymphocytic Leukemia ... 展开 >> Fatigue Fever Hypogammaglobulinemia Lymphadenopathy Lymphocytosis Night Sweats Paraproteinemia Small Lymphocytic Lymphoma Thrombocytopenia 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> M D Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT03031483 | Mucosa Associated Lymphoid Tis... 展开 >>sue (MALT) Lymphoma 收起 << | Phase 2 | Recruiting | February 2029 | Austria ... 展开 >> Medical University of Vienna Not yet recruiting Vienna, Austria Contact: Markus Raderer, MD Italy A.O. Spedali Civili di Brescia Recruiting Brescia, Italy, 25123 Contact: Giuseppe Rossi, MD IRCCS Ospedale San Raffaele Recruiting Milan, Italy, 20132 Contact: Andrés Ferreri, MD Fondazione IRCCS - Istituto Nazionale dei Tumori Recruiting Milan, Italy, 20133 Contact: Liliana Devizzi, MD Fondazione IRCCS - Policlinico San Matteo Not yet recruiting Pavia, Italy, 27100 Contact: Luca Arcanini, MD Università degli Studi di Roma La Sapienza Not yet recruiting Rome, Italy, 00185 Contact: Alessandro Pulsoni, MD Ospedale di Circolo e Fondazione Macchi di Varese Recruiting Varese, Italy, 21100 Contact: Michele Merli, MD AOUI Verona - Ospedale Borgo Roma Not yet recruiting Verona, Italy, 37134 Contact: Achille Ambrosetti, Prof Azienda Sanitaria ULSS 6 - Ospedale S.Bortolo Not yet recruiting Vicenza, Italy, 36100 Contact: Carlo Visco, MD Spain Instituto de Enfermedades Hematológicas y Oncológicas Not yet recruiting Barcelona, Barcellona, Spain, 08036 Contact: Armando Lopez Guillermo, MD Institut Català D'Oncologia Hospital Duran I Reynals Not yet recruiting Hospitalet de Llobregat, Barcelona, Spain, 08908 Contact: Eva Domingo Domenench, MD Hospital del Mar Not yet recruiting Barcelona, Spain, 08003 Contact: Antonio Salar, MD MD Anderson Cancer Center Not yet recruiting Madrid, Spain, 28033 Contact: Carlos Montalban, MD Hospital Universitario Not yet recruiting Salamanca, Spain, 37007 Contact: Norma Gutierrez, MD 收起 << |
NCT02252172 | Multiple Myeloma | Phase 3 | Active, not recruiting | November 22, 2022 | - |
NCT01054144 | Multiple Myeloma | Phase 2 | Active, not recruiting | April 2020 | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 收起 << |
NCT01772420 | Adult Myelodysplastic Syndrome... 展开 >> Anemia Chronic Myelomonocytic Leukemia 收起 << | Phase 2 | Unknown | - | United States, Kansas ... 展开 >> University of Kansas Cancer Center Recruiting Kansas City, Kansas, United States, 66160 Contact: Suman Kambhampati 913-588-6029 skambhampati@kumc.edu Principal Investigator: Suman Kambhampati United States, New York Albert Einstein College of Medicine Recruiting Bronx, New York, United States, 10461 Contact: Amit K. Verma 718-430-8761 amit.verma@einstein.yu.edu Principal Investigator: Amit K. Verma 收起 << |
NCT01038388 | Multiple Myeloma | Phase 1 | Active, not recruiting | January 2019 | United States, Georgia ... 展开 >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 收起 << |
NCT01737177 | Mantle Cell Lymphoma | Phase 2 | Completed | - | Italy ... 展开 >> UOC Ematologia Trani Trani, Barletta-Andria-Trani (BT), Italy, 76125 Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRST Meldola Meldola, Forlì Cesena, Italy, 47014 Ematologia Istituto Clinico Humanitas Rozzano, Milano, Italy, 20089 Centro di riferimento Oncologico CRO Aviano Aviano, Pordenone, Italy, 33081 IRCCS‐Centro di Riferimento Oncologico UO di Ematologia e Trapianto Cellule Staminali Rionero in Vulture, Potenza, Italy, 85028 Medicina Interna 2 ad indirizzo Ematologico AOU San Luigi Gonzaga Orbassano, Torino, Italy, 10043 SC Ematologia AO SS. Antonio e Biagio e C. Arrigo Alessandria, Italy, 15121 Clinica di Ematologia AOU Umberto I Ospedali Riuniti Ancona, Italy, 60100 SC Ematologia Spedali Civili Brescia, Italy, 25123 Ematologia Ospedale Cardarelli ASREM Campobasso, Italy, 86100 Oncoematologia Ospedale SS. Anna e Sebastiano Caserta, Italy, 81100 UOC Ematologia Osp. Garibaldi Nesima Catania, Italy, 95100 Azienda Ospedaliera Pugliese Ciaccio Dipartimento oncoematologico Catanzaro, Italy, 88100 Clinica Ematologica AOU San Martino Genova, Italy, 16132 Ematologia AOU S. Martino - IST Genova, Italy, 16132 UOC Ematologia Universitaria Polo Pontino Sapienza Latina, Italy, 04100 SC Ematologia Azienda Ospedali Riuniti Papardo Piemonte Messina, Italy, 98100 UOC Ematologia Policlinico Universitario AOU G. Martino Messina, Italy SC Ematologia ‐ Trapianto di midollo osseo Fond. IRCCS Istituto Nazionale Tumori Milano, Italy, 20133 SC Ematologia AO Niguarda Cà Granda Milano, Italy, 20162 SCDU Ematologia ‐ Università del Piemonte Orientale Novara, Italy, 28100 Divisione di Ematologia, Azienda Ospedali Riuniti Villa Sofia Cervello Palermo, Italy, 90146 U.O. Complessa di Ematologia Ospedale di Parma Parma, Italy, 43100 Ematologia Policlinico San Matteo Pavia, Italy, 27100 Unità Ematologia Ospedale Civile di Piacenza Piacenza, Italy, 29100 UO Ematologia Az Ospedaliera Pisana Ospedale "S.Chiara" Pisa, Italy, 56100 UO Ematologia Ospedale Santa Maria delle Croci Ravenna, Italy, 48100 Divisione di Ematologia AO Bianchi Melacrino Morelli Reggio Calabria, Italy, 89124 SC Ematologia AO Santa Maria Nuova IRCCS Reggio Emilia, Italy, 42123 UO Oncoematologia ospedale degli Infermi Rimini, Italy, 47900 Ematologia Ospedale San Eugenio Roma, Italy, 00144 UOC Ematologia e Trapianto Istituto Regina Elena (IFO) Roma, Italy, 00144 Ematologia Ospedale S.Camillo Forlanini Roma, Italy, 00149 Ematologia Università La Sapienza Roma, Italy, 00161 UOC Ematologia AO San Giovanni Addolorata Roma, Italy, 00184 Ematologia e Trapianti A.O. San Giovanni di DIO e Ruggi D'Aragona Salerno, Italy, 84131 Ematologia Ospedale SG Moscati Taranto, Italy, 74100 SC Oncoematologia con autotrapianto AO Santa Maria Terni, Italy, 05100 SC Ematologia - AO Città della Salute e della Scienza Torino, Italy, 10126 SC Ematologia U - AO Città della Salute e della Scienza Torino, Italy, 10126 Clinica Ematologica ASUI Integrata di Udine Udine, Italy, 33100 Oncologia Medica Varese Ospedale di Circolo e Fondazione Macchi Varese, Italy, 21100 UO Ematologia Ospedale di Circolo e Fondazione Macchi Varese, Italy, 21100 收起 << |
NCT00828802 | Myelodysplastic Syndromes | Phase 1 | Completed | - | United States, North Carolina ... 展开 >> Duke University Medical Center Durham, North Carolina, United States, 27710 收起 << |
NCT01936532 | Newly Diagnosed Multiple Myelo... 展开 >>ma 收起 << | Phase 2 | Active, not recruiting | July 2020 | France ... 展开 >> CHRU - Hôpital du Haut Lévêque Bordeaux pessac, France, 33604 CHRU Dijon Dijon, France, 21000 Centre hospitalier départemental Vendée La Roche Sur Yon, France, 85925 CHRU - Hôpital Claude Huriez Lille, France, 59037 Nantes University Hospital Nantes, France, 44093 Hôpital Saint-Antoine Paris, France, 75 571 Centre Hospitalier Lyon sud Pierre Benite, France, 69495 Pole IUC Oncopole CHU Toulouse cedex 9, France, 31059 CHRU - Hôpital Bretonneau Tours, France, 37044 CHRU - Hôpitaux de Brabois Vandoeuvre Les Nancy, France, 54511 收起 << |
NCT00179712 | Ovarian Cancer | Phase 1 Phase 2 | Completed | - | United States, Georgia ... 展开 >> Medical College of GeorgiaDept of OBGYN Augusta, Georgia, United States, 30912-3335 United States, Minnesota University of MinnesotaObstetrics & Gynecology, MMC Minneapolis, Minnesota, United States, 55455 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 收起 << |
NCT03050450 | Central Nervous System Tumors | Phase 1 | Recruiting | August 2022 | United States, Florida ... 展开 >> Johns Hopkins All Childen's Hospital Recruiting Saint Petersburg, Florida, United States, 33701 Contact: Stacie Stapleton, MD 727-767-4176 Stacie.Stapleton@jhmi.edu Contact: Jennifer Flanary, RN 727-767-6466 Jennifer.Flanary@jhmi.edu 收起 << |
NCT00786851 | MANTLE CELL LYMPHOMA | Phase 2 | Completed | - | Italy ... 展开 >> Ospedale SS. Antonio Biagio e Cesare Arrigo Alessandria, Italy Centro diriferimento oncologico Aviano (PN), Italy Ematologia Spedali Civili Brescia, Italy Ematologia Ospedale Businco Cagliari, Italy Fondazione IRCCS UO Ematologia 1 Milano, Italy Ospedale Niguarda Cà granda Milano, Italy Ospedale San Raffaele Ematologia Milano, Italy Università Policlinico San Matteo Divione di Ematologia Pavia, Italy AO Bianchi Melacrino Morelli UO Ematologia Reggio Calabria, Italy AO Arcispedale S.Maria Nuova Ematologia Reggio Emilia, Italy Università La Sapienza Ematologia Roma, Italy Istituto Clinica Humanitas Rozzano (MI), Italy AO Universitaria di Sassari Istituto di Ematologia Sassari, Italy Policlinico Le Scotte Clinica Ematologica Siena, Italy Osp. San Giovanni Battista Ematologia2 Torino, Italy Osp. Cardinalle Panico Divisione di Ematologia Tricase (LE), Italy AO Universitaria clinica Ematologica ed Unità terapie Cellulari Carlo Melzi Udine, Italy 收起 << |
NCT02897830 | Multiple Myeloma | Phase 2 | Active, not recruiting | April 2021 | France ... 展开 >> University Hosptial Toulouse Toulouse, France, 31000 收起 << |
NCT02705638 | Immunoglobulin G Subclass 4 Re... 展开 >>lated Disease IgG4-related Disease Autoimmune Pancreatitis IgG4-related Sclerosing Cholangitis Retroperitoneal Fibrosis 收起 << | Phase 1 | Recruiting | April 2019 | United States, Minnesota ... 展开 >> Mayo Clinic in Rochester Recruiting Rochester, Minnesota, United States, 55905 Contact: Mark D Topazian, MD 507-284-7602 Topazian.Mark@mayo.edu Principal Investigator: Mark D Topazian, MD 收起 << |
NCT01639898 | POEMS Syndrome | Phase 2 | Unknown | July 2017 | France ... 展开 >> CHU d'Angers Recruiting Angers, France, 49933 Contact: Ifrah NORBERT, MD 0241354472 Principal Investigator: Ifrah NORBERT, MD Sub-Investigator: Mamoun DIB, MD Sub-Investigator: Martine GARDEMBAS-PAIN, MD CHU de Caen Recruiting Caen, France, 14000 Contact: Margaret MACRO, MD 02 31 27 25 39 macro-m@chu-caen.fr Principal Investigator: Margaret MACRO, MD Sub-Investigator: Khaled BENABED, MD Sub-Investigator: Sylvain CHANTEPIE, MD Sub-Investigator: Xavier TROUSSARD, MD Sub-Investigator: Stéphane CHEZE, MD Sub-Investigator: Anne-Claire GAC-BESNARD, MD Sub-Investigator: Hyacinthe Atchroué JOHNSON-ANSAH, MD Sub-Investigator: Oumédaly REMAN, MD CHU de Lille Recruiting Lille, France, 59037 Contact: Xavier LELEU, MD 0320444290 Principal Investigator: Xavier LELEU, MD Sub-Investigator: Thierry FACON, MD CHU de Limoges Recruiting Limoges, France, 87042 Contact: Arnaud JACCARD, MD 0555056651 arnaurd.jaccard@chu-limoges.fr Contact: Julie ABRAHAM, MD 0555056651 julie.abraham@chu-limoges.fr Principal Investigator: Arnaud JACCARD, MD Sub-Investigator: Michel COGNE, MD Sub-Investigator: Dominique BORDESSOULE, MD Sub-Investigator: Stéphane MOREAU, MD Sub-Investigator: Liliane REMINIERAS, MD Sub-Investigator: Marie-Pierre GOURIN, MD Sub-Investigator: Mohamed TOUATI, MD Sub-Investigator: Stéphane GIRAULT, MD Sub-Investigator: Pascal TURLURE, MD Hospices Civil de Lyon Recruiting Lyon, France, 69000 Contact: lionel KARLIN, MD 0478864309 lionel.karlin@chu-lyon.fr Sub-Investigator: Lionel Karlin, MD Centre Léon Bérard Not yet recruiting Lyon, France, 69373 Contact: GHESQUIERES Hervé, MD 0478782684 ghesquie@lyon.fnclcc.fr Principal Investigator: Hervé GHESQUIERES, MD CHU de Nantes Recruiting Nantes, France, 44093 Contact: Philippe MOREAU, MD 0240083271 philippe.moreau@chu-nantes.fr Principal Investigator: Philippe MOREAU, MD Hôpital Saint-Louis Recruiting Paris, France, 75010 Contact: Jean-Paul FERMAND, MD 0142499692 jpfermand@yahoo.fr Principal Investigator: Jean-Paul FERMAND, MD Pitié Salpétrière Recruiting Paris, France, 75013 Contact: Véronique LEBLOND, MD 0142162824 Principal Investigator: Véronique LEBLOND, MD Sub-Investigator: Sylvain CHOQUET, MD Hôpital Necker Recruiting Paris, France, 75743 Contact: Olivier HERMINE, MD 0144495282 Contact: Felipe SUAREZ, MD 0144495286 felipe.suarez@nck.aphp.fr Principal Investigator: Olivier HERMINE, MD Sub-Investigator: Felipe SUAREZ, MD Sub-Investigator: Flore SICRE de FONTBRUNE, MD Sub-Investigator: Ambroise MARCAIS, MD Sub-Investigator: Laurent FRENZEL, MD Sub-Investigator: Richard DELARUE, MD CHU de Toulouse Recruiting Toulouse, France, 31059 Contact: Michel Attal, MD 0561777784 attal.m@chu-toulouse.fr Principal Investigator: Michel ATTAL, MD 收起 << |
NCT01440582 | Myeloma | Phase 1 | Active, not recruiting | February 1, 2019 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT02986451 | Relapse/Refractory Multiple My... 展开 >>eloma 收起 << | Phase 2 | Withdrawn | December 2019 | China, Guangdong ... 展开 >> Sun Yat-sen University Cancer Center GuangZhou, Guangdong, China, 510060 收起 << |
NCT01681537 | Acute Myelogenous Leukemia | Phase 1 | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 << |
NCT00087672 | - | Completed | - | - | |
NCT02405364 | Multiple Myeloma | Phase 2 | Active, not recruiting | December 2019 | France ... 展开 >> CHU de Toulouse Toulouse, France, 31000 University hospital of Toulouse Toulouse, France, 31000 收起 << |
NCT03433001 | - | Recruiting | March 31, 2021 | Japan ... 展开 >> Takeda Selected Site Recruiting Tokyo, Japan 收起 << | |
NCT01132586 | Acute Myeloid Leukemia Arising... 展开 >> From Previous Myelodysplastic Syndrome Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA Alkylating Agent-Related Acute Myeloid Leukemia de Novo Myelodysplastic Syndrome Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndrome Untreated Adult Acute Myeloid Leukemia 收起 << | Phase 1 | Completed | - | United States, Ohio ... 展开 >> Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 收起 << |
NCT00179751 | Pancreatic Cancer | Phase 1 Phase 2 | Terminated | - | United States, Louisiana ... 展开 >> Cancer and Blood Institute Metairie, Louisiana, United States, 70006 United States, Missouri Bernard Cancer Center St. Louis, Missouri, United States, 63110 United States, Ohio Case Western Reserve University Hospitals Ireland Cancer Center Cleveland, Ohio, United States, 44106 United States, South Carolina Charleston Cancer Center Charleston, South Carolina, United States, 29406 United States, Tennessee Sarah Cannon Cancer Center Nashville, Tennessee, United States, 37203-1632 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00087672 | Myelofibrosis | Phase 2 | Completed | - | United States, Texas ... 展开 >> M.D. Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01098656 | Lymphoma | Phase 3 | Terminated(recruitment prematu... 展开 >>rely halted following company's decision to stop financial support to the study) 收起 << | - | Austria ... 展开 >> Medical University of Graz Graz, Austria, 8036 Medical University Vienna - General Hospital Vienna, Austria, 1090 Belgium Cliniques Universitaires St. Luc Brussels, Belgium Hôpitaux Universitaires Bordet-Erasme - Institut Jules Bordet Brussels, Belgium U.Z. Leuven - Campus Gasthuisberg Leuven, Belgium Finland Helsinky University Central Hospital - Skin & Allergy Hospital Helsinki, Finland, 00029 France Nouvel Hopital Estaing Clermont-Ferrand, Cedex 1, France, 66003 Chu de Bordeaux - Hopital Du Haut Leveque Bordeaux, Pessac Cedex, France, 33604 Chu Lyon - Centre Hospitalier Lyon Sud Lyon, Pierre-Benite Cedex, France, 69495 Chu Amiens - Hopital Sud Amiens, France, 80054 Hopital Saint-Louis Paris, France, 75475 CHU de Reims - Hôpital Robert Debré Reims, France, 51092 Germany Charite - Universitaetsmedizin Berlin - Campus Mitte Berlin, Germany Johannes Gutenberg Universitaetskliniken Mainz, Germany Johannes Wesling Klinikum Minden Minden, Germany Spain Csu de Bellvitge (Institut Catala D'Oncologia) L'Hospitalet De Llobregat, Spain, 08907 Hospital Universitario 12 De Octubre Madrid, Spain Switzerland UniversitaetsSpital Zurich - Division of Oncology Zurich, Switzerland United Kingdom NHS Greater Glasgow and Clyde - Beatson West of Scotland Cancer Centre Glasgow, United Kingdom Guy'S and St Thomas' Nhs - St Thomas Hospital London, United Kingdom, SE1 7EH Christie Nhs Foundation Trust Manchester, United Kingdom, M20 4BX Nottingham University Hospitals NHS Trust - City Hospital campus Nottingham, United Kingdom 收起 << |
NCT01429025 | Refractory/Relapsed Indolent N... 展开 >>on-Hodgkin Lymphoma 收起 << | Phase 1 | Active, not recruiting | - | United States, Iowa ... 展开 >> Medical Oncology and Hematology Associates-West Des Moines Clive, Iowa, United States, 50325 Mercy Cancer Center-West Lakes Clive, Iowa, United States, 50325 Iowa Methodist Medical Center Des Moines, Iowa, United States, 50309 Iowa Oncology Research Association CCOP Des Moines, Iowa, United States, 50309 Medical Oncology and Hematology Associates-Des Moines Des Moines, Iowa, United States, 50309 Medical Oncology and Hematology Associates Des Moines, Iowa, United States, 50314 Mercy Medical Center - Des Moines Des Moines, Iowa, United States, 50314 Iowa Lutheran Hospital Des Moines, Iowa, United States, 50316 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 Mercy Medical Center-Sioux City Sioux City, Iowa, United States, 51104 St. Luke's Regional Medical Center Sioux City, Iowa, United States, 51104 Methodist West Hospital West Des Moines, Iowa, United States, 50266-7700 Mercy Medical Center-West Lakes West Des Moines, Iowa, United States, 50266 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, North Dakota Mid Dakota Clinic Bismarck, North Dakota, United States, 58501 Saint Alexius Medical Center Bismarck, North Dakota, United States, 58501 Sanford Bismarck Medical Center Bismarck, North Dakota, United States, 58501 收起 << |
NCT02697344 | Recurrent Plasma Cell Myeloma | Phase 1 Phase 2 | Suspended(per study design to ... 展开 >>temporarily close) 收起 << | June 15, 2021 | United States, Florida ... 展开 >> Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 收起 << |
NCT00829647 | Chronic Lymphocytic Leukemia ... 展开 >> Leukemia 收起 << | Phase 1 Phase 2 | Withdrawn(Unable to enroll) | - | - |
NCT02086552 | Recurrent Plasma Cell Myeloma ... 展开 >> Refractory Plasma Cell Myeloma 收起 << | Phase 2 | Active, not recruiting | January 30, 2019 | United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT01644799 | Recurrent Follicular Lymphoma | Phase 1 | Completed | - | United States, District of Col... 展开 >>umbia MedStar Georgetown University Hospital Washington, District of Columbia, United States, 20007 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Weill Medical College of Cornell University New York, New York, United States, 10065 United States, North Carolina University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27599 United States, Ohio Ohio State University Medical Center Columbus, Ohio, United States, 43210 收起 << |
NCT03715296 | - | Not yet recruiting | September 15, 2020 | China, Shanghai ... 展开 >> Ruijin hospital Shanghai, Shanghai, China, 200025 收起 << | |
NCT02420860 | Hematopoietic Cell Transplanta... 展开 >>tion Recipient Plasma Cell Myeloma 收起 << | Phase 2 | Recruiting | April 30, 2020 | United States, Texas ... 展开 >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Sheeba K. Thomas 713-792-2860 Principal Investigator: Sheeba K. Thomas 收起 << |
NCT01829568 | Ann Arbor Stage II Grade 1 Con... 展开 >>tiguous Follicular Lymphoma Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma Ann Arbor Stage II Grade 3 Contiguous Follicular Lymphoma Ann Arbor Stage II Grade 3 Non-Contiguous Follicular Lymphoma Ann Arbor Stage III Grade 1 Follicular Lymphoma Ann Arbor Stage III Grade 2 Follicular Lymphoma Ann Arbor Stage III Grade 3 Follicular Lymphoma Ann Arbor Stage IV Grade 1 Follicular Lymphoma Ann Arbor Stage IV Grade 2 Follicular Lymphoma Ann Arbor Stage IV Grade 3 Follicular Lymphoma CD20 Positive 收起 << | Phase 1 | Active, not recruiting | - | United States, District of Col... 展开 >>umbia MedStar Georgetown University Hospital Washington, District of Columbia, United States, 20007 United States, Illinois University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Weill Medical College of Cornell University New York, New York, United States, 10065 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 United States, Ohio Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 收起 << |
NCT03558750 | Recurrent Central Nervous Syst... 展开 >>em Lymphoma Recurrent Diffuse Large B-Cell Lymphoma Refractory Central Nervous System Lymphoma Refractory Diffuse Large B-Cell Lymphoma 收起 << | Phase 1 Phase 2 | Recruiting | May 31, 2023 | United States, Tennessee ... 展开 >> Vanderbilt-Ingram Cancer Center Recruiting Nashville, Tennessee, United States, 37232 Contact: VICC Clinical Trials Information Program 800-811-8480 cip@vanderbilt.edu Principal Investigator: Nishitha Reddy, `MD 收起 << |
NCT00729118 | Multiple Myeloma ... 展开 >> Plasma Cell Neoplasm 收起 << | Phase 1 | Active, not recruiting | December 31, 2018 | United States, Ohio ... 展开 >> Ohio State University Columbus, Ohio, United States, 43210 收起 << |
NCT01712828 | Healthy | Phase 1 | Completed | - | United States, Texas ... 展开 >> Covance Clinical Research Unit Dallas Dallas, Texas, United States, 75247 收起 << |
NCT01093183 | Adenocarcinoma of the Prostate... 展开 >> Hormone-resistant Prostate Cancer Recurrent Prostate Cancer 收起 << | Phase 1 Phase 2 | Terminated(study sponsors with... 展开 >>drew support for the study drug.) 收起 << | - | United States, Nebraska ... 展开 >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 收起 << |
NCT01093183 | - | Terminated(study sponsors with... 展开 >>drew support for the study drug.) 收起 << | - | - | |
NCT01060384 | Non-Hodgkin's Lymphoma | Phase 1 Phase 2 | Active, not recruiting | January 2020 | United States, Nebraska ... 展开 >> Saint Francis Medical Center Grand Island, Nebraska, United States, 68803 University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 收起 << |
NCT01060384 | - | Active, not recruiting | - | - | |
NCT00963105 | Relapsed or Refractory Chronic... 展开 >> Lymphocytic Leukemia 收起 << | Phase 2 | Completed | - | - |
NCT00875667 | Mantle Cell Lymphoma ... 展开 >> Lymphoma, Mantle-Cell 收起 << | Phase 2 | Active, not recruiting | July 5, 2019 | - |
NCT00890929 | Acute Myeloid Leukemia (AML) ... 展开 >> Adult Acute Myeloblastic Leukemia 收起 << | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> Stanford University School of Medicine Stanford, California, United States, 94305 收起 << |
NCT00963105 | - | Completed | - | - | |
NCT00848328 | Lymphoma | Phase 2 | Active, not recruiting | January 2019 | United States, California ... 展开 >> University of California Davis Cancer Center Sacramento, California, United States, 95817 收起 << |
NCT00890929 | - | Completed | - | - | |
NCT03015922 | Multiple Myeloma | Phase 1 | Recruiting | October 1, 2020 | United Kingdom ... 展开 >> St James's University Hospital Recruiting Leeds, United Kingdom Contact: Christopher Parrish Principal Investigator: Christopher Parrish Sheffield Teaching Hospitals NHS Foundation Trust, Northern General Hospital Not yet recruiting Sheffield, United Kingdom Contact: Andrew Chantry Principal Investigator: Andrew Chantry 收起 << |
NCT00546897 | Leukemia, Myeloid, Acute | Phase 2 | Completed | - | United States, Missouri ... 展开 >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 收起 << |
NCT00546897 | - | Completed | - | - | |
NCT02334865 | Partial Response of Multiple M... 展开 >>yeloma or Plasma Cell Leukemia Plasma Cell Myeloma 收起 << | Phase 1 | Recruiting | November 9, 2023 | United States, New York ... 展开 >> Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Kelvin P. Lee 716-845-4106 kelvin.lee@roswellpark.org Principal Investigator: Kelvin P. Lee 收起 << |
NCT00104962 | Childhood Myelodysplastic Synd... 展开 >>romes de Novo Myelodysplastic Syndromes Previously Treated Myelodysplastic Syndromes Refractory Anemia Refractory Anemia With Excess Blasts Refractory Anemia With Ringed Sideroblasts Refractory Cytopenia With Multilineage Dysplasia Secondary Myelodysplastic Syndromes Unspecified Childhood Solid Tumor, Protocol Specific 收起 << | Phase 1 | Completed | - | United States, California ... 展开 >> COG Phase I Consortium Arcadia, California, United States, 91006-3776 收起 << |
NCT01621672 | Multiple Myeloma | Phase 3 | Completed | - | United States, Arkansas ... 展开 >> University of Arkansas for Medical Science-MIRT Little Rock, Arkansas, United States, 72205 收起 << |
NCT03191981 | Myeloma Multiple | Phase 1 Phase 2 | Withdrawn(Withdrawal of pharma... 展开 >> support prior to opening to recruitment) 收起 << | - | United Kingdom ... 展开 >> Queen Elizabeth Hospital Birmingham, United Kingdom, B15 2TH University College Hospital London, United Kingdom, NW1 2BU Guys and St Thomas NHS Foundation Trust London, United Kingdom, SE1 9RT Southampton General Hospital Southampton, United Kingdom, SO16 6YD 收起 << |
NCT01621672 | - | Completed | - | - | |
NCT00942578 | Metastatic Prostate Cancer | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT01202890 | Ovarian Cancer ... 展开 >> Epithelial Ovarian Cancer Fallopian Tube Carcinoma Primary Peritoneal Carcinoma 收起 << | Phase 1 | Terminated(Terminated due to i... 展开 >>nadequate rate of accrual.) 收起 << | - | United States, New Mexico ... 展开 >> University of New Mexico Cancer Center Albuquerque, New Mexico, United States, 87106 收起 << |
NCT02077166 | Relapsed Diffuse Large B-Cell ... 展开 >>Lymphoma Refractory Diffuse Large B-Cell Lymphoma 收起 << | Phase 1 Phase 2 | Active, not recruiting | October 2020 | - |
NCT00772915 | - | Completed | - | - | |
NCT00942578 | - | Completed | - | - | |
NCT01497496 | Chronic Lymphocytic Leukemia ... 展开 >> Small Lymphocytic Lymphoma 收起 << | Phase 2 | Active, not recruiting | December 2020 | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 收起 << |
NCT00772915 | Multiple Myeloma and Plasma Ce... 展开 >>ll Neoplasm 收起 << | Phase 2 | Completed | - | United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT01217957 | Multiple Myeloma | Phase 1 Phase 2 | Completed | - | United States, Arizona ... 展开 >> Mayo Clinic Arizona Scottsdale, Arizona, United States, 85259 United States, California Cedars Sinai Medical Center Los Angeles, California, United States, 90048 United States, Colorado Rocky Mountain Cancer Center Rose Denver, Colorado, United States, 80218 United States, Connecticut Cancer Center of Central Connecticut Southington, Connecticut, United States, 06489 United States, Florida Mayo Clinic Jacksonville Jacksonville, Florida, United States, 32224 Mt Sinai Medical Center Miami Beach, Florida, United States, 33140 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Maryland Harry and Jeannette Weinberg Cancer Center at Franklin Square Hospital Baltimore, Maryland, United States, 21215 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Missouri Washington University Saint Louis, Missouri, United States, 63110 United States, New York New York Presbyterian Hospital - Weill-Cornell New York, New York, United States, 10021 United States, Tennessee Sarah Cannon Cancer Center Nashville, Tennessee, United States, 37203 United States, West Virginia W VA University Mary Babb Randolph Cancer Center Morgantown, West Virginia, United States, 26506 United States, Wisconsin The Medical College of Wisconsin, Inc. Milwaukee, Wisconsin, United States, 53226 收起 << |
NCT02340936 | Diffuse Large B-cell Lymphoma | Phase 1 Phase 2 | Active, not recruiting | September 2019 | Spain ... 展开 >> ICO- Hospital Universitari Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 ICO- Hospital Duran i Reynals L´Hospitalet de Llobregat, Barcelona, Spain, 08908 Hospital del Mar Barcelona, Spain, 08003 Hospital Clinic i Provincial de Barcelona Barcelona, Spain, 08036 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital Regional Universitario de Málaga Málaga, Spain, 29010 Alejandro Martín Salamanca, Spain, 37007 Hospital Universitario Virgen del Rocío Sevilla, Spain, 41013 Hospital Universitario La Fe Valencia, Spain, 46026 收起 << |
NCT01217957 | - | Completed | - | - | |
NCT03376672 | Multiple Myeloma | Phase 2 | Recruiting | December 31, 2027 | Finland ... 展开 >> Helsinki University Central Hospital Recruiting Helsinki, Finland Contact: Pekka Anttila, MD pekka.anttila@hus.fi Central Finland Central Hospital Recruiting Jyväskylä, Finland Contact: Anu Sikiö, MD anu.sikio@ksshp.fi Kainuu Central Hospital Recruiting Kajaani, Finland Contact: Kristiina Kananen, MD, PhD kristiina.kananen@kainuu.fi Kymenlaakso Central Hospital Recruiting Kotka, Finland Contact: Anu Räsänen, MD anu.rasanen@carea.fi Kuopio University Hospital Recruiting Kuopio, Finland Contact: Anu Partanen, MD anu.partanen@kuh.fi Päijät-Häme Cebtral Hospital Not yet recruiting Lahti, Finland Contact: Maija Mikkola, MD maija.mikkola@phsotey.fi Oulu University Hospital Recruiting Oulu, Finland Contact: Marjaana Säily, MD, PhD marjaana.saily@ppshp.fi Tampere University Hospital Recruiting Tampere, Finland Contact: Marja Sankelo, MD, PhD marja.sankelo@pshp.fi Turku University Hospital Recruiting Turku, Finland Contact: Mervi Putkonen, MD, PhD mervi.putkonen@tyks.fi Lithuania VIlnius University Hospital Not yet recruiting Vilnius, Lithuania Contact: Valdas Peceliunas, MD, PhD Norway Forde Central Hospital South Not yet recruiting Forde, Norway Contact: Damian Lukasz Szatkowski, MD Oslo University Hospital Not yet recruiting Oslo, Norway Contact: Fredrik Schjesvold, MD Stavanger University Hospital Not yet recruiting Stavanger, Norway Contact: Einar Haukås, MD Trondheim University Hospital Not yet recruiting Trondheim, Norway Contact: Anders Waage, MD, Prof. Sweden Borås University Hospital Not yet recruiting Borås, Sweden Contact: Ulf-Henrik Mellqvist, MD Göteborg University Hospital Not yet recruiting Göteborg, Sweden Contact: Cecilie Blimark, MD Halmstad Hospital Region Halland Not yet recruiting Halmstad, Sweden Contact: Conny Karlsson, MD Linköping University Hospital Not yet recruiting Linköping, Sweden Contact: Lucia Ahlberg, MD Sunderby Hospital Region Norrbotten Not yet recruiting Luleå, Sweden Contact: Birgitta Lauri, MD Lund University Hospital Not yet recruiting Lund, Sweden Contact: Markus Hansson, MD Helsingborg Hospital Skane Not yet recruiting Skane, Sweden Contact: Per Axelsson, MD Karolinska University Hospital Not yet recruiting Stockholm, Sweden Contact: Hareth Nahi, Ass.Prof.PhD hareth.nahi@karolinska.se Uddevalla Hospital Not yet recruiting Uddevalla, Sweden Contact: Johanna Abelsson, MD Uppsala University Hospital Not yet recruiting Uppsala, Sweden Contact: Kristina Carlson, MD Varberg Hospital Not yet recruiting Varberg, Sweden Contact: Mikael Olsson, MD Örebro University Hospital Not yet recruiting Örebro, Sweden Contact: Olle Linder, MD 收起 << |
NCT00424047 | Multiple Myeloma | Phase 3 | Completed | - | - |
NCT01732861 | Leukemia Lymphocytic Chronic B... 展开 >>-Cell 收起 << | Phase 1 | Active, not recruiting | March 30, 2019 | United States, Alabama ... 展开 >> Clearview Cancer Institute Oncology Specialties, P.C Huntsville, Alabama, United States, 35805 United States, Indiana Horizon Oncology Center Lafayette, Indiana, United States, 47905 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Mount Sinai School of Medicine New York, New York, United States, 10029 United States, Tennessee The West Clinic Memphis, Tennessee, United States, 38120 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Austria Universitatsklinik fur Innere Medizin Innsbruck, Austria AKh Linz Linz, Austria, 4021 Universitatsklinik der PMU Salzburg, Austria, 5020 Allgemeines Krankenhaus Wien Wien, Austria, 1090 Medizinische Abteilung-Zentrum fur Onkologie und Hamatologie Wien, Austria, 1100 收起 << |
NCT01042704 | Myeloma | Phase 1 | Completed | - | United States, Michigan ... 展开 >> Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Ohio UPMC Cancer Centers - Teramana Cancer Center Steubenville, Ohio, United States, 43952 United States, Pennsylvania UPMC Cancer Centers - Beaver Beaver, Pennsylvania, United States, 15009 UPMC Cancer Centers - Jefferson Clairton, Pennsylvania, United States, 15025 UPMC Cancer Centers - Arnold Palmer at Mountain View Greensburg, Pennsylvania, United States, 15601 UPMC Cancer Centers - Arnold Palmer at Oakbrook Greensburg, Pennsylvania, United States, 15601 UPMC Cancer Centers - Indiana Indiana, Pennsylvania, United States, 15701 UPMC Cancer Centers - Johnstown Johnstown, Pennsylvania, United States, 15901 Hematology-Oncology Associates of UPCI McKeesport, Pennsylvania, United States, 15132 Hematology/Oncology - Private Practice McKeesport, Pennsylvania, United States, 15132 UPMC Cancer Centers - Monroeville Monroeville, Pennsylvania, United States, 15146 UPMC Cancer Centers - Arnold Palmer at Mt. Pleasant Mount Pleasant, Pennsylvania, United States, 15666 UPMC Cancer Centers - New Castle New Castle, Pennsylvania, United States, 16105 UPMC Cancer Centers - St. Margaret's Pittsburgh, Pennsylvania, United States, 15215 UPMC Cancer Centers - Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 UPMC Cancer Centers - Passavant Pittsburgh, Pennsylvania, United States, 15237 VA Healthcare System - 646 Pittsburgh, Pennsylvania, United States, 15240 UPMC Cancer Centers - Drake Pittsburgh, Pennsylvania, United States, 15241 UPMC Cancer Centers - Uniontown Uniontown, Pennsylvania, United States, 15401 UPMC Cancer Centers - Washington Washington, Pennsylvania, United States, 15301 UPMC Cancer Centers - North Hills Wexford, Pennsylvania, United States, 15090 UPMC Cancer Centers - Windber Windber, Pennsylvania, United States, 15963 收起 << |
NCT03031730 | Hypercalcemia ... 展开 >> Plasmacytoma Recurrent Plasma Cell Myeloma Refractory Plasma Cell Myeloma 收起 << | Phase 1 | Suspended(Temporarily stopped ... 展开 >>for assessment. Contact ctsucontact@westat.com for specifics) 收起 << | March 31, 2019 | United States, California ... 展开 >> University of California Davis Comprehensive Cancer Center Sacramento, California, United States, 95817 United States, Colorado University of Colorado Hospital Aurora, Colorado, United States, 80045 United States, Texas M D Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01194791 | Primary Systemic Amyloidosis | Phase 2 | Completed | - | Spain ... 展开 >> Hospital Universitario de Canarias Tenerife, Islas Canarias, Spain Hospital Germans Trias i Pujol Badalona, Spain Hospital Clínic Barcelona, Spain Hospital de la Santa Creu i Sant Pau Barcelona, Spain Hospital Clínico San Carlos Madrid, Spain Hospital Doce de Octubre Madrid, Spain Hospital Morales Messeguer Murcia, Spain Hospitalm Clínico de Salamanca Salamanca, Spain Hospital La Fe Valencia, Spain Hospital Lozano Blesa Zaragoza, Spain 收起 << |
NCT02802163 | Multiple Myeloma | Phase 1 Phase 2 | Withdrawn(study drug unavailab... 展开 >>le) 收起 << | December 2020 | - |
NCT01743859 | Acute Myeloid Leukemia | Phase 2 | Completed | - | United States, Colorado ... 展开 >> University of Colorado Cancer Center Aurora, Colorado, United States, 80045 收起 << |
NCT02159365 | Multiple Myeloma | Phase 2 | Completed | - | - |
NCT02159365 | - | Completed | - | - | |
NCT00424047 | - | Completed | - | - | |
NCT02579863 | Multiple Myeloma | Phase 3 | Active, not recruiting | September 30, 2020 | - |
NCT01496976 | Chronic Lymphocytic Leukemia ... 展开 >> Small Lymphocytic Lymphoma 收起 << | Phase 2 | Active, not recruiting | December 2020 | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 收起 << |
NCT01685814 | Previously Untreated Symptomat... 展开 >>ic Multiple Myeloma 收起 << | Phase 3 | Active, not recruiting | May 2020 | Germany ... 展开 >> Universitätsklinikum Aachen, Med. Klinik IV, Hämatologie u. Onkologie Aachen, Germany, 52074 Schön Klinik Starnberger See, Hämatologie und Onkologie Berg, Germany, 82335 Campus Virchow-Klinikum Charite´, Charite´- Centrum 14, Med. Klinik Hämatologie u. Onkologie Berlin, Germany, 13353 Klinikum Bremen-Mitte gGmbH, Klinik für Innere Medizin I Bremen, Germany, 28177 Universitätsklinikum Carl Gustav Carus an der TU Dresden, Medizinische Klinik und Poliklinik I Dresden, Germany, 01307 Universitätsklinikum Erlangen, Medizinische Klinik 5 Erlangen, Germany, 91054 Malteser Krankenhaus St. Franziskus-Hospital, medizinische Klinik I Flensburg, Germany, 24939 Klinikum der Johann Woflgang Goethe Universität, Frankfurt am Mai Frankfurt am Main, Germany, 60596 Klinikum Frankfurt (Oder) GmbH Medizinische Klinik I Frankfurt/Oder, Germany, 15236 Universitätsklinikum Freiburg, Abteilung für Innere Medizin I Freiburg, Germany, 79106 Universitätmedizin Greifswald, Klinik und Poliklinik für Innere Medizin C Greifswald, Germany, 174751 St. Marien-Hospital gem. GmbHKna Hamm, Germany, 59071 Universitätsklinikum des Saarlandes Innere Medizin I Homburg/Saar, Germany, 66421 Klinikum der Friedrich-Schiller-Universität Jena, Klinikum für Innrere Medizin II Jena, Germany, 07747 Städtisches Klinikum Karlsruhe Medizinische Klinik III, Abt. Hämatologie u. Onkologie Karlsruhe, Germany, 76133 Universitätsklinikum Schleswig-Holstein Campus Kiel, II. Med. Poliklinik Kiel, Germany, 24105 Universitätsklinikum Schleswig-Holstein, Medizinische Klinik und Poliklinik II im städtischen Krankenhaus Kiel Kiel, Germany, 24116 Stiftungsklinikum Mittelrhein GmbH, Klinik für Innere Medizin Koblenz, Germany, 56068 Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Medizinische Klinik I Lübeck, Germany, 23538 Universitätsmedizin Mannheim medizinische Klinik III Mannheim, Germany, 68167 Klinikum Schwabing München, Germany, 80804 Klinikum der Universität München-Großhadern München, Germany, 81366 III. Med. Klinik und Poliklinik, Klinikum rechts der Isar der TU München München, Germany, 81675 Universitätsklinikum Münster, Medizinische Klinik u. Poliklinik A Münster, Germany, 48149 Klinikum Nürnberg Nord, 5. Medizinische LKinik, Onkologie/Hämatologie Nürnberg, Germany, 90419 Klinikum Oldenburg GmbH, Klinik für Innere Medizin II Oldenburg, Germany, 26133 Klinikum Ernst von Bergmann, Klinik für Hämatologie, Onkologie Potsdam, Germany, 14467 Uniklinikum Regensburg, Abteilung für Hämatologie und internistische Onkologie Regensburg, Germany, 93053 Klinikum Stuttgart, Katharinenhospital Stuttgart, Germany, 70174 Robert-Bosch-Krankenhaus, Abt. Hämatologie, Onkologie u. Palliativmedizin Stuttgart, Germany, 70376 Universitätsklinikum Ulm,Klinik für Innere Medizin III Ulm, Germany, 89081 Schwarzwald-Baar Klinkum Villingen-Schwennigen GmbH Villingen-Schwenningen, Germany, 78048 Dr. Horst Schmidt Kliniken, Klinik Innere Medizin III Wiesbaden, Germany, 65199 Universitätsklinikum Wuerzburg, Medizinische Klinik II Wuerzburg, Germany, 97080 收起 << |
NCT01754857 | Lymphoid Leukemia ... 展开 >> Small Lymphocytic Lymphoma Lymphoma, Non-Hodgkin 收起 << | Phase 2 | Recruiting | November 2021 | United States, Wisconsin ... 展开 >> University of Wisconsin Recruiting Madison, Wisconsin, United States, 53792 Contact: Julie Chang, MD 608-263-1836 jc2@medicine.wisc.edu Contact: Kaitlin Chambers 608-263-5006 kchambers2@wic.edu 收起 << |
NCT02390869 | Lymphoma, Follicular | Phase 3 | Recruiting | March 2022 | Italy ... 展开 >> AO Niguarda Ca' Granda Recruiting Milano, MI, Italy, 20162 Contact: Chiara Rusconi, MD 02-64442668 chiara.rusconi@ospedaleniguarda.it Principal Investigator: Chiara Rusconi, MD Centro di Riferimento Oncologico della Basilicata Active, not recruiting Rionero in Vulture, PZ, Italy, 85028 AUSL di Ravenna Recruiting Ravenna, RA, Italy, 48100 Contact: Monica Tani, MD 0544-286223 monica.tani@ausl.ra.it Principal Investigator: Monica Tani, MD Fondazione Del Piemonte Per L'Oncologia Ircc Di Candiolo Recruiting Candiolo, Torino, Italy, 10060 Principal Investigator: Massimo Aglietta, MD Ospedale S. Giacomo di Castelfranco Veneto Recruiting Castelfranco Veneto, Treviso, Italy, 31033 Contact: Roberto Sartori, MD 0423-732346 roberto.sartori@ulssasolo.ven.it Principal Investigator: Roberto Sartori, MD A.O. S. Maria di Terni Recruiting Terni, TR, Italy, 05100 Contact: Anna Marina Liberati, MD +39 0744-205971 marinal@unipg.it Principal Investigator: Anna Marina Liberati, MD Osp. S. Antonio Abate Gallarate Recruiting Gallarate, Varese, Italy Principal Investigator: Fabrizio Ciambelli, MD Ospedale SS Antonio Biagio e Cesare Arrigo Recruiting Alessandria, Italy Principal Investigator: Alessandro Levis, MD Ospedale C. e G. Mazzoni UOS Ematologia Recruiting Ascoli Piceno, Italy Principal Investigator: Piero Galieni, MD Centro di riferimento Oncologico - Oncologia Medica A Active, not recruiting Aviano (PN), Italy SOS Ematologia Divisione Medicina Interna Ospedale degli Infermi Recruiting Biella, Italy Contact: Annarita Conconi, MD Principal Investigator: Annarita Conconi, MD Asp Di Bolzano - Comprensorio Sanitario Di Bolzano Active, not recruiting Bolzano, Italy, 39100 Divisione di Ematologia Spedali Civili Recruiting Brescia, Italy Principal Investigator: Giuseppe Rossi, MD A.O. Universitaria Ospedale Vittorio Emanuele E Ferrarotto Di Catania Recruiting Catania, Italy, 95124 Principal Investigator: Francesco Di Raimondo, MD AO Santa Croce e Carle Recruiting Cuneo, Italy, 12100 Contact: Claudia Castellino 0171641070 castellino.c@ospedale.cuneo.it Principal Investigator: Claudia Castellino, DM A.O. Universitaria Careggi Di Firenze Recruiting Firenze, Italy, 50139 Principal Investigator: Luigi Rigacci, MD Ospedale S Martino Active, not recruiting Genova, Italy A.S.L. 9 Opsedali Riuniti del Canavese Not yet recruiting Ivrea, Italy Principal Investigator: Roberto Freilone, MD Area Vasta Romagna e IRST Recruiting Meldola (FC), Italy Principal Investigator: Gerardo Musuraca, MD A O Papardo Recruiting Messina, Italy Principal Investigator: Donato Mannina, MD A.O. Universitaria Policlinico Di Modena Recruiting Modena, Italy, 41124 Principal Investigator: Stefano Sacchi, MD AOU Maggiore della Carità di Novara Recruiting Novara, Italy, 28100 Principal Investigator: Gianluca Gaidano IRCCS Istituto Oncologico Veneto -Oncologia 1 Recruiting Padova, Italy Principal Investigator: Dario Marino A.O. Ospedali Riuniti Villa Sofia-Cervello - Divisione di Ematologia Not yet recruiting Palermo, Italy Contact: Caterina Patti, MD k.patti@villasofia.it Principal Investigator: Caterina Patti, MD Ausl Di Piacenza Recruiting Piacenza, Italy, 29121 Principal Investigator: Annalisa Arcari, MD Azienda Ospedaliero Universitaria Pisana U.O. Ematologia Active, not recruiting Pisa, Italy A.O.R. San Carlo - U.O. Ematologia Active, not recruiting Potenza, Italy AO Arcispedale S.Maria Nuova Ematologia Recruiting Reggio Emilia, Italy Principal Investigator: Francesco Merli, MD Ausl Di Rimini Active, not recruiting Rimini, Italy, 47924 AOU La Sapienza Not yet recruiting Roma, Italy, 00161 Contact: Alessandro Pulsoni, MD 0649974779 pulsoni@bce.uniroma1.it Principal Investigator: Maurizio Martelli, MD Policlinico Universitario Campus Bio-Medico - Area Ematologia Trapianto Cellule Staminali Medicina Trasfusionale e Terapia cellulare Not yet recruiting Roma, Italy Principal Investigator: Ombretta Annibali, MD Nuovo Ospedale Civile di Sassuolo - Day Hospital Oncologico Recruiting Sassuolo, Italy Contact: Giovanni Partesotti, MD g.partesotti@ospedalesassuolo.it Principal Investigator: Giovanni Partesotti, MD A.O. Universitaria Citta' Della Salute E Della Scienza Di Torino Recruiting Torino, Italy, 10126 Principal Investigator: Umberto Vitolo, MD A.O.U. Citta della Salute e della Scienza di Torino - Ematologia Universitaria Recruiting Torino, Italy Contact: Federica Cavallo, MD f.cavallo@unito.it Principal Investigator: Federica Cavallo, MD Ematologia - OSPEDALE DI CIRCOLO E FONDAZIONE MACCHI Recruiting Varese, Italy, 21100 Contact francesco.passamonti@ospedale.varese.it Principal Investigator: Francesco Passamonti, Proff. 收起 << |
NCT01562405 | Multiple Myeloma | Phase 1 | Recruiting | August 2019 | United States, Georgia ... 展开 >> Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Ajay Nooka, MD 404-779-1900 anooka@emory.edu United States, Massachusetts Massachusetts General Hosptial Recruiting Boston, Massachusetts, United States, 02115 Contact 617-724-4000 ayee1@mgh.harvard.edu Principal Investigator: Andrew J. Yee, M.D. Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02215 Principal Investigator: Jacob Laubach, M.D. Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Principal Investigator: Jacob Laubach, M.D. 收起 << |
NCT00480363 | Multiple Myeloma | Phase 3 | Completed | - | Spain ... 展开 >> Hospital germans Trias i Pujol Badalona, Spain Hospital Clínic i Provincial de Barcelona Barcelona, Spain Hospital de la Santa Creu i Sant Pau Barcelona, Spain Hospital del SAS de Jerez de la Frontera Jerez de la Frontera, Spain Hospital de la Princesa Madrid, Spain Hospital Dode de Octubre Madrid, Spain Hospital Ramón y Cajal Madrid, Spain Hospital General Univeristario Morales Messeguer Murcia, Spain Hospital Clínico de Salamanca Salamanca, Spain Hospital Universitario de Canarias Tenerife, Spain Hospital Clínico de Valencia Valencia, Spain Hospital Universitario la Fe Valencia, Spain Hospital Clínico Universitario Lozano Blesa Zaragoza, Spain 收起 << |
NCT01005979 | Leukemia, Lymphocytic, Chronic... 展开 >>, B-Cell Chronic Lymphocytic Leukemia Lymphoma, Small Lymphocytic 收起 << | Phase 1 | Terminated(Slow Accrual) | - | United States, Georgia ... 展开 >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 收起 << |
NCT00322985 | T-cell Lymphoma | Phase 2 | Completed | - | Canada, Alberta ... 展开 >> Tom Baker Cancer Centre Calgary, Alberta, Canada Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, Manitoba Cancer Care Manitoba Winnipeg, Manitoba, Canada Canada, Nova Scotia Queen Elizabeth II, Health Services Centre Halifax,, Nova Scotia, Canada Canada, Ontario Ottawa Hospital General Campus Ottawa, Ontario, Canada 收起 << |
NCT02843074 | Multiple Myeloma | Phase 2 | Recruiting | March 2022 | United States, Colorado ... 展开 >> Colorado Blood Cancer Institute Recruiting Denver, Colorado, United States, 80218 United States, Maryland Center for Cancer and Blood Disorders Recruiting Bethesda, Maryland, United States, 20817 United States, Missouri HCA Midwest Health/Research Medical Center Recruiting Kansas City, Missouri, United States, 64132 United States, Nebraska Nebraska Methodist Hospital Recruiting Omaha, Nebraska, United States, 68114 United States, Tennessee Tennessee Oncology Recruiting Chattanooga, Tennessee, United States, 37404 Tennessee Oncology Recruiting Nashville, Tennessee, United States, 37203 Contact: Jesus Berdeja, MD 收起 << |
NCT03746223 | Primary Intraocular Lymphoma | Phase 2 | Not yet recruiting | October 15, 2025 | - |
NCT03433365 | - | Completed | - | Italy ... 展开 >> AOU Città della Salute e della Scienza di Torino Torino, Italy, 10126 收起 << | |
NCT00540644 | - | Completed | - | - | |
NCT00482911 | Intraocular Melanoma ... 展开 >> Malignant Conjunctival Neoplasm 收起 << | Phase 2 | Terminated(Investigator left t... 展开 >>he institute.) 收起 << | - | United States, Maryland ... 展开 >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 收起 << |
NCT02765854 | Recurrent Plasma Cell Myeloma ... 展开 >> Refractory Plasma Cell Myeloma 收起 << | Phase 2 | Recruiting | September 2020 | United States, Georgia ... 展开 >> Grady Memorial Hospital Recruiting Atlanta, Georgia, United States, 30303 Contact: Stephanie McMillan, RN, MSN 404-778-1361 sjmcmil@emory.edu Emory University/Winship Cancer Institute Recruiting Atlanta, Georgia, United States, 30322 Contact: Jennifer Shipp 404-778-4191 jennifer.shipp@emory.edu United States, Michigan University of Michigan/Rogel Cancer Center Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Craig Cole, MD colec@med.umich.edu United States, Missouri Washington University/Siteman Cancer Center Recruiting Saint Louis, Missouri, United States, 63110 Contact: Ravi Vij, MD rvij@wustl.edu 收起 << |
NCT01531998 | Myeloma | Phase 1 Phase 2 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00540644 | Multiple Myeloma | Phase 2 | Completed | - | United States, Indiana ... 展开 >> Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 收起 << |
NCT01531998 | - | Completed | - | - | |
NCT01045928 | Adult Non-Hodgkin Lymphoma ... 展开 >> Adult Grade III Lymphomatoid Granulomatosis Contiguous Stage II Adult Burkitt Lymphoma Contiguous Stage II Adult Diffuse Large Cell Lymphoma Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma Contiguous Stage II Adult Lymphoblastic Lymphoma Contiguous Stage II Grade 1 Follicular Lymphoma Contiguous Stage II Grade 2 Follicular Lymphoma Contiguous Stage II Grade 3 Follicular Lymphoma Contiguous Stage II Mantle Cell Lymphoma Contiguous Stage II Marginal Zone Lymphoma Contiguous Stage II Small Lymphocytic Lymphoma Cutaneous B-cell Non-Hodgkin Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Noncontiguous Stage II Adult Burkitt Lymphoma Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma Noncontiguous Stage II Adult Lymphoblastic Lymphoma Noncontiguous Stage II Grade 1 Follicular Lymphoma Noncontiguous Stage II Grade 2 Follicular Lymphoma Noncontiguous Stage II Grade 3 Follicular Lymphoma Noncontiguous Stage II Mantle Cell Lymphoma Noncontiguous Stage II Marginal Zone Lymphoma Noncontiguous Stage II Small Lymphocytic Lymphoma Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Splenic Marginal Zone Lymphoma Stage I Adult Burkitt Lymphoma Stage I Adult Diffuse Large Cell Lymphoma Stage I Adult Diffuse Mixed Cell Lymphoma Stage I Adult Diffuse Small Cleaved Cell Lymphoma Stage I Adult Immunoblastic Large Cell Lymphoma Stage I Adult Lymphoblastic Lymphoma Stage I Grade 1 Follicular Lymphoma Stage I Grade 2 Follicular Lymphoma Stage I Grade 3 Follicular Lymphoma Stage I Mantle Cell Lymphoma Stage I Marginal Zone Lymphoma Stage I Small Lymphocytic Lymphoma Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Small Lymphocytic Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Small Lymphocytic Lymphoma Waldenstrom Macroglobulinemia 收起 << | Phase 1 | Terminated(Extreme toxicity in... 展开 >> Phase I, study did not proceed to Phase II) 收起 << | - | United States, Ohio ... 展开 >> Fairview Cancer Hospital Cleveland, Ohio, United States, 44111 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Hillcrest Hospital Cancer Center Mayfield Heights, Ohio, United States, 44124 收起 << |
NCT03054532 | LYMPHOMA | Phase 2 | Not yet recruiting | July 2021 | Singapore ... 展开 >> National University Hospital Singapore Not yet recruiting Singapore, Singapore, 119228 Contact: Michelle Poon, MD 6567795555 NUH_Enquiries@nuhs.edu.sg Singapore General Hospital Not yet recruiting Singapore, Singapore, 169608 Contact: Colin Phipps, MD 6562223322 colin.phipps.diong@singhealth.com.sg National Cancer Centre Singapore Not yet recruiting Singapore, Singapore, 169610 Contact: Soon Thye Lim, MD 6564368000 callcentre@nccs.com.sg Raffles Hospital Singapore Not yet recruiting Singapore, Singapore, 188770 Contact: Daryl Tan, MD 6563111111 enquiries@raffleshospital.com 收起 << |
NCT00445692 | DS Stage I Plasma Cell Myeloma... 展开 >> DS Stage II Plasma Cell Myeloma DS Stage III Plasma Cell Myeloma Refractory Plasma Cell Myeloma 收起 << | Phase 2 | Completed | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT00445692 | - | Completed | - | - | |
NCT01197560 | Diffuse Large B-cell Lymphoma | Phase 2 Phase 3 | Completed | - | - |
NCT00939510 | Prostate Cancer | Phase 1 Phase 2 | Completed | - | United States, Ohio ... 展开 >> Cleveland Clinic Taussig Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 收起 << |
NCT01197560 | - | Completed | - | - | |
NCT00939510 | - | Completed | - | - | |
NCT00628238 | Chronic Lymphocytic Leukemia ... 展开 >> CLL Untreated Front-line First-Line Initial Therapy 收起 << | Phase 2 | Unknown | July 2011 | United States, California
... 展开 >>
University of California San Diego
Recruiting
La Jolla, California, United States, 92093
Contact: Jamie N Gould 858-822-5364 jngould@ucsd.edu
Contact: Danelle F James 858-822-7894 dfjames@ucsd.edu
Principal Investigator: Thomas J Kipps, M.D., Ph.D.
Principal Investigator: Danelle F James, M.D.
United States, Massachusetts
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
Recruiting
Boston, Massachusetts, United States, 02115
Contact: Evgeny Mikler, P.A. 617-632-4719
Contact: Clinical Trials Office - Dana-Farber/Harvard Cancer Center 617-582-8480
Principal Investigator: Jennifer R Brown, M.D.,Ph.D
United States, New York
Long Island Jewish Medical Center
Recruiting
New Hyde Park, New York, United States, 11040
Contact: Nancy Driscoll, RPA-C 516-470-4767 Ndriscol@lij.edu
Contact (516)470-4050
Principal Investigator: Kanti Rai, M.D.
United States, Ohio
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University
Not yet recruiting
Columbus, Ohio, United States, 43210-1240
Contact: Clinical Trials Office - OSU Comprehensive Cancer Center 614-293-4976 osu@emergingmed.com
Principal Investigator: Michael Grever, M.D.
Principal Investigator: John Byrd, M.D.
Sub-Investigator: Thomas Lin, M.D.
United States, Texas
M. D. Anderson Cancer Center at University of Texas
Recruiting
Houston, Texas, United States, 77030-4009
Contact: Susan C Smith 713-745-0553 Susan Smith |
NCT01185262 | Chronic Lymphocytic Leukemia | Phase 1 | Completed | - | Spain ... 展开 >> Hospital Universitario Reina Sofía Córdoba, Spain, 14004 MD Anderson Internacional España Madrid, Spain, 28033 Hospital Universitario La Paz Madrid, Spain, 28046 Hospital Clínico de Salamanca Salamanca, Spain, 37007 Hospital Virgen del Rocío Sevilla, Spain, 41013 Hospital Clínico Universitario de Valencia Valencia, Spain, 46010 Hospital Universitario Miguel Servet Zaragoza, Spain, 50009 收起 << |
NCT00482911 | - | Terminated(Investigator left t... 展开 >>he institute.) 收起 << | - | - | |
NCT03252600 | Recurrent Primary Amyloidosis | Phase 2 | Recruiting | December 31, 2020 | United States, Michigan ... 展开 >> Wayne State University/Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 Contact: Silva Pregja 313-576-8673 Pregjas@karmanos.org Contact: Christiane Houde 313-576-9381 Houdec@karmanos.org Principal Investigator: Jeffrey A. Zonder 收起 << |
NCT02561273 | Anaplastic Large Cell Lymphoma... 展开 >>, ALK-Negative Anaplastic Large Cell Lymphoma, ALK-Positive Hepatosplenic T-Cell Lymphoma Peripheral T-Cell Lymphoma, Not Otherwise Specified Stage II Angioimmunoblastic T-cell Lymphoma Stage II Enteropathy-Associated T-Cell Lymphoma Stage III Angioimmunoblastic T-cell Lymphoma Stage III Enteropathy-Associated T-Cell Lymphoma Stage IV Angioimmunoblastic T-cell Lymphoma Stage IV Enteropathy-Associated T-Cell Lymphoma 收起 << | Phase 1 Phase 2 | Active, not recruiting | October 2021 | United States, California ... 展开 >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 Stanford Cancer Institute Palo Alto, California, United States, 94304 United States, Colorado University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States, 80045 United States, Georgia Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 收起 << |
NCT00987493 | Lymphoma | Phase 1 Phase 2 | Completed | - | Switzerland ... 展开 >> Kantonsspital Baden Baden, Switzerland, CH-5404 Universitaetsspital Basel Basel, Switzerland, 4031 St. Claraspital AG Basel, Switzerland, CH-4016 Istituto Oncologico della Svizzera Italiana - Ospedale Regionale Bellinzona e Valli Bellinzona, Switzerland, 6500 Inselspital Bern Bern, Switzerland, 3010 Kantonsspital Bruderholz Bruderholz, Switzerland, CH-4101 Kantonsspital Graubünden Chur, Switzerland, 7000 Hopital Fribourgeois Fribourg, Switzerland, 1708 Hôpitaux Universitaires de Genève HUG Geneva 14, Switzerland, 1211 Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Kantonsspital Liestal Liestal, Switzerland, CH-4410 Kantonsspital Olten Olten, Switzerland, CH-4600 Kantonsspital St. Gallen St. Gallen, Switzerland, 9007 Kantonsspital Winterthur Winterthur, Switzerland, 8401 Stadtspital Triemli Zürich, Switzerland, 8063 Universitäts Spital Zürich Zürich, Switzerland, 8091 收起 << |
NCT03319667 | Plasma Cell Myeloma | Phase 3 | Recruiting | January 2025 | - |
NCT01816971 | Stage I Multiple Myeloma ... 展开 >> Stage II Multiple Myeloma Stage III Multiple Myeloma 收起 << | Phase 2 | Active, not recruiting | December 2018 | United States, Illinois ... 展开 >> University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States, 60637-1470 United States, Massachusetts Dana Farber Boston, Massachusetts, United States, 02215 United States, Missouri Washington University in St Louis Saint Louis, Missouri, United States, 63130 United States, Tennessee Sarah Cannon Cancer Center Nashville, Tennessee, United States, 37203 Canada, Ontario Princess Margaret Toronto, Ontario, Canada, M5T 2M9 收起 << |
NCT00607581 | Amyloidosis | Phase 2 | Completed | - | Italy ... 展开 >> Amyloidosis Research and Treatment Center - Fondazione IRCCS Policlinico San Matteo Pavia, Italy, 27100 收起 << |
NCT00915408 | Multiple Myeloma | Phase 1 Phase 2 | Completed | - | United Kingdom ... 展开 >> King's College Hospital NHS Foundation Trust London, United Kingdom, SE5 9RS Royal Marsden NHS Foundation Trust London, United Kingdom, SM2 5PT 收起 << |
NCT00100880 | Childhood Atypical Teratoid/Rh... 展开 >>abdoid Tumor Childhood Central Nervous System Germ Cell Tumor Childhood Choroid Plexus Tumor Childhood Craniopharyngioma Childhood Ependymoblastoma Childhood Grade I Meningioma Childhood Grade II Meningioma Childhood Grade III Meningioma Childhood High-grade Cerebellar Astrocytoma Childhood High-grade Cerebral Astrocytoma Childhood Infratentorial Ependymoma Childhood Low-grade Cerebellar Astrocytoma Childhood Low-grade Cerebral Astrocytoma Childhood Medulloepithelioma Childhood Mixed Glioma Childhood Oligodendroglioma Childhood Supratentorial Ependymoma Recurrent Childhood Brain Tumor Recurrent Childhood Cerebellar Astrocytoma Recurrent Childhood Cerebral Astrocytoma Recurrent Childhood Ependymoma Recurrent Childhood Medulloblastoma Recurrent Childhood Pineoblastoma Recurrent Childhood Subependymal Giant Cell Astrocytoma Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor Recurrent Childhood Visual Pathway and Hypothalamic Glioma 收起 << | Phase 1 | Completed | - | United States, Tennessee ... 展开 >> Pediatric Brain Tumor Consortium Memphis, Tennessee, United States, 38105 收起 << |
NCT00179686 | Non-Small Cell Lung Cancer | Phase 2 | Completed | - | United States, Alabama ... 展开 >> Birmingham Cancer Center Birmingham, Alabama, United States, 35294 United States, Illinois Rush Cancer Institute Chicago, Illinois, United States, 60612 University of Chicago Chicago, Illinois, United States, 60637 United States, Louisiana Cancer and Blood Institute Metairie, Louisiana, United States, 70006 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT02158702 | Multiple Myeloma ... 展开 >> Relapse After Use of Lenalidomide and Bortezomib 收起 << | Phase 2 | Active, not recruiting | November 2018 | Singapore ... 展开 >> National University Hospital Singapore, Singapore, 119074 Singapore General Hospital Singapore, Singapore 收起 << |
NCT03413800 | Relapsed Hematologic Malignanc... 展开 >>y Multiple Myeloma 收起 << | Phase 2 | Recruiting | January 29, 2023 | Canada, Quebec ... 展开 >> CIUSSS de l'Est-de-l'île-de-Montréal, Installation Hôpital Maisonneuve Rosemond Recruiting Montréal, Quebec, Canada, H1T2M4 Contact: Séverine Landais, PhD 514-252-3400 ext 3609 slandais.hmr@ssss.gouv.qc.ca Contact: Jean Roy, MD 514-252-3400 jroy.hmr@ssss.gouv.qc.ca 收起 << |
NCT03098589 | - | Recruiting | October 2, 2021 | Japan ... 展开 >> ASO KK Iizuka Hospital Recruiting Iizuka, Fukuoka, Japan, 820-8505 收起 << | |
NCT01575860 | Lymphoma | Phase 1 Phase 2 | Unknown | - | United States, Pennsylvania ... 展开 >> Jakub Svoboda Recruiting Philadelphia, Pennsylvania, United States, 19104 Principal Investigator: Jakub Svoboda, MD 收起 << |
NCT02375555 | Multiple Myeloma | Phase 2 | Active, not recruiting | June 2022 | United States, Georgia ... 展开 >> Emory University Atlanta, Georgia, United States, 30322 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, North Carolina Levine Cancer Institute Charlotte, North Carolina, United States, 28204 United States, Virginia Virginia Cancer Specialists Fairfax, Virginia, United States, 22031 收起 << |
NCT01749969 | Plasma Cell Myeloma | Phase 1 | Active, not recruiting | June 2019 | United States, California ... 展开 >> Investigational Site Number 840004 San Francisco, California, United States, 94117 United States, Florida Investigational Site Number 840001 Tampa, Florida, United States, 33612 United States, Missouri Investigational Site Number 840002 Saint Louis, Missouri, United States, 63110 United States, New York Investigational Site Number 840005 New York, New York, United States, 10021 United States, Ohio Investigational Site Number 840003 Columbus, Ohio, United States, 43210 收起 << |
NCT01053806 | Myelodysplastic Syndrome | Phase 2 | Unknown | - | Israel ... 展开 >> Department of internal medicine A Recruiting Tel-Aviv, Israel Contact: Moshe Mittelman, Prof moshemt@tasmc.health.gov.il Principal Investigator: Moshe Mittelman, Prof 收起 << |
NCT00046735 | Neoplasms | Phase 1 | Completed | - | United States, North Carolina ... 展开 >> Wake Forest University Winston-Salem, North Carolina, United States, 27157 收起 << |
NCT03015792 | Recurrent Plasma Cell Myeloma ... 展开 >> Refractory Plasma Cell Myeloma 收起 << | Phase 1 Phase 2 | Suspended(temporary closing pe... 展开 >>r study design) 收起 << | February 15, 2022 | United States, Florida ... 展开 >> Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 收起 << |
NCT00679367 | Multiple Myeloma | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Boston University Cancer Research Center Boston, Massachusetts, United States, 02118 收起 << |
NCT02874742 | Multiple Myeloma | Phase 2 | Active, not recruiting | December 2021 | - |
NCT02335983 | Multiple Myeloma | Phase 1 | Active, not recruiting | March 8, 2019 | - |
NCT00679367 | - | Completed | - | - | |
NCT03212807 | EBV Related Non-Hodgkin's Lymp... 展开 >>homa Primary CNS Lymphoma Primary Testicular Lymphoma 收起 << | Phase 2 | Withdrawn(FDA Hold for Combina... 展开 >>tion Studies using Imids and PD1/PDL1 Compounds) 收起 << | August 2023 | Singapore ... 展开 >> National Cancer Center Singapore, Singapore National University Hospital Singapore, Singapore Raffles Hospital Singapore, Singapore Singapore General Hospital Singapore, Singapore 收起 << |
NCT01206205 | Multiple Myeloma | Phase 2 | Completed | - | France ... 展开 >> Centre François Baclesse Caen, cedex 5, France, 14076 University Hospital of Dijon, Hôpital des Enfants Dijon, France, 21000 University Hospital of Grenoble, Hôpital A.Michallon, BP 217 X Grenoble Cedex 09, France, 38043 University Hospital Of Lille, Hôpital Claude Huriez Lille Cedex, France, 59037 Institut Paoli Calmette Marseille Cedex, France, 13273 University Hospital of Bordeaux, "Hôpital du Haut Lévêque " Pessac, France, 33604 University Hospital of Toulouse, Purpan Toulouse, France, 31059 Hôpital Bretonneau, Tours Tours Cedex, France, 37044 Hôpitaux de Brabois Nancy Vandoeuvre cedex, France, 54511 收起 << |
NCT01502085 | Multiple Myeloma | Phase 1 Phase 2 | Unknown | May 2016 | United States, New Jersey ... 展开 >> John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 收起 << |
NCT02341781 | - | Completed | - | United States, Arizona ... 展开 >> Mayo Clinic Scottsdale Phoenix, Arizona, United States, 85054 United States, California Innovative Clinical Research Institute Whittier, California, United States, 90603 United States, Florida University of Miami and Sylvester Comprehensive Cancer Miami, Florida, United States, 33136 United States, Michigan University of Michigan Comprehensive Cancer Center Division of Hematology Oncology Ann Arbor, Michigan, United States, 48109 United States, Missouri Columbia Comprehensive Cancer Care Clinic Jefferson City, Missouri, United States, 65101 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Weill Cornell Medical College New York, New York, United States, 10065 United States, North Carolina Levine Cancer Institute Charlotte, North Carolina, United States, 28204 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Wisconsin Froedtert and The Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Germany Universitatsmedizin der Johannes Gutenberg- Universitat Mainz, Rhineland-Palatinate, Germany, 55131 Italy Azienda Ospedaliero Universitaria Di Bologna - Policlinico S.Orsola Malpighi Bologna, Emilia-Romagna, Italy, 40138 United Kingdom Derriford Hospital Plymouth Oncology Center Clinical Plymouth, Devon, United Kingdom, Pl68DH 收起 << | |
NCT00536341 | - | Completed | - | - | |
NCT00536341 | Chronic Lymphocytic Leukemia | Phase 1 Phase 2 | Completed | - | United States, Florida ... 展开 >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 National Capital Clinical Research Consortium Bethesda, Maryland, United States, 20817 United States, South Carolina South Carolina Oncology Associates, PA Columbia, South Carolina, United States, 29210 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 收起 << |
NCT01016600 | Leukemia, Myeloid, Acute | Phase 1 Phase 2 | Completed | - | United States, Missouri ... 展开 >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 收起 << |
NCT01049945 | Refractory Multiple Myeloma | Phase 1 Phase 2 | Unknown | - | United States, California ... 展开 >> City of Hope Duarte, California, United States, 91010 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 55904 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637-1470 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Missouri Washington Universtiy School of Medicine St. Louis, Missouri, United States, 63110 收起 << |
NCT01016600 | - | Completed | - | - | |
NCT00695786 | Ann Arbor Stage III Grade 1 Fo... 展开 >>llicular Lymphoma Ann Arbor Stage III Grade 2 Follicular Lymphoma Ann Arbor Stage III Indolent Adult Non-Hodgkin Lymphoma Ann Arbor Stage III Marginal Zone Lymphoma Ann Arbor Stage III Small Lymphocytic Lymphoma Ann Arbor Stage IV Grade 1 Follicular Lymphoma Ann Arbor Stage IV Grade 2 Follicular Lymphoma Ann Arbor Stage IV Indolent Adult Non-Hodgkin Lymphoma Ann Arbor Stage IV Marginal Zone Lymphoma Ann Arbor Stage IV Small Lymphocytic Lymphoma 收起 << | Phase 2 | Active, not recruiting | June 30, 2020 | United States, Texas ... 展开 >> M D Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00166413 | Amyloidosis | Phase 2 | Completed | - | United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT01183663 | Advanced Cancers | Phase 1 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00502112 | Myelodysplastic Syndrome (MDS) | Phase 1 | Completed | - | United States, Alabama ... 展开 >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294 United States, Colorado Rocky Mountain Cancer Center Denver, Colorado, United States, 80218 United States, District of Columbia Georgetown University Washington, District of Columbia, United States, 20007 United States, Georgia Georgia Cancer Specialists Atlanta, Georgia, United States, 30342 United States, New York St.Vincent's Comprehensive Cancer Center New York, New York, United States, 10011 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 United States, South Dakota Avera Cancer Institute Sioux Falls, South Dakota, United States, 57105 收起 << |
NCT01049945 | - | Unknown | - | - | |
NCT00790842 | Multiple Myeloma ... 展开 >> Plasma Cell Neoplasm 收起 << | Phase 1 Phase 2 | Terminated(Slow enrollment) | - | United States, Arizona ... 展开 >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259-5499 United States, Georgia Emory University Winship Cancer Atlanta, Georgia, United States, 30322 United States, Illinois University of IL at Chicago Chicago, Illinois, United States, 60612 United States, Iowa McFarland Clinic Ames, Iowa, United States, 50010 Siouxland Hematology Oncology Associates Sioux City, Iowa, United States, 51101 United States, Michigan Michigan Cancer Research Consortium and Oncology Research- St. Joseph Mercy Hospital - Ann Arbor Ann Arbor, Michigan, United States, 48106-0955 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Metro MN CCOP Saint Louis Park, Minnesota, United States, 55416 United States, Nebraska Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68106 United States, North Carolina Kinston Medical Specialists Kinston, North Carolina, United States, 28501 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 Reading Hospital and Medical Center West Reading, Pennsylvania, United States, 19611 United States, West Virginia WVU Mary Babb Randolph Cancer Center Morgantown, West Virginia, United States, 26506 United States, Wisconsin Gundersen Lutheran La Crosse, Wisconsin, United States, 54601 Waukesha Memorial Hospital (ProHealth Care) Waukesha, Wisconsin, United States, 53188 Aurora Cancer Center Wauwatosa, Wisconsin, United States, 53226 收起 << |
NCT00833534 | Leukemia Lymp... 展开 >>homa 收起 << | Phase 2 | Withdrawn(No patient enrolled ... 展开 >>on study. Did not get patients in timely fashion. All referrals for study when assessed were not eligible.) 收起 << | - | - |
NCT02921893 | Plasmacytoma ... 展开 >>POEMS Syndrome 收起 << | Phase 2 | Recruiting | October 15, 2021 | United States, Minnesota ... 展开 >> Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Referral Office 855-776-0015 Principal Investigator: Angela Dispenzieri 收起 << |
NCT00532675 | Multiple Myeloma | Phase 1 | Completed | - | United States, California ... 展开 >> UCSF Medical Center UCSF MC at Parnassus (SC) San Francisco, California, United States, 94143 United States, Georgia Emory University School of Medicine/Winship Cancer Institute Dept. of Winship Cancer Inst. Atlanta, Georgia, United States, 30322 United States, New York St. Vincent's Comprehensive Cancer Center New York, New York, United States, 10011 Australia, Queensland Novartis Investigative Site South Brisbane, Queensland, Australia, 4101 Australia, Victoria Novartis Investigative Site Prahran, Victoria, Australia, 3181 France Novartis Investigative Site Lille, France, 59037 Novartis Investigative Site Montpellier cedex 5, France, 34295 Novartis Investigative Site Nantes, France, 44035 Spain Novartis Investigative Site Salamanca, Castilla Y Leon, Spain, 37007 Novartis Investigative Site Valencia, Comunidad Valenciana, Spain, 46026 收起 << |
NCT01393756 | Follicular Lymphoma | Phase 2 | Completed | - | France ... 展开 >> Institut Bergonié Bordeaux, France, 33076 Polyclinique Bordeaux Nord Aquitaine Bordeaux, France, 33077 CHU Estaing Clermont ferrand, France, 63000 Hôpital Henri Mondor Creteil, France, 94010 CHU de DIJON Dijon, France, 21034 Chru Lille Lille, France, 59037 Centre Léon Bérard Lyon, France, 69373 Institut Paoli Calmettes Marseille, France, 13273 Hôpital Notre Dame de Bon Secours Metz, France, 57038 Hôpital Saint Eloi Montpellier, France, 34295 CHU de NANTES Nantes, France, 44093 Hôpital Saint Antoine Paris, France, 75012 Hôpital de la Pitié Salpétrière Paris, France, 75013 Hôpital Necker Paris, France, 75015 Institut Curie Paris, France, 75231 Hôpital St Louis Paris, France, 75475 Chu Lyon Sud Pierre-benite, France, 69310 CHU de Poitiers Poitiers, France, 86021 Hôpital Robert Debré Reims, France, 51092 Hôpital Pontchaillou Rennes, France, 35033 Centre Henri BECQUEREL Rouen, France, 76038 Hôpital René Huguenin Saint-Cloud, France, 92211 Chu Brabois Vandoeuvre-les-nancy, France, 54511 Institut Gustave Roussy Villejuif, France, 94805 收起 << |
NCT01217203 | Patients With Multiple Myeloma... 展开 >> Experiencing a First or Second Relapse 收起 << | Phase 1 | Completed | - | United States, Massachusetts ... 展开 >> Dana Farber Boston, Massachusetts, United States, 02115 United States, New York NYU Clinical Cancer Center New York, New York, United States, 10016 Mount Sinai Medical Center New York, New York, United States, 10029 United States, Ohio The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, South Carolina Saint Francis Hospital Greensville, South Carolina, United States, 29601 收起 << |
NCT01349569 | Multiple Myeloma | Phase 2 | Completed | - | United States, Maryland ... 展开 >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 收起 << |
NCT00966693 | Recurrent Plasma Cell Myeloma ... 展开 >> Refractory Plasma Cell Myeloma 收起 << | Phase 1 Phase 2 | Completed | - | United States, Texas ... 展开 >> M D Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00179608 | Malignant Melanoma | Phase 1 | Completed | - | United States, Texas ... 展开 >> MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 收起 << |
NCT03070327 | Multiple Myeloma | Phase 1 | Recruiting | February 2020 | United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Sham Mailankody, MD 212-639-2131 Contact: Craig Sauter, MD 212-639-3460 Principal Investigator: Sham Mailankody, MD 收起 << |
NCT01649791 | B-cell Chronic Lymphocytic Leu... 展开 >>kemia Chronic Lymphocytic Leukemia Stage 0 Chronic Lymphocytic Leukemia Stage I Chronic Lymphocytic Leukemia Stage II Chronic Lymphocytic Leukemia 收起 << | Not Applicable | Terminated | - | United States, New York ... 展开 >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 收起 << |
NCT02492750 | Indolent Plasma Cell Myeloma ... 展开 >> Plasma Cell Myeloma Smoldering Plasma Cell Myeloma 收起 << | Phase 1 Phase 2 | Suspended(per study design) | July 2020 | United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT01169337 | Light Chain Deposition Disease... 展开 >> Smoldering Plasma Cell Myeloma 收起 << | Phase 3 | Active, not recruiting | - | - |
NCT00790842 | - | Terminated(Slow enrollment) | - | - | |
NCT01501370 | Multiple Myeloma | Phase 2 | Withdrawn | - | Italy ... 展开 >> Clinica di Ematologia, A.O.U. Ospedali Riuniti, Ospedale Umberto I di Ancona Ancona, Italy, 60020 U.O.S. di Ematologia, Ospedale Mazzoni Ascoli Piceno, Italy, 63100 Dh ematologia, A.O.U. Careggi Firenze, Italy, 50139 Ematologia, Ospedale S. Maria della Misericordia Perugia, Italy, 06156 Ematologia e Immunoematologia, Azienda Ospedaliera Riuniti Marche Nord Pesaro, Italy, 61100 Dip. Ematologia-U.O di Ematologia Generale-Azienda USL di Pescara-P.O. dello Spirito Santo Pescara, Italy, 65100 Ematologia , A.O.U. Pisana Pisa, Italy, 56126 Universitaria di Ematologia, A.O.U. San Giovanni Battista di Torino, Torino, Italy, 10126 收起 << |
NCT02076009 | Multiple Myeloma | Phase 3 | Active, not recruiting | September 29, 2020 | - |
NCT00410605 | Multiple Myeloma in Relapse ... 展开 >> Stage II Multiple Myeloma Stage III Multiple Myeloma 收起 << | Phase 2 | Completed | - | United States, Pennsylvania ... 展开 >> University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 收起 << |
NCT00410605 | - | Completed | - | - | |
NCT02076009 | - | Active, not recruiting | - | - | |
NCT00466921 | Lymphoma | Phase 2 | Active, not recruiting | February 2020 | United States, California ... 展开 >> Stanford Cancer Center Stanford, California, United States, 94305-5824 United States, Illinois Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611-3013 United States, Texas M. D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 收起 << |
NCT01645930 | - | Completed | - | - | |
NCT01649791 | - | Terminated | - | - | |
NCT02880228 | Plasma Cell Myeloma | Phase 2 | Active, not recruiting | December 1, 2021 | United States, Florida ... 展开 >> Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT00580242 | Myelodysplasia | Phase 1 | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 << |
NCT00553644 | - | Completed | - | - | |
NCT01645930 | Multiple Myeloma | Phase 1 | Completed | - | Hong Kong ... 展开 >> Pokfulam, Hong Kong Shatin, Hong Kong Korea, Republic of Incheon, Korea, Republic of Seoul, Korea, Republic of Singapore Singapore, Singapore 收起 << |
NCT01351896 | Ann Arbor Stage I Small Lympho... 展开 >>cytic Lymphoma Ann Arbor Stage II Small Lymphocytic Lymphoma Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemia With Unmutated Immunoglobulin Heavy Chain Variable-Region Gene Small Lymphocytic Lymphoma With Unmutated Immunoglobulin Heavy Chain Variable-Region Gene Stage 0 Chronic Lymphocytic Leukemia Stage I Chronic Lymphocytic Leukemia Stage II Chronic Lymphocytic Leukemia 收起 << | Phase 2 | Active, not recruiting | - | United States, Ohio ... 展开 >> Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 收起 << |
NCT00553644 | Recurrent Mantle Cell Lymphoma | Phase 2 | Completed | - | - |
NCT01199575 | - | Active, not recruiting | - | - | |
NCT01383928 | Multiple Myeloma | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> UCSF Medical Center Berkeley, California, United States, 94704 City of Hope National Medical Center Duarte, California, United States, 91010 Stanford University Stanford, California, United States, 94305 United States, Florida H Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 United States, Illinois University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Maryland Associates of Oncology/Hematology PC Rockville, Maryland, United States, 20850 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 Michigan State University Lansing, Michigan, United States, 48910 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10021 Mount Sinai Hospital New York, New York, United States, 31406 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27705 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 Mercy St Anne Hospital Toledo, Ohio, United States, 43623 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Tennessee SCRI Tennessee Oncology Nashville Nashville, Tennessee, United States, 37203 United States, Texas Baylor Sammons Cancer Center Dallas, Texas, United States, 75246 United States, Virginia Virginia Cancer Care Specialist Fairfax, Virginia, United States, 22031 Virginia Cancer Specialists PC Fairfax, Virginia, United States, 22031 收起 << |
NCT00352794 | Myelofibrosis | Phase 2 | Active, not recruiting | July 2019 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01199575 | Chronic Lymphocytic Leukemia ... 展开 >> CLL 收起 << | Phase 2 | Active, not recruiting | March 2019 | United States, California ... 展开 >> University of California, San Diego La Jolla, California, United States, 92093 收起 << |
NCT03505944 | Relapsed Non Hodgkin Lymphoma | Phase 1 Phase 2 | Not yet recruiting | June 1, 2022 | Sweden ... 展开 >> Skane University Hospital Not yet recruiting Lund, Sweden Contact: Mats Jerkeman, MD +46 4617 7520 mats.jerkeman@med.lu.se 收起 << |
NCT01650701 | Follicular Lymphoma | Phase 3 | Active, not recruiting | September 2024 | - |
NCT00056160 | - | Completed | - | - | |
NCT02128061 | Diffuse Large B Cell Lymphoma | Phase 3 | Active, not recruiting | February 2019 | - |
NCT02213913 | Adult Grade III Lymphomatoid G... 展开 >>ranulomatosis B-cell Chronic Lymphocytic Leukemia Contiguous Stage II Adult Diffuse Large Cell Lymphoma Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma Contiguous Stage II Grade 1 Follicular Lymphoma Contiguous Stage II Grade 2 Follicular Lymphoma Contiguous Stage II Grade 3 Follicular Lymphoma Contiguous Stage II Mantle Cell Lymphoma Contiguous Stage II Marginal Zone Lymphoma Contiguous Stage II Small Lymphocytic Lymphoma Cutaneous B-cell Non-Hodgkin Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Intraocular Lymphoma Nodal Marginal Zone B-cell Lymphoma Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma Noncontiguous Stage II Grade 1 Follicular Lymphoma Noncontiguous Stage II Grade 2 Follicular Lymphoma Noncontiguous Stage II Grade 3 Follicular Lymphoma Noncontiguous Stage II Mantle Cell Lymphoma Noncontiguous Stage II Marginal Zone Lymphoma Noncontiguous Stage II Small Lymphocytic Lymphoma Progressive Hairy Cell Leukemia, Initial Treatment Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Stage 0 Chronic Lymphocytic Leukemia Stage I Adult Diffuse Large Cell Lymphoma Stage I Adult Diffuse Mixed Cell Lymphoma Stage I Adult Diffuse Small Cleaved Cell Lymphoma Stage I Adult Hodgkin Lymphoma Stage I Adult Immunoblastic Large Cell Lymphoma Stage I Chronic Lymphocytic Leukemia Stage I Grade 1 Follicular Lymphoma Stage I Grade 2 Follicular Lymphoma Stage I Grade 3 Follicular Lymphoma Stage I Mantle Cell Lymphoma Stage I Marginal Zone Lymphoma Stage I Small Lymphocytic Lymphoma Stage II Adult Hodgkin Lymphoma Stage II Chronic Lymphocytic Leukemia Stage II Small Lymphocytic Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Adult Hodgkin Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Chronic Lymphocytic Leukemia Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Small Lymphocytic Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Hodgkin Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Small Lymphocytic Lymphoma Testicular Lymphoma Untreated Hairy Cell Leukemia Waldenström Macroglobulinemia 收起 << | Phase 1 Phase 2 | Recruiting | July 29, 2021 | United States, Illinois ... 展开 >> Rush University Medical Center Recruiting Chicago, Illinois, United States, 60612 Contact: Reem Karmali, MD reem_karmali@rush.edu University of Chicago Recruiting Chicago, Illinois, United States, 60637 Contact: Sonali Smith 773-834-2895 smsmith@medicine.bsd.uchicago.edu Principal Investigator: Sonali Smith Decatur Memorial Hospital Cancer Care Institute Recruiting Decatur, Illinois, United States, 62526 Contact: James L. Wade, MD 217-876-6603 NorthShore University HealthSystem Recruiting Evanston, Illinois, United States, 60201 Contact: Lynne Kaminer, MD 847-570-2515 Illinois Cancer Care Recruiting Peoria, Illinois, United States, 61615 Contact: Paul AS Fishkin, MD 309-243-3000 Principal Investigator: Paul AS Fishkin, MD United States, Maryland University of Maryland Recruiting Baltimore, Maryland, United States, 21202 Contact: Amy Kimball akimball@umm.edu 收起 << |
NCT01383928 | - | Completed | - | - | |
NCT01246622 | Adult Acute Myeloid Leukemia W... 展开 >>ith 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Recurrent Adult Acute Myeloid Leukemia 收起 << | Phase 1 | Active, not recruiting | December 1, 2018 | United States, New York ... 展开 >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263 收起 << |
NCT00056160 | Multiple Myeloma | Phase 3 | Completed | - | - |
NCT02886065 | Smoldering Multiple Myeloma | Phase 1 | Recruiting | May 2021 | United States, Massachusetts ... 展开 >> Massachusetts general Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Noopur Raje, MD 617-726-0711 Principal Investigator: Noopur Raje, MD Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02115 Contact: David Avigan, MD Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Paul Richardson, MD 收起 << |
NCT01003769 | Recurrent Chronic Lymphocytic ... 展开 >>Leukemia 收起 << | Phase 1 Phase 2 | Suspended(The accrual objectiv... 展开 >>e for this study has not been met and is currently being re-prioritized until beacon validation sessions are completed.) 收起 << | June 2020 | United States, Florida ... 展开 >> Mayo Clinic in Florida Jacksonville, Florida, United States, 32224-9980 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 收起 << |
NCT00837031 | Metastatic Pancreatic Cancer | Phase 2 | Completed | - | United States, Florida ... 展开 >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 Watson Clinic Center for Cancer Care and Research Lakeland, Florida, United States, 33805 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Kentucky Norton Cancer Institute Louisville, Kentucky, United States, 40207 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 United States, South Carolina South Carolina Oncology Associates, PA Columbia, South Carolina, United States, 29210 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 United States, Virginia Virginia Cancer Institute Richmond, Virginia, United States, 23235 收起 << |
NCT00837031 | - | Completed | - | - | |
NCT03697356 | Waldenström's Macroglobulinemi... 展开 >>a 收起 << | Phase 2 | Not yet recruiting | October 31, 2023 | - |
NCT02636322 | Lymphoma | Phase 2 | Recruiting | March 2023 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 收起 << |
NCT00120120 | Radiculopathy | Phase 2 Phase 3 | Completed | - | - |
NCT02446236 | Mantle Cell Lymphoma | Phase 1 | Recruiting | June 2022 | United States, New Jersey ... 展开 >> The Cancer Center at Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Ewelina Protomastro 551-996-4469 收起 << |
NCT01062152 | Myelodysplastic Syndrome | Phase 1 | Completed | - | United States, Arizona ... 展开 >> Mayo Clinic Phoenix, Arizona, United States, 85054 United States, Illinois Loyola University Chicago Cardinal Benardin Cancer Center Maywood, Illinois, United States, 60153 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Columbia University Medical Center New York, New York, United States, 10032 University of Rochester Medical Center Rochester, New York, United States, 14642 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Texas MDAnderson Houston, Texas, United States, 77030 Cancer Care Centers of South Texas San Antonio, Texas, United States, 78229 收起 << |
NCT01133665 | Squamous Cell Carcinoma | Phase 2 | Completed | - | United States, Illinois ... 展开 >> The University of Chicago Chicago, Illinois, United States, 60637 收起 << |
NCT02086604 | Lymphoma, Large B-Cell, Diffus... 展开 >>e 收起 << | Phase 1 | Active, not recruiting | November 30, 2019 | United States, Missouri ... 展开 >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, Ohio Ohio State University, James Cancer Hospital Columbus, Ohio, United States, 43210 收起 << |
NCT01133665 | - | Completed | - | - | |
NCT00287287 | Thyroid Neoplasms | Phase 2 | Active, not recruiting | December 2018 | United States, Kentucky ... 展开 >> University of Kentucky Markey Cancer Center Lexington, Kentucky, United States, 40536 收起 << |
NCT01472562 | - | Active, not recruiting | - | - | |
NCT01155505 | Advanced Solid Tumors | Phase 1 | Unknown | March 2012 | Italy ... 展开 >> Fondazione IRCSS Istituto Nazionale dei Tumori Milan, Italy, 20133 Switzerland Istituto Oncologico della Svizzera Italiana Bellinzona, Switzerland, 6500 收起 << |
NCT01375140 | Myeloproliferative Diseases | Phase 2 | Completed | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01472562 | Mantle Cell Lymphoma | Phase 2 | Active, not recruiting | October 2022 | United States, Florida ... 展开 >> Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, New York Weill Cornell Medical College New York, New York, United States, 10065 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 收起 << |
NCT01938001 | Lymphoma, Non-Hodgkin | Phase 3 | Active, not recruiting | December 28, 2021 | - |
NCT01779167 | Waldenstrom Macroglobulinemia | Phase 2 | Terminated(Slow Accrual) | - | United States, New York ... 展开 >> Weill Cornell Medical College New York, New York, United States, 10065 收起 << |
NCT01779167 | - | Terminated(Slow Accrual) | - | - | |
NCT01116193 | Leukemia, Lymphoid ... 展开 >> Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 收起 << | Phase 2 | Completed | - | France ... 展开 >> CHU de Clermont-Ferrand Clermont-Ferrand, France, 63003 Hôpital Michallon Grenoble, France, 38000 Hôpital Edouard Herriot Lyon, France, 69003 Institut de Cancerologie de la Loire St Priest en Jarez, France, 42271 收起 << |
NCT01572480 | Multiple Myeloma | Phase 2 | Recruiting | June 1, 2023 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 收起 << |
NCT01352962 | Urethral Neoplasms ... 展开 >> Neoplasms, Urethral Ureter Cancer Cancer of the Urethra Urethral Cancer 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT01297764 | Multiple Myeloma | Phase 1 Phase 2 | Active, not recruiting | August 2019 | United States, New Jersey ... 展开 >> Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 收起 << |
NCT00555100 | Multiple Myeloma | Phase 1 | Completed | - | Japan ... 展开 >> Nagoya City University Hospital Nagoya, Aichi, Japan National Hospital Organization Nagoya Medical Center Nagoya, Aichi, Japan Jichi Medical University Hospital Shimotsuke, Tochigi, Japan Niigata Cancer Center Hospital Niigata, Japan Keio University Hospital Tokyo, Japan 收起 << |
NCT03720041 | Multiple Myeloma | Phase 3 | Not yet recruiting | December 2024 | - |
NCT00415064 | Multiple Myeloma | Phase 1 | Completed | - | United States, Michigan ... 展开 >> Ann Arbor, Michigan, United States, 48109 收起 << |
NCT01126450 | Colon Cancer ... 展开 >>Rectal Cancer 收起 << | Phase 1 | Terminated(low accrual,loss of... 展开 >> funding and results from EU study showing drug ineffective.) 收起 << | - | United States, Ohio ... 展开 >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 收起 << |
NCT00415116 | Unspecified Adult Solid Tumor,... 展开 >> Protocol Specific 收起 << | Phase 1 | Completed | - | - |
NCT00560391 | - | Completed | - | - | |
NCT02955823 | Diffuse Large B-cells Non-Hodg... 展开 >>kin Lymphoma 收起 << | Phase 2 | Recruiting | March 2021 | Italy ... 展开 >> Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (I.R.S.T.) - Ematologia Not yet recruiting Meldola, Forlì-Cesena, Italy Principal Investigator: Gerardo Musuraca, MD A.O. C. Panico - U.O.C Ematologia e Trapianto Recruiting Tricase, Lecce, Italy Principal Investigator: Vicenzo Pavone, MD Ospedale della Versilia USL12 - UOC Medicina - Sezione Ematologia Not yet recruiting Camaiore, Lucca, Italy Principal Investigator: Federico Simonetti, MD ASUR 8 - Medicina Interna e Ematologia Terminated Civitanova Marche, Macerata, Italy Azienda Ospedaliera Arcispedale Santa Maria Nuova - IRCCS - Ematologia Recruiting Reggio nell'Emilia, Reggio Emilia, Italy Principal Investigator: Francesco Merli, MD Ospedali Riuniti del Canavese - S.C. Medicina trasfusionale ed Ematologia Terminated Ivrea, Torino, Italy Ospedale Dell'Angelo - U.O. Ematologia Recruiting Mestre, Venezia, Italy Principal Investigator: Renato Bassan, MD A.O. SS. Antonio e Biagio e Cesare Arrigo - S.C. Ematologia Not yet recruiting Alessandria, Italy Principal Investigator: Marco Ladetto, MD Clinica di Ematologia A.O.Universitaria Ospedali Riuniti, Ancona Recruiting Ancona, Italy Principal Investigator: Guido Gini, MD A.O. Spedali Civili di Brescia - Ematologia Recruiting Brescia, Italy Principal Investigator: Alessandra Tucci, MD Arnas Nuovo Ospedale Garibaldi Nesima - U.O.C. Oncoematologia Not yet recruiting Catania, Italy Principal Investigator: Ugo Consoli, MD IRCCS AOU S. Martino - IST - Clinica Ematologica Recruiting Genova, Italy Principal Investigator: Filippo Ballerini, MD Ospedale Vito Fazzi - Ematologia Not yet recruiting Lecce, Italy Principal Investigator: Nicola Di Renzo, MD Ospedale Madonna delle Grazie - Ematologia Not yet recruiting Matera, Italy Principal Investigator: Alberto Fragasso, MD Azienda Ospedali Riuniti Papardo-Piemonte - S.C. Ematologia Not yet recruiting Messina, Italy Principal Investigator: Donato Mannina, MD Istituto Scientifico San Raffaele - Unità Linfomi - Dipartimento Oncoematologia Terminated Milano, Italy Ospedale Maggiore - Policlinico - Fondazione IRCCS Ca' Granda - Ematologia Not yet recruiting Milano, Italy Principal Investigator: Luca Baldini, MD Ospedale Niguarda Ca' Granda - SC Ematologia Not yet recruiting Milano, Italy Principal Investigator: Vittorio Ruggero Zilioli, MD Azienda Ospedaliero - Universitaria Policlinico di Modena - Dipartimento di Medicina Diagnostica, Clinica e di Sanità Pubblica Recruiting Modena, Italy Principal Investigator: Stefano Sacchi, MD I.R.C.C.S. Istituto Oncologico Veneto - Oncologia 1 Not yet recruiting Padova, Italy Principal Investigator: Dario Marino, MD AOU di Parma - U.O. Complessa di Ematologia Recruiting Parma, Italy Principal Investigator: Francesca Re, MD AO di Perugia - Ematologia Not yet recruiting Perugia, Italy Principal Investigator: Leonardo Flenghi, MD A.O.R. San Carlo - U.O. Ematologia Not yet recruiting Potenza, Italy Principal Investigator: Michele Cimminiello, MD Ospedale delle Croci - Ematologia Recruiting Ravenna, Italy Principal Investigator: Monica Tani, MD Ospedale degli Infermi di Rimini - U.O. di Ematologia Not yet recruiting Rimini, Italy Principal Investigator: Annalia Molinari, MD Azienda Ospedaliera S. Andrea - Ematologia Not yet recruiting Roma, Italy Principal Investigator: Maria Christina Cox, MD Policlinico Universitario Campus Bio-Medico - Area Ematologia Trapianto Cellule Staminali Medicina Trasfusionale e Terapia cellulare Recruiting Roma, Italy Principal Investigator: Ombretta Annibali, MD AOU Senese - U.O.C. Ematologia Not yet recruiting Siena, Italy Principal Investigator: Alberto Fabbri, MD Univ. Perugia Sede Terni - Oncoematologia Recruiting Terni, Italy Principal Investigator: Anna Marina Liberati, MD A.O.U. Citta della Salute e della Scienza di Torino - S.C. Ematologia U Not yet recruiting Torino, Italy Principal Investigator: Federica Cavallo, MD Ospedale ULSS 6 di Vicenza - Ematologia Recruiting Vicenza, Italy Principal Investigator: Carlo Visco, MD 收起 << |
NCT00687674 | - | Terminated(Due to study design... 展开 >> (and toxicity), this trial closed to accrual prior to opening the phase II portion.) 收起 << | - | - | |
NCT00560391 | Multiple Myeloma | Phase 1 | Completed | - | United States, Arizona ... 展开 >> Mayo Clinic Arizona Scottsdale, Arizona, United States, 85259 Australia, Victoria Local Institution Prahran, Victoria, Australia, 3181 France Local Institution Toulouse Cedex 03, France, 31059 Local Institution Vandoeuvre Les Nancy, France, 54511 收起 << |
NCT00522392 | - | Terminated(Slow accrual) | - | - | |
NCT02188368 | Multiple Myeloma | Phase 2 | Recruiting | December 2018 | United States, California ... 展开 >> California Cancer Associates for Research & Excellence (cCARE) Recruiting Encinitas, California, United States, 92024 Contact: Alberto Bessudo, MD Contact: Beth Kimball, RN (760) 452-3909 BKimball@ccare.com Compassionate Care Research Group Recruiting Fountain Valley, California, United States, 92708 Contact: Haresh Jhangiani, MD Contact: Barbara Lepthien (714) 698-0300 barbaral@compcareresearch.com Comprehensive Cancer Center at Desert Regional Medical Center Completed Palm Springs, California, United States, 92262 Inland Hematology Oncology Medical Group, Inc Recruiting San Bernardino, California, United States, 92404 Contact: Samir Kubba, MD Contact: Emmarin Saribut (909) 886-6806 es.ihomg@gmail.com Wellness Oncology and Hematology Recruiting West Hills, California, United States, 91307 Contact: Ashkan Lashkari, MD Contact: Mary Mau (818) 346-1773 mary@wellnessoncology.com James R. Berenson, MD, Inc. Recruiting West Hollywood, California, United States, 90069 Contact: Regina Swift, RN 310-623-1222 rswift@berensononcology.com Contact: James R. Berenson, MD 310-623-1214 jberenenson@imbcr.org Principal Investigator: James Berenson, MD United States, Nevada VA Sierra Nevada Completed Reno, Nevada, United States, 89502 United States, New Mexico San Juan Oncology Associates Recruiting Farmington, New Mexico, United States, 87401 Contact: Jeffrey Neidhart, MD Contact: Rosemarie Mestas (505) 564-6874 rosemarie@sjonc.com United States, Ohio Gabrail Cancer Center Recruiting Canton, Ohio, United States, 44718 Contact: Nashat Gabrail, MD Contact: Kirstie Armstrong (330) 492-3345 karmstrong@gabrailcancercenter.com United States, South Dakota Rapid City Regional Hospital Completed Rapid City, South Dakota, United States, 57701 United States, Tennessee Wellmont Medical Associates Oncology and Hematology Recruiting Kingsport, Tennessee, United States, 37660 Contact: Ibrahim Nakhoul, MD Contact: Justin Reynolds (423) 578-8553 Justin.Reynolds@wellmont.org United States, Washington Vista Oncology Completed Olympia, Washington, United States, 98502 收起 << |
NCT00522392 | Stage I Multiple Myeloma ... 展开 >> Stage II Multiple Myeloma Stage III Multiple Myeloma 收起 << | Phase 3 | Terminated(Slow accrual) | - | - |
NCT01301820 | Acute Myeloid Leukemia | Phase 2 | Completed | - | France ... 展开 >> Mathilde HUNAULT BERGER Angers, France, 49033 收起 << |
NCT00065351 | Multiple Myeloma | Phase 2 | Completed | - | - |
NCT02219178 | Multiple Myeloma | Phase 2 | Active, not recruiting | November 2019 | Ireland ... 展开 >> University Hospital Waterford Waterford, Co Waterford, Ireland Cork University Hospital Cork, Ireland Beaumont Hospital Dublin, Ireland Mater Misericordiae University Hospital Dublin, Ireland St James's Hospital Dublin, Ireland University Hospital Galway Galway, Ireland University Hospital Limerick Limerick, Ireland Midlands Regional Hospital Tullamore, Ireland 收起 << |
NCT00687674 | Multiple Myeloma and Plasma Ce... 展开 >>ll Neoplasm 收起 << | Phase 1 Phase 2 | Terminated(Due to study design... 展开 >> (and toxicity), this trial closed to accrual prior to opening the phase II portion.) 收起 << | - | United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT00843310 | - | Terminated(Due to slow accrual... 展开 >>) 收起 << | - | - | |
NCT02970747 | - | Recruiting | April 2022 | Germany ... 展开 >> Centrum für Hämatologie und Onkologie Bethanien Recruiting Frankfurt, Germany, 60389 Contact: Wolfgang Knauf, Professor 收起 << | |
NCT02728102 | Multiple Myeloma | Phase 2 | Recruiting | August 2022 | United States, California ... 展开 >> University of California, San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Nina Shah, MD nina.shah@ucsf.edu United States, Georgia Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Ajay Nooka, MD anooka@emory.edu United States, Maryland University of Maryland/Greenebaum Cancer Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Aaron Rapaport, MD arapoport@umm.edu United States, Massachusetts Beth Israel Deaconess Medical Center/Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: David Avigan, MD davigan@bidmc.harvard.edu United States, Minnesota University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Mukta Arora, MD arora005@umn.edu United States, Nebraska University of Nebraska Medical Center Recruiting Omaha, Nebraska, United States, 68198-7680 Contact: Muhamed Balievic, MD muhamed.baljevic@unmc.edu United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Pallawi Torka, MD pallawi.torka@roswellpark.org Mount Sinai Medical Center Recruiting New York, New York, United States, 10029 Contact: Keren Osman, MD keren.osman@mountsinai.org Memorial Sloan-Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: David Chung, MD ChungD1@MSKCC.ORG United States, Ohio University Hospitals of Cleveland/Case Western Recruiting Cleveland, Ohio, United States, 44106 Contact: Ehsan Malek, MD ehsan.malek@uhhospitals.org Ohio State University/Arthur G. James Cancer Hospital Recruiting Columbus, Ohio, United States, 43210 Contact: Yvonne Efebera, MD Yvonne.Efebera@osumc.edu United States, Pennsylvania Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 191074 Contact: John Wagner, MD john.wagner@jefferson.edu United States, Texas University of Texas/MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Krina Patel, MD kpatel1@mdanderson.org United States, Washington Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States, 98109-1024 Contact: Leona Holmberg, MD lholmber@fredhutch.org United States, Wisconsin University of Wisconsin Hospital & Clinics Recruiting Madison, Wisconsin, United States, 53792 Contact: Natalie Callendar nsc@medicine.wisc.edu Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53211 Contact: Binod Dhakal, MD bdakal@mcw.edu 收起 << |
NCT02528838 | - | Active, not recruiting | October 30, 2018 | - | |
NCT00843310 | Multiple Myeloma | Phase 2 | Terminated(Due to slow accrual... 展开 >>) 收起 << | - | United States, New York ... 展开 >> Bellevue Hospital New York, New York, United States, 10016 NYU Cancer Center New York, New York, United States, 10016 NYU Tisch Hospital New York, New York, United States, 10016 收起 << |
NCT01239797 | Lymphoma Mult... 展开 >>iple Myeloma 收起 << | Phase 3 | Active, not recruiting | September 30, 2020 | - |
NCT00974233 | - | Completed | - | - | |
NCT00551928 | Multiple Myeloma ... 展开 >> Newly Diagnosed Patients 收起 << | Phase 3 | Active, not recruiting | June 2019 | Italy ... 展开 >> Division of Hematology, Molinette Hospial Torino, Italy, 10126 收起 << |
NCT03500445 | Myeloma Multi... 展开 >>ple Myeloma 收起 << | Phase 2 | Not yet recruiting | January 2023 | United States, Illinois ... 展开 >> The University of Chicago Not yet recruiting Chicago, Illinois, United States, 60637 Contact: Amanda McIver 773-834-5884 amciver@medicine.bsd.uchicago.edu Principal Investigator: Andrzej Jakubowiak, MD, PhD 收起 << |
NCT00538824 | Multiple Myeloma | Phase 2 | Terminated(low enrollment) | - | United States, New York ... 展开 >> Weill Medical College of Cornell University New York, New York, United States, 10021 收起 << |
NCT00974233 | Chronic Lymphocytic Leukemia ... 展开 >> Small Lymphocytic Lymphoma 收起 << | Phase 2 | Completed | - | United States, Wisconsin ... 展开 >> St Vincent Regional Cancer Center Green Bay, Wisconsin, United States, 54301 Bellin Memorial Hospital Green Bay, Wisconsin, United States, 54313 Mercy Health System Heme/Onc Janesville, Wisconsin, United States, 53548 Gundersen Clinic La Crosse, Wisconsin, United States, 54601 University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States, 53792 Marshfield Clinic Marshfield, Wisconsin, United States, 54449 Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Oconomowoc Memorial Hospital Oconomowoc, Wisconsin, United States, 53066 Waukesha Memorial Hospital Waukesha, Wisconsin, United States, 53188 Riverview Hospital Wisconsin Rapids, Wisconsin, United States, 54494 收起 << |
NCT00538824 | - | Terminated(low enrollment) | - | - | |
NCT01615029 | Multiple Myeloma | Phase 1 Phase 2 | Active, not recruiting | December 8, 2022 | United States, Massachusetts ... 展开 >> Boston, Massachusetts, United States Denmark Copenhagen Ø, Denmark Vejle, Denmark France Lille Cedex, France Nantes N/A, France Vandoeuvre Les Nancy, France Netherlands Utrecht, Netherlands United Kingdom London, United Kingdom 收起 << |
NCT02280525 | Leukemia | Phase 1 | Active, not recruiting | March 2021 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01239797 | - | Active, not recruiting | - | - | |
NCT00478218 | Multiple Myeloma and Plasma Ce... 展开 >>ll Neoplasm 收起 << | Phase 2 | Completed | - | United States, Arizona ... 展开 >> Mayo Clinic Scottsdale Scottsdale, Arizona, United States, 85259-5499 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 收起 << |
NCT03544281 | Multiple Myeloma | Phase 2 | Recruiting | November 28, 2022 | United States, Alabama ... 展开 >> GSK Investigational Site Recruiting Birmingham, Alabama, United States, 35294 Contact: US GSK Clinical Trials Call Center 877-379-3718 GSKClinicalSupportHD@gsk.com Contact: EU GSK Clinical Trials Call Center +44 (0) 20 8990 4466 GSKClinicalSupportHD@gsk.com 收起 << |
NCT01638936 | Multiple Myeloma | Phase 1 Phase 2 | Active, not recruiting | November 2018 | United States, California ... 展开 >> City of Hope Duarte, California, United States, 91010 USC Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 United States, Florida Mayo Clinic Jacksonville, Florida, United States, 32224 Memorial Healthcare System Pembroke Pines, Florida, United States, 33028 United States, Georgia Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Illinois The University of Chicago Chicago, Illinois, United States, 60637 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Mount Sinai Medical Center New York, New York, United States, 10029 United States, Texas University of Texas Health Science Center San Antonio, Texas, United States, 78229 收起 << |
NCT02928419 | Myelodysplastic Syndromes | Phase 2 | Terminated("the study has been... 展开 >> closed due to a low rate of patient enrollment (2 patients since the start of the trial)") 收起 << | - | - |
NCT01615029 | - | Active, not recruiting | - | - | |
NCT00478218 | - | Completed | - | - | |
NCT00902915 | Multiple Myeloma Light Chain I... 展开 >>nduced Renal Insufficiency 收起 << | Phase 2 | Unknown | May 2014 | Austria ... 展开 >> LKH Salzburg, 3rd Med. Dept. Salzburg, Austria, 5020 Austrian Forum Against Cancer; 1st Med. Dept., Center for Hematology and Oncology, Wilhelminenspital, Montleartstrasse 37 Vienna, Austria, 1160 Clinic Wels-Grieskirchen, 4th Internal Dept. Wels, Austria, 4600 Czech Republic Faculty Hospital Brno and Faculty of Medicine MU Brno, Czech Republic, 62500 Charles University Prague Prague, Czech Republic, 12821 收起 << |
NCT03367143 | Diffuse Large B-Cell Lymphoma ... 展开 >>Refractory 收起 << | Phase 2 | Recruiting | December 2019 | China, Shanghai ... 展开 >> Shanghai Ruijin Hospital Recruiting Shanghai, Shanghai, China, 200025 Contact: Weili Zhao, MD, PhD 64370045 ext 610707 Zhao.weili@yahoo.com Contact: Pengpeng Xu, MD 64370045 ext 610707 Xpproc@msn.com 收起 << |
NCT01121757 | - | Terminated(The study closed te... 展开 >>mporarily in February 2012 pending analysis of samples collected. In October, 2012, Celgene requested closure of the study.) 收起 << | - | - | |
NCT00253344 | Unspecified Adult Solid Tumor,... 展开 >> Protocol Specific 收起 << | Phase 1 | Completed | - | United States, Ohio ... 展开 >> Ireland Cancer Center at University Hosptials Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 收起 << |
NCT02969837 | Multiple Myeloma | Phase 2 | Recruiting | December 2020 | United States, Illinois ... 展开 >> University of Chicago Recruiting Chicago, Illinois, United States, 60637 Contact: Jennifer Nam 773-702-7716 jnam@medicine.bsd.uchicago.edu NorthShore University Health System Not yet recruiting Evanston, Illinois, United States, 60201 United States, Michigan University of Michigan Comprehensive Cancer Center Not yet recruiting Ann Arbor, Michigan, United States, 48109 收起 << |
NCT01121757 | Follicular Lymphoma ... 展开 >> Marginal Zone Lymphoma 收起 << | Phase 2 | Terminated(The study closed te... 展开 >>mporarily in February 2012 pending analysis of samples collected. In October, 2012, Celgene requested closure of the study.) 收起 << | - | United States, North Carolina ... 展开 >> Duke University Medical Center Durham, North Carolina, United States, 27710 收起 << |
NCT02733224 | - | Unknown | August 2018 | - | |
NCT01782963 | Multiple Myeloma | Phase 2 | Completed | - | United States, Maryland ... 展开 >> John Hopkins University Baltimore, Maryland, United States United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Brigham and Women's Hospital Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Massachusetts General Hospital/North Shore Cancer Center Danvers, Massachusetts, United States, 01923 收起 << |
NCT01307592 | Lymphoma | Phase 2 | Unknown | - | Puerto Rico ... 展开 >> Centro de Cancer del Hospital Auxilio Mutuo Recruiting San Juan, Puerto Rico, 00936-2712 Contact: Clinical Trial Coordinator 787-771-7933 ext. 3569 iliboy@auxiliomutuo.com 收起 << |
NCT01518465 | Stage I Multiple Myeloma ... 展开 >> Stage II Multiple Myeloma Stage III Multiple Myeloma 收起 << | Phase 2 | Terminated(Insufficient Accrua... 展开 >>l) 收起 << | - | United States, California ... 展开 >> USC/Norris Comprehensive Cancer Center Los Angeles, California, United States, 90033 收起 << |
NCT00698776 | Myeloma | Phase 1 | Completed | - | United States, Connecticut ... 展开 >> Yale University School of Medicine New Haven, Connecticut, United States, 06520 收起 << |
NCT01554852 | Multiple Myeloma | Phase 3 | Active, not recruiting | December 2022 | United Kingdom ... 展开 >> 112 sites UK wide United Kingdom, United Kingdom 收起 << |
NCT01782963 | - | Completed | - | - | |
NCT02628405 | CD20 Positive ... 展开 >> Recurrent B-Cell Non-Hodgkin Lymphoma Recurrent Diffuse Large B-Cell Lymphoma Recurrent Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma Recurrent Transformed Non-Hodgkin Lymphoma Refractory B-Cell Non-Hodgkin Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Primary Mediastinal (Thymic) Large B-Cell Cell Lymphoma Refractory Transformed Non-Hodgkin Lymphoma 收起 << | Phase 1 Phase 2 | Recruiting | January 20, 2023 | United States, Florida ... 展开 >> Mayo Clinic in Florida Recruiting Jacksonville, Florida, United States, 32224-9980 Contact: Kathleen M. Burke 904-953-2000 Burke.Kathleen@mayo.edu Principal Investigator: Han W. Tun United States, Illinois Illinois CancerCare-Peoria Withdrawn Peoria, Illinois, United States, 61615 Carle Cancer Center NCI Community Oncology Research Program Recruiting Urbana, Illinois, United States, 61801 Contact: Pauline Mbuvi 217-383-4085 Pauline.Mbuvi@Carle.com Principal Investigator: Priyank P. Patel United States, Iowa University of Iowa/Holden Comprehensive Cancer Center Recruiting Iowa City, Iowa, United States, 52242 Contact: Susan B. Butcher 319-467-5827 susan-butcher@uiowa.edu Principal Investigator: Umar Farooq United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Mayo Clinic Clinical Trials Office 855-776-0015 Principal Investigator: Grzegorz S. Nowakowski Coborn Cancer Center at Saint Cloud Hospital Recruiting Saint Cloud, Minnesota, United States, 56303 Contact: Stacy St. Onge 320-229-4907 stacy.stonge@centracare.com Principal Investigator: Donald J. Jurgens Metro Minnesota Community Oncology Research Consortium Recruiting Saint Louis Park, Minnesota, United States, 55416 Contact: Elizabeth J. Wagner 952-992-1555 Elizabeth.wagner@parknicollet.com Principal Investigator: Daniel M. Anderson United States, Nebraska University of Nebraska Medical Center Withdrawn Omaha, Nebraska, United States, 68198 United States, New Hampshire Dartmouth Hitchcock Medical Center Recruiting Lebanon, New Hampshire, United States, 03756 Contact: Julie Gurnsey 603-653-3640 Julie.d.gurnsey@hitchcock.org Principal Investigator: Frederick Lansigan United States, New Jersey Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Kara M. Yannotti 551-996-5900 Kara.Yannotti@HackensackMeridian.org Principal Investigator: Tatyana A. Feldman United States, New York State University of New York Upstate Medical University Recruiting Syracuse, New York, United States, 13210 Contact: Joanne M. Chilton 315-464-8240 chiltonj@upstate.edu Principal Investigator: Teresa C. Gentile United States, Pennsylvania Geisinger Medical Center Withdrawn Danville, Pennsylvania, United States, 17822 United States, South Dakota Rapid City Regional Hospital Completed Rapid City, South Dakota, United States, 57701 United States, Wisconsin Marshfield Clinic Recruiting Marshfield, Wisconsin, United States, 54449 Contact: Sheryl L. Mandel 715-389-4457 Mandel.Sheryl@mcrf.mfldclin.edu Principal Investigator: Ali W. Bseiso 收起 << |
NCT00378209 | Multiple Myeloma | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 << |
NCT00864942 | Chronic Lymphocytic Leukemia ... 展开 >> Non-Hodgkin's Lymphoma 收起 << | Phase 1 | Completed | - | United States, District of Col... 展开 >>umbia Georgetown University Hospital/Lombardi Cancer Center Washington, District of Columbia, United States, 20007 收起 << |
NCT01160484 | Multiple Myeloma | Phase 2 | Completed | - | United States, California ... 展开 >> Comprehensive Blood and Cancer Center Bakersfield, California, United States, 93309 Hematology-Oncology Medical Group of Fresno, Inc. Fresno, California, United States, 93720 Loma Linda University Loma Linda, California, United States, 92354 Santa Barbara Hematology Oncology Santa Barbara, California, United States, 93105 James R. Berenson, M.D., Inc. West Hollywood, California, United States, 90069 United States, Florida Watson Clinic, LLP, Center for Care and Research Lakeland, Florida, United States, 33805 United States, New York Bassett Cancer Institute Cooperstown, New York, United States, 13326 Broome Oncology Johnson City, New York, United States, 13790 收起 << |
NCT00445484 | Multiple Myeloma and Plasma Ce... 展开 >>ll Neoplasm 收起 << | Phase 2 | Completed | - | United States, Maryland ... 展开 >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 收起 << |
NCT01160484 | - | Completed | - | - | |
NCT00445484 | - | Completed | - | - | |
NCT00378209 | - | Completed | - | - | |
NCT01522976 | Chronic Myelomonocytic Leukemi... 展开 >>a Chronic Myelomonocytic Leukemia-1 Chronic Myelomonocytic Leukemia-2 Myelodysplastic Syndrome Myelodysplastic Syndrome With Excess Blasts Myelodysplastic Syndrome With Excess Blasts-1 Myelodysplastic Syndrome With Excess Blasts-2 Previously Treated Myelodysplastic Syndrome 收起 << | Phase 2 | Active, not recruiting | - | - |
NCT01522976 | - | Active, not recruiting | - | - | |
NCT02983097 | Diffuse Large B-cell Lymphoma ... 展开 >>(DLBCL) Follicular Lymphoma Grade III (FL III°) Mantle Cell Lymphoma (MCL), Blastoid Variant Burkitt Lymphoma (BL) Aggressive Marginal Zone Lymphoma (MZL) 收起 << | Phase 1 Phase 2 | Terminated(Phase II no scienti... 展开 >>fic interests are given anymore) 收起 << | - | Germany ... 展开 >> Diakonie Krankenhaus Bremen Bremen, Germany, 28239 Klinikum Chemnitz Chemnitz, Germany, 09113 Universitätsklinikum Essen Essen, Germany, 45122 Klinikum Frankfurt/Oder Frankfurt/Oder, Germany, 15236 Universitätsklinikum Göttingen Göttingen, Germany, 37075 Asklepios Klinik St. Georg Hamburg, Germany, 20099 Asklepios Klinik Altona Hamburg, Germany, 22763 Universitätsklinikum Heidelberg Heidelberg, Germany, 69120 Universitätsklinikum des Saarlandes Homburg, Germany, 66421 Westpfalz Klinikum Kaiserslautern, Germany, 67665 Städtisches Klinikum Karlsruhe Karlsruhe, Germany, 76133 LMU Klinikum München-Großhadern München, Germany, 81377 收起 << |
NCT02279394 | Smoldering Myeloma ... 展开 >> Smoldering Multiple Myeloma 收起 << | Phase 2 | Active, not recruiting | October 2023 | United States, Colorado ... 展开 >> Colorado Blood Cancer Institute Denver, Colorado, United States, 80218 United States, Connecticut St Francis Hospital and Medical Center Hartford, Connecticut, United States, 06105 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, Maine Eastern Maine Medical Center Brewer, Maine, United States, 04412 United States, Maryland University of Maryland Baltimore, Maryland, United States, 21201 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Newton-Wellesley Hospital Newton, Massachusetts, United States, 02462 United States, Michigan Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, North Carolina Levine Cancer Institute Charlotte, North Carolina, United States, 28204 收起 << |
NCT01374217 | Multiple Myeloma | Phase 2 | Terminated(early stopping rule... 展开 >>) 收起 << | - | United States, Maryland ... 展开 >> Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21287 收起 << |
NCT00807599 | Multiple Myeloma | Phase 2 | Completed | - | United States, New Jersey ... 展开 >> Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States United States, New York Memorial Sloan-Kettering Cancer Center @ Suffolk Commack, New York, United States, 11725 Memorial Sloan Kettering West Harrison Harrison, New York, United States, 10604 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Memorial Sloan Kettering at Mercy Medical Center Rockville Centre, New York, United States Memoral Sloan Kettering Cancer Center at Phelps Sleepy Hollow, New York, United States, 10591 Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center Sleepy Hollow, New York, United States, 10591 收起 << |
NCT00424229 | Myelodysplastic Syndromes | Phase 2 | Unknown | - | France ... 展开 >> CHU Angers Recruiting Angers, France, 49033 Contact: Mathilde HUNAULT-BERGER, MD 0033241354475 MHunault@chu-angers.fr Principal Investigator: HUNAULT-BERGER, MD CHRU Hurriez Recruiting Lille, France, 59057 Contact: Bruno QUESNEL, Profesor 0033320446640 b-quesnel@chru.fr Principal Investigator: QUESNEL, Professor Hopital Paoli Calmette Recruiting Marseille, France, 13273 Contact: Norbert VEY, MD 0033431223695 veyn@marseille.fnclcc.fr Principal Investigator: VEY, MD Sub-Investigator: CHARBONNIER, MD Sub-Investigator: GASTAUT, Professor Sub-Investigator: BOUABDALLAH, MD Sub-Investigator: REY, MD Sub-Investigator: STOPPA, MD Hopital Hotel Dieu Recruiting Nantes, France, 44093 Contact: Jean-Luc HAROUSSEAU 0033240083271 Principal Investigator: Jacques Delaunay Hopital Archet Recruiting Nice, France, 06202 Contact: Laurence LEGROS 0033492035844 legros.l@chu-nice.fr Principal Investigator: LEGROS, MD Hoiptal St Louis Recruiting Paris, France, 75475 Contact: Herve DOMBRET, Profesor 0033142499643 herve.dombret@sls.aphp.fr Principal Investigator: Hervé Dombret Hopital Cochin Recruiting Paris, France, 75679 Contact: Francois DREYFUS, Professor 003358412120 francois.dreyfus@cch.aphp.fr Principal Investigator: DREYFUS, Professor Hopital Jean-Bernard Recruiting Poitiers, France, 86021 Contact: Francois GUILHOT, Professor 0033549444201 f.guilhot@chu-poitiers.fr Principal Investigator: GUILHOT, Profesor Sub-Investigator: ROY, MD Centre Henry Becquerel Recruiting Rouen, France, 76 038 Contact: Aspasia Stamatoullas, MD 33 2 32 08 22 88 aspsta@rouen.fnclcc.fr Principal Investigator: Aspasia Stamatoullas Chu Purpan Recruiting Toulouse, France, 31059 Contact: Odile BEYNE-RAUZY, Doctor 0033561779679 beynerauzy.o@chu-toulouse.fr Principal Investigator: Odile BEYNE-RAUZY CHU Brabois Recruiting Vandoeuvre, France, 54511 Contact: Agnes GUERCI-BRESLER, MD 0033383153281 a.guerci@chu-nancy.fr Principal Investigator: GUERCI-BRESLER, MD 收起 << |
NCT01374217 | - | Terminated(early stopping rule... 展开 >>) 收起 << | - | - | |
NCT00378105 | - | Active, not recruiting | - | - | |
NCT03669445 | Multiple Myeloma | Phase 2 | Not yet recruiting | December 2024 | France ... 展开 >> University Hosptial Toulouse Toulouse, France, 31000 收起 << |
NCT01035463 | Adult Nasal Type Extranodal NK... 展开 >>/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Peripheral T-cell Lymphoma Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Splenic Marginal Zone Lymphoma Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Cutaneous T-cell Non-Hodgkin Lymphoma Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Mycosis Fungoides/Sezary Syndrome Stage III Small Lymphocytic Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Mycosis Fungoides/Sezary Syndrome Stage IV Small Lymphocytic Lymphoma Waldenström Macroglobulinemia 收起 << | Phase 1 Phase 2 | Active, not recruiting | May 2018 | United States, Kansas ... 展开 >> University of Kansas Hospital - Westwood Cancer Center Westwood, Kansas, United States, 66205 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 United States, Ohio Seidman Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 收起 << |
NCT00378105 | Multiple Myeloma | Phase 1 Phase 2 | Active, not recruiting | February 2019 | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 << |
NCT02495922 | Multiple Myeloma | Phase 3 | Active, not recruiting | March 2021 | - |
NCT01865110 | Mantle Cell Lymphoma | Phase 3 | Recruiting | March 2024 | - |
NCT01629082 | Myeldysplastic Syndrome (MDS) ... 展开 >> Chronic Myelomonocytic Leukemia Bone Marrow Diseases Neutropenia Acute Myeloid Leukemia (AML) 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 收起 << |
NCT01208051 | Recurrent Thyroid Gland Carcin... 展开 >>oma Stage I Thyroid Gland Follicular Carcinoma AJCC v7 Stage I Thyroid Gland Papillary Carcinoma AJCC v7 Stage II Thyroid Gland Follicular Carcinoma AJCC v7 Stage II Thyroid Gland Papillary Carcinoma AJCC v7 Stage III Thyroid Gland Follicular Carcinoma AJCC v7 Stage III Thyroid Gland Papillary Carcinoma AJCC v7 Stage IV Thyroid Gland Follicular Carcinoma AJCC v7 Stage IV Thyroid Gland Papillary Carcinoma AJCC v7 Stage IVA Thyroid Gland Follicular Carcinoma AJCC v7 Stage IVA Thyroid Gland Papillary Carcinoma AJCC v7 Stage IVB Thyroid Gland Follicular Carcinoma AJCC v7 Stage IVB Thyroid Gland Papillary Carcinoma AJCC v7 Stage IVC Thyroid Gland Follicular Carcinoma AJCC v7 Stage IVC Thyroid Gland Papillary Carcinoma AJCC v7 收起 << | Phase 1 Phase 2 | Active, not recruiting | September 30, 2018 | - |
NCT03173092 | Multiple Myeloma | Phase 4 | Recruiting | November 30, 2023 | - |
NCT03673826 | Smouldering Myeloma | Phase 2 | Recruiting | October 2025 | Netherlands ... 展开 >> Erasmus MC Recruiting Rotterdam, Netherlands Contact: A. Broyl 收起 << |
NCT02631577 | Lymphoma, Follicular | Phase 1 Phase 2 | Active, not recruiting | November 10, 2020 | United States, Alabama ... 展开 >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35294-0017 United States, Florida University Miami Miami, Florida, United States, 33136 United States, Kentucky Norton Medical Plaza II Louisville, Kentucky, United States, 40207 United States, New York Memorial Sloan-Kettering Cancer Center; Hematology/Oncology New York, New York, United States, 10065 United States, North Carolina Levine Cancer Institute Charlotte, North Carolina, United States, 28204 France Hopital Henri Mondor; 51 Av Mal Lattre De Tassigny Creteil, France, 94010 Hopital du Bocage Dijon, France, 21034 Centre Jean Bernard Le Mans, France, 72015 Centre Hospitalier Le Mans Le Mans, France, 72037 CHRU de Lille - Hopital Claude Huriez Lille, France, 59037 CHU Montpellier - Saint ELOI Montpellier, France, 34295 CHU - Hôtel Dieu hematolgie clinique Nantes, France, 44093 Centre Hospitalier Lyon Sud; Hematolgie Pierre Benite, France, 69495 CHU de Rennes - Hopital de Pontchaillo Rennes, France, 35033 Centre Henri Becquerel Rouen, France, 76038 Chu Toulouse Toulouse, France, 31059 收起 << |
NCT00724568 | - | Completed | - | - | |
NCT01742793 | Hodgkin's Lymphoma ... 展开 >> Mature T-cell Lymphoma Multiple Myeloma 收起 << | Phase 1 Phase 2 | Terminated | - | United States, Connecticut ... 展开 >> Yale Cancer Center New Haven, Connecticut, United States, 06519 收起 << |
NCT03702725 | Refractory Multiple Myeloma ... 展开 >> Multiple Myeloma in Relapse Multiple Myeloma 收起 << | Phase 1 | Not yet recruiting | October 1, 2021 | - |
NCT01080391 | Relapsed Multiple Myeloma | Phase 3 | Completed | - | - |
NCT00724568 | Multiple Myeloma | Phase 1 Phase 2 | Completed | - | United States, Georgia ... 展开 >> Emory University Hospital Atlanta, Georgia, United States, 30322 United States, Illinois The University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Massachusetts Dana Farber Cancer Institute (and Massachusetts General) Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 United States, Ohio The Ohio State University Medical Center Columbus, Ohio, United States, 43210 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 收起 << |
NCT00477750 | Multiple Myeloma and Plasma Ce... 展开 >>ll Neoplasm 收起 << | Phase 1 Phase 2 | Completed | - | United States, Arizona ... 展开 >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259-5499 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT00477750 | - | Completed | - | - | |
NCT02142049 | Diffuse Large B Cell Lymphoma ... 展开 >>Relapsed Diffuse Large B Cell Lymphoma Refractory 收起 << | Phase 1 Phase 2 | Unknown | November 2017 | United States, California ... 展开 >> SITE-1 Duarte, California, United States, 91010 SITE-2 Los Angeles, California, United States, 90095 SITE-10 Orange, California, United States, 92868 United States, Illinois SITE-3 Chicago, Illinois, United States, 60612 United States, Maryland SITE-5 Baltimore, Maryland, United States, 21201 SITE-6 Bethesda, Maryland, United States, 20892 United States, Michigan SITE-4 Ann Arbor, Michigan, United States, 48109 United States, New Mexico SITE-8 Albuquerque, New Mexico, United States, 87106 United States, New York SITE-9 Stony Brook, New York, United States, 11794 United States, South Carolina SITE-7 Charleston, South Carolina, United States, 29425 收起 << |
NCT03617731 | Multiple Myeloma | Phase 3 | Recruiting | December 2025 | Germany ... 展开 >> HELIOS Klinikum, Klinik für Hämatologie, Onkologie und Immunologie Not yet recruiting Berlin, Germany, 13125 Contact: Stephan Fuhrmann, Dr. 030 ext 940112151 stephan.fuhrmann@helios-kliniken.de Contact: Judith Niederland, Dr. judith.niederland@helios-kliniken.de Klinikum Bielefeld, Klinik für Hämatologie, Onkologie und Palliativmedizin Not yet recruiting Bielefeld, Germany, D-33604 Contact: Martin Görner, Dr. med. 0521-581-3601 martin.goerner@klinikumbielefeld.de Contact: Ulrich Krümpelmann, Dr. ulrich.kruempelmann@klinikumbielefeld.de Medizinische Universitätsklinik, Knappschaftskrankenhaus Not yet recruiting Bochum, Germany, D-44892 Contact: Roland Schroers, Prof. Dr. med. 0234-2993447 roland.schroers@rub.de Contact: Lars Petersen, Dr. Universitätsklinikum Bonn, Medizinische Klinik und Poliklinik III, Schwerpunkt Onkologie, Hämatologie und Rheumatologie Not yet recruiting Bonn, Germany, 53105 Contact: Annkristin Heine, Dr. 0228 ext 28717232 annkristin.heine@ukb.uni-bonn.de; Contact: Jai-Juen Shiue, Dr. Klinikum Chemnitz GmbH, Innere Medizin III Not yet recruiting Chemnitz, Germany, D-09116 Contact: Mathias Hänel, PD Dr. med. 0371-333-43045 m.haenel@skc.de Contact: Anke Morgner, Dr. Onkologisches Studienzentrum Darmstadt Not yet recruiting Darmstadt, Germany, 64283 Contact: Gerrit Dingeldein Contact: Georgi Kojouharoff, Dr. 06151-130480 Klinikum Darmstadt, Med. Klinik V, Hämatologie/Onkologie Not yet recruiting Darmstadt, Germany, D-64283 Contact: Helga Bernhard, Prof. Dr. 06151-107-6651 helga.bernhard@mail.klinikum-darmstadt.de Contact: Tu-Anh Dang, Dr. tu-anh.dang@mail.klinikum-darmstadt.de HELIOS St. Johannes Klinik, Akademisches Krankenhaus der Heinrich-Heine-Universität Düsseldorf Not yet recruiting Duisburg, Germany, 47166 Contact: Michael n.a. Heinsch, Dr. 0203 ext 5462442 michael.heinsch@helios-kliniken.de Universitätsklinikum Düsseldorf, Klinik für Hämatologie,Onkologie und Klin. Immunologie Not yet recruiting Düsseldorf, Germany, D-40225 Contact: Roland Fenk, Prof. Dr. 0211-811-7760 fenk@med.uni-duesseldorf.de Contact: Amelie Boquoi, Dr. Universitätsklinik Erlangen Not yet recruiting Erlangen, Germany, 91054 Contact: Barbara Ferstl, Dr. 09131 ext 8543104 Barbara.Ferstl@uk-erlangen.de Contact: Andreas Mackensen, Prof. Andreas.Mackensen@uk-erlangen.de Universitätsklinikum Essen, Klinik für Hämatologie Not yet recruiting Essen, Germany, D-45147 Contact: Jan Dürig, Prof. Dr. 0201-72384621 jan.duerig@uni-essen.de Contact: Karl Richard Maria Noppeney, Dr. 0201-72384215 Ev. Krankenhaus Essen-Werden gGmbH, Zentrum für Innere Medizin, Klinik für Hämatologie, Onkologie und Stammzelltransplantation Not yet recruiting Essen, Germany, D-45239 Contact: Mohammed Wattad, Dr. 0201-4089 2246 m.wattad@kliniken-essen-sued.de Contact: Peter Reimer, Prof. Dr. 0201-4089-0 p.reimer@kliniken-essen-sued.de Universitätsklinikum Frankfurt, Goethe-Universität Medizinische Klinik II Not yet recruiting Frankfurt am Main, Germany, 60590 Contact: Wilde Birgit 069-6301 ext 86708 Birgit.Wilde@kgu.de Kath. Krankenhaus Hagen gGmbH, Abt. Hämatologie/Onkologie Not yet recruiting Hagen, Germany, D-58095 Contact: Hans-Walter Lindemann, Dr. 02331-129-0 w.lindemann@kkh-hagen.de Contact: Cordula Maria Elisabeth Maciejewski maciejewskic@kkh-hagen.de Asklepios Klinik Hamburg Altona, II. Med. Klinik Not yet recruiting Hamburg, Germany, D-22763 Contact: Hans Salwender, Dr. 040-181881-1212 h.salwender@asklepios.com KRH Klinikum Siloah, Klinik für Hämatologie und Onkologie Not yet recruiting Hannover, Germany, 30459 Contact: Martin Müller, PD Dr. Contact: Kim Marienhagen University Hospital Heidelberg, Med. Klinik V Recruiting Heidelberg, Germany, D-69120 Contact: GMMG Study Office studiensekretariat.gmmg@med.uni-heidelberg.de Principal Investigator: Hartmut Goldschmidt, Prof. Dr. SLK Kliniken Heilbronn, Med. Klinik III Not yet recruiting Heilbronn, Germany, D-74078 Contact: Uwe Martens, Prof. Dr. uwe.martens@slk-kliniken.de Contact: Markus Lindauer, Dr. Praxisklinik für Hämatologie und Onkologie Not yet recruiting Koblenz, Germany, D-56068 Contact: Jörg Thomalla, Dr. med. 0261-30493-0 thomalla@onkologie-koblenz.de Contact: Rudolf Weide, Prof. Dr. Med. Klinik A, Klinikum der Stadt Ludwigshafen am Rhein gGmbH Not yet recruiting Ludwigshafen am Rhein, Germany, 67063 Contact: Martin Hoffmann, Dr. 0621 ext 50340702 HoffmanM@klilu.de Contact: Michael Uppenkamp, Prof. Dr. 0621 ext 50340702 Universitätsmedizin der Johannes Gutenberg-Universität Mainz, III. Med. Klinik Not yet recruiting Mainz, Germany, D-55131 Contact: Markus Munder, PD. Dr. med. 06131-17-5948 markus.munder@unimedizin-mainz.de Contact: Georg Heß, PD Dr. III. Medizinische Klinik Hämatologie und Internistische Onkologie Not yet recruiting Mannheim, Germany, 68167 Contact: Stefan Klein, PD Dr. 0621-383-4114 stefan.klein@umm.de Mannheimer Onkologie Praxis Not yet recruiting Mannheim, Germany, D-68161 Contact: Manfred Hensel, Prof. Dr. med. hensel@mannheimer-onkologie-praxis.de Contact: Dieter Schuster, Dr. med. Philipps-Universität Marburg, Hämatologie/Onkologie/Immunologie Not yet recruiting Marburg, Germany, 35032 Contact: Andreas Neubauer, Prof. Dr. neubauer@med.uni-marburg.de Contact: Ellen Wollmer, Dr. wollmer@med.uni-marburg.de Mühlenkreiskliniken (AöR) Johannes Wesling Klinikum Minden, Hämatologie/Onkologie, Hämostaseologie und Palliativmedizin Not yet recruiting Minden, Germany, 32429 Contact: Hans-Joachim Tischler, Dr. 0571 ext 7904202 hans-joachim.tischler@muehlenkreiskliniken.de Contact: Kai Wille, Dr. 0571 ext 79051193 kai.wille@muehlenkreiskliniken.de Krankenhaus Maria Hilf GmbH, Franziskuskrankenhaus, Med. Klinik I Not yet recruiting Mönchengladbach, Germany, D-41063 Contact: Ullrich Graeven, PD Dr. 02161-892-2201 Ullrich.Graeven@mariahilf.de Contact: Heidi Herfert 02161-892-2372 heidi.herfert@mariahilf.de Krankenhaus Barmherzige Brüder, Klinik für Onkologie und Hämatologie Not yet recruiting Regensburg, Germany, 93049 Contact: Bernhard Heilmeier, Dr. 0941 ext 36992152 bernhard.heilmeier@barmherzige-regensburg.de Contact: Anke Schlenska-Lange, Dr. anke.schlenska-lange@barmherzige-regensburg.de; Diakonie-Klinikum Schwäbisch Hall gGmbH, Innere Medizin III Not yet recruiting Schwäbisch Hall, Germany, 74523 Contact: Sabine Kraft 0791-753-4018 ext 4486 sabine.kraft@dasdiak.de Contact: Samiha Priwitzer Samiha.priwitzer@dasdiak.de ZAHO-Zentrum für ambulante Hämatologie und Onkologie, Standort Siegburg Not yet recruiting Siegburg, Germany, D-53721 Contact: Stefan Fronhoffs, Dr. sfronhoffs@zaho-rheinland.de Contact: Bettina Bürgel 02241-5954-23 studienbuero@zaho-rheinland.de Onkologische Schwerpunktpraxis Speyer Not yet recruiting Speyer, Germany, D-67346 Contact: Joachim Behringer, Dr. med. j.behringer@onkologie-speyer.de Contact: Lars Scheuer, Dr. 06232-604460 onkologie-speyer@t-online.de University Hospital Tübingen, Med. Klinik und Poliklinik, Abt. II Not yet recruiting Tübingen, Germany, D-72076 Contact: Katja Weisel, PD Dr. 07071-29-84321 katja.weisel@med.uni-tuebingen.de Contact: Britta Besemer, Dr. britta.besemer@med.uni-tuebingen.de 收起 << |
NCT01711671 | Multiple Myeloma | Phase 1 | Completed | - | United States, Georgia ... 展开 >> Emory University Hospital Atlanta, Georgia, United States, 30322 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 收起 << |
NCT01080391 | - | Completed | - | - | |
NCT00567229 | Multiple Myeloma and Plasma Ce... 展开 >>ll Neoplasm 收起 << | Phase 2 | Terminated(Lack of Accrual) | - | United States, New York ... 展开 >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 收起 << |
NCT00238238 | Lymphoma | Phase 2 | Completed | - | - |
NCT00621400 | Amyloidosis | Phase 1 Phase 2 | Completed | - | France ... 展开 >> CHRU d'Amiens Amiens, France, 80054 CHRU de Lille Lille, France, 59037 CHU de Limoges Limoges, France, 87042 CHU de Nantes Nantes, France, 44093 Hôpital Saint-Louis Paris, France, 75475 Hôpital Pitié Salpetrière Paris, France, 75651 Hôpital necker Paris, France, 75743 Hôpitaux Civils de Lyon Pierre-Bénite, France, 69495 CHU de Poitiers Poitiers, France, 86021 CHU de Rennes Rennes, France, 35203 CHU de Toulouse Toulouse, France, 31059 CHRU deTours Tours, France, 37044 收起 << |
NCT00567229 | - | Terminated(Lack of Accrual) | - | - | |
NCT01099267 | - | Completed | - | United States, Arizona ... 展开 >> Mayo Clinic - Scottsdale Scottsdale, Arizona, United States, 85259 United States, California Stanford University Cancer Center Stanford, California, United States, 94305 United States, Florida Cancer & Blood Disease Center Lecanto, Florida, United States, 34461 H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Georgia Northwest Georgia Oncology Centers, P.C. Marietta, Georgia, United States, 30060 United States, Illinois Hematology Oncology Associates of Illinois Chicago, Illinois, United States, 60611 Rush University Medical Center Chicago, Illinois, United States, 60612 University of Chicago Chicago, Illinois, United States, 60637 United States, Maryland John Hopkins University Hospital Baltimore, Maryland, United States, 21231 United States, Minnesota Mayo Clinic - Rochester Rochester, Minnesota, United States, 55905 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Wake Forest University Winston-Salem, North Carolina, United States, 27157 United States, Ohio The Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Germany St. Johannes Hospital Duisburg, Germany, D-47166 收起 << | |
NCT01208662 | Multiple Myeloma | Phase 3 | Active, not recruiting | September 2018 | - |
NCT00642954 | Relapsed or Refractory Multipl... 展开 >>e Myeloma 收起 << | Phase 1 | Completed | - | - |
NCT01099267 | - | Completed | - | - | |
NCT00860457 | Chronic Lymphocytic Leukemia | Phase 2 | Completed | - | United States, District of Col... 展开 >>umbia Lombardi Cancer Center at Georgetown University Medical Center Washington, District of Columbia, United States, 20007 收起 << |
NCT00860457 | - | Completed | - | - | |
NCT01668719 | DS Stage I Plasma Cell Myeloma... 展开 >> DS Stage II Plasma Cell Myeloma DS Stage III Plasma Cell Myeloma 收起 << | Phase 1 Phase 2 | Active, not recruiting | September 2021 | - |
NCT02353468 | Refractory Plasma Cell Myeloma | Phase 2 | Terminated(Principle investiga... 展开 >>tor left the institution) 收起 << | - | United States, Colorado ... 展开 >> University of Colorado Aurora, Colorado, United States, 80045 收起 << |
NCT02353468 | - | Terminated(Principle investiga... 展开 >>tor left the institution) 收起 << | - | - | |
NCT00644228 | DS Stage I Plasma Cell Myeloma... 展开 >> DS Stage II Plasma Cell Myeloma DS Stage III Plasma Cell Myeloma 收起 << | Phase 3 | Active, not recruiting | - | - |
NCT00644228 | - | Active, not recruiting | - | - | |
NCT02685826 | Multiple Myeloma | Phase 1 | Active, not recruiting | September 6, 2022 | - |
NCT00792077 | Leukemia CLL | Not Applicable | Active, not recruiting | November 2019 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00911105 | - | Completed | - | Germany ... 展开 >> Onkologische Schwerpunktpraxis Bad Homburg, Germany, 61348 Onkologische Schwerpunktpraxis Berlin, Germany, 10365 Onkologisches Versorgungszentrum Friedrichshain Berlin, Germany, 10407 Onkologische Praxis Berlin, Germany, 13439 Onkologische Gemeinschaftspraxis Frankfurt am Main, Germany, 60389 Praxis für Innere Medizin Germering, Germany, 82110 MedResearch - Medizinisches Studien- und Dokumentationszentrum Leipziger Land Groitzsch, Germany, 04539 Internistische Gemeinschaftspraxis Guestrow, Germany, 18273 Praxis für Innere Medizin, Haematologie und Internistische Onkologie Hamburg, Germany, 22587 Tumorpraxis Heidenheim Heidenheim, Germany, 89518 Onkol. Gem.praxis Dr. M. Neise & Dr. A. Lollert Krefeld, Germany, 47805 Onkologisches Zentrum Lebach Lebach, Germany, 66822 Onkologische Gemeinschaftspraxis Lehrte, Germany, 31275 Gemeinschaftspraxis Dr. Aldaoud - Dr. Schwarzer Leipzig, Germany, 04289 Praxis für Haematologie und Onkologie Muehlheim, Germany, 45468 Praxis fuer Innere Medizin Neumarkt I. D. O., Germany, 92318 Praxis fuer Onkologie und Haematologie Neuss, Germany, 41462 Haematologisch-Onkologische Gemeinschaftspraxis Nordhorn, Germany, 48527 Onkologische Praxis Oldenburg Oldenburg, Germany, 26121 Onkologische Gemeinschaftspraxis Wuerselen, Germany, 52146 收起 << | |
NCT00067743 | Complex Regional Pain Syndrome... 展开 >> (RSD) 收起 << | Phase 2 | Completed | - | United States, California ... 展开 >> UCSD Center for Pain and Palliative Medicine La Jolla, California, United States, 92093 United States, Maryland Johns Hopkins Hospital Baltimore, Maryland, United States, 21287 United States, North Carolina UNC Hospitals University of North Carolina Chapel Hill, North Carolina, United States, 27599-7010 The Center for Clinical Research Winston Salem, North Carolina, United States, 27103 United States, Pennsylvania Drexel University College of Medicine Philadelphia, Pennsylvania, United States, 19102 United States, Washington Swedish Pain Management Seattle, Washington, United States, 98122-4379 收起 << |
NCT01093196 | Multiple Myeloma | Phase 3 | Active, not recruiting | November 2021 | Italy ... 展开 >> Division Of Hematology, A.O.U. San Giovanni Battista Torino, TO, Italy, 10126 收起 << |
NCT03001804 | - | Recruiting | December 30, 2019 | Austria ... 展开 >> KH der Elisabethinen Linz , 1. Interne Hämato-Onkologie Recruiting Linz, Austria, 4020 Krankenhaus der Barmherzigen Schwestern Ried Innere Medizin 1 Recruiting Ried, Austria, 4910 Landeskrankenhaus Steyr - Innere Medizin Active, not recruiting Steyr, Austria, 4400 Innere Medizin I, Abteilung Hämatologie & Hämostaseologie Recruiting Vienna, Austria, 1000 - 1901 St. Josef Krankenhaus Recruiting Vienna, Austria, 1130 Wilhelminenspital, 1. Med.Abteilung, Zentrum für Onkologie Not yet recruiting Vienna, Austria, 1160 Salzkammergut-Klinikum Vöcklabruck Abteilung Innere Medizin Active, not recruiting Vöcklabruck, Austria, 4840 收起 << | |
NCT00419250 | Chronic Lymphocytic Leukemia ... 展开 >> Leukemia, B-Cell, Chronic 收起 << | Phase 1 | Completed | - | - |
NCT01050790 | Multiple Myeloma | Not Applicable | Completed | - | United States, Virginia ... 展开 >> Virginia Commonwealth University Richmond, Virginia, United States, 23298 收起 << |
NCT00238238 | - | Completed | - | - | |
NCT00602836 | Leukemia Lymp... 展开 >>homa 收起 << | Phase 2 | Completed | - | United States, Arizona ... 展开 >> Mayo Clinic Scottsdale Scottsdale, Arizona, United States, 85259-5499 United States, Florida Mayo Clinic - Jacksonville Jacksonville, Florida, United States, 32224 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 收起 << |
NCT01701076 | Multiple Myeloma | Phase 2 | Completed | - | Switzerland ... 展开 >> Kantonsspital St. Gallen St. Gallen, Switzerland, 9000 收起 << |
NCT01191060 | Myeloma | Phase 3 | Active, not recruiting | September 2020 | - |
NCT01050790 | - | Completed | - | - | |
NCT00602836 | - | Completed | - | - | |
NCT02460276 | Relapsed/Refractory Mantle Cel... 展开 >>l Lymphoma 收起 << | Phase 2 | Recruiting | March 2019 | Denmark ... 展开 >> Rigshospitalet Not yet recruiting Copenhagen, Denmark Contact: Martin Hutchings, MD, PhD martin.hutchings@regionh.dk Principal Investigator: Martin Hutchings, MD, PhD Finland Helsinki University Hospital Not yet recruiting Helsinki, Finland Contact: Riikka Räty, MD, PhD +358 10 328 1900 riikka.raty@hus.fi Principal Investigator: Riikka Räty, MD, PhD Norway Norwegian Radium Hospital Not yet recruiting Oslo, Norway, 0424 Contact: Arne Kolstad, MD, PhD +47 915 02 770 arne.kolstad@oslo-universitetssykehus.no Principal Investigator: Arne Kolstad, MD, PhD Sweden Lund University Hospital Recruiting Lund, Sweden, 221 85 Contact: Mats Jerkeman, MD, PhD +46 46 17 75 20 mats.jerkeman@med.lu.se Principal Investigator: Mats Jerkeman, MD, PhD Uppsala Akademiska Hospital Recruiting Uppsala, Sweden, 751 85 Contact: Anna Laurell, MD, PhD 018-611 00 00 anna.laurell@akademiska.se Principal Investigator: Anna Laurell, MD, PhD 收起 << |
NCT01125176 | Chronic Lymphocytic Leukemia | Phase 2 | Active, not recruiting | May 2019 | United States, New York ... 展开 >> Weill Cornell Medical College New York, New York, United States, 10065 收起 << |
NCT03710603 | Multiple Myeloma | Phase 3 | Not yet recruiting | November 2029 | Australia ... 展开 >> Alfred Hospital Melbourne, Australia Belgium University Hospital Leuven Not yet recruiting Leuven, Belgium Contact: Delforge Principal Investigator: Delforge Czechia University Hospital Ostrava Not yet recruiting Ostrava, Czechia Contact: Hajek Principal Investigator: Hajek Denmark Odense University Hospital Not yet recruiting Odense, Denmark Contact: Abligaard Principal Investigator: Abligaard France CHRU Hôtel Dieu Not yet recruiting Nantes, France Contact: Moreau Principal Investigator: Moreau Greece Regional General Hospital Alexandra Athens, Greece Italy Azienda Ospedaliero-Universitaria Ospedali Riuniti Umberto I - G.M. Lancisi - G. Salesi Di Ancona Ancona, Italy Netherlands Erasmus MC Not yet recruiting Rotterdam, Netherlands Contact: Pieter Sonneveld Principal Investigator: Pieter Sonneveld Norway Oslo University Hospital Not yet recruiting Oslo, Norway Contact: Schjesvold Principal Investigator: Schjesvold Poland Uniwersytet Jagiellonski Collegium Medicum Not yet recruiting Kraków, Poland Contact: Jurczyszyn Principal Investigator: Jurczyszyn Spain Hospital Clinic I Provincial de Barcelona Not yet recruiting Barcelona, Spain Contact: Rosiñol Principal Investigator: Rosiñol Switzerland Kantonsspital St. Gallen Not yet recruiting Saint Gallen, Switzerland Contact: Driessen Principal Investigator: Driessen Turkey Ankara University Ankara, Turkey 收起 << |
NCT03012880 | Plasma Cell Myeloma | Phase 2 | Recruiting | April 15, 2019 | United States, Minnesota ... 展开 >> Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Referral Office 855-776-0015 Principal Investigator: Shaji K. Kumar 收起 << |
NCT00654186 | Prostate Cancer | Phase 2 | Completed | - | United States, Illinois ... 展开 >> Oncology Specialists, S.C Niles, Illinois, United States, 60714 Oncology Specialists, S.C Park Ridge, Illinois, United States, 60068 收起 << |
NCT01355705 | Multiple Myeloma | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> Stanford University School of Medicine Stanford, California, United States, 94305 收起 << |
NCT01564537 | Relapsed Multiple Myeloma ... 展开 >> Refractory Multiple Myeloma 收起 << | Phase 3 | Active, not recruiting | December 1, 2020 | - |
NCT00654186 | - | Completed | - | - | |
NCT02193698 | POEMS Syndrome | Phase 2 | Completed | - | Japan ... 展开 >> Chiba University Graduate School of Medicine Department of neurology Chiba, Japan, 260-8760 收起 << |
NCT01355705 | - | Completed | - | - | |
NCT01965353 | Multiple Myeloma in Relapse | Phase 1 | Active, not recruiting | December 2019 | United States, Massachusetts ... 展开 >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 收起 << |
NCT01564537 | - | Active, not recruiting | - | - | |
NCT00744536 | Myelodysplastic Syndromes ... 展开 >> Leukemia, Myelomonocytic, Chronic Angiogenesis 收起 << | Phase 2 | Completed | - | Canada, Ontario ... 展开 >> Sunnybrook Health Sciences Centre, Odette Cancer Center Toronto, Ontario, Canada, M4N3M5 收起 << |
NCT01029054 | Multiple Myeloma | Phase 1 Phase 2 | Completed | - | United States, Michigan ... 展开 >> University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Mt. Sinai Medical Center New York, New York, United States, 10029 收起 << |
NCT02903381 | Smoldering Multiple Myeloma | Phase 2 | Suspended(FDA Partial Clinical... 展开 >> Hold) 收起 << | February 2024 | United States, Massachusetts ... 展开 >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 收起 << |
NCT01401322 | - | Terminated(low accrual) | - | - | |
NCT01029054 | - | Completed | - | - | |
NCT01401322 | Leukemia Rela... 展开 >>psed Adult Acute Lymphocytic Leukemia 收起 << | Phase 2 | Terminated(low accrual) | - | United States, California ... 展开 >> Stanford University School of Medicine Stanford, California, United States, 94305 收起 << |
NCT01702831 | Multiple Myeloma | Phase 2 | Active, not recruiting | December 2022 | Canada, Alberta ... 展开 >> Cross Cancer Institute 11560 University Ave Edmonton, Alberta, Canada, T6G-1Z2 Canada, British Columbia Vancouver General Hospital, Centennial Pavilion, 6th Floor Vancouver, British Columbia, Canada, V5Z 1M9 Canada, New Brunswick Saint John Regional Hospital, 5DN Research Department, 400 University Ave Saint John, New Brunswick, Canada, E2L 4L2 Canada, Nova Scotia Queen Elizabeth II Health Sciences Centre. Halifax, Nova Scotia, Canada, B3H 2Y9 Canada, Ontario London Regional Cancer Program 790 Commissioners Road East London, Ontario, Canada, N6A 4L6 The Ottawa Hospital Ottawa, Ontario, Canada, K1H 8L6 Princess Margaret Cancer Centre Toronto, Ontario, Canada, M5G 2M9 Canada, Quebec Hôpital Maisonneuve-Rosemont, 5415, boul. de l'Assomption Montreal, Quebec, Canada, H1T 2M4 Royal Victoria Hospital, MUHC Glen Site, Cedars Cancer Centre Montreal, Quebec, Canada, H4A 3J1 Canada, Saskatchewan Saskatoon Cancer Centre 20 Campus Drive Saskatoon, Saskatchewan, Canada, S7N 4H4 收起 << |
NCT00759603 | Chronic Lymphocytic Leukemia ... 展开 >> Small Lymphocytic Lymphoma 收起 << | Phase 2 | Completed | - | United States, Texas ... 展开 >> The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT02160015 | Ann Arbor Stage III Small Lymp... 展开 >>hocytic Lymphoma Ann Arbor Stage IV Small Lymphocytic Lymphoma Recurrent Chronic Lymphocytic Leukemia Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Small Lymphocytic Lymphoma Stage III Chronic Lymphocytic Leukemia Stage IV Chronic Lymphocytic Leukemia 收起 << | Phase 1 | Active, not recruiting | - | United States, District of Col... 展开 >>umbia MedStar Georgetown University Hospital Washington, District of Columbia, United States, 20007 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 收起 << |
NCT00759603 | - | Completed | - | - | |
NCT02075021 | - | Terminated(PI left the institu... 展开 >>tion) 收起 << | - | - | |
NCT01090089 | Multiple Myeloma | Phase 3 | Recruiting | January 2020 | Germany ... 展开 >> Universitätsklinikum Münster Recruiting Muenster, North Rhein Westfallen, Germany, 48149 Contact: Martin Kropff, PD Dr. med. 0251-8347590 martin.kropff@ukmuenster.de Universitätsklinikum Aachen Recruiting Aachen, Germany, 52074 Contact: Tim H. Brümmendorf, Prof. Dr. 0241 / 80-89805 tbruemmendorf@ukaachen.de Agirov Klinik Recruiting Berg, Germany, 82335 Contact: Christian Straka, PD Dr. med. +49-0815117806 cstraka@schoen-kliniken.de HELIOS Klinikum Berlin-Buch Recruiting Berlin, Germany, 13125 Contact: Christian Gerecke, Dr. med. +49-030 9401 12 190 christian.gerecke@helios-kliniken.de Evangelisches Krankenhaus Bielefeld Not yet recruiting Bielefeld, Germany, 33611 Contact: Eva Bettina Zinngrebe, MD 05 21 / 772-75750 Bettina.Zinngrebe@evkb.de Klinikum Bremen-Mitte Recruiting Bremen, Germany, 28177 Contact: Bernd Hertenstein, Prof. Dr. +49-421-4975240 bernd.hertenstein@klinikum-bremen-mitte.de Universitätsklinik Erlangen Recruiting Erlangen, Germany, 91054 Contact: Wolf Rösler, Dr. med. Contact +49-9131-85 36991 wolf.roesler@uk-erlangen.de Universitätsklinikum Freiburg Recruiting Freiburg, Germany, 79106 Contact: Monika Engelhardt, Prof. Dr. +49-7 612 70 - 34 61 monika.engelhardt@uniklinik-freiburg.de Universitätsklinikum der Ernst-Moritz-Arndt-Universität Greifswald -Anstalt öffentlichen Rechts- Not yet recruiting Greifswald, Germany, 17475 Contact: Gottfried Dölken, Prof. Dr. 03834-86-6698 doelken@uni-greifswald.de Universitätsklinikum Göttingen Recruiting Göttingen, Germany, 37075 Contact: Wolfram Jung, Dr. med. +49-551-39 8558 wolfram.jung@med.uni-goettingen.de Universitätsklinikum Hamburg-Eppendorf Recruiting Hamburg, Germany, 20246 Contact: Georgia Schilling, Dr. med. +49-40-741055692 g.schilling@uke.uni-hamburg.de Asklepios Klinik Altona Recruiting Hamburg, Germany, 22763 Contact: Hans Salwender, Dr. med. +49-40- 181881-1211 h.salwender@asklepios.com Universitätsklinikum Schleswig-Holstein Recruiting Kiel, Germany, 24105 Contact: Martin Gramatzki, Prof. Dr. 0431-597 5802 m.gramatzki@med2.uni-kiel.de Stiftungsklinikum Mittelrhein gGmbH Recruiting Koblenz, Germany, 56068 Contact: Ralph Naumann, Prof. Dr. ralph.naumann@stiftungsklinikum.de Klinikum Landshut gemeinnützige GmbH Recruiting Landshut, Germany, 84034 Contact: Juliana Ababei, Dr. med. +49-871-698-0 juliana.ababei@klinikum-landshut.de Stauferklinikum Schwäbisch Gmünd Recruiting Mutlangen, Germany, 73557 Contact: Holger Hebart, Prof. Dr. +49- 07171-701-1302 holger.hebart@stauferklinikum.de Hämato-Onkologische Schwerpunktpraxis Not yet recruiting München, Germany, 80331 Contact: Jochem Walther, Dr. med. 089554416 jochenwalther@gmx.de Onkologische Praxis Elisenhof Recruiting München, Germany, 80335 Contact: Peter Bojko, PD Dr. med. +49-89- 452256-0 p.bojko@onkologie-elisenhof.de Klinikum München Harlaching Recruiting München, Germany, 81545 Contact: Marcus Hentrich, PD Dr. med. 089-62102663 tumorzentrum.hentrich@khmh.de Klinikum rechts der Isar Recruiting München, Germany, 81675 Contact: Tobias Dechow, PD Dr. med. +49-89-4140 5834 t.dechow@lrz.tum.de Klinikum Nord Recruiting Nürnberg, Germany, 90419 Contact: Hannes Wandt, Prof. Dr. +49-911-398 3650 Hannes.Wandt@klinikum-nuernberg.de Klinikum Oldenburg Recruiting Oldenburg, Germany, 26133 Contact: Bernd Metzner, Dr. med. +49-441-403 72955 metzner.bernd@klinikum-oldenburg.de Klinikum Ernst von Bergmann gGmbH Recruiting Potsdam, Germany, 14467 Contact: Georg Maschmeyer, Prof. Dr. 0331-241-6001 gmaschmeyer@klinikumevb.de Gemeinschaftspraxis für Innere Medizin, Hämatologie und Onkologie Recruiting Ravensburg, Germany, 88214 Contact: Thomas Decker, PD Dr. med. +49 751/ 36650-35 decker@onkonet.eu Klinikum der Universität Regensburg Recruiting Regensburg, Germany, 93053 Contact: Albrecht Reichle, Prof. Dr. +49-941-944 5541 albrecht.reichle@klinik.uni-regensburg.de Diakonie-Klinikum Stuttgart-Diakonissenkrankenhaus und Paulinenhilfe gGmbH Recruiting Stuttgart, Germany, 70176 Contact: Else Heidemann, Prof. Dr. +49-711-991-3501 heidemann@diak-stuttgart.de Robert-Bosch-Krankenhaus Recruiting Stuttgart, Germany, 70376 Contact: Martin Kaufmann, Dr. med. 0711-8101-3174 martin.kaufmann@rbk.de Klinikum Traunstein Recruiting Traunstein, Germany, 83278 Contact: Thomas W Kubin, Dr. med. +49-861-705 1243 thomas.kubin@klinikum-traunstein.de Universitätsklinikum Ulm Recruiting Ulm, Germany, 89081 Contact: Christian Langer, Dr. med. +49-731-500-45743 christian.langer@uniklinik-ulm.de HSK Dr. Horst-Schmidt-Kliniken gmbh Recruiting Wiesbaden, Germany, 65199 Contact: Norbert Frickhofen, Prof. Dr. +49- 611-43-3009 norbert.frickhofen@hsk-wiesbaden.de Universitätsklinikum Würzburg Recruiting Würzburg, Germany, 97080 Contact: Stefan Knop, PD Dr. med. +49-931-20170800 knop_s@medizin.uni-wuerzburg.de 收起 << |
NCT00403169 | Kidney Cancer | Phase 2 | Completed | - | United States, Ohio ... 展开 >> Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 收起 << |
NCT02075021 | Relapsed or Refractory Multipl... 展开 >>e Myeloma 收起 << | Phase 1 Phase 2 | Terminated(PI left the institu... 展开 >>tion) 收起 << | - | United States, New York ... 展开 >> NYU School of Medicine New York, New York, United States, 10016 收起 << |
NCT00977132 | Myelodysplastic Syndrome MDS | Phase 2 | Terminated(delayed recruitment... 展开 >>) 收起 << | - | Germany ... 展开 >> Medizinische Universitätsklinik Freiburg, Abteilung Innere Medizini Freiburg, Baden Würtemberg, Germany, 79106 Universitätsklinikum Ulm, Klinik für Innere Medizin III Ulm, Bayern, Germany, 89081 Georg-August-Universität,Universitätsklinikum - Abteilung Hämatologie und Onkologie Goettingen, Niedersachsen, Germany, 37075 Heinrich-Heine-University Duesseldorf, Department of Hematology, Oncology and Clinical Immunology Duesseldorf, NRW, Germany, 40225 St. Johannes Hospital Duisburg Duisburg, NRW, Germany, 47166 Universitätsklinikum Carl Gustav Carus an der TU Dresden, Medizinische Klinik und Poliklinik I Dresden, Sachsen, Germany, 01307 收起 << |
NCT00603447 | Relapsed Multiple Myeloma | Phase 1 | Completed | - | United States, California ... 展开 >> Pacific Shores Medical Group Long Beach, California, United States, 90813 Cedars Sinai Medical Center Los Angeles, California, United States, 90048 University of California San Francisco San Francisco, California, United States, 94143 United States, Florida H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 United States, Illinois Northwestern University Chicago, Illinois, United States, 60611 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Cornell University New York, New York, United States, 10021 United States, Ohio Gabrail Cancer Center Canton, Ohio, United States, 44718 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Washington Fred Hutch Cancer Research Center Seattle, Washington, United States, 98103-1204 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Canada, Quebec Jewish General Hospital Montreal, Quebec, Canada, H3T 1E2 收起 << |
NCT00603447 | - | Completed | - | - | |
NCT01109004 | Multiple Myeloma | Phase 3 | Completed | - | - |
NCT02568553 | CD19 Positive ... 展开 >> Mediastinal Lymphoma Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma Recurrent Burkitt Lymphoma Recurrent Diffuse Large B-Cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mediastinal Lymphoma Recurrent Non-Hodgkin Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma Refractory Burkitt Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Follicular Lymphoma Refractory Mantle Cell Lymphoma Refractory Marginal Zone Lymphoma Refractory Mediastinal Lymphoma Refractory Non-Hodgkin Lymphoma Refractory Small Lymphocytic Lymphoma 收起 << | Phase 1 | Recruiting | - | United States, California ... 展开 >> City of Hope Comprehensive Cancer Center Recruiting Duarte, California, United States, 91010 Contact: Site Public Contact 800-826-4673 becomingapatient@coh.org Principal Investigator: Jasmine M. Zain UC San Diego Moores Cancer Center Recruiting La Jolla, California, United States, 92093 Contact: Site Public Contact 858-822-5354 cancercto@ucsd.edu Principal Investigator: Divya T. Koura Los Angeles County-USC Medical Center Suspended Los Angeles, California, United States, 90033 USC / Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Site Public Contact 323-865-0451 Principal Investigator: Mojtaba Akhtari Keck Medical Center of USC Pasadena Suspended Pasadena, California, United States, 91105 University of California Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Site Public Contact 916-734-3089 Principal Investigator: Joseph M. Tuscano United States, Connecticut Smilow Cancer Center/Yale-New Haven Hospital Recruiting New Haven, Connecticut, United States, 06510 Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu Principal Investigator: Iris Isufi Yale University Recruiting New Haven, Connecticut, United States, 06520 Contact: Site Public Contact 203-785-5702 canceranswers@yale.edu Principal Investigator: Iris Isufi United States, Florida Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Site Public Contact 800-456-7121 canceranswers@moffitt.org Principal Investigator: Julio C. Chavez United States, Kentucky University of Kentucky/Markey Cancer Center Active, not recruiting Lexington, Kentucky, United States, 40536 United States, Maryland Johns Hopkins University/Sidney Kimmel Cancer Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Site Public Contact 410-955-8804 jhcccro@jhmi.edu Principal Investigator: Nina D. Wagner-Johnston United States, Massachusetts Massachusetts General Hospital Cancer Center Recruiting Boston, Massachusetts, United States, 02114 Contact: Site Public Contact 877-726-5130 Principal Investigator: Jon E. Arnason Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Site Public Contact 617-667-9925 Principal Investigator: Jon E. Arnason Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Site Public Contact 877-442-3324 Principal Investigator: Jon E. Arnason United States, Ohio Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Site Public Contact 800-293-5066 Jamesline@osumc.edu Principal Investigator: Basem M. William United States, Tennessee Vanderbilt University/Ingram Cancer Center Active, not recruiting Nashville, Tennessee, United States, 37232 United States, Wisconsin University of Wisconsin Hospital and Clinics Recruiting Madison, Wisconsin, United States, 53792 Contact: Site Public Contact 800-622-8922 Principal Investigator: Christopher D. Fletcher 收起 << |
NCT02532257 | Lymphoma Foll... 展开 >>icular Lymphoma (FL) 收起 << | Phase 2 | Active, not recruiting | April 2021 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01109004 | - | Completed | - | - | |
NCT02619682 | Plasma Cell Myeloma ... 展开 >> Transplant-Related Carcinoma 收起 << | Phase 2 | Recruiting | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States, 98109 Contact: Leona A. Holmberg 206-667-6447 lholmber@fredhutch.org Principal Investigator: Leona A. Holmberg 收起 << |
NCT00165477 | Glioblastoma ... 展开 >>Gliosarcoma Malignant Gliomas 收起 << | Phase 2 | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Virginia University of Virginia Charlottesville, Virginia, United States, 22908-0394 收起 << |
NCT01553357 | Primary Plasma Cell Leukemia | Phase 2 | Completed | - | Italy ... 展开 >> IRCCS - CROB Ethic Committee Rionero in Vulture, Pz, Italy, 85028 收起 << |
NCT00352001 | Leukemia Myel... 展开 >>odysplastic Syndromes 收起 << | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> University of California at Los Angeles Los Angeles, California, United States, 90095-1781 United States, Florida H. Lee Moffitt Cancer Center and Research Institute at University of South Florida Tampa, Florida, United States, 33612-9497 United States, Ohio Cleveland Clinic Taussig Cancer Instititute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 收起 << |
NCT00670358 | Lymphoma | Phase 1 Phase 2 | Recruiting | May 2019 | United States, Arizona ... 展开 >> Mayo Clinic in Arizona Active, not recruiting Scottsdale, Arizona, United States, 85259-5499 United States, Florida Mayo Clinic in Florida Active, not recruiting Jacksonville, Florida, United States, 32224 United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Referral Office 855-776-0015 Principal Investigator: Grzegorz S. Nowakowski, M.D. 收起 << |
NCT00352001 | - | Completed | - | - | |
NCT00352365 | Adult Acute Basophilic Leukemi... 展开 >>a Adult Acute Eosinophilic Leukemia Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Secondary Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia 收起 << | Phase 2 | Completed | - | - |
NCT01241292 | - | Completed | - | - | |
NCT00352365 | - | Completed | - | - | |
NCT00991562 | Multiple Myeloma | Phase 1 | Completed | - | United States, California ... 展开 >> University of Southern California Los Angeles, California, United States, 90033 Comprehensive Cancer Center of the Desert Palm Springs, California, United States, 92262 United States, Florida Florida Cancer Specialists Sarasota, Florida, United States, 34232 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Weill Medical College New York, New York, United States, 10021 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas CTRC at University of Texas Health Science Center San Antonio, Texas, United States, 78229 收起 << |
NCT01242930 | Multiple Myeloma | Phase 2 | Completed | - | United States, Maryland ... 展开 >> University of Maryland Medical Center - M & S Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 Sidney Kimmel Cancer Center Johns Hopkins Hospital Baltimore, Maryland, United States, 21231 收起 << |
NCT01056679 | Hodgkin Lymphoma | Phase 1 | Completed | - | Germany ... 展开 >> 1st Dept. of Medicine, Cologne University Hospital Cologne, NRW, Germany, 50924 收起 << |
NCT03290950 | Multiple Myeloma | Phase 2 | Recruiting | September 2019 | United States, New Jersey ... 展开 >> Memoral Sloan Kettering Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Ola Landgren, MD 212-639-5126 Contact: Neha Korde 212-639-7664 Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Ola Landgren, MD, PhD 212-639-5126 Memorial Sloan Kettering Bergen Recruiting Montvale, New Jersey, United States, 07645 Contact: Ola Landgren, MD, PhD 212-639-5126 United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Ola Landgren, MD, PhD 212-639-5126 Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Ola Landgren, MD, PhD 212-639-5126 Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Ola Landgren, MD, PhD 212-639-5126 Contact: Neha Korde, MD 212-639-7664 Principal Investigator: Ola Landgren, MD,PhD Memorial Sloan Kettering Rockville Centre Recruiting Rockville Centre, New York, United States, 11570 Contact: Ola Landgren, MD, PhD 212-639-5126 收起 << |
NCT02537808 | - | Active, not recruiting | September 2023 | Germany ... 展开 >> Hämatologisch-Onkologische Schwerpunktpraxis Bochum, Germany, 44787 收起 << | |
NCT01430546 | - | Completed | - | Sweden ... 展开 >> Karolinska Institute Stockholm, Sweden, S-141 86 收起 << | |
NCT01245673 | Myeloma | Phase 2 | Active, not recruiting | August 2018 | United States, Maryland ... 展开 >> University of Maryland Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 收起 << |
NCT01241292 | Multiple Myeloma | Phase 1 | Completed | - | Japan ... 展开 >> Local Institution Nagoya-shi, Aichi, Japan, 4600001 Local Institution Nagoya-shi, Aichi, Japan, 4678602 Local Institution Niigata-shi, Niigata, Japan, 9518566 收起 << |
NCT02516423 | Solitary Osseous Plasmacytoma | Phase 3 | Active, not recruiting | - | - |
NCT01160107 | Multiple Myeloma | Phase 2 | Active, not recruiting | August 2020 | - |
NCT00057616 | Melanoma Neop... 展开 >>lasm Metastasis 收起 << | Phase 3 | Completed | - | - |
NCT02911142 | Primary Effusion Lymphoma ... 展开 >> B-Cell Lymphoma 收起 << | Phase 1 Phase 2 | Recruiting | October 1, 2025 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 收起 << |
NCT00074282 | Leukemia | Phase 2 | Unknown | - | - |
NCT00405756 | Newly Diagnosed Multiple Myelo... 展开 >>ma 收起 << | Phase 3 | Completed | - | - |
NCT02741544 | - | Active, not recruiting | August 21, 2021 | Japan ... 展开 >> Shinko Hospital Kobe, Hyogo, Japan, 651-0072 收起 << | |
NCT03645395 | Non-hodgkin Lymphoma ... 展开 >> B Cell Refractory Diffuse Large B-Cell Lymphoma Relapsed Diffuse Large B-Cell Lymphoma 收起 << | Phase 2 | Not yet recruiting | July 30, 2022 | - |
NCT00779922 | Multiple Myeloma ... 展开 >> Impaired Renal Function 收起 << | Phase 2 | Completed | - | France ... 展开 >> Poitiers University Hospital Poitiers, France, 86000 收起 << |
NCT00460031 | Prostate Cancer | Phase 2 | Active, not recruiting | December 20, 2018 | United States, Ohio ... 展开 >> Lake/University Seidman Cancer Center Cleveland, Ohio, United States, 44060 University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 University Suburban Health Center Cleveland, Ohio, United States, 44121 UHHS Chagrin Highlands Medical Center Cleveland, Ohio, United States, 44122 UHHS Westlake Medical Center Cleveland, Ohio, United States, 44145 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 收起 << |
NCT03065790 | - | Recruiting | February 6, 2020 | United States, Pennsylvania ... 展开 >> Abramson Cancer Center of the University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Michael Farwell, MD 855-216-0098 PennCancerTrials@emergingmed.com 收起 << | |
NCT00581919 | Multiple Myeloma | Phase 2 | Completed | - | United States, Wisconsin ... 展开 >> Mercy Health Systems Janesville, Wisconsin, United States Gundersen Lutheran LaCrosse, Wisconsin, United States University of Wisconsin Cancer Center Madison, Wisconsin, United States, 53792 Regional Cancer Center Waukesha/Oconomowoc, Wisconsin, United States Aspirus Wausau Hospital, Aspirus Regional Cancer Center Wausau, Wisconsin, United States 收起 << |
NCT01019174 | Multiple Myeloma | Phase 1 Phase 2 | Completed | - | Germany ... 展开 >> University Clinic München-Großhadern München, Germany, 81377 University of Münster, Department of Hematology/Oncology Münster, Germany, 48129 Tübingen University, Department of Hematology/Oncology/Immunology Tübingen, Germany, 72076 University Clinic Ulm, Department Internal Medicine Ulm, Germany, 89081 收起 << |
NCT00405756 | - | Completed | - | - | |
NCT03601624 | Multiple Myeloma in Relapse ... 展开 >> Multiple Myeloma Progression Refractory Multiple Myeloma 收起 << | Phase 2 | Recruiting | July 30, 2020 | Mexico ... 展开 >> ISSSTE Recruiting Ciudad de Mexico, Mexico, 03229 Contact: MARTHA A ALVARADO, MD 15525600960 normoblasto@gmail.com 收起 << |
NCT03140943 | Relapsed and/or Refractory Mul... 展开 >>tiple Myeloma 收起 << | Phase 2 | Recruiting | June 1, 2022 | Hong Kong ... 展开 >> Queen Mary Hospital Not yet recruiting Hong Kong, Hong Kong Korea, Republic of Not yet recruiting South Korea, Korea, Republic of Singapore National University Hospital Recruiting Singapore, Singapore Taiwan National Taiwan University Not yet recruiting Taipei, Taiwan 收起 << |
NCT00581919 | - | Completed | - | - | |
NCT02244125 | Multiple Myeloma ... 展开 >> First Relapse 收起 << | Phase 2 | Active, not recruiting | December 2020 | France ... 展开 >> CHRU Hopital Sud Amiens, France, 80054 Centre Hospitalier de la côte Basque Bayonne, France, 64109 Hôpital Avicenne Bobigny, France, 93009 ICH - Hôpital A. Morvan Brest, France, 29609 Institut d'Hématologie de Basse Normandie - IHBN Caen, France, 14033 Chu Estaing Clermont Ferrand, France, 63003 CHU Henri Mondor Creteil, France, 94010 CHRU Dijon Dijon, France, 21000 Centre Hospitalier Général Dunkerque, France, 59385 Chru Grenoble Grenoble, France, 38043 Centre Hospitalier départemental de Vendée La Roche sur Yon, France, 85925 Clinique Victor Hugo Le Mans, France, 72000 CHRU - Hôpital Claude Huriez Lille, France, 59037 CHU de Limoges Limoges, France, 87042 Institut Paoli Calmette Marseille, France, 13273 Hopital Emile Muller Mulhouse, France, 68100 CHU de Nantes Nantes, France, 44093 CHU Carémeau Nimes, France, 30029 Institut Curie Paris, France, 750005 CHRU Hopital Saint Antoine Paris, France, 75012 CHRU Hôpital Haut Lévêque Pessac, France, 33604 Centre Hospitalier Lyon Sud Pierre Benite, France, 69495 Centre Hospitalier Annecy Genevois Pringy, France, 74374 CHRU Hopital Pontchaillou Rennes, France, 35033 Centre Henri Becquerel Rouen, France, 76038 Centre Hospitalier Yves Le Foll Saint Brieuc, France, 22027 Centre René Huguenin Saint Cloud, France, 92210 Institut Universitaire du Cancer Toulouse-Oncopôle (IUCT-O) Toulouse, France, 31059 CHRU Hopital Bretonneau Tours, France, 37044 CHRU Hopitaux de Brabois Vandoeuvre les Nancy, France, 54511 收起 << |
NCT01319422 | Multiple Myeloma | Phase 2 | Completed | - | United States, Connecticut ... 展开 >> Yale University New Haven, Connecticut, United States, 06520 收起 << |
NCT01319422 | - | Completed | - | - | |
NCT03651128 | Multiple Myeloma | Phase 3 | Not yet recruiting | June 9, 2025 | United States, Tennessee ... 展开 >> Sarah Cannon Research Institute Center for Blood Not yet recruiting Nashville, Tennessee, United States, 37203: 收起 << |
NCT03570892 | Non-Hodgkin Lymphoma | Phase 3 | Not yet recruiting | May 26, 2025 | - |
NCT03100877 | Plasma Cell Leukemia in Remiss... 展开 >>ion Plasma Cell Myeloma 收起 << | Phase 1 Phase 2 | Withdrawn(Feasibility Issues) | May 24, 2020 | United States, California ... 展开 >> City of Hope Medical Center Duarte, California, United States, 91010 收起 << |
NCT02294357 | Multiple Myeloma | Phase 2 | Recruiting | December 2018 | United States, California ... 展开 >> California Cancer Associates for Research & Excellence (cCARE) Recruiting Encinitas, California, United States, 92024 Contact: Alberto Bessudo, MD Contact: Beth Kimball, RN (760) 452-3909 BKimball@ccare.com Wellness Oncology and Hematology Recruiting West Hills, California, United States, 91307 Contact: Ashkan Lashkari, MD Contact: Mary Mau (818) 346-1773 mary@wellnessoncology.com James R Berenson, MD, Inc. Recruiting West Hollywood, California, United States, 90069 Contact: James Berenson, MD Contact: Regina Swift, RN, BSN 310-623-1222 rswift@berensononcology.com United States, Florida Cancer Specialists of North Florida Recruiting Fleming Island, Florida, United States, 32003 Contact: Mehdi Moezi, MD Contact: Jenni Bachhofer (904) 363-7462 Jenni.Bachhofer@CSNF.us United States, New York Hudson Valley Hem/Onc Associates Completed Poughkeepsie, New York, United States, 12601 United States, Ohio Gabrail Cancer Center Recruiting Canton, Ohio, United States, 44718 Contact: Nashat Gabrail, MD Contact: Kirstie Armstrong (330) 492-3345 karmstrong@gabrailcancercenter.com United States, Texas Blood & Cancer Center of East Texas Completed Tyler, Texas, United States, 75701 收起 << |
NCT03004287 | Multiple Myeloma | Phase 2 | Recruiting | January 2021 | United States, Arkansas ... 展开 >> University of Arkansas for Medical Sciences Recruiting Little Rock, Arkansas, United States, 72205 Contact: Nathan Petty 501-526-6990 ext 2435 pettynathanm@uams.edu 收起 << |
NCT03019640 | Mantle Cell Lymphoma ... 展开 >> Recurrent Diffuse Large B-Cell Lymphoma Recurrent Follicular Lymphoma Recurrent Indolent Adult Non-Hodgkin Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Follicular Lymphoma Refractory Indolent Adult Non-Hodgkin Lymphoma 收起 << | Phase 2 | Recruiting | March 31, 2020 | United States, Texas ... 展开 >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Yago L. Nieto 713-792-8750 Principal Investigator: Yago L. Nieto 收起 << |
NCT01659658 | Relapsed or Refractory Systemi... 展开 >>c Light Chain Amyloidosis 收起 << | Phase 3 | Recruiting | August 31, 2022 | - |
NCT01537861 | Multiple Myeloma | Early Phase 1 | Terminated(Unexpected toxicity... 展开 >> (2 early deaths)) 收起 << | - | United States, Missouri ... 展开 >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 收起 << |
NCT02260414 | Lymphoma Mult... 展开 >>iple Myeloma 收起 << | Phase 2 | Completed | - | France ... 展开 >> CHU de Saint-Etienne Saint-Etienne, France, 42055 收起 << |
NCT00833833 | Multiple Myeloma | Phase 1 Phase 2 | Completed | - | - |
NCT02164955 | - | Recruiting | August 31, 2022 | - | |
NCT02721043 | Solid Tumors | Phase 1 | Recruiting | July 2020 | United States, New York ... 展开 >> Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029 Contact: Rhea Boxill, MPh 212-824-8448 rhea.boxill@mssm.edu Principal Investigator: Nina Bhardwaj, MD, PhD 收起 << |
NCT03242460 | Relapsed and/or refractorY Mul... 展开 >>tiple Myeloma 收起 << | Phase 2 | Recruiting | December 31, 2019 | Korea, Republic of ... 展开 >> Catholic university of korea, Seoul ST. Mary's Hospital. Recruiting Seoul, Korea, Republic of Contact: Chang-Ki Min, MD, PhD. ckmin@catholic.ac.kr Contact: Ho-Sup Lee, MD, PhD. hs3667@hanmail.net Principal Investigator: Chang-Ki Min, MD, PhD. Sub-Investigator: Sung-su Yoon, MD, PhD. 收起 << |
NCT02461888 | Multiple Myeloma | Phase 2 | Recruiting | May 2019 | United Kingdom ... 展开 >> Queen Elizabeth Medical Centre Recruiting Birmingham, United Kingdom, B15 2TH Heart of England NHS Foundation Trust Recruiting Birmingham, United Kingdom, B9 5ST Royal Bournemouth General Hospital Recruiting Bournemouth, United Kingdom, BH7 7DW University Hospital Bristol NHS Foundation Trust Recruiting Bristol, United Kingdom, BS1 3NU North Tees and Hartlepool NHS Foundation Trust Recruiting Hartlepool, United Kingdom, TS24 9AH Leeds Teaching Hospitals NHS Trust Recruiting Leeds, United Kingdom, LS9 7TF Royal Liverpool and Broadgreen University Hospital NHS Trust Recruiting Liverpool, United Kingdom, L7 8XP Barts and the London NHS Trust Recruiting London, United Kingdom, E1 1BB University College London Hospitals NHS Foundation Trust Recruiting London, United Kingdom, NW1 2PG Guy's and St Thomas's NHS Foundation Trust Recruiting London, United Kingdom, SE1 9RT Royal Marsden Hospital Recruiting London, United Kingdom, SW3 6JJ Imperial College Healthcare NHS Trust Recruiting London, United Kingdom, W2 1NY The Christie NHS Foundation Trust Recruiting Manchester, United Kingdom, M20 4BX Nottingham University Hospital NHS Trust Recruiting Nottingham, United Kingdom, NG7 2UH Churchill Hospital Recruiting Oxford, United Kingdom, OX3 7LE Sheffield Teaching Hospitals NHS Foundation Trust Recruiting Sheffield, United Kingdom, S5 7AU Southampton University Hospital NHS Trust Recruiting Southampton, United Kingdom, SO16 6YD The Royal Wolverhampton Hospital NHS Trust Recruiting Wolverhampton, United Kingdom, WV10 0QP 收起 << |
NCT03746652 | Multiple Myeloma | Phase 2 | Not yet recruiting | December 2021 | Greece ... 展开 >> General Hospital of Athens "Alexandra" Not yet recruiting Athens, Attica, Greece, 11528 Contact: Evangelos Terpos, Prof. +302103381512 收起 << |
NCT02719613 | Multiple Myeloma | Phase 2 | Recruiting | May 29, 2020 | United States, Arizona ... 展开 >> Arizona Clinical Research Center, Inc Active, not recruiting Tucson, Arizona, United States, 85715 United States, California Comprehensive Blood And Cancer Center Recruiting Bakersfield, California, United States, 93309 Contact: Alan Cartmell, Site 0017 James R. Berenson, MD, Inc. Recruiting Bakersfield, California, United States, 93309 Contact: James Berenson, Site 0016 Robert A. Moss, Md Facp, Inc. Recruiting Fountain Valley, California, United States, 92708 Contact: Robert Moss, Site 0022 United States, Colorado Rocky Mountain Cancer Centers (Williams) - USOR Recruiting Denver, Colorado, United States, 80218 Contact: Robert Rifkin, Site 0019 United States, Florida Cancer Specialists of North FL Recruiting Jacksonville, Florida, United States, 32256 Contact: Suprith Badarinath, Site 0021 United States, Georgia Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Sagar Lonial, Site 0009 404-778-4176 United States, Indiana Investigative Clinical Research Of Indiana, Llc Recruiting Indianapolis, Indiana, United States, 46260 Contact: Robert Manges, Site 0003 317-297-2208 United States, Massachusetts Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Paul Richardson, Site 0002 United States, Missouri Washington University School Of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Ravi Vij, Site 0008 314-747-7813 United States, New York Icahn School Of Medicine At Mount Sinai Recruiting New York, New York, United States, 10029 Contact: Sundar Jagannath, Site 0004 212-241-2592 United States, Pennsylvania St. Luke's University Health Network Recruiting Bethlehem, Pennsylvania, United States, 18015 Contact: Yacoub Faroun, Site 0001 484-503-4150 United States, Texas Texas Oncology Recruiting Dallas, Texas, United States, 75231 Contact: Kristi McIntyre, Site 0018 Canada, Ontario Local Institution Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Site 0011 Canada Local Institution Recruiting Halifax, Canada, B3H 2Y9 Contact: Site 0010 Italy Local Institution Recruiting Ancona, Italy, 60126 Contact: Site 0015 Local Institution Recruiting Firenze, Italy, 50134 Contact: Site 0012 Local Institution Recruiting Genova, Italy, 16132 Contact: Site 0013 Local Institution Recruiting Torino, Italy, 10126 Contact: Site 0014 收起 << |
NCT00511238 | Multiple Myeloma | Phase 2 | Completed | - | - |
NCT01365559 | Multiple Myeloma | Phase 1 Phase 2 | Completed | - | United States, California ... 展开 >> Pacific Oncology and Hematology Encinitas, California, United States, 92024 Pacific Cancer Care Salinas, California, United States, 93901 Central Coast Medical Oncology Santa Maria, California, United States, 93454 James R. Berenson, MD, Inc. West Hollywood, California, United States, 90069 United States, Illinois Cancer Centers of America Zion, Illinois, United States, 60099 United States, Indiana Franciscan St. Francis Health Indianapolis, Indiana, United States, 46237 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Tennessee Family Cancer Center Foundation, Inc. Memphis, Tennessee, United States, 38119 United States, Virginia Virginia Cancer Specialists Fairfax, Virginia, United States, 233031 收起 << |
NCT00511238 | - | Completed | - | - | |
NCT00833833 | - | Completed | - | - | |
NCT02004275 | Multiple Myeloma in Relapse | Phase 1 Phase 2 | Recruiting | - | - |
NCT02966522 | Cardiac Amyloidosis | Phase 2 | Recruiting | September 2019 | Korea, Republic of ... 展开 >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Contact: Youngil Koh, MD, PhD go01@snu.ac.kr Contact: Ryul Kim, MD chrono0707@icloud.com 收起 << |
NCT02666209 | - | - | - | United States, Massachusetts ... 展开 >> Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 收起 << | |
NCT02331368 | - | Completed | - | - | |
NCT02331368 | Multiple Myeloma | Phase 2 | Completed | - | United States, Michigan ... 展开 >> University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States, 48109 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 收起 << |
NCT02075996 | - | Active, not recruiting | March 2021 | Germany ... 展开 >> iOMEDICO AG Freiburg, Baden-Wuerttemberg, Germany, 79108 收起 << | |
NCT02336815 | Multiple Myeloma | Phase 2 | Active, not recruiting | October 2019 | - |
NCT02206425 | Multiple Myeloma | Phase 1 Phase 2 | Terminated(Data collection for... 展开 >> endpoints have been reached) 收起 << | - | United States, California ... 展开 >> Comprehensive Blood and Cancer Center Bakersfield, California, United States, 93309 John Muir Health Clinical Research Center Concord, California, United States, 94520 California Cancer Associates for Research & Excellence (cCARE) Encinitas, California, United States, 92024 Robert A. Moss, MD, FACP, Inc Fountain Valley, California, United States, 92708 cCARE Fresno Fresno, California, United States, 93720 Comprehensive Cancer Center at Desert Regional Medical Center Palm Springs, California, United States, 92262 James Berenson, MD, Inc West Hollywood, California, United States, 90069 United States, Florida Cancer Specialists of North Florida Fleming Island, Florida, United States, 32003 United States, Georgia Lewis Hall Singletary Oncology Center Thomasville, Georgia, United States, 31792 United States, Illinois Oncology Specialists, SC Niles, Illinois, United States, 60714 United States, Mississippi Hattiesburg Clinic Hematology/Oncology Hattiesburg, Mississippi, United States, 39401 United States, Washington Vista Oncology Olympia, Washington, United States, 98502 收起 << |
NCT01215344 | Multiple Myeloma | Phase 2 | Completed | - | United States, Tennessee ... 展开 >> University of Tennessee Cancer Institute, Boston Baskin Cancer Group Memphis, Tennessee, United States, 38104 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 收起 << |
NCT01215344 | - | Completed | - | - | |
NCT02419118 | Multiple Myeloma | Phase 2 Phase 3 | Completed | - | Denmark ... 展开 >> Department of Hematology Vejle Hospital Vejle, Denmark, 7100 收起 << |
NCT01088048 | Indolent Non-Hodgkin's Lymphom... 展开 >>a Chronic Lymphocytic Leukemia Mantle Cell Lymphoma 收起 << | Phase 1 | Completed | - | United States, Alabama ... 展开 >> Clearview Cancer Institute Huntsville, Alabama, United States, 35805 United States, California UCLA Los Angeles, California, United States, 90024 Stanford Cancer Center Palo Alto, California, United States, 94304-5548 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Long Island Jewish Medical Center New Hyde Park, New York, United States, 11040 Weill Medical College of Cornell New York, New York, United States, 10021 United States, Oregon Willamette Valley Cancer Institute and Research Center Springfield, Oregon, United States, 97477 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas MD Anderson Cancer Houston, Texas, United States, 77030 United States, Washington North Star Lodge Cancer Center Yakima, Washington, United States, 98902 收起 << |
NCT03412565 | Multiple Myeloma | Phase 2 | Active, not recruiting | February 1, 2021 | - |
NCT02431208 | Multiple Myeloma | Phase 1 | Recruiting | September 26, 2020 | - |
NCT01291745 | - | Unknown | September 2015 | Italy ... 展开 >> U.O. Medicina Interna Universitaria 2 ed Ematologia Ospedale Civile San Salvatore Not yet recruiting Coppito, L'Aquila, Italy, 67010 Contact: Alessandro Lucchesi, MD +390862368589 ale.lucchesi@gmail.com Sub-Investigator: Alessandro Lucchesi, MD Unità di Ematologia e Trapianto di Midollo Osseo, IRCCS-CROB, Centro di Riferimento Oncologico della Basilicata Not yet recruiting Rionero in Vulture, Potenza, Italy Contact: Pellegrino Musto, MD +390972726225 p.musto@crob.it Sub-Investigator: Pellegrino Musto, MD U. O. C. Ematologia - Azienda Ospedaliera Sant'Andrea Not yet recruiting Rome, Roma, Italy, 00189 Contact: Maria A Aloe Spiriti, MD +390633775052 aloespiritisapienza@gmail.com Sub-Investigator: Maria A Aloe Spiriti, MD U.O. Ematologia - A.O. Spedali Civili di Brescia Not yet recruiting Brescia, Italy Contact: Giuseppe Rossi, MD +390303996573 ematologia@spedalicivili.brescia.it Sub-Investigator: Giuseppe Rossi, MD Divisione di Ematologia Presidio Ospedaliero "A. Perrino" Not yet recruiting Brindisi, Italy Contact: Giovanni Quarta, MD +390831537507 quarta.gianni@gmail.com Sub-Investigator: Giovanni Quarta, MD Divisione Clinicizzata di Ematologia con Trapianto di Midollo Osseo. Ospedale Ferrarotto. Azienda Policlinico Not yet recruiting Catania, Italy Contact: Giuseppe Palumbo, MD ga.palumbo@gmail.com Sub-Investigator: Giuseppe Palumbo, MD S.O.C. Ematologia Azienda Ospedaliera di Catanzaro"Pugliese-Ciaccio" Not yet recruiting Catanzaro, Italy Contact: Domenico Magro, MD +390961883120 magro.dom@virgilio.it Sub-Investigator: Domenico Magro, MD Unità Operativa Complessa di Ematologia- Azienda Ospedaliera di Cosenza Recruiting Cosenza, Italy, 87100 Contact: Fortunato Morabito, MD +390984681329 omdsprotocol@fondazioneameliascorza.it Principal Investigator: Fortunato Morabito, MD Unità di Ematologia, Ospedale Madonna delle Grazie, ASM Not yet recruiting Matera, Italy Contact: Alberto Fragasso, MD alberto.fragasso@libero.it Sub-Investigator: Alberto Fragasso, MD Dipartimento di Oncologia, Oncoematologia e Unità Trapianto di Midollo Osseo, 'La Maddalena' Not yet recruiting Palermo, Italy Contact: Maurizio Musso, MD +390916806814 mamusso@libero.it Sub-Investigator: Maurizio Musso, MD U.O. di Ematologia Azienda Ospedaliera Universitaria Pisana Not yet recruiting Pisa, Italy Contact: Mario Petrini, MD Contact: Sara Galimberti, MD s.galimberti@med.unipi.it Sub-Investigator: Sara Galimberti, MD Divisione Ematologia - Azienda Ospedaliera "Bianchi-Melacrino-Morelli" Not yet recruiting Reggio Calabria, Italy Contact: Esther Oliva, MD estheroliva@hotmail.com Sub-Investigator: Esther Oliva, MD Dipartimento di Biotecnologie Cellulari ed Ematologia, Università La Sapienza Not yet recruiting Roma, Italy, 00161 Contact: Giuliana Alimena, MD alimena@bce.uniroma1.it Sub-Investigator: Giuliana Alimena, MD U.O.C. di Ematologia - Policlinico Agostino Gemelli- Not yet recruiting Roma, Italy Contact: Maria T Voso, MD 0630154278 ext 0039 mtvoso@rm.unicatt.it Sub-Investigator: Maria T Voso, MD 收起 << | |
NCT03188172 | Multiple Myeloma | Phase 2 | Recruiting | December 31, 2021 | United Kingdom ... 展开 >> Queen Elizabeth Hospital Recruiting Birmingham, United Kingdom, B15 2TH Contact: Guy Pratt 01214243698 guy.pratt@uhb.nhs.uk Birmingham Heartlands Hospital Recruiting Birmingham, United Kingdom Contact: Anand Lokare Blackpool Victoria Hospital Recruiting Blackpool, United Kingdom Contact: Mark Grey Royal Hampshire County Hospital Recruiting Bournemouth, United Kingdom, BH7 7DW Contact: Noel Ryman Royal Bournemouth Hospital Recruiting Bournemouth, United Kingdom Contact: Rachel Hall Bristol Haematology & Oncology Centre Recruiting Bristol, United Kingdom Contact: Jenny Bird Ninewells Hospital Recruiting Dundee, United Kingdom, DD1 9SY Contact: Gordon Marron Beatson Oncology Centre Recruiting Glasgow, United Kingdom Contact: Jennifer Travers Kettering General Hosptial Recruiting Kettering, United Kingdom, NN16 8UZ Contact: Auran Razzak Leicester Royal Infirmary Recruiting Leicester, United Kingdom, LE1 5WW Contact: Mamta Garg Kings College Hosptial Recruiting London, United Kingdom Contact: Kirsty Cuthill Manchester Royal Infirmary Recruiting Manchester, United Kingdom Contact: Alberto Rocci The Christie Hospital Recruiting Manchester, United Kingdom Contact: Jim Cavet Norfolk and Norwich University Hospital Recruiting Norwich, United Kingdom Contact: Kristian Bowles Nottingham University Hosptial Recruiting Nottingham, United Kingdom Contact: Dean Smith Churchill Hospital Recruiting Oxford, United Kingdom Contact: Karthik Ramasamy Derriford Hospital Recruiting Plymouth, United Kingdom Contact: Hannah Hunter Southampton General Hospital Recruiting Southampton, United Kingdom, SO16 6YD Contact: Matthew Jenner 02381204438 matthew.jenner@uhs.nhs.uk Royal Stoke Hospital Recruiting Stoke-on-Trent, United Kingdom Contact: Kamaraj Karunanithi Royal Marsden Hospital Recruiting Sutton, United Kingdom, SM2 5PT Contact: Martin Kaiser 02087224265 martin.kaiser@icr.ac.uk Worcester Royal Hospital Recruiting Worcester, United Kingdom, WR5 1DD Contact: Salim Shafeek 收起 << |
NCT03742297 | Newly Diagnosed Multiple Myelo... 展开 >>ma 收起 << | Phase 3 | Recruiting | October 22, 2021 | - |
NCT03314636 | Myeloma | Phase 2 | Recruiting | March 2025 | Denmark ... 展开 >> Copenhagen University Hospital, Rigshospitalet Not yet recruiting Copenhagen, Denmark Contact: Annette Vangsted annette.juul.vangsted@regionh.dk Odense University Hospital Not yet recruiting Odense, Denmark Contact: Niels Abildgaard Niels.Abildgaard@rsyd.dk Norway Oslo University Hospital Recruiting Oslo, Norway Contact: Fredrik H Schjesvold, MDPhD +4799697796 fredrikschjesvold@gmail.com Sweden Skåne University Hospital Not yet recruiting Lund, Sweden Contact: Markus Hansson markus.hansson@med.lu.se 收起 << |
NCT02733042 | Lymphoma Leuk... 展开 >>emia, Lymphocytic, Chronic, B-Cell 收起 << | Phase 1 Phase 2 | Active, not recruiting | July 8, 2022 | - |
NCT00495872 | Solid Tumors | Phase 1 | Completed | - | United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01269203 | Multiple Myeloma | Phase 2 | Withdrawn | - | - |
NCT01827137 | Multiple Myeloma | Not Applicable | Active, not recruiting | April 2018 | United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 收起 << |
NCT01619761 | Leukemia Chro... 展开 >>nic Lymphocytic Leukemia 收起 << | Phase 1 | Recruiting | May 2019 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 收起 << |
NCT02626481 | Multiple Myeloma | Phase 2 | Active, not recruiting | January 2021 | Belgium ... 展开 >> AZ ST Jan hematology department Bruges, Belgium, 8000 Hematologie Laarbeeklaan Brussel, Belgium, 101 - 1090 Jules Bordet Institute Brussel, Belgium, B - 1000 CHU Dinant Godinne | UCL Namur asbl Yvoir, Belgium, 1 - 5530 France CHRU - Hôpital du Bocage (Amiens) Amiens, France, 49033 CHRU-Hôpital Sud d'Amiens Amiens, France, 80054 Hôpital Avicenne Bobigny, France, 93009 Polyclinique Bordeaux Nord Aquitaine Bordeaux, France, 33300 Hôpital du Haut Lévêque Centre François Magendie Bordeaux, France, 33604 Clinique - ICH CHU de Brest Hôpital Morvan Brest, France, 29609 CHRU Côte de Nacre Caen, France, 14033 Centre Hospitalier William Morey Chalon-sur-Saône, France, 71100 Hôpital d'instruction des armées Percy Clamart, France, 92141 Hématologie Clinique CHU DIJON Dijon, France, 21000 Centre Hospitalier Général Dunkerque, France, 59 385 CHRU, Hôpital A.Michallon Grenoble, France, 38043 Médecine interne Centre hospitalier départemental La Roche sur Yon, France, 85025 Service d'Hématologie CHV André Mignot Le Chesnay Cedex, France, 78157 CHRU , Hôpital Claude Huriez Lille, France Sce Hématologie Thérapie Cellulaire CHU Limoges Limoges, France, 87000 Institut Paoli Calmette Marseille, France, 13273 Hopital J Monod Sce Rhumato Nord Montivilliers, France, 76290 Service Hématologie CHRU Montpellier Montpellier, France, 34090 Hopital E Muller Mulhouse, France, 68100 Maladies du sang CHRU Hôtel Dieu Nantes, France, 44035 Hôpital Saint-Louis PARIS cedex 10, France, 75475 CHU - Hôpital St Antoine PARIS cedex 12, France, 75571 URC/CIC Paris Descartes Necker-Cochin Paris, France, 75015 Centre Hospitalier Lyon sud Pierre - Bénite, France, 69495 CHU de la milétrie Poitiers, France, 86000 Unité de Recherche Clinique - CH Périgueux Périgueux, France, 24019 Hôpital R.Debré Reims, France, 51032 Hôpital de Pontchaillou Rennes, France, 35033 Service d'Hématologie Clinique Institut de Cancérologie Lucien Neuwirth Saint Priest en Jarez, France, 42270 Service Hématologie Centre Hospitalier Yves le Foll Saint-Brieuc, France, 22000 Département d'Hématologie et Oncologie Hôpitaux Universitaires de Strasbourg Strasbourg, France, 67091 Hématologie CHRU IUCT Oncopole Toulouse cedex 9, France, 31100 Onco-hématologie CHRU Hôpital Bretonneau Tours cedex, France, 37044 Hôpitaux de Brabois Vandœuvre-lès-Nancy, France, 54511 service hématologie CH Bretagne Atlantique Vannes, France, 56017 Curie Institut ¨Paris, France, 75248 收起 << |
NCT01342692 | MDS | Phase 2 | Active, not recruiting | January 2019 | France ... 展开 >> Avicenne hospital Bobigny, France, 93009 收起 << |
NCT01790737 | Multiple Myeloma | Phase 2 | Active, not recruiting | December 2018 | Finland ... 展开 >> Kuopio University Hospital Kuopio, North Savo, Finland, 70200 Tampere University Hospital Tampere, Pirkanmaa, Finland, 33100 Helsinki University Hospital Helsinki, Finland Kanta-Häme Central Hospital Hämeenlinna, Finland Jyväskylä Central Finland Central Hospital Jyväskylä, Finland Kainuu Kajaani Central Hospital Kajaani, Finland Länsi-Pohja Central Hospital Kemi, Finland Kymenlaakso Central Hospital Kotka, Finland Mikkeli Southern-Savo Central Hospital Mikkeli, Finland Oulu University Hospital Oulu, Finland Satakunta Central Hospital Pori, Finland Turku University Central Hospital Turku, Finland 收起 << |
NCT02608515 | - | Completed | - | Greece ... 展开 >> Patra Patra, Greece, 26443 收起 << | |
NCT01706666 | - | Completed | - | - | |
NCT03440411 | Multiple Myeloma | Phase 3 | Recruiting | February 18, 2023 | Italy ... 展开 >> FO.NE.SA.Onlus Recruiting Torino, Italy, 10126 Contact: Mario Boccadoro, MD +390116336107 clinicaltrialoffice@fonesa.it 收起 << |
NCT03224507 | Multiple Myeloma | Phase 2 | Recruiting | April 1, 2023 | United States, Alabama ... 展开 >> University of Alabama at Birmingham Recruiting Birmingham, Alabama, United States, 35294 Contact: Kimberly Aldridge, RN 205-934-6709 kaldridg@uabmc.edu 收起 << |
NCT03289299 | Smoldering Multiple Myeloma | Phase 2 | Recruiting | June 1, 2026 | United States, Florida ... 展开 >> Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Mark Melody Mark.Melody@moffitt.org Principal Investigator: Melissa Alsina, MD United States, Illinois University of Chicago Medical Center Recruiting Chicago, Illinois, United States, 60637 Contact: Jennifer Nam 773-702-7716 jnam@medicine.bsd.uchicago.edu Contact: Amanda McIver 7738345884 amciver@medicine.bsd.uchicago.edu Principal Investigator: Andrzej Jakubowiak, MD United States, Indiana Indiana University Simon Cancer Center Recruiting Indianapolis, Indiana, United States, 46202 Contact: Chelsea Young 317-278-5621 youngchs@iu.edu Principal Investigator: Rafat Abonour, MD United States, Kansas University of Kansas Cancer Center Recruiting Westwood, Kansas, United States, 66205 Contact: Kerry Hepler 913-945-7552 khepler@kumc.edu Principal Investigator: Al-Ola Abdallah, MD United States, Maryland University of Maryland Medical Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Emily Lederer 410-328-7558 elederer@umm.edu Principal Investigator: Ashraf Badros, MD United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Clinical Trials Referral Office https://www.mayo.edu/research/forms/cancer-clinical-trials 855-776-0015 Principal Investigator: Shaji Kumar, MD United States, New York Weill Cornell Medicine Recruiting New York, New York, United States, 10022 Contact: Sheetal Ramnath shr2026@med.cornell.edu Principal Investigator: Ruben Niesvizky, MD United States, Washington Swedish Cancer Institute Recruiting Seattle, Washington, United States, 98104 Contact: Neil Bailey 206-215-1471 neil.bailey@swedish.org Principal Investigator: William Bensinger, MD United States, Wisconsin Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: MCW Cancer Center 414-805-8900 cccto@mcw.edu Principal Investigator: Binod Dhakal, MD 收起 << |
NCT02036502 | Multiple Myeloma | Phase 1 | Active, not recruiting | October 23, 2019 | - |
NCT01706666 | Stage I Multiple Myeloma ... 展开 >> Stage II Multiple Myeloma Stage III Multiple Myeloma 收起 << | Phase 2 | Completed | - | United States, Arizona ... 展开 >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Maryland Johns Hopkins University Baltimore, Maryland, United States, 21287-8936 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, Texas Baylor Medical Center Garland, Texas, United States, 75042 收起 << |
NCT02060656 | Diffuse Large B-Cell Lymphoma | Phase 2 | Unknown | - | United Kingdom ... 展开 >> Royal Marsden NHS Foundation Trust - London and Surrey Recruiting London, United Kingdom, SM2 5PT Contact: Bijal Patel, Msc +44 (0)208 661 3808 bijal.patel@rmh.nhs.uk Principal Investigator: David Cunningham, MD FRCP 收起 << |
NCT02343042 | Multiple Myeloma | Phase 1 Phase 2 | Recruiting | April 2019 | United States, California ... 展开 >> Jonnsson Comprehensive Cancer Center / University of Los Angeles Recruiting Los Angeles, California, United States, 0095 Contact: Gary Schiller, MD, PhD 888-798-0719 GSchiller@mednet.ucla.edu Principal Investigator: Gary Schiller, MD, PhD United States, New York Columbia University Recruiting New York, New York, United States, 10032 Contact: Suzanne Lentzsch, MD 212-305-5065 CTOInformation@columbia.edu Principal Investigator: Suzanne Lentzsch, MD Wilmot Cancer Center/ University of Rochester Recruiting Rochester, New York, United States Contact: Brea Lipe, MD Brea_Lipe@URMC.Rochester.edu Principal Investigator: Brea Lipe, MD United States, North Carolina University of North Carolina - Chapel Hill Comprehensive Cancer Center Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Sascha Alexander Tuchman, MD, MHS 984-974-0000 sascha_tuchman@med.unc.edu Principal Investigator: Sascha Alexander Tuchman, MD, MHS Duke Institute of Cancer/ Duke University Recruiting Durham, North Carolina, United States, 27710 Contact: Cristina Gasparetto, MD 919-668-1017 gaspa001@mc.duke.edu Principal Investigator: Cristina Gasparetto, MD United States, Washington Swedish Cancer Institute Recruiting Seattle, Washington, United States, 98109 Contact: William Bensinger, MD 855-922-6237 Principal Investigator: William Bensinger, MD United States, Wisconsin University of Wisconsin School of Medicine and Public Health Recruiting Madison, Wisconsin, United States, 53792 Contact: Natalie Callander, MD 608-265-8554 nsc@medicine.wisc.edu Principal Investigator: Natalie Callander, MD Canada, Alberta Tom Baker Cancer Center/Alberta Health Services Recruiting Calgary, Alberta, Canada, T2N 4Z6 Contact: Nizar Bahlis, MD +1 (403) 944-1880 nbahlis@ucalgary.ca Principal Investigator: Nizar Bahlis, MD Cross Cancer Institute / University of Alberta Recruiting Edmonton, Alberta, Canada, T6G 1Z2 Contact: Chris Venner 780-432-8771 Principal Investigator: Chris Venner, MD Canada, British Columbia Vancouver General Hospital Recruiting Vancouver,, British Columbia, Canada, V5Z 1M9 Contact: Heather Sutherland 604.736.2033 Principal Investigator: Heather Sutherland, MD Canada, Manitoba Cancer Care Manitoba Active, not recruiting Winnipeg, Manitoba, Canada, R3E 0V9 Canada, Newfoundland and Labrador Memorial Hospital of Newfoundland Active, not recruiting St. John's, Newfoundland and Labrador, Canada, A1B 3V6 Canada, Nova Scotia Queen Elizabeth II Health Sciences Center Recruiting Halifax, Nova Scotia, Canada, B3H 2Y9 Contact: Darrell White Principal Investigator: Darrell White, MD Canada, Ontario Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Saima Dean 416 946 4501 ext 5241 Principal Investigator: Christine Chen Canada, Quebec Maisonneuve-Rosemont Hospital Active, not recruiting Montreal, Quebec, Canada, H1T 2M4 Royal Victoria Hospital / McGill University Active, not recruiting Montreal, Quebec, Canada, H3A 1A1 收起 << |
NCT01793051 | Myeloma | Phase 2 | Active, not recruiting | March 2019 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT03477539 | Minimal Residual Disease ... 展开 >> Plasma Cell Myeloma 收起 << | Phase 2 | Recruiting | April 1, 2019 | United States, Florida ... 展开 >> Mayo Clinic in Florida Recruiting Jacksonville, Florida, United States, 32224-9980 Contact: Clinical Trials Referral Office 855-776-0015 Principal Investigator: Sikander Ailawadhi 收起 << |
NCT03475628 | Multiple Myeloma | Phase 2 | Recruiting | February 20, 2020 | Greece ... 展开 >> General Hospital of Athens "Alexandra" Recruiting Athens, Attica, Greece, 11528 Contact: Evangelos Terpos, Assoc Prof +30210 3381512 收起 << |
NCT03168100 | Multiple Myeloma | Phase 2 | Recruiting | July 2028 | United States, Arkansas ... 展开 >> University of Arkansas for Medical Sciences Recruiting Little Rock, Arkansas, United States, 72205 Contact: Beth Scanlan 501-686-8274 bscanlan@uams.edu Contact: Matthew Kovak 501-686-8274 mrkovak@uams.edu 收起 << |
NCT01718899 | Smoldering Multiple Myeloma | Phase 1 | Completed | - | United States, Georgia ... 展开 >> Winship Cancer Institute, Emory University Atlanta, Georgia, United States, 30322 United States, Illinois Illinois Cancer Specialists Niles, Illinois, United States, 60714 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02115 United States, Texas University of Texas, MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01055301 | Multiple Myeloma ... 展开 >> Plasma Cell Myeloma 收起 << | Phase 2 | Withdrawn(lack of accrual) | - | United States, Louisiana ... 展开 >> Tulane Cancer Center Office of Clinical Research Alexandria, Louisiana, United States, 71315-3198 Hematology-Oncology Clinic Baton Rouge, Louisiana, United States, 70809 United States, Michigan Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 United States, Mississippi University of Mississippi Cancer Clinic Jackson, Mississippi, United States, 39216 United States, Washington Island Hospital Cancer Care Center at Island Hospital Anacortes, Washington, United States, 98221 St. Joseph Cancer Center Bellingham, Washington, United States, 98225 Olympic Hematology and Oncology Bremerton, Washington, United States, 98310 Highline Medical Center Cancer Center Burien, Washington, United States, 98166 Columbia Basin Hematology Kennewick, Washington, United States, 99336 Skagit Valley Hospital Cancer Care Center Mount Vernon, Washington, United States, 98274 Harrison Poulsbo Hematology and Onocology Poulsbo, Washington, United States, 98370 Harborview Medical Center Seattle, Washington, United States, 98104 Minor and James Medical, PLLC Seattle, Washington, United States, 98104 Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Group Health Central Hospital Seattle, Washington, United States, 98112 Swedish Cancer Institute at Swedish Medical Center - First Hill Campus Seattle, Washington, United States, 98122-4307 University Cancer Center at University of Washington Medical Center Seattle, Washington, United States, 98195 North Puget Oncology at United General Hospital Sedro-Woolley, Washington, United States, 98284 Cancer Care Northwest - Spokane South Spokane, Washington, United States, 99202 Evergreen Hematology and Oncology, PS Spokane, Washington, United States, 99218 Wenatchee Valley Medical Center Wenatchee, Washington, United States, 98801-2028 收起 << |
NCT03428373 | Multiple Myeloma in Relapse ... 展开 >> Multiple Myeloma Progression Multiple Myeloma Stage II Multiple Myeloma Stage I Multiple Myeloma With Failed Remission Multiple Myeloma Stage III 收起 << | Phase 2 Phase 3 | Not yet recruiting | January 2019 | - |
NCT00907348 | Non Hodgkin Lymphoma ... 展开 >> Follicular Lymphoma 收起 << | Phase 2 | Unknown | January 2012 | Italy ... 展开 >> Divisione di Ematologia Osp. SS. Antonio e Biagio Alessandria, Italy Divisione di Oncologia Medica A Centro di Riferimento Oncologico Aviano, Italy Cattedra di Ematologia Università Policlinico Bari, Italy IRCCS Istituto Tumori Giovanni Paolo II Bari, Italy Istituto di Ematologia "Seragnoli" Polic.S.Orsola-Malpighi Bologna, Italy, 40138 Divisione di Ematologia Spedali Civili Brescia, Italy Divisione di Ematologia Osp. Businco Cagliari, Italy Onco-Ematologia I.R.C.C. Candiolo (TO), Italy Ematologia 1 Ospedale S. Martino Genova, Italy, 16132 Divisione di Ematologia Ospedale Niguarda Milano, Italy UO Ematologia II Facoltà di Medicina e Chirurgia Università Federico II Napoli, Italy Divisione di Ematologia Università Avogadro Novara, Italy UO Ematologia Università - Policlinico San Matteo Pavia, Italy Dipartimento di biotecnologie cellulari ed ematologia Ospedale Umberto I - La Sapienza Roma, Italy Oncoematologia - Univ. Perugia Sede Terni, Terni, Italy, 05100 S.C.Ematologia 1 AOU San Giovanni Battista Torino, Italy, 10126 SC Ematologia 2 ASO San Giovanni Battista Torino, Italy UO Ematologia Osp. Cardinale Panico Tricase (LE), Italy 收起 << |
NCT03495960 | Primary Central Nervous System... 展开 >> Lymphoma 收起 << | Phase 2 | Not yet recruiting | October 31, 2023 | Italy ... 展开 >> Bari IRCCS Istituto Tumori Bari, Italy Meldola, IRST - ISTITUTO SCIENTIFICO ROMAGNOLO PER LO STUDIO E LA CURA DEI TUMORI Meldola, Italy Milano, IRCCS Ospedale San Raffaele Milan, Italy, 20132 Milano - Îstituto Besta Milan, Italy Milano Niguarda Milan, Italy Modena, Policlinico Universitario Modena, Italy Padova, Istituto Oncologico Veneto Padova, Italy Parma, Azienda Ospedaliera Parma, Italy Pescara, Presidio Ospedaliero UOS dipartimentale centro di diagnosi e terapia Linfomi Pescara, Italy Piacenza Piacenza, Italy Ravenna - Ospedale di Ravenna - IRST Ravenna, Italy Reggio Emilia - Arcispedale Santa Maria Nuova - IRCCS Reggio Emilia, Italy Roma - Ospedale S. Andrea Roma, Italy Roma - Unicampus-Bio Roma, Italy S. Giovanni Rotondo - Casa Sollievo della sofferenza San Giovanni Rotondo, Italy Siena - Azienda Ospedaliera Universitaria Senese Siena, Italy Terni - Ospedale di Terni Terni, Italy Torino neurooncologia - AOU CITTA' DELLA SALUTE E DELLA SCIENZA DI TORINO Torino, Italy Tricase - Ospedale "Card. G. Panico" Tricase, Italy Udine, Azienda Ospedaliera Universitaria Udine, Italy Switzerland Basel - Universitätsspital Recruiting Basel, Switzerland Contact: Benjamin kasenda, MD Principal Investigator: Benjamin Kasenda IOSI - Oncology Institute of Southern Switzerland Bellinzona, Switzerland, 6500 Bern - Inselspital Bern, Switzerland Lausanne - CHUV Lausanne, Switzerland St. Gallen - Kantonsspital Saint Gallen, Switzerland 收起 << |
NCT01421186 | Multiple Myeloma | Phase 1 Phase 2 | Active, not recruiting | December 2018 | Austria ... 展开 >> AKH (Allgemeines Krankenhaus der Stadt Wien), Abteilung für Klinische Onkologie, Universitätsklinik für Innere Medizin I Vienna, Austria, 1090 Germany Charité - Universitätsmedizin Berlin, CBF: Campus Benjamin Franklin, CC 14: Tumormedizin, Medizinische Klinik mit Schwerpunkt Hämatologie, Onkologie Berlin, Germany, 12200 Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus Dresden, Germany, 01307 Medizinische Klinik 5 - Hämatologie und Internist. Onkologie, Universitätsklinikum Erlangen Erlangen, Germany, 91054 Medizinische Universitätsklinik, Abt. Innere Medizin I Freiburg, Germany, 79106 Universitäsklinikum Heidelberg, Klin.-Pharmakologisches Studienzentrum Heidelberg, Germany, 69120 Sektion für Stammzell- und Immuntherapie, II. Medizinischen Klinik, Kiel, Germany, 24105 Klinikum rechts der Isar/ Studien / III. Med. Klinik Munich, Germany, 81675 Medizinische Klinik II, Abt. Hämatologie, Onkologie, Tübingen, Germany, 7206 Universitätsklinikum Würzburg, Medizinische Klinik und Poliklinik II, Studienambulanz für Hämatologie/Onkologie und Infektiologie Würzburg, Germany, 97080 收起 << |
NCT01526694 | Multiple Myeloma | Phase 2 | Completed | - | Italy ... 展开 >> Division of Hematology and CBMT Bolzano, BZ, Italy, 39100 Presidio Ospedaliero di Camposampiero Camposampiero, Padova, Italy, 35012 Ospedale S. Martino Belluno, Italy, 32100 Ospedale di Castelfranco Veneto Castelfranco Veneto, Italy, 31033 Ospedale Civile di Dolo Dolo, Italy, 30031 AULSS 2 Feltre Feltre, Italy, 32032 Azienda Ospedaliera Universitaria G. Martino Messina, Italy, 98125 Ospedale dell'Angelo di Mestre Mestre, Italy, 30170 A.O di Padova Ematologia e Immunologia Clinica Padova, Italy, 35127 A.O di Padova Ematologia Padova, Italy, 35127 AULLS 18 di Rovigo Rovigo, Italy, 45100 Ospedale di Trento - P.O. S. Chiara Trento, Italy, 38100 Ospedale Ca Foncello Treviso, Italy, 31100 A.O.U Ospedali Riuniti di Trieste Medicina II Trieste, Italy, 34142 A.O.U Ospedali Riuniti di Trieste Trieste, Italy, 34142 A.O.U S. Maria della Misericordia Udine, Italy, 33100 Ospedale Policlinico G.B Rossi (Borgo Roma) Ematologia Verona, Italy, 37134 Ospedale Policlinico G.B Rossi (Borgo Roma) Medicina II Verona, Italy, 37134 AULSS 6 Vicenza Vicenza, Italy, 36100 收起 << |
NCT01953692 | Myelodysplastic Syndrome ... 展开 >> Multiple Myeloma Hodgkin Lymphoma Non-Hodgkin Lymphoma Diffuse Large B-Cell Lymphoma Follicular Lymphoma Primary Mediastinal B-Cell Lymphoma 收起 << | Phase 1 | Active, not recruiting | June 10, 2022 | - |
NCT01422486 | Myelodysplastic Syndrome (MDS) | Phase 2 | Terminated(Study TLK199.2107 w... 展开 >>as terminated for business reasons.) 收起 << | - | United States, Illinois ... 展开 >> Loyola University Maywood, Illinois, United States, 60153 SIU School of Medicine, Simmons Cancer Center Springfield, Illinois, United States, 62794-9677 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, New York Columbia University New York, New York, United States, 10032 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37232 收起 << |
NCT01053949 | Multiple Myeloma | Phase 2 | Completed | - | France ... 展开 >> CHRU-Hôpital Sud, avenue Laennec, Amiens, France, 80054 Hématologie, Hôpital Avicenne Bobigny, France, 93009 Hématologie, CHU, avenue G.Clemenceau Caen, France, 14033 Hématologie Clinique, CHU, Hôpital d'Enfants Dijon, France, 21000 Hématologie, CHRU, Hôpital A.Michallon Grenoble, France, 38043 Service des Maladies du Sang, CHRU Lille, France, 59037 Hôpital Edouard HERRIOT Lyon, France, 69437 Hématologie, Institut Paoli Calmette Marseille, France, 13273 Hématologie, CHRU, Hôpitaux de Brabois Nancy, France, 54511 Maladies du Sang, CHRU, Hôtel Dieu Nantes, France, 44035 Service Immuno-Hématologie, Hôpital Saint-Louis Paris, France, 75475 Maladies du Sang, CHU - Hôpital St Antoine Paris, France, 75571 Service des Maladies du Sang, Hôpital Haut-Levèque Pessac, France, 33604 Service d'Hématologie, Centre Hospitalier Lyon Sud Pierre Benite, France, 69495 Hématologie Clinique, Hôpital Robert Debré, CHU Reims Reims, France, 51092 Hôpital PONTCHAILLOU, CHU de RENNES Rennes, France, 35033 Médecine Interne, CHRU, Hôpital Sud Rennes, France, 35056 Hématologie, CHRU, Hôpital Purpan Toulouse, France, 31059 Onco-Hématologie, CHRU- Hôpital Bretonneau Tours, France, 37044 收起 << |
NCT03180736 | Multiple Myeloma | Phase 3 | Recruiting | July 1, 2023 | - |
NCT03606577 | Multiple Myeloma | Phase 2 | Not yet recruiting | November 2, 2026 | France ... 展开 >> CHU de Nantes Not yet recruiting Nantes, Pays De La Loire, France, 44000 Contact: Philippe Moreau, MD 02.40.08.32.71 ext +33 philippe.moreau@chu-nantes.fr 收起 << |
NCT03490344 | Multiple Myeloma | Phase 2 | Recruiting | October 2020 | United States, New Jersey ... 展开 >> Memoral Sloan Kettering Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Sham Mailankody, MBBS 212-639-2131 Memoral Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Sham Mailankody, MBBS 212-639-2131 Memorial Sloan Kettering Bergen Recruiting Montvale, New Jersey, United States, 07645 Contact: Sham Mailankody, MBBS 212-639-2131 United States, New York Memorial Sloan Kettering Cancer Center @ Commack Recruiting Commack, New York, United States, 11725 Contact: Sham Mailankody, MBBS 212-639-2131 Memoral Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Sham Mailankody, MBBS 212-639-2131 Memorial Sloan - Kettering Cancer Center Not yet recruiting New York, New York, United States, 10021 Contact: Sham Mailankody, MBBS 212-639-2131 Memorial Sloan Kettering @ Rockville Recruiting Rockville Centre, New York, United States, 11570 Contact: Sham Mailankody, MBBS 212-639-2131 收起 << |
NCT03361306 | Multiple Myeloma | Phase 2 | Recruiting | December 31, 2020 | United States, North Carolina ... 展开 >> Levine Cancer Institute (Main) Recruiting Charlotte, North Carolina, United States, 28204 Contact: Mallory Tucker 收起 << |
NCT00507442 | Multiple Myeloma | Phase 1 Phase 2 | Completed | - | United States, Colorado ... 展开 >> Rocky Mountain Cancer Center Denver, Colorado, United States, 80218 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55904-0001 收起 << |
NCT00507442 | - | Completed | - | - | |
NCT03000634 | Multiple Myeloma | Phase 2 | Withdrawn(Study was not and wi... 展开 >>ll not be initiated due to lack of funding.) 收起 << | May 2023 | - |
NCT01481194 | Multiple Myeloma | Phase 2 | Active, not recruiting | December 2019 | Denmark ... 展开 >> Department of Hematology Vejle, Denmark 收起 << |
NCT02612779 | Multiple Myeloma | Phase 2 | Active, not recruiting | January 15, 2020 | - |
NCT01460420 | Hematologic Malignancies ... 展开 >> Multiple Myeloma 收起 << | Phase 1 Phase 2 | Completed | - | Germany ... 展开 >> Medizinische Klinik and Poliklinik II, University Hospital Würzburg,, Germany Italy S Giovanni Battista Hospital Torino, Italy Azienda Ospedaliera Universitaria di Udine Udine, Italy Spain Hospital Clinic i Provincial, Barcelona,, Spain Hospital Santa Creu I Sant Pau, Barcelona,, Spain Hospital Universitario Ramón y Cajal Madrid, Spain, 28034 Hospital Gregorio Marañón, Madrid, Spain Hospital Clinico Universitario Salamanca, Salamanca,, Spain Hospital Universitario Virgen del Rocío, Sevilla, Spain Sweden Karolinska University Hospital, Huddinge Stockholm, Sweden 收起 << |
NCT02891811 | Multiple Myeloma | Phase 2 | Recruiting | September 2023 | Austria ... 展开 >> Medizinische Universitaet Graz, Univ.-Klinik f. Innere Medizin, Onkologie Recruiting Graz, Austria, A-8036 Contact: Siegfried Sormann, MD 0043 316 385 ext 81814 siegfried.sormann@klinikum-graz.at Contact: Pia-Carina Gallaun, BSc Pia-Carina.Gallaun@klinikum-graz.at Principal Investigator: Siegfried Sormann, MD Med. Universität Innsbruck, Univ.-Klinik f. Innere Medizin V, Hämatologie u. Onkologie Recruiting Innsbruck, Austria, 6020 Contact: Eberhard Gunsilius, MD +43 512 504 ext 80669 Eberhard.Gunsilius@i-med.ac.at Principal Investigator: Eberhard Gunsilius, MD Bezirkskrankenhaus Kufstein, Innere Medizin, Interne II u. onkologische Tagesklinik Recruiting Kufstein, Austria, 6330 Contact: August Zabernigg, MD +43 5372 6966 ext 3000 august.zabernigg@bkh-kufstein.at Principal Investigator: August Zabernigg, MD LKH Hochsteiermark, Standort Leoben Recruiting Leoben, Austria, A-8700 Contact: Christoph Tinchon, MD, DL 0043 3842 401 ext 3402 christoph.tinchon@lkh-leoben.at Contact: Manuela Maderdonner, BSc, MSc Manuela.Maderdonner@kages.at Principal Investigator: Christoph Tinchon, MD, DL Ordensklinikum Linz - Barmherzige Schwestern Linz, Interne I Recruiting Linz, Austria, A-4010 Contact: Andreas Petzer, MD 0043 732 7677 ext 4555 andreas.petzer@ordensklinikum.at Contact: Martina Lang studien.linz@ordensklinikum.at Principal Investigator: Andreas Petzer, MD Ordensklinikum Linz - Elisabethinen, I. Interne Abt. Haemato-Onkologie Recruiting Linz, Austria, A-4020 Contact: Sigrid Machherndl-Spandl, MD 0043 732 7676 ext 4428 sigrid.machherndl-spandl@ordensklinikum.at Contact: Silvia Löschenberger silvia.loeschenberger@ordensklinikum.at Principal Investigator: Sigrid Machherndl-Spandl, MD Kepler Univ.-Klinikum Linz, Klinik f. Interne 3 Recruiting Linz, Austria, A-4021 Contact: Michael Fridrik, MD 0043 5 7680 82 ext 6195 michael.fridrik@kepleruniklinikum.at Contact: Bettina Pfleger bettina.pfleger@kepleruniklinikum.at Principal Investigator: Michael Fridrik, MD Univ.Klinikum Krems, Klin. Abt. f. Innere Medizin 2 Recruiting Mitterweng, Austria, 3500 Contact: Klaus Podar, MD, Dr. +43 2732 9004 ext 4456 klaus.podar@krems.lknoe.at Contact: Elisabeth Zwickl-Traxler, Mag. 4161 ext 4161 studienzentrale@krems.lknoe.at Principal Investigator: Klaus Podar, MD, Dr. Landeskrankenhaus Rankweil, Interne E (Hämatologie u. Onkologie) Recruiting Rankweil, Austria, 6830 Contact: Alois Lang, MD +43 5522 303 ext 2301 alois.lang@lkhf.at Principal Investigator: Alois Lang, MD PMU Salzburg Recruiting Salzburg, Austria, 5020 Contact: Richard Greil, MD +43 57255 ext 25801 r.greil@salk.at Contact: Michaela Schachner m.schachner@salk.at Principal Investigator: Richard Greil, MD Landeskrankenhaus Steyr, Innere Medizin II Onkologie Recruiting Steyr, Austria, A-4400 Contact: Johannes Andel, MD 0043 5 055466 ext 24200 johannes.andel@gespag.at Contact: Regina Neuhauser regina.neuhauser@gespag.at Principal Investigator: Johannes Andel, MD Medizinische Univ. Wien, Univ.Klinik f. Innere Medizin I, Onkologie Not yet recruiting Vienna, Austria, 1090 Contact: Hermine Agis, MD +43 1 40400 ext 44570 hermine.agis@meduniwien.ac.at Contact: Ursula Schäff, Mag. +43 1 40400 ext 44325 ursula.schaeff@meduniwien.ac.at Principal Investigator: Hermine Agis, Priv.Doz.Dr. Sozialmedizinisches Zentrum Ost - Donauspital, 2. Medizinische Abteilung Recruiting Vienna, Austria, 1220 Contact: Reinhard Ruckser, MD +43 1 288 02 ext 3202 reinhard.ruckser@wienkav.at Contact: Elvira Kitzweger +43 1 288 02 ext 743261 elvira.kitzweger@wienkav.at Principal Investigator: Reinhard Ruckser, MD Medizinische Univ. Wien, Univ.Klinik f. Innere Medizin I, Hämatologie u. Hämostaseologie Not yet recruiting Vienna, Austria, A-1090 Contact: Maria-Theresa Krauth, MD 0043 40400 ext 44010 maria.krauth@meduniwien.ac.at Contact: Renate Schoder renate.schoder@meduniwien.ac.at Principal Investigator: Maria-Theresa Krauth, MD Wilhelminenspital Recruiting Vienna, Austria, A-1160 Contact: Niklas Zojer, MD 0043149150 ext 2151 niklas.zojer@wienkav.at Contact: Heidrun Forstner heidrun.forstner@extern.wienkav.at Principal Investigator: Niklas Zojer, MD Krankenhaus Zams, Innere Medizin, Internistische Onkologie u. Hämatologie Recruiting Zams, Austria, 6511 Contact: Ewald Wöll, MD +43 5442 600 ext 7413 ewald.woell@krankenhaus-zams.at Contact: Carmen Ruepp carmen.ruepp@krankenhaus-zams.at Principal Investigator: Ewald Wöll, Univ.Doz.Dr. 收起 << |
NCT02922543 | - | Active, not recruiting | December 31, 2019 | Japan ... 展开 >> Shinko Hospital Kobe, Hyogo, Japan, 651-0072 收起 << | |
NCT02856438 | - | - | - | Japan ... 展开 >> Local Institution Nagoya-shi, Aichi, Japan, 4600001 Contact: Site 0002 Local Institution Nagoya-shi, Aichi, Japan, 4678602 Contact: Site 0003 Local Institution Shibukawa-shi, Gunma, Japan, 3770280 Contact: Site 0001 Local Institution Osaka-shi, Osaka, Japan, 5438555 Contact: Site 0004 收起 << | |
NCT02921815 | - | Active, not recruiting | December 31, 2019 | Japan ... 展开 >> Shinko Hospital Kobe, Hyogo, Japan, 651-0072 收起 << | |
NCT02481934 | Multiple Myeloma | Phase 1 | Completed | - | Spain ... 展开 >> Hospital Universitario 12 de Octubre Madrid, Spain, 28041 收起 << |
NCT00961467 | Multiple Myeloma | Phase 2 | Completed | - | Italy ... 展开 >> Azienda Ospedaliera S Giovanni Battista Torino, Italy/Torino, Italy, 10126 收起 << |
NCT01484626 | - | Terminated(Celgene would no lo... 展开 >>nger supply lenalidomide for the study) 收起 << | - | - | |
NCT03269669 | Grade 1 Follicular Lymphoma ... 展开 >> Grade 2 Follicular Lymphoma Grade 3a Follicular Lymphoma Recurrent Follicular Lymphoma Refractory Follicular Lymphoma 收起 << | Phase 2 | Recruiting | December 31, 2022 | - |
NCT02481934 | - | Completed | - | - | |
NCT00602459 | Stage I Chronic Lymphocytic Le... 展开 >>ukemia Stage II Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia Stage IV Chronic Lymphocytic Leukemia 收起 << | Phase 2 | Completed | - | - |
NCT01858558 | Multiple Myeloma | Phase 2 | Recruiting | July 2024 | United States, Maryland ... 展开 >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21231 Contact: Ivan Borrello, M.D. 410-955-4967 Principal Investigator: Ivan Borrello, M.D. 收起 << |
NCT00055562 | Melanoma Neop... 展开 >>lasm Metastasis 收起 << | Phase 2 Phase 3 | Completed | - | - |
NCT01946477 | Multiple Myeloma | Phase 2 | Active, not recruiting | December 1, 2024 | - |
NCT02415413 | Smoldering Multiple Myeloma | Phase 2 | Active, not recruiting | May 2020 | Spain ... 展开 >> Hospital Clínic de Barcelona Barcelona, Spain Hospital Universitari Germans Trias i Pujol Barcelona, Spain Hospital Clínico San Carlos Madrid, Spain Hospital Universitario 12 de Octubre Madrid, Spain Hospital Universitario Ramón y Cajal Madrid, Spain Hospital Universitario Morales Meseguer Murcia, Spain Hospital Universitario Central de Asturias Oviedo, Spain Clínica Universidad de Navarra Pamplona, Spain Hospital de Son Llàtzer Plama De Mallorca, Spain Hospital Universitario de Salamanca Salamanca, Spain Hospital Universitario Reina Sofía Sevilla, Spain Hospital Universitario Virgen del Rocío Sevilla, Spain Hospital Universitario de Canarias Tenerife, Spain Hospital Clínico Universitario de Valencia Valencia, Spain Hospital Universitario Doctor Peset Valencia, Spain Hospital Clínico Universitario Lozano Blesa Zaragoza, Spain 收起 << |
NCT00998049 | - | Completed | - | - | |
NCT01484626 | Multiple Myeloma | Phase 1 Phase 2 | Terminated(Celgene would no lo... 展开 >>nger supply lenalidomide for the study) 收起 << | - | United States, Illinois ... 展开 >> Loyola University Medical Center Maywood, Illinois, United States, 60153 收起 << |
NCT03223610 | Lymphoma Non-... 展开 >>Hodgkin Lymphoma Diffuse Large B-Cell Lymphoma Burkitt Lymphoma 收起 << | Phase 1 | Recruiting | September 1, 2022 | United States, Maryland ... 展开 >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office 888-624-1937 收起 << |
NCT02368301 | - | - | - | - | |
NCT00998049 | Multiple Myeloma ... 展开 >> Refractory Multiple Myeloma Stage I Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma 收起 << | Phase 2 | Completed | - | United States, Arizona ... 展开 >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT01301963 | Refractory Multiple Myeloma | Phase 3 | Terminated(Slow Accrual) | - | United States, Ohio ... 展开 >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 收起 << |
NCT00602459 | - | Completed | - | - | |
NCT01301963 | - | Terminated(Slow Accrual) | - | - | |
NCT02513186 | Plasma Cell Myeloma | Phase 1 | Recruiting | August 2022 | France ... 展开 >> Investigational Site Number 250002 Active, not recruiting Nantes Cedex 01, France, 44093 Investigational Site Number 250003 Completed Pierre Benite, France, 69310 Investigational Site Number 250001 Active, not recruiting Toulouse Cedex 9, France, 31059 Germany Investigational Site Number 276003 Active, not recruiting Berlin, Germany, 12200 Investigational Site Number 276002 Active, not recruiting Leipzig, Germany, 04103 Italy Investigational Site Number 380003 Active, not recruiting Milano, Italy, 20132 Investigational Site Number 380002 Completed Roma, Italy, 00161 Investigational Site Number 380001 Active, not recruiting Torino, Italy, 10126 Spain Investigational Site Number 724003 Recruiting Madrid, Spain, 28041 Investigational Site Number 724001 Recruiting Pamplona, Spain, 31008 Investigational Site Number 724002 Recruiting Salamanca, Spain, 37007 收起 << |
NCT01237249 | Multiple Myeloma | Phase 2 | Completed | - | - |
NCT03151811 | Multiple Myeloma | Phase 3 | Recruiting | December 2021 | - |
NCT00112827 | Refractory Multiple Myeloma ... 展开 >> Smoldering Multiple Myeloma Stage I Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma 收起 << | Phase 1 Phase 2 | Active, not recruiting | November 2019 | United States, California ... 展开 >> City of Hope Medical Center Duarte, California, United States, 91010 收起 << |
NCT00460031 | - | Active, not recruiting | - | - | |
NCT02426723 | Multiple Myeloma | Phase 1 | Recruiting | - | United States, Texas ... 展开 >> The University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Principal Investigator: Elisabet Manasanch, MD Korea, Republic of Seoul National University Hospital Recruiting Seoul, Korea, Republic of Principal Investigator: Sung-Soo Yoon, MD Seoul St.Mary's Hospital Recruiting Seoul, Korea, Republic of Contact: Chang-Ki Min, MD Yonsei Severance Hospital Recruiting Seoul, Korea, Republic of Contact: Jin Seok Kim, MD 收起 << |
NCT01393964 | Multiple Myeloma | Phase 1 | Completed | - | United States, Georgia ... 展开 >> Winship Cancer Institute, Emory University Atlanta, Georgia, United States, 30322 United States, Indiana Investigative Clinical Research Of Indiana, Llc Indianapolis, Indiana, United States, 46260 United States, Iowa University Of Iowa Hospitals And Clinics Iowa City, Iowa, United States, 52242 United States, Maryland University Of Maryland Baltimore, Maryland, United States, 21201 United States, Michigan Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Missouri Washington University School Of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Weill Cornell Medical College New York, New York, United States, 10021 Mount Sinai Medical Center New York, New York, United States, 10029 United States, Tennessee Tennessee Oncology, Pllc Nashville, Tennessee, United States, 37203 United States, Texas The University Of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 United States, Washington Va Puget Sound Health Care System Seattle, Washington, United States, 98108 收起 << |
NCT02575144 | Multiple Myeloma | Phase 3 | Recruiting | December 2019 | Spain ... 展开 >> Hospital Universitario Germans Trias i Pujol Not yet recruiting Badalona, Spain Contact: Albert Oriol, Dr aoriol@iconcologia.net Hospital Clinic Not yet recruiting Barcelona, Spain Contact: Joan Blade, Dr JBLADE@clinic.ub.es Hospital Universitario Vall d'Hebrón Not yet recruiting Barcelona, Spain Contact: Mercedes Gironella, Dr mgironella@vhebron.net Hospital General de Castelló Not yet recruiting Castellón, Spain Contact: Adriana Gascon, Dr adriana.gascon@uv.es Hospital de Cabueñes Recruiting Gijon, Spain Contact: Esther Gonzalez, Dr esthergongar@yahoo.es Hospital Universitario Virgen de las Nieves Not yet recruiting Granada, Spain Contact: Rafael Ríos, Dr rafael.rios.sspa@juntadeandalucia.es Hospital de León Not yet recruiting León, Spain Contact: Fernando Escalante, Dr fescalanteb@yahoo.es Hospital Universitario 12 de Octubre Not yet recruiting Madrid, Spain Contact: Juan José Lahuerta, Dr jjlahuerta@telefonica.net Hospital Universitario de la Princesa Not yet recruiting Madrid, Spain Contact: Adrián Alegre, Dr aalegre.hlpr@salud.madrid.org Hospital Costa del Sol Not yet recruiting Marbella, Spain Contact: María Casanova, Dr mariacasanova@yahoo.com Hospital Geenral Universitario Morales Messeguer Not yet recruiting Murcia, Spain Contact: Felipe de Arriba, DR farriba@um.es Hospital Universitario Virgen de la Victoria Not yet recruiting Málaga, Spain Contact: Ricarda García, Dr ricarda_g@yahoo.es Clinica Universitaria de Navarra Not yet recruiting Pamplona, Spain Contact: Paula Rodriguez, Dr paurodriguez@unav.es Hospital Univeristario Salamanca Not yet recruiting Salamanca, Spain Contact: Mª Victoria Mateos, Dr mvmateos@usal.es Hospital Universitario de Santiago de Compostela Not yet recruiting Santiago de Compostela, Spain Contact: Marta Sonia González, Dr marta.sonia.gonzalez.perez@sergas.es Hospital Universitario Virgen de Valme Not yet recruiting Sevilla, Spain Contact: Eduardo Rios, Dr eduardo.rios.sspa@juntadeandalucia.es Hospital Universitario Virgen del Rocío Not yet recruiting Sevilla, Spain Contact: Jesús Martín, Dr jesus.martin.sspa@juntadeandalucia.es Hospital Universitario de Canarias Not yet recruiting Tenerife, Spain Contact: Miguel Teodoro Hernández, Dr mthernan@ull.edu.es Hospital Universitario Dr Peset Not yet recruiting Valencia, Spain Contact: Javier de la Rubia, Dr delarubia_jav@gva.es Hospital Universitario y Politécnico La Fe Not yet recruiting Valencia, Spain Contact: Isidro Jarque, Dr jarque_isi@gva.es 收起 << |
NCT00305812 | Multiple Myeloma and Plasma Ce... 展开 >>ll Neoplasm 收起 << | Phase 2 | Completed | - | Canada, Alberta ... 展开 >> Tom Baker Cancer Centre - Calgary Calgary, Alberta, Canada, T2N 4N2 Cross Cancer Institute at University of Alberta Edmonton, Alberta, Canada, T6G 1Z2 Canada, British Columbia British Columbia Cancer Agency - Centre for the Southern Interior Kelowna, British Columbia, Canada, V1Y 5L3 Canada, New Brunswick Moncton Hospital Moncton, New Brunswick, Canada, E1C 6Z8 Canada, Nova Scotia Nova Scotia Cancer Centre Halifax, Nova Scotia, Canada, B3H 1V7 Canada, Ontario Margaret and Charles Juravinski Cancer Centre Hamilton, Ontario, Canada, L8V 5C2 London Regional Cancer Program at London Health Sciences Centre London, Ontario, Canada, N6A 4L6 Algoma District Cancer Program at Sault Area Hospital Sault Ste. Marie, Ontario, Canada, P6A 2C4 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Humber River Regional Hospital - Weston Toronto, Ontario, Canada, M9N 1N8 Canada, Quebec Hopital Charles Lemoyne Greenfield Park, Quebec, Canada, J4V 2H1 Hopital Notre-Dame du CHUM Montreal, Quebec, Canada, H2L 4M1 McGill Cancer Centre at McGill University Montreal, Quebec, Canada, H2W 1S6 Canada, Saskatchewan Allan Blair Cancer Centre at Pasqua Hospital Regina, Saskatchewan, Canada, S4T 7T1 收起 << |
NCT02921802 | - | Active, not recruiting | June 19, 2020 | Japan ... 展开 >> Shinko Hospital Kobe, Hyogo, Japan, 651-0072 收起 << | |
NCT01010243 | Multiple Myeloma | Phase 1 Phase 2 | Unknown | October 2016 | Germany ... 展开 >> Schön Klinik Starnberger See Recruiting Berg, Germany, 82335 Contact: Christian Straka, PD MD Principal Investigator: Christian Straka, PD MD Gemeinschaftspraxis Dres. med. J. Wilke u. H. Wagner Recruiting Fürth, Germany, 90766 Contact: Jochen Wilke, MD Principal Investigator: Jochen Wilke, MD Universitätsklinikum Schleswig-Holstein, II Medizin, Sekt. f. Stammzell- u. Immuntherapie Recruiting Kiel, Germany, 24105 Contact: Martin Gramatzki, Prof. MD Principal Investigator: Martin Gramatzki, Prof. MD Klinikum d. Universität München, Med. Klinik u. Poliklinik IV, Abt. H/O Recruiting München, Germany, 80336 Contact: Christian Adam, MD Principal Investigator: Christian Adam, MD Gemeinschaftspraxis Hämato/Onkologie Recruiting München, Germany, 81241 Contact: Burkhard Schmidt, MD Principal Investigator: Burkhard Schmidt, MD University of Regensburg Recruiting Regensburg, Germany, 93053 Contact: Albrecht Reichle, Professor albrecht.reichle@klinik.uni-regensburg.de Sub-Investigator: Matthias Grube, MD Sub-Investigator: Joachim Hahn, MD Sub-Investigator: Stephanie Mayer, MD Sub-Investigator: Martin Vogelhuber, MD Sub-Investigator: Christina Hart, MD Sub-Investigator: Karin Landfried, MD Sub-Investigator: Marco Petronio, MD Sub-Investigator: Dagmar Roll, MD Sub-Investigator: Tanja Zilch, MD 收起 << |
NCT02446457 | Lymphoma | Phase 2 | Active, not recruiting | July 2019 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01647165 | Multiple Myeloma | Phase 2 | Withdrawn | June 26, 2015 | - |
NCT00538733 | Multiple Myeloma | Phase 2 | Active, not recruiting | December 2019 | United States, New York ... 展开 >> Weill Medical College of Cornell University New York, New York, United States, 10021 收起 << |
NCT03091127 | - | Recruiting | March 17, 2020 | - | |
NCT01311687 | Multiple Myeloma | Phase 3 | Completed | - | - |
NCT01324947 | - | Completed | - | - | |
NCT00889798 | - | Active, not recruiting | December 2019 | - | |
NCT03406091 | - | Recruiting | January 31, 2022 | Italy ... 展开 >> A.O.U. Città della Salute e della Scienza di Torino Recruiting Torino, Italy, 10126 Contact: Mario Boccadoro, MD +390116334263 mario.boccadoro@unito.it Contact: FO.NE.SA. Onlus +390116336107 clinicaltrialoffice@fonesa.it 收起 << | |
NCT01311687 | - | Completed | - | - | |
NCT01324947 | Multiple Myeloma | Phase 3 | Completed | - | - |
NCT00558896 | Multiple Myeloma and Plasma Ce... 展开 >>ll Neoplasm 收起 << | Phase 2 | Completed | - | United States, Arizona ... 展开 >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259-5499 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT01410981 | - | Completed | - | United States, South Carolina ... 展开 >> Medical University of South Carolina Charleston, South Carolina, United States, 29425 收起 << | |
NCT01995708 | Multiple Myeloma | Phase 1 | Active, not recruiting | November 2019 | United States, New York ... 展开 >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 收起 << |
NCT01393964 | - | Completed | - | - | |
NCT02406742 | Leukemia, Lymphocytic, Chronic... 展开 >>, B-Cell 收起 << | Phase 1 Phase 2 | Active, not recruiting | June 9, 2020 | United States, California ... 展开 >> University of California San Diego La Jolla, California, United States, 92093 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Weill Cornell Medical College Dr. Feldman's Office New York, New York, United States, 10065 United States, Ohio Ohio State University Medical CenterJames Cancer Hospital Columbus, Ohio, United States, 43210 United States, Tennessee The West Clinic Memphis, Tennessee, United States, 38120 United States, Texas MD Anderson Cancer Center The University of Texas Houston, Texas, United States, 77030 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98118 Austria University Hospital Innsbruck Innsbruck, Austria, 6020 University Hospital of Salzburg St Johanns Spital Salzburg, Austria, 5020 Allgemeines Krankenhaus Wien Wien, Austria, 1090 Germany Universitaetsklinikum EssenInnere Klinik und Poliklinik Essen, Germany, 45147 University of Schleswig-Holstein Kiel, Germany, 24116 Universitat zu Koln Köln, Germany, 50937 Universitatsklinikum Würzburg Würzburg, Germany, 97080 Italy Fondazione Centro San Raffaele del Monte Tabor Milano, Italy, 20132 Ospedale Niguarda Milano Milano, Italy, 20162 Arcispedale Santa Maria Nuova Reggio Emilia, Italy, 42100 Istituto Clinico Humanitas Rozzano (MI), Italy, 20089 Spain Hospital Universitario Vall D hebron Barcelona, Spain, 08035 Fundacion Jimenez Daaz Madrid, Spain, 28040 Hospital Universitario 12 de Octubre Madrid, Spain, 28041 Hospital Universitario de Salamanca Salamanca, Spain, 37007 Hospital Universitario Virgen Del Rocio Sevilla, Spain, 41013 收起 << |
NCT01243944 | Polycythemia Vera | Phase 3 | Completed | - | - |
NCT03506802 | HLA-A*0201 Positive Cells Pres... 展开 >>ent NY-ESO-1 Positive Tumor Cells Present Recurrent Plasma Cell Myeloma Refractory Plasma Cell Myeloma 收起 << | Phase 1 | Recruiting | May 2, 2022 | United States, California ... 展开 >> UCLA / Jonsson Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90095 Contact: Paula Cabrea 310-206-2090 ISTWAM@mednet.ucla.edu Principal Investigator: Sarah Larson, M.D. 收起 << |
NCT00558896 | - | Completed | - | - | |
NCT01497093 | Multiple Myeloma | Phase 1 | Active, not recruiting | September 12, 2019 | United States, Georgia ... 展开 >> Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115-6084 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, Ohio Ohio State University Medical Center Columbus, Ohio, United States, 43210 收起 << |
NCT02718833 | Multiple Myeloma | Phase 2 | Recruiting | September 2023 | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Cancer Center Recruiting Boston, Massachusetts, United States, 02114 Contact: Andrew J Yee, MD 617-724-4000 ayee1@mgh.harvard.edu Principal Investigator: Andrew J Yee, MD Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Jacob Laubach, MD 617-632-4218 Principal Investigator: Jacob Laubach, MD Mass General/North Shore Cancer Center Recruiting Danvers, Massachusetts, United States, 01923 Contact: Andrew Yee, MD 617-724-4000 ayee1@mgh.harvard.edu Newton-Wellesley Hospital Recruiting Newton, Massachusetts, United States, 02462 Contact: Omar Nadeem, MD 617-219-1230 onadeem@partners.org United States, Michigan University of Michigan Recruiting Ann Arbor, Michigan, United States, 48109 Contact: Erica Campagnaro, MD 734-936-5310 ericacam@med.umich.edu United States, New York University of Rochester Recruiting Rochester, New York, United States, 14642 Contact: Brea C. Lipe, MD 585-275-5823 Principal Investigator: Brea C. Lipe, MD 收起 << |
NCT01243944 | - | Completed | - | - | |
NCT03126617 | - | - | - | - | |
NCT02057640 | Multiple Myeloma ... 展开 >> Kahler Disease Plasma-Cell Myeloma Myelomatosis 收起 << | Phase 1 Phase 2 | Active, not recruiting | December 2018 | United States, Ohio ... 展开 >> University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 收起 << |
NCT03619252 | Multiple Myeloma ... 展开 >> Pneumococcal Infection Febrile Neutropenia Pneumococcal Pneumonia 收起 << | Phase 4 | Enrolling by invitation | November 1, 2019 | Belarus ... 展开 >> Minsk Scientific Practical Center of Surgery, Transplantation and Hematology, Belarus Minsk, Belarus, 220045 收起 << |
NCT02031419 | Lymphoma, Large B-Cell, Diffus... 展开 >>e 收起 << | Phase 1 | Active, not recruiting | November 30, 2020 | United States, California ... 展开 >> Sansum Clinic Santa Barbara, California, United States, 93105 Stanford Cancer Center Stanford, California, United States, 94305 United States, Colorado Rocky Mountain Cancer Centers, LLP [Boulder-COBO] Boulder, Colorado, United States, 80303 United States, Connecticut Yale Cancer Center New Haven, Connecticut, United States, 06510 United States, Florida H. Lee Moffitt Cancer Cencer and Research Institute Tampa, Florida, United States, 33612 United States, Illinois Northwestern University, Division of Hematology Oncology, Dept. of Medicine Chicago, Illinois, United States, 60611 Illinois Cancer Specialists Niles, Illinois, United States, 60714 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Oregon Willamette Valley Cancer Center Eugene, Oregon, United States, 97401-8122 United States, Tennessee West Cancer Center Germantown, Tennessee, United States, 38138 Sarah Cannon Cancer Center Nashville, Tennessee, United States, 37203 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030-400 United States, Wisconsin University of Wisconsin Osteoporosis Clinical Center and Research Program Madison, Wisconsin, United States, 53792 Canada, Alberta Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 France Institut Bergonie Centre Regional de Lutte Contre Le Cancer de Bordeaux Et Sud Ouest Bordeaux, France, 33076 Centre Leon Berard Lyon, France, 69373 Institut Gustave Roussy Villejuif Cedex, France, 94805 Italy Istituto Nazionale Dei Tumori Milano, Italy, 20133 Istituto Clinico Humanitas Rozzano (MI), Italy, 20089 Azienda Sanitaria Ospedaliera San Giovanni Battista Molinette Turin, Italy, 10126 收起 << |
NCT02858999 | Multiple Myeloma | Phase 2 | Completed | - | France ... 展开 >> CH Pays d'Aix Aix-en-Provence, France, 13616 CHU Amiens Amiens, France, 80054 CHU Besançon Besançon, France, 25030 CHU Caen Caen, France, 14033 CHU Clermont Ferrand Clermont Ferrand, France, 63003 CHU Dijon Dijon, France, 21034 CH Dunkerque Dunkerque, France, 59385 CHRU Lille Lille, France, 59037 Hospices Civils de Lyon Lyon, France, 69229 CHU Nancy Nancy, France, 54035 CHU Nantes Nantes, France, 44093 CHU Nice Nice, France, 06003 AP-HP Paris, France, 75004 CHU Poitiers Poitiers, France, 86021 CHU Rennes Rennes, France, 35033 CHU Strasbourg Strasbourg, France, 67091 CHU Toulouse Toulouse, France, 31059 CHU Tours Tours, France, 37044 收起 << |
NCT01998971 | Multiple Myeloma | Phase 1 | Active, not recruiting | June 12, 2020 | United States, California ... 展开 >> Duarte, California, United States United States, Georgia Atlanta, Georgia, United States United States, Illinois Chicago, Illinois, United States United States, Indiana Indianapolis, Indiana, United States United States, Massachusetts Boston, Massachusetts, United States United States, New York New York, New York, United States Rochester, New York, United States United States, North Carolina Charlotte, North Carolina, United States United States, Pennsylvania Philadelphia, Pennsylvania, United States United States, Texas Dallas, Texas, United States France Lille Cedex, France Nantes, France Paris, France Pessac, France Toulouse Cedex 9, France Tours, France Spain Badalona, Spain Barcelona, Spain Madrid, Spain Pamplona, Spain Salamanca, Spain Valencia, Spain 收起 << |
NCT02905552 | - | Unknown | September 2018 | France ... 展开 >> Henri Mondor Hospital Recruiting Creteil, France, 94010 Contact: Laetitia Grégoire 01 49 81 41 64 Laetitia.gregoire@aphp.fr 收起 << | |
NCT02265510 | Solid Tumors ... 展开 >>Advanced Malignancies Metastatic Cancer 收起 << | Phase 1 Phase 2 | Active, not recruiting | June 2019 | United States, Alabama ... 展开 >> Birmingham, Alabama, United States United States, California West Hollywood, California, United States United States, Connecticut New Haven, Connecticut, United States United States, Georgia Atlanta, Georgia, United States United States, Indiana Indianapolis, Indiana, United States United States, North Carolina Greenville, North Carolina, United States United States, Oregon Portland, Oregon, United States United States, Tennessee Nashville, Tennessee, United States United States, Texas Dallas, Texas, United States 收起 << |
NCT01570387 | AL Amyloidosis | Phase 1 Phase 2 | Active, not recruiting | February 2030 | United States, Massachusetts ... 展开 >> Boston Medical Center Boston, Massachusetts, United States, 02118 收起 << |
NCT02871284 | Exercise Chem... 展开 >>otherapy-induced Polyneuropathy 收起 << | Phase 2 Phase 3 | Recruiting | December 2019 | Germany ... 展开 >> National Center for Tumor Diseases Recruiting Heidelberg, Germany, 69120 Contact: Joachim Wiskemann, Dr. joachim.wiskemann@nct-heidelberg.de Contact: Jana Müller jana.mueller@nct-heidelberg.de 收起 << |
NCT03695744 | Multiple Myeloma ... 展开 >> Myeloma 收起 << | Phase 2 | Not yet recruiting | October 2023 | Singapore ... 展开 >> Singapore General Hospital Singapore, Singapore 收起 << |
NCT02176213 | Multiple Myeloma in Relapse ... 展开 >> Multiple Myeloma, Refractory 收起 << | Phase 2 | Active, not recruiting | June 2019 | United States, New York ... 展开 >> Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 收起 << |
NCT03104270 | Multiple Myeloma | Phase 2 | Recruiting | May 2020 | United States, California ... 展开 >> California Cancer Associates for Research & Excellence (cCARE) Recruiting Encinitas, California, United States, 92024 Contact: Daniela Slavin, PhD 760-452-3909 dslavin@ccare.com Principal Investigator: Alberto Bessudo, MD Robert A. Moss, MD, FACP, Inc Recruiting Fountain Valley, California, United States, 92708 Contact: Helen Tam 714-641-1128 helen.tam@sbcglobal.net Principal Investigator: Robert A Moss, MD Pacific Cancer Care Recruiting Monterey, California, United States, 93940 Contact: Dorothy Tenney 831-375-4105 dtenney@pacificcancercare.com Principal Investigator: Laura Stampleman, MD James Berenson, MD, Inc Recruiting West Hollywood, California, United States, 90069 Contact: Regina Swift, RN 310-623-1227 rswift@berensononcology.com Principal Investigator: James R Berenson, MD United States, Florida Millennium Oncology Research Clinic Recruiting Pembroke Pines, Florida, United States, 33024 Contact: Maria Contreras, MD 954-266-7885 mcontreras@millenniumoncologyfl.com Principal Investigator: Isaac Levy, MD 收起 << |
NCT02749617 | Anti-Xa Activity | Phase 2 | Recruiting | May 2018 | Canada, British Columbia ... 展开 >> Vancouver General Hospital Recruiting Vancouver, British Columbia, Canada, V5Z 1M9 Contact: Agnes Lee, MD MSc FRCPC 收起 << |
NCT03288974 | - | Recruiting | June 8, 2023 | Korea, Republic of ... 展开 >> Korea University Ansan Hospital Recruiting Ansan, Korea, Republic of, 15355 Hallym University Sacred Heart Hospital Recruiting Anyang, Korea, Republic of, 14068 Soonchunhyang University Hospital Recruiting Bucheon, Korea, Republic of, 14584 Inje University Busan Paik Hospital Recruiting Busan, Korea, Republic of, 47932 Inje University Haeundae Paik Hospital Recruiting Busan, Korea, Republic of, 48108 Dong-A University Hospital Recruiting Busan, Korea, Republic of, 49201 Pusan National University Hospital Recruiting Busan, Korea, Republic of, 49241 Kosin University Gospel Hospital Recruiting Busan, Korea, Republic of, 49267 Keimyung University Dongsan Medical Recruiting Daegu, Korea, Republic of, 41931 Yeungnam University Medical Center Recruiting Daegu, Korea, Republic of, 42415 Daegu Catholic University Medical Center Recruiting Daegu, Korea, Republic of, 42472 Chungnam National University Hospital Recruiting DaeJeon, Korea, Republic of, 35015 Chonnam National University Hwasun Hospital Recruiting Hwasun, Korea, Republic of, 58128 Inha University Hospital Recruiting Incheon, Korea, Republic of, 22332 Chonbuk National University Hospital Recruiting Jeonju, Korea, Republic of, 54907 Gyeongsang National University Hospital Recruiting JinJu, Korea, Republic of, 52727 Inje University Sanggye Paik Hospital Recruiting Seoul, Korea, Republic of, 01757 Korea University Anam Hospital Recruiting Seoul, Korea, Republic of, 02841 Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Severance Hospital Recruiting Seoul, Korea, Republic of, 03722 Samsung Medical Center Recruiting Seoul, Korea, Republic of, 06351 The catholic University of Korea Seoul St. Maty's Recruiting Seoul, Korea, Republic of, 06591 Seoul Metropolitan Government Seoul National University Boramae Medical Center Recruiting Seoul, Korea, Republic of, 07061 Ewha Womans University Medical Recruiting Seoul, Korea, Republic of, 07985 Korea University Guro Hospital Recruiting Seoul, Korea, Republic of, 08308 Ajou Unversity Medical Center Recruiting Suwon, Korea, Republic of, 16499 Ulsan University Hospital Recruiting Ulsan, Korea, Republic of, 44033 Wonju Severance Christian Hospital Recruiting Wonju, Korea, Republic of, 26426 Pusan National University Yangsan Recruiting Yangsan, Korea, Republic of, 50612 收起 << | |
NCT02751255 | Multiple Myeloma | Phase 1 Phase 2 | Active, not recruiting | May 1, 2020 | Netherlands ... 展开 >> VU University Medical Center Amsterdam, NH, Netherlands, 1081HV 收起 << |
NCT01159574 | Multiple Myeloma | Phase 2 | Active, not recruiting | June 2020 | United States, New York ... 展开 >> Weill Cornell Medical College New York, New York, United States, 10065 收起 << |
NCT01159574 | - | Active, not recruiting | - | - | |
NCT03374085 | Multiple Myeloma | Phase 1 | Recruiting | March 1, 2020 | United States, California ... 展开 >> City of Hope Cancer Center Recruiting Duarte, California, United States, 91010-300 United States, Colorado Colorado Blood Cancer Institute Not yet recruiting Denver, Colorado, United States, 80218 United States, Georgia Emory Clinic Recruiting Atlanta, Georgia, United States, 30322 United States, Massachusetts Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 United States, Tennessee Sarah Cannon Cancer Center Recruiting Nashville, Tennessee, United States, 37203 United States, Texas MD Anderson Cancer Center The University of Texas Recruiting Houston, Texas, United States, 77030 Canada, Alberta Tom Baker Cancer Center Recruiting Calgary, Alberta, Canada, T2N 4N2 Canada, Ontario Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 2M9 Denmark Rigshospitalet University Hospital Recruiting Copenhagen, Denmark, 2100 Finland Helsinki University Hospital Recruiting Helsinki, Finland, 00029 Spain Hospital Universitari Germans Trias i Pujol Can Ruti Recruiting Badalona (Barcelona), Spain, 08916 Hospital 12 de Octobre Recruiting Madrid, Spain, 28041 Clínica Universidad de Navarra Recruiting Pamplona, Spain, 31008 Hospital Universitario de Salamanca Recruiting Salamanca, Spain, 37007 United Kingdom University College London Hospitals Cancer Clinical Trials Unitist FloorCentral wing Recruiting London, United Kingdom, NW1 2PG Oxford University Hospitals NHS Trust- Churchill Hospital-Oxford Centre for Respiratory Medicine Recruiting Oxford, United Kingdom, 0X3 7LE The Royal Marsden NHS Foundation Trust Recruiting Sutton, United Kingdom, SM2 5PT 收起 << |
NCT02092922 | Advanced Multiple Myeloma | Phase 2 | Completed | - | - |
NCT00445068 | Multiple Myeloma | Phase 2 | Terminated | - | - |
NCT02439476 | - | Recruiting | June 2020 | France ... 展开 >> Hématologie Clinique, Hôpital Saint Antoine Recruiting Paris, France, 75571 Contact: Mohamad Mohty, MD, PHD +33 (0)149282624 mohamad.mohty@inserm.fr 收起 << | |
NCT03030261 | Multiple Myeloma in Relapse | Phase 2 | Recruiting | February 28, 2026 | United States, Missouri ... 展开 >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Ravi Vij, M.D. 314-454-8323 rvij@wustl.edu Principal Investigator: Ravi Vij, M.D. 收起 << |
NCT03660072 | - | Not yet recruiting | December 29, 2023 | - | |
NCT03023527 | Multiple Myeloma | Phase 1 | Terminated(Safety) | - | Spain ... 展开 >> ICO Badalona Badalona, Spain Hospital Clinic Barcelona, Spain Hospital Universitario Virgen de las Nieves Granada, Spain Hospital Universitario de Canarias Las Palmas de Gran Canaria, Spain Hospital Ramón y Cajal Madrid, Spain Hospital Universitario 12 de octubre Madrid, Spain Hospital Morales Messeguer Murcia, Spain Hospital Central de Asturias Oviedo, Spain Hospital Son Llatzer Palma de Mallorca, Spain Clinica Universidad de Navarra Pamplona, Spain Hospital Universitario de Salamanca Salamanca, Spain Complejo Hospitalario Regional Virgen del Rocío Sevilla, Spain 收起 << |
NCT00781170 | Multiple Myeloma ... 展开 >> Stem Cell Transplantation 收起 << | Phase 2 | Completed | - | - |
NCT02555839 | - | Recruiting | September 30, 2019 | Austria ... 展开 >> LKH Feldkirch, Intern E, Hämatologie Recruiting Feldkirch, Austria, 6800: Medical University Graz Recruiting Graz, Austria, 8036: KH der Elisabethinen Linz , 1. Interne Hämato-Onkologie Recruiting Linz, Austria, 4020: SCRI-CCCIT gemeinnützige GmbH & Universitätsklinikum der PMU Salzburg Gemeinnützige Salzburger Landeskliniken BetriebsgmbH Recruiting Salzburg, Austria, 5020: LKH Steyr, Innere Medizin II Recruiting Steyr, Austria, 4400 AKH, Innere Medizin I, Klin. Abt. f. Hämatologie Recruiting Vienna, Austria, 1090: AKH, Universitätsklinik für Innere Medizin I /Klin. Abteilung für Onkologie Recruiting Vienna, Austria, 1090: St. Josef Krankenhaus Wien,1. Abteilung für Innere Medizin Zentrum für Onkologie Recruiting Vienna, Austria, 1130: Hanusch Krankenhaus Wien 3. Medizinische Abteilung Hämatolog Not yet recruiting Vienna, Austria, 1140: Wilhelminenspital, 1. Med.Abteilung, Zentrum für Onkologie Not yet recruiting Vienna, Austria, 1160: 收起 << | |
NCT00542828 | - | Terminated(Study terminated du... 展开 >>e to slow enrollment.) 收起 << | - | - | |
NCT01177735 | - | Completed | - | - | |
NCT01177735 | Multiple Myeloma | Phase 2 | Completed | - | United States, Arkansas ... 展开 >> University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy Little Rock, Arkansas, United States, 72205 收起 << |
NCT00166452 | Complex Regional Pain Syndrome... 展开 >>, Type 1 收起 << | Phase 3 | Completed | - | United States, Minnesota ... 展开 >> Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT00542828 | Myelodysplastic Syndrome (MDS) | Phase 2 | Terminated(Study terminated du... 展开 >>e to slow enrollment.) 收起 << | - | France ... 展开 >> Hopital Avicenne/University Paris, France, 93009 Germany St. Johannes-Hospital Duisburg Duisburg, Germany, 47166 Medizinische Hochschule Hannover Hannover, Germany, 30625 Netherlands UMC St Radboud Centraal Nijmegen, Netherlands, 6525 GA United Kingdom Royal Bournemouth Hospital Bournemouth, England, United Kingdom, BH7 7DW St. James Hospital Leeds, England, United Kingdom, LS9 7TF King's College Hospital London, England, United Kingdom, SE5 9RS 收起 << |
NCT03143036 | Relapse and / or Refractory My... 展开 >>eloma 收起 << | Phase 2 | Recruiting | July 1, 2022 | Hong Kong ... 展开 >> Queen Mary Hospital Not yet recruiting Hong Kong, Hong Kong Korea, Republic of Samsung Medical Center Not yet recruiting South Korea, Korea, Republic of Singapore National University Hospital Recruiting Singapore, Singapore Singapore General Hospital Recruiting Singapore, Singapore Taiwan National Taiwan University Not yet recruiting Taipei, Taiwan 收起 << |
NCT02468687 | Multiple Myeloma | Phase 1 | Recruiting | February 2019 | Australia, Victoria ... 展开 >> Peter MacCallum Cancer Centre Recruiting Melbourne, Victoria, Australia, 3002 Contact: Anetta Matera, Masters +61 03 9656 3661 anneta.matera@petermac.org 收起 << |
NCT03143049 | Relapse Multiple Myeloma | Phase 3 | Recruiting | June 1, 2022 | Hong Kong ... 展开 >> Queen Mary Hospital Not yet recruiting Hong Kong, Hong Kong Japan Not yet recruiting Japan, Japan Korea, Republic of Not yet recruiting South Korea, Korea, Republic of Singapore National University Hospital Recruiting Singapore, Singapore Taiwan National Taiwan University Not yet recruiting Taipei, Taiwan 收起 << |
NCT03170882 | Relapsed and/or Refractory Mul... 展开 >>tiple Myeloma 收起 << | Phase 2 Phase 3 | Recruiting | March 31, 2023 | - |
NCT00538733 | - | Active, not recruiting | - | - | |
NCT03477643 | - | Recruiting | December 13, 2019 | Spain ... 展开 >> Hospital de Sant Joan de Déu Not yet recruiting Barcelona, Spain Contact: Cristina Motllo, Dr + 34 932 53 21 00 cristinamotllo@gmail.com Hospital Donostia-Donostia Ospitalea Not yet recruiting Donostia, Spain Contact: Mailen Sirvent, Dr + 34 943 00 70 00 MAIALEN.SIRVENTAUZMENDI@osakidetza.eus Hospital Universitario Virgen de Las Nieves Not yet recruiting Granada, Spain Contact: Rafael Rios, Dr + 34 958 02 00 00 rriost33@gmail.com Hospital General San Jorge - Huesca Not yet recruiting Huesca, Spain Contact: Ilda Maria Murillo, Dr + 34 974 24 70 00 immurillof@gmail.com Hospital de Jaén Not yet recruiting Jaén, Spain Contact: Soledad Duran, Dr + 34 902 50 50 61 soledadduran@hotmail.com Hospital Lucus Augusti Not yet recruiting Lugo, Spain Contact: Esperanza la Villa, Dr + 34 982 29 60 00 esperanza.lavilla.rubira@sergas.es Hospital Clínico San Carlos Not yet recruiting Madrid, Spain Contact: Belen Iñigo, Dr + 34 913 30 30 01 belen.inigo@gmail.com Hospital Del Tajo Not yet recruiting Madrid, Spain Contact: Ana Lafuente, Dr + 34 918 01 41 00 apaz.lafuenteguijosa@salud.madrid.org Hospital General Universitario Gregorio Marañón Not yet recruiting Madrid, Spain Contact: Cristina Encinas, Dr + 34 915 86 80 00 crisenro@hotmail.com Hospital Ramón Y Cajal Not yet recruiting Madrid, Spain Contact: Mª Jesus Blanchard, Dr + 34 913 36 80 00 mjesusblanchard@yahoo.es Hospital Universitario 12 de Octubre Recruiting Madrid, Spain Contact: Juan José Lahuerta, Dr + 34 913 90 80 00 jjlahuerta@telefonica.net Hospital Universitario de La Princesa Not yet recruiting Madrid, Spain Contact: Adrián Alegre, Dr + 34 915202200 adrian.alegre@telefonica.net Hospital Universitario Virgen de La Arrixaca Not yet recruiting Murcia, Spain Contact: Valentin Cabañas, Dr + 34 968 36 95 00 valentin.cabanas@gmail.com Complejo Hospitalario de Especialidades Virgen de La Victoria Not yet recruiting Málaga, Spain Contact: Ricarda García, Dr + 34 951 03 20 00 ricarda_g@yahoo.es Hospital Central de Asturias Not yet recruiting Oviedo, Spain Contact: Ana Pilar Gonzalez, Dr + 34 985 10 80 00 anapilargonzalez@gmail.com Hospital Universitari Son Espases Not yet recruiting Palma De Mallorca, Spain Contact: Antonia Sampol, Dr + 34 871 20 50 00 antonia.sampolm@ssib.es Complejo Hospitalario de Navarra Not yet recruiting Pamplona, Spain Contact: Jose María Arguiñano Pérez, Dr 948 25 54 00 jm.arguinano.perez@cfnavarra.es Hospital El Bierzo Not yet recruiting Ponferrada, Spain Contact: Erik de Cabo, Dr + 34 987 45 52 00 erikbierzo@hotmail.com Hospital Universitario de Salamanca Not yet recruiting Salamanca, Spain Contact: María Victoria Mateos, Dr + 34 983 42 00 00 mvmateos@usal.es Hospital Mutua Terrassa Recruiting Terrassa, Spain Contact: Josep Mª Tutusaus, Dr + 34 93 736 50 50 jmarti@mutuaterrassa.es Complejo Hospitalario de Toledo Not yet recruiting Toledo, Spain Contact: Luis Casado Montero, Dr + 34 925 26 92 00 lfcasadom@telefonica.net Hospital Universitario Dr. Peset Aleixandre Not yet recruiting Valence, Spain Contact: Paz Ribas + 34 961622300 ribas_paz@gva.es Hospital Arnau de Vilanova Not yet recruiting Valencia, Spain Contact: Aurelio Lopez, dr + 34 973 705 246 ... aureliolopmar@hotmail.com Hospital Universitario La Fe Not yet recruiting Valencia, Spain Contact: Mario Arnao, Dr +34 961 244 350 arnao_mar@gva.es HOSPITAL CLíNICO UNIVERSITARIO DE VALLADOLID Recruiting Valladolid, Spain Contact: Alfonso García de Coca, Dr +34 983 42 00 00 agarciadecoca@gmail.com Hospital Txagorritxu Not yet recruiting Vitoria, Spain Contact: Ernesto Pérez, Dr + 34 945007000 ernesto.perezpersona@osakidetza.net 收起 << | |
NCT00899080 | - | Completed | - | - | |
NCT00064038 | Multiple Myeloma ... 展开 >> Plasma Cell Neoplasm 收起 << | Phase 3 | Completed | - | United States, Michigan ... 展开 >> William Beaumont Hospital - Royal Oak Campus Royal Oak, Michigan, United States, 48073 United States, Utah Utah Cancer Specialists at UCS Cancer Center Salt Lake City, Utah, United States, 84106 收起 << |
NCT00064038 | - | Completed | - | - | |
NCT03641456 | Myeloma Newly... 展开 >> Diagnosed High Risk 收起 << | Phase 2 | Not yet recruiting | September 30, 2022 | China, Guangdong ... 展开 >> Sun Yat-sen University Cancer Center GuangZhou, Guangdong, China, 510060 收起 << |
NCT03104842 | Multiple Myeloma | Phase 2 | Recruiting | July 2024 | Germany ... 展开 >> Klinikum Augsburg Recruiting Augsburg, Germany Contact: Björn Hackanson, MD Vivantes Am Urban Recruiting Berlin, Germany, 10967 Contact: Annette Dieing, MD Campus Benjamin Franklin Charite Berlin Recruiting Berlin, Germany Contact: Igor Blau, MD Vivantes Klinikum Neukölln Recruiting Berlin, Germany Contact: Maike deWit, Prof Krankenhaus Bielefeld Recruiting Bielefeld, Germany Contact: Stefan Mahlmann, MD Städt. Kliniken Bielefeld Klinikum Mitte Recruiting Bielefeld, Germany Contact: Martin Görner, MD Johanniter-Krankenhaus Bonn Recruiting Bonn, Germany, 53113 Contact: Yon-Dschun Ko Universitätsklinikum Essen Recruiting Essen, Germany Contact: Jan Dürig, MD University Hospital Heidelberg Recruiting Heidelberg, Germany Contact: Hartmut Goldschmidt, Prof Uniklinik Köln Recruiting Koln, Germany Contact: Christoph Scheid, MD Universitätsmedizin der Johannes Gutenberg-Universität Mainz Recruiting Mainz, Germany, D-55131 Contact: Markus M Munder, MD Philipps-Universität Marburg Recruiting Marburg, Germany, 35032 Contact: Andreas Neubauer, MD Klinik für Hämatologie, Onkologie und GastroenterologieKliniken Maria Hilf GmbH Recruiting Mönchengladbach, Germany, 41063 Contact: Ullrich Graeven Zentrum für Tumordiagnostik und -therapieHämatologie/Int. Onkologie Recruiting Osnabruck, Germany Contact: Rudolf Peceny, MD Universitätsklinikum Tuebingen Recruiting Tuebingen, Germany Contact: Loreen Degen Principal Investigator: Katja Weisel, Prof 收起 << |
NCT00742560 | Hematologic Cancer | Phase 2 | Completed | - | - |
NCT02516696 | Multiple Myeloma | Phase 3 | Recruiting | August 2021 | United States, New York ... 展开 >> Weill Cornell Medical College Recruiting New York, New York, United States, 10065 Contact: Linda Tegnestam, RN 212-746-1480 lit2011@med.cornell.edu 收起 << |
NCT00031941 | Lymphoma Smal... 展开 >>l Intestine Cancer Unspecified Adult Solid Tumor, Protocol Specific 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 NCI - Center for Cancer Research Bethesda, Maryland, United States, 20892 收起 << |
NCT01617213 | Multiple Myeloma | Phase 2 | Terminated(Study is no longer ... 展开 >>needed as recent data have answered the primary hypotheses for this study.) 收起 << | - | United States, Virginia ... 展开 >> University of Virginia Charlottesville, Virginia, United States, 22908 收起 << |
NCT00396045 | Multiple Myeloma | Phase 1 Phase 2 | Completed | - | Italy ... 展开 >> Unità Operativa di Ematologia Trapianto di Cellule Staminali, Casa Sollievo della Sofferenza San Giovanni Rotondo, Foggia, Italy, 71013 Unità Operativa di Ematologia, Spedali Civili Brescia, Italy, 25100 Reparto di Ematologia, Ospedale Ferrarotto Catania, Italy, 95124 Unità Operativa Complessa Di Ematologia, Presidio Ospedaliero Dell’Annunziata, Azienda Ospedaliera Di Cosenza Cosenza, Italy Clinica Ematologica, Ospedale San Martino -Università di Genova Genova, Italy, 16132 Cattedra di Ematologia, Dipart. Di Medicina Interna e Scienze Biomediche Parma, Italy, 43100 Divisione di Ematologia-Policlinico Umberto I-Università La Sapienza Roma, Italy, 00161 Divisione di Ematologia, Azienda Ospedaliera Senese Ospedale A. Sclavo Siena, Italy, 53100 Div. Univ. Di Ematologia, Az. Osp. San Giovanni Battista Torino, Italy, 10126 收起 << |
NCT00446433 | Crohn's Disease | Phase 2 | Completed | - | United States, Arizona ... 展开 >> Advanced Clinical Therapeutics Tucson, Arizona, United States, 85712 United States, California Advanced Clinical Research Institute Anaheim, California, United States, 92801 United States, District of Columbia Washington Hospital Center Physicians Office Building Washington, District of Columbia, United States, 20010 United States, Illinois Springfield Clinic Springfield, Illinois, United States, 62794-9248 United States, North Carolina Wake Research Associates Raleigh, North Carolina, United States, 27612 France Hopital Saint Louis Paris, France, 75010 Israel Rambam Hospital Haifa, Israel Department of Medicine A, Liver & Gastroenterology Units Jerusalem, Israel, 91120 Department of Gastroenterology and Hepatology Tel-Hashomer, Israel, 52621 United Kingdom Department of Gastroenterology Dartford, Kent, United Kingdom, DA2 8DA Department of Gastroenterology Bristol, United Kingdom, BS2 8HW Addenbrookes Hospital Cambridge, United Kingdom, CB2 2QQ Department of Medicine Cardiff, United Kingdom, CF 14 4XW Department of Gastroenterology London, United Kingdom, NW3 2QG Department of Gastroenterology London, United Kingdom, W12 0HS Department of Gastroenterology London, United Kingdom, W1N 8AA Department of Gastroenterology Manchester, United Kingdom, M13 9WL St. Mark's Hospital Middlesex, United Kingdom, HA 1 3UI Department of Gastroentroerology Newcastle, United Kingdom, NE1 4LP Nottingham, United Kingdom 收起 << |
NCT00036894 | Brain and Central Nervous Syst... 展开 >>em Tumors 收起 << | Phase 1 | Completed | - | United States, Maryland ... 展开 >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 收起 << |
NCT02544308 | Plasmacytoma | Phase 3 | Recruiting | December 2025 | United Kingdom ... 展开 >> Royal United Hospital Recruiting Bath, United Kingdom Contact: Sally Moore sallymoore5@nhs.net Blackpool Victoria Hospital Recruiting Blackpool, United Kingdom Contact: Mark Grey Mark.Grey@bfwhospitals.nhs.uk University Hospital Wales Recruiting Cardiff, United Kingdom Contact: Ceri Bygrave Ceri.Bygrave@wales.nhs.uk Velindre Cancer Centre Recruiting Cardiff, United Kingdom Contact: Eve Gallop-Evans eve.gallop-evans@nhs.net Beatson West of Scotland Cancer Centre Recruiting Glasgow, United Kingdom Contact: Richard Soutar richard.soutar@nhs.net St James University Hospital Recruiting Leeds, United Kingdom Contact: Roger Owen rogerowen@nhs.net University College London Hospital Recruiting London, United Kingdom Contact: Neil Rabin neil.rabin@nhs.net The Christie Hospital Recruiting Manchester, United Kingdom Contact: Margaret Harris Margaret.Harris@christie.nhs.uk Freeman Hospital Recruiting Newcastle, United Kingdom Contact: Graham Jackson Graham.Jackson@nuth.nhs.uk Mount Vernon Cancer Centre Recruiting Northwood, United Kingdom Contact: Peter Hoskin peterhoskin@nhs.net Royal Preston Hospital Recruiting Preston, United Kingdom Contact: Mark Grey Mark.Grey@bfwhospitals.nhs.uk Salisbury District Hospital Recruiting Salisbury, United Kingdom Contact: Jonathan Cullis jonathan.cullis@nhs.uk Southampton General Hospital Recruiting Southampton, United Kingdom Contact: Andrew Bates andrew.bates@uhs.nhs.uk 收起 << |
NCT02406144 | Multiple Myeloma | Phase 3 | Completed | - | - |
NCT00742560 | - | Completed | - | - | |
NCT03605056 | Multiple Myeloma | Phase 2 | Not yet recruiting | July 31, 2022 | China, Shanghai ... 展开 >> 180 Fenglin Road Active, not recruiting Shanghai, Shanghai, China, 200032 收起 << |
NCT03556332 | Multiple Myeloma | Phase 2 | Recruiting | June 2021 | United States, New Jersey ... 展开 >> Memorial Sloan Kettering Basking Ridge Recruiting Basking Ridge, New Jersey, United States, 07920 Contact: Gunjan Shah, MD 212-639-8356 Memoral Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Gunjan Shah, MD 212-639-8356 Memorial Sloan Kettering Bergen Recruiting Montvale, New Jersey, United States, 07645 Contact: Gunjan Shah, MD 212-639-8356 United States, New York Memorial Sloan Kettering Commack Recruiting Commack, New York, United States, 11725 Contact: Gunjan Shah, MD 212-639-8356 Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Gunjan Shah, MD 212-639-8356 Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Gunjan Shah, MD, MS 212-639-8356 Principal Investigator: Gunjan Shah, MD,MS Memorial Sloan Kettering Rockville Centre Recruiting Rockville Centre, New York, United States, 11570 Contact: Gunjan Shah, MD 212-639-8356 收起 << |
NCT00051116 | Multiple Myeloma | Phase 2 | Completed | - | United States, Arkansas ... 展开 >> Myeloma Institute University of Arkansas for Medical Sciences Little Rock, Arkansas, United States, 72205 收起 << |
NCT01216683 | Lymphoma | Phase 2 | Active, not recruiting | April 2023 | - |
NCT02954406 | Lymphoma, Non-Hodgkin | Phase 1 | Recruiting | April 26, 2019 | United States, Arizona ... 展开 >> University of Arizona Cancer Center, Tucson Recruiting Tucson, Arizona, United States, 85724 United States, California University of California San Diego (UCSD) - Moores Cancer Center Recruiting La Jolla, California, United States, 92093 Cedars-Sinai Medical Center (CSMC) - Samuel Oschin Comprehensive Cancer Institute Not yet recruiting West Hollywood, California, United States, 90048 United States, Kentucky University of Louisville Kentucky James Graham Brown Cancer Center Recruiting Louisville, Kentucky, United States, 40202 United States, Maryland Center for Cancer and Blood Disorders Recruiting Bethesda, Maryland, United States, 20817 United States, Massachusetts Tufts Medical Center Not yet recruiting Boston, Massachusetts, United States, 02111 United States, Michigan Henry Ford Hospital Recruiting Detroit, Michigan, United States, 48202-2608 United States, New York NYU Langone Medical Center - NYU Medical Oncology Associates Recruiting New York, New York, United States, 10016-4744 United States, North Carolina University of North Carolina - Lineberger Comprehensive Cancer Center Recruiting Chapel Hill, North Carolina, United States, 27514 United States, Ohio University Hospitals of Cleveland Recruiting Cleveland, Ohio, United States, 44106 United States, West Virginia West Virginia University Recruiting Morgantown, West Virginia, United States, 26506 Canada, Nova Scotia Queen Elizabeth II Health Sciences Centre Recruiting Halifax, Nova Scotia, Canada, B3H 2Y9 Canada, Quebec McGill University - Jewish General Hospital Recruiting Montreal, Quebec, Canada, H3T 1E2 收起 << |
NCT00114101 | DS Stage I Plasma Cell Myeloma... 展开 >> DS Stage II Plasma Cell Myeloma DS Stage III Plasma Cell Myeloma Refractory Plasma Cell Myeloma Smoldering Plasma Cell Myeloma 收起 << | Phase 3 | Active, not recruiting | - | - |
NCT02525250 | Acute Myeloid Leukemia or Myel... 展开 >>odysplasic Syndrome 收起 << | Not Applicable | Completed | - | France ... 展开 >> Thomas PREBET, MD Marseille, France, 13009 收起 << |
NCT01729091 | Plasma Cell Leukemia ... 展开 >> Plasma Cell Myeloma 收起 << | Phase 2 | Recruiting | June 28, 2019 | United States, Texas ... 展开 >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Rohtesh S. Mehta 713-745-9669 Principal Investigator: Rohtesh S. Mehta 收起 << |
NCT03715309 | Follicular Lymphoma | Phase 2 | Not yet recruiting | November 1, 2020 | - |
NCT00114101 | - | Active, not recruiting | - | - | |
NCT01155583 | Refractory Multiple Myeloma | Phase 1 Phase 2 | Active, not recruiting | February 2018 | United States, Ohio ... 展开 >> University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 收起 << |
NCT01916252 | Multiple Myeloma | Phase 3 | Completed | - | - |
NCT03003520 | Lymphoma, Large B-Cell, Diffus... 展开 >>e 收起 << | Phase 2 | Active, not recruiting | March 13, 2023 | United States, Arizona ... 展开 >> Banner MD Anderson Cancer Center Gilbert, Arizona, United States, 85234 United States, Indiana Parkview Research Center Fort Wayne, Indiana, United States, 46845 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 University of Rochester Medical Center Rochester, New York, United States, 14642 United States, Ohio Mid Ohio Oncology Hematology Inc Columbus, Ohio, United States, 43219 United States, Washington Swedish Cancer Institute Seattle, Washington, United States, 98104 Austria Innsbruck Medical University Department of Internal Medicine Innsbruck, Austria, 6020 Landeskrankenhaus Salzburg Salzburg, Austria, 5020 Medical University of Vienna Internalmedicine 1, Hematology Vienna, Austria, 1190 Hanusch Krankenhaus Wien, Austria, 1140 Denmark Aarhus Sygehus Arhus C, Denmark, DK-8000 Rigshospitalet, Kobenhavns Universitet - Centre for Clinical Intervention Research - The Copenhagen Copenhagen, Denmark, 2100 Odense Universitetshospital Odense C, Denmark, DK5000 Estonia (North Estonia Medical Centre) - Onkoloogia-ja Hematoloogiakliinik Tallinn, Estonia, 13419 Tartu University Hospital Tartu, Estonia, 51014 United Kingdom University Hospital Birmingham Birmingham, United Kingdom, B15 2TH Royal Marsden Hospital London, United Kingdom, SW3 6JJ Oxford University Hospitals NHS Trust- Churchill Hospital-Oxford Centre for Respiratory Medicine Oxford, United Kingdom, 0X3 7LE 收起 << |
NCT03117361 | Multiple Myeloma | Phase 2 | Terminated(PharmaMar has decid... 展开 >>ed to end this study due to the slow recruitment rate of the trial) 收起 << | - | France ... 展开 >> CHRU de Lille - Hôpital Claude Huriez Lille, France, 59037 Institut Gustave Roussy Villejuif, France, 94800 Italy Policlinico Vittorio Emanuele Hospital Catania, Italy, 95123 Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori Meldola, Italy, 47014 Azienda Ospedaliera Città della Salute e della Scienza di Torino Torino, Italy, 00126 Spain Hospital Universitario Germans Trias i Pujol Badalona, Barcelona, Spain, 08916 Clinica Universidad de Navarra Pamplona, Navarra, Spain, 31008 Institut Català d´Oncologia Girona Girona, Spain, 17007 Institut Català d´Oncologia L´Hospitalet Hospitalet de Llobregat, Spain, 08908 Hospital General Universitario J.M. Morales Meseguer Murcia, Spain, 30008 Hospital Universitario de Salamanca Salamanca, Spain, 37007 Complexo Hospitalario Universitario de Santiago Santiago De Compostela, Spain, 15706 Complejo Hospitalario Regional Virgen Del Rocio Sevilla, Spain, 41013 收起 << |
NCT00091624 | Multiple Myeloma | Phase 1 | Completed | - | United States, Ohio ... 展开 >> Cleveland Clinic Myeloma Program Cleveland, Ohio, United States, 44195 收起 << |
NCT01075321 | Adult Nasal Type Extranodal NK... 展开 >>/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Nodal Marginal Zone B-cell Lymphoma Peripheral T-cell Lymphoma Post-transplant Lymphoproliferative Disorder Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Hodgkin Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Splenic Marginal Zone Lymphoma Waldenstrom Macroglobulinemia 收起 << | Phase 1 Phase 2 | Active, not recruiting | December 2018 | United States, Arizona ... 展开 >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT00044382 | Myelodysplastic Syndrome | Phase 2 | Completed | - | United States, Arizona ... 展开 >> Arizona Cancer Center Tucson, Arizona, United States, 85724 收起 << |
NCT00093028 | Multiple Myeloma | Phase 3 | Completed | - | United States, Arkansas ... 展开 >> University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States, 72205 收起 << |
NCT01208766 | Multiple Myeloma | Phase 3 | Active, not recruiting | April 2021 | Netherlands ... 展开 >> Erasmus MC Rotterdam, Netherlands, 3075 EA 收起 << |
NCT00098475 | - | Active, not recruiting | - | - | |
NCT00925821 | Multiple Myeloma | Phase 2 | Completed | - | Germany ... 展开 >> Charité University Hospital - Virchow Klinikum Berlin, Germany Dresden University Hospital Dresden, Germany, 01307 Erlangen University Hospital Erlangen, Germany, 91054 Freiburg University Hospital Freiburg, Germany, 79106 Jena University Hospital Jena, Germany Kiel University Hospital Kiel, Germany, 24105 Munich Grosshadern University Hospital Munich, Germany, 81377 University Hospital of Munich Technical University Munich, Germany, 81675 Klinikum Nuremberg Nuremberg, Germany, 90419 Regensburg University Hospital Regensburg, Germany, 93053 Rostock University Hospital Rostock, Germany, 18057 Ulm University Hospital Ulm, Germany, 89081 收起 << |
NCT00418665 | Myelodysplastic Syndromes ... 展开 >> Thrombocytopenia 收起 << | Phase 2 | Completed | - | - |
NCT00418665 | - | Completed | - | - | |
NCT00098475 | DS Stage I Plasma Cell Myeloma... 展开 >> DS Stage II Plasma Cell Myeloma DS Stage III Plasma Cell Myeloma 收起 << | Phase 3 | Active, not recruiting | - | - |
NCT00908232 | Multiple Myeloma | Phase 2 | Completed | - | - |
NCT01359657 | Multiple Myeloma | Phase 1 | Completed | - | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 United States, Kansas University Of Kansas Cancer Center And Medical Pavillion Westwood, Kansas, United States, 66205 United States, Massachusetts Dana Faber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Washington University Of Washington School Of Medicine Seattle, Washington, United States, 98109 收起 << |
NCT01166113 | Multiple Myeloma | Phase 1 Phase 2 | Active, not recruiting | July 2021 | Italy ... 展开 >> A.O.U. San Giovanni Battista Torino, Italy, 10126 收起 << |
NCT00306813 | Relapse Refra... 展开 >>ctory Multiple Myeloma 收起 << | Phase 1 Phase 2 | Completed | - | Germany ... 展开 >> Dept. of Internal Medicine II, University of Wuerzburg Wuerzburg, Bavaria, Germany, 97070 收起 << |
NCT00908232 | - | Completed | - | - | |
NCT00525447 | Multiple Myeloma | Phase 1 | Completed | - | United States, Colorado ... 展开 >> Rocky Mountain Cancer Center Denver, Colorado, United States, 80218 United States, Florida H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 United States, Nebraska Nebraska Methodist Hospital Omaha, Nebraska, United States, 68114 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Weill Medical College of Cornell University New York, New York, United States, 10021 United States, South Dakota Avera Cancer Institute Sioux Falls, South Dakota, United States, 57105 United States, Texas Baylor University Medical Center Dallas, Texas, United States, 75246 收起 << |
NCT02556905 | - | Completed | - | Korea, Republic of ... 展开 >> Hallym University Sacred Heart Hospital Anyang, Korea, Republic of, 14068 Soon Chun Hyang University Hospital Bucheon Bucheon, Korea, Republic of, 14584 Inje University Busan Paik Hospital Busan, Korea, Republic of, 47392 Inje University Haeundae Paik Hospital Busan, Korea, Republic of, 48108 Dong-a University Medical Center Busan, Korea, Republic of, 49201 Pusan National University Hospital Busan, Korea, Republic of, 49241 Kosin University Gospel Hospital Busan, Korea, Republic of, 49267 Kyungpook National University Hospital Daegu, Korea, Republic of, 41954 Chungnam National University Hospital Daejeon, Korea, Republic of, 35015 Hwasun Chonnam National University Hospital Hwasun-gun, Korea, Republic of, 58128 Chonbuk National University Hospital Jeonju, Korea, Republic of, 54907 Inje University Sanggye Paik Hospital Seoul, Korea, Republic of, 01757 Korea University Anam Hospital Seoul, Korea, Republic of, 02841 Seoul National University Hospital Seoul, Korea, Republic of, 03080 Severance Hospital Seoul, Korea, Republic of, 03722 Konkuk University Hospital Seoul, Korea, Republic of, 05030 Asan Medical Center Seoul, Korea, Republic of, 05505 Samsung Medical Center Seoul, Korea, Republic of, 06351 The Catholic University of Korea, Seoul St. Mary's Hospital Seoul, Korea, Republic of, 06591 Boramae Medical Center Seoul, Korea, Republic of, 07061 Ewha Womans University Mokdong Hospital Seoul, Korea, Republic of, 07985 Korea University Guro Hospital Seoul, Korea, Republic of, 08308 Ulsan University Hospital Ulsan, Korea, Republic of, 44033 Wonju Severance Christian Hospital Wonju, Korea, Republic of, 26426 Pusan National University Yangsan Hospital Yangsan, Korea, Republic of, 50612 收起 << | |
NCT02285062 | Lymphoma, Large B-Cell, Diffus... 展开 >>e 收起 << | Phase 3 | Active, not recruiting | August 3, 2022 | - |
NCT03416374 | Relapsed and/or Refractory Mul... 展开 >>tiple Myeloma 收起 << | Phase 4 | Recruiting | May 31, 2021 | Japan ... 展开 >> Kameda Medical Center Recruiting Kamogawa, Chiba, Japan The Jikei University Kashiwa Hospital Recruiting Kashiwa, Chiba, Japan Ogaki Municipal Hospital Recruiting Ogaki, Gifu, Japan Gunma University Hospital Recruiting Maebashi, Gunma, Japan Shibukawa Medical Center Recruiting Shibukawa, Gunma, Japan Kobe city Medical Center General Hospital Recruiting Kobe, Hyogo, Japan Kanazawa University Hospital Recruiting Kanazawa, Ishikawa, Japan Iwate Medical University Recruiting Morioka, Iwate, Japan Yokohama Municipal Citizen's Hospital Recruiting Yokohama, Kanagawa, Japan Suwa Red Cross Hospital Recruiting Suwa, Nagano, Japan Dokkyo Medical University Recruiting Koshigaya, Saitama, Japan Juntendo University Hospital Recruiting Bunkyo-ku, Tokyo, Japan Nippon Medical School Hospital Recruiting Bunkyo-ku, Tokyo, Japan Nihon University Itabashi Hospital Recruiting Itabashi-ku, Tokyo, Japan The Cancer Institute Hospital of JFCR Recruiting Koto-ku, Tokyo, Japan The Jikei University Hospital Recruiting Minato-ku, Tokyo, Japan Kyorin University Hospital Recruiting Mitaka, Tokyo, Japan Japanese Red Cross Medical Center Recruiting Shibuya-ku, Tokyo, Japan Tokyo Disaster Medical Center Recruiting Tachikawa, Tokyo, Japan Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital Recruiting Hiroshima, Japan Kyoto Kuramaguchi Medical Center Recruiting Kyoto, Japan Niigata Cancer Center Hospital Recruiting Niigata, Japan Osaka Red Cross Hospital Recruiting Osaka, Japan 收起 << |
NCT02387879 | - | Active, not recruiting | July 30, 2021 | Turkey ... 展开 >> Baskent University Adana Application and Research Hospital Adana, Turkey, 01250 Cukurova University Medical Faculty Adana, Turkey, 01330: Gulhane Military Medical Academy Ankara, Turkey, 06010: Ankara University Medical Faculty Ankara, Turkey, 06100: Ankara Numune Training and Research Hospital Ankara, Turkey, 06100 Diskapi Yildirim Beyazit Training and Research Hospital Ankara, Turkey, 06110 Dr. Abdurrahman Yurtaslan Ankara Onkology Training and Research Hospital Ankara, Turkey, 06200 Hacettepe University Medical Faculty Ankara, Turkey, 06230 Ankara Bayindir Hospital Ankara, Turkey, 06250 Baskent University Ankara Hospital Ankara, Turkey, 06490 Gazi University Medical Faculty Ankara, Turkey, 06560 Antalya Medstar Hospital Antalya, Turkey, 07030 Akdeniz University Medical Faculty Antalya, Turkey, 07070: Ali Osman Sonmez Oncology Hospital Bursa, Turkey, 16040 Uludag University Medical Faculty Bursa, Turkey, 16059 Pamukkale University Medical Faculty Denizli, Turkey, 20070 Dicle University Medical Faculty Diyarbakir, Turkey, 21280: Trakya University Medical Faculty Edirne, Turkey, 22030 Osmangazi University Medical Faculty Eskisehir, Turkey, 26480 Gaziantep University Medical Faculty Gaziantep, Turkey, 27310 Istanbul University Istanbul Medical Faculty Istanbul, Turkey, 34093 Istanbul University Cerrahpasa Medical Faculty Istanbul, Turkey, 34098 Bakırkoy Dr.Sadi Konuk Training and Research Hospital Istanbul, Turkey, 34147 Medipol University Medical Faculty Istanbul, Turkey, 34214 Kartal Training and Research Hospital Istanbul, Turkey, 34865 Marmara University Pendik Training and Research Istanbul, Turkey, 34890: Ege University Medical Faculty Izmir, Turkey, 35100 Dokuz Eylul University Medical Faculty Izmir, Turkey, 35340: Izmir Medical Park Hospital Izmir, Turkey, 35575 Erciyes University Medical Faculty Kayseri, Turkey, 38039 Kocaeli University Medical Faculty Kocaeli, Turkey, 41380 Necmettin Erbakan University Meram Medical Faculty Konya, Turkey, 42090 Inonu University Medical Faculty Malatya, Turkey, 44280 Celal Bayar University Medical Faculty Manisa, Turkey, 45030 Mersin University Medical Faculty Mersin, Turkey, 33343: Ondokuz Mayis University Medical Faculty Samsun, Turkey, 55139 Namik Kemal University Medical Faculty Tekirdag, Turkey, 59100 Karadeniz Technical University Medical Faculty Trabzon, Turkey, 61080 收起 << | |
NCT01729338 | - | Terminated | - | - | |
NCT01335399 | Multiple Myeloma | Phase 3 | Active, not recruiting | May 31, 2019 | - |
NCT00151203 | Multiple Myeloma | Phase 2 | Active, not recruiting | August 2022 | United States, New York ... 展开 >> Weill Medical College of Cornell University New York, New York, United States, 10021 收起 << |
NCT01729338 | Multiple Myeloma | Phase 2 | Terminated | - | United States, North Carolina ... 展开 >> Duke University Medical Center Durham, North Carolina, United States, 27710 收起 << |
NCT01415752 | Lymphoma Neur... 展开 >>otoxicity Therapy-related Toxicity 收起 << | Phase 2 | Recruiting | March 2019 | - |
NCT02937571 | Multiple Myeloma | Phase 1 Phase 2 | Recruiting | October 2019 | United States, New Jersey ... 展开 >> Memoral Sloan Kettering Cancer Center Recruiting Basking Ridge, New Jersey, United States Contact: Neha Korde, MD 212-639-7664 Memorial Sloan Kettering Monmouth Recruiting Middletown, New Jersey, United States, 07748 Contact: Neha Korde, MD 212-639-7664 Memorial Sloan Kettering Bergen Recruiting Montvale, New Jersey, United States, 07645 Contact: Neha Korde, MD 212-639-7664 United States, New York Memorial Sloan Kettering Cancer Center @ Suffolk Recruiting Commack, New York, United States, 11725 Contact: Neha Korde, MD 212-639-7664 Memorial Sloan Kettering Westchester Recruiting Harrison, New York, United States, 10604 Contact: Neha Korde, MD 212-639-7664 Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Neha Korde, MD 212-639-7664 Contact: Ola Landgren, MD, PhD 212-639-5126 Principal Investigator: Neha Korde, MD Memorial Sloan Kettering at Mercy Medical Center Recruiting Rockville Centre, New York, United States Contact: Neha Korde, MD 212-639-7664 收起 << |
NCT00617591 | Multiple Myeloma | Phase 2 | Completed | - | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 收起 << |
NCT02720510 | Multiple Myeloma | Phase 2 | Terminated(A study was termina... 展开 >>ted due to low enrollment.) 收起 << | - | United States, California ... 展开 >> David Geffen School of Medicine at UCLA UCLA Los Angeles, California, United States, 90095 United States, Florida Memorial West Cancer Center Memorial Cancer Institute Pembroke Pines, Florida, United States, 33028 United States, Georgia Northside Hospital Central Research Dept. Atlanta, Georgia, United States, 30342 United States, Nebraska Oncology Hematology West Nebraska Cancer Specialists dbaNebraska Cancer Specialists Omaha, Nebraska, United States, 68124 United States, Texas Brooke Army Medical Center Hematology/Oncology San Antonio, Texas, United States, 78234 收起 << |
NCT01863550 | Plasma Cell Myeloma | Phase 3 | Recruiting | - | - |
NCT00564889 | Multiple Myeloma and Plasma Ce... 展开 >>ll Neoplasm 收起 << | Phase 2 | Completed | - | United States, Arizona ... 展开 >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259-5499 United States, Florida Mayo Clinic in Florida Jacksonville, Florida, United States, 32224 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT00617591 | - | Completed | - | - | |
NCT02916771 | Smoldering Multiple Myeloma | Phase 2 | Recruiting | April 2024 | United States, Massachusetts ... 展开 >> Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Irene M Ghobrial, MD 617-632-4198 Irene_Ghobrial@dfci.harvard.edu Principal Investigator: Irene M Ghobrial, MD 收起 << |
NCT00602641 | Plasma Cell Myeloma | Phase 3 | Active, not recruiting | - | - |
NCT02720510 | - | Terminated(A study was termina... 展开 >>ted due to low enrollment.) 收起 << | - | - | |
NCT02600897 | Relapsed or Refractory Follicu... 展开 >>lar Lymphoma, Relapsed or Refractory Diffuse Large B-Cell Lymphoma 收起 << | Phase 1 | Recruiting | February 23, 2022 | United States, Georgia ... 展开 >> Northwest Georgia Oncology Centers Completed Marietta, Georgia, United States, 30060 United States, Michigan Barbara Ann Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 United States, Missouri University of Missouri/Ellis Fischel Completed Columbia, Missouri, United States, 65212 Washington University; Wash Uni. Sch. Of Med Recruiting Saint Louis, Missouri, United States, 63110 United States, New York NYU School of Medicine Recruiting New York, New York, United States, 10016 United States, Texas Rocky Mountain Cancer Centers, LLP Recruiting Irving, Texas, United States, 75063 Texas Oncology-Tyler Recruiting Irving, Texas, United States, 75063 Texas Oncology San Antonio Medical Center Recruiting San Antonio, Texas, United States, 78229 Spain Insititut Catala D'Oncologia Recruiting Hospitalet de Llobregat, Barcelona, Spain, 08908 Hospital Clínico Málaga Recruiting Málaga, Malaga, Spain, 29010 Complejo Hospitalario de Navarra Recruiting Pamplona, Navarra, Spain, 31008 Clínica Universidad de Navarra Recruiting Pamplona, Navarra, Spain, 31620 Hospital Santa Creu i Sant Pau Recruiting Barcelona, Spain, 08025 Hospital Universitari Vall d'Hebron Recruiting Barcelona, Spain, 08035 Hospital Clínic. Barcelona Recruiting Barcelona, Spain, 08036 Hospital Gregorio Marañon Recruiting Madrid, Spain, 28007 Hospital Universitario Fundacion Jimenez Diaz. Recruiting Madrid, Spain, 28040 Hospital Universitario Virgen del Rocio; Servicio de Hematologia Withdrawn Sevilla, Spain, 41013 Hospital La Fe Recruiting Valencia, Spain United Kingdom St James University Hospital Recruiting Leeds, United Kingdom, LS9 7TF University Hospitals of Leicester NHS Trust - Leicester Royal Infirmary Recruiting Leicester, United Kingdom, LE1 5WW Royal Liverpool University Hospital Recruiting Liverpool, United Kingdom, L7 8XP Barts Hospital; Institute of Cancer Recruiting London, United Kingdom, EC1M 6BQ Sarah Cannon Research Institute Recruiting London, United Kingdom, W1G 6AD Maidstone & Tonbridge Wells Hospital; Kent Oncology Center Recruiting Maidstone, United Kingdom, ME16 9QQ Nottingham University Hospitals NHS Trust - City Hospital Recruiting Nottingham, United Kingdom, NG5 1PB Barking, Havering and Redbridge University Hospitals NHS Trust - Queen's Hospital Completed Romford, United Kingdom, RM7 0AG The Royal Wolverhampton Hospitals NHS Trust; Department of Haematology Recruiting Wolverhampton, United Kingdom, WV10 0QP 收起 << |
NCT00564889 | - | Completed | - | - | |
NCT03375567 | Multiple Myeloma | Not Applicable | Recruiting | September 2020 | United States, Connecticut ... 展开 >> Yale Cancer Center Recruiting New Haven, Connecticut, United States, 06520-8028 Contact: Natalia Neparidze, MD 203-785-5702 natalia.neparidze@yale.edu 收起 << |
NCT00602641 | - | Active, not recruiting | - | - | |
NCT00784927 | Lymphoma | Phase 2 | Completed | - | United States, Arizona ... 展开 >> Mayo Clinic in Arizona Scottsdale, Arizona, United States, 85259-5499 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 收起 << |
NCT02573896 | Neuroblastoma | Phase 1 | Recruiting | August 2022 | United States, California ... 展开 >> Children's Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027-0700 Contact: Araz Marachelian, MD 323-361-5687 amarachelian@chla.usc.edu UCSF Helen Diller Family Comprehensive Cancer Center Not yet recruiting San Francisco, California, United States, 94115 Contact: Katherine Matthay, MD 415-476-3831 matthayK@peds.ucsf.edu United States, Georgia AFLAC Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta - Egleston Campus Not yet recruiting Atlanta, Georgia, United States, 30322 Contact: Kelly Goldsmith, MD 404-785-0853 kgoldsm@emory.edu United States, Illinois University of Chicago Comer Children's Hospital Not yet recruiting Chicago, Illinois, United States, 60637 Contact: Ami Desai, MD 773-843-3943 adesai12@peds.bsd.uchicago.edu United States, Massachusetts Childrens Hospital Boston, Dana-Farber Cancer Institute. Not yet recruiting Boston, Massachusetts, United States, 02115 Contact: Suzanne Shusterman, MD 617-632-3725 suzanne_shusterman@dfci.harvard.edu United States, Michigan C.S Mott Children's Hospital Not yet recruiting Ann Arbor, Michigan, United States, 48109 Contact: Rajen Mody, MD rmody@umich.edu United States, North Carolina University of North Carolina, Chapel Hill Not yet recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Patrick Thompson, MD patom@email.unc.edu United States, Ohio Cincinnati Children's Hospital Medical Center Not yet recruiting Cincinnati, Ohio, United States, 45229-3039 Contact: Brian Weiss, MD 513-636-9863 brian.weiss@chmcc.org Nationwide Children's Hospital Recruiting Columbus, Ohio, United States, 43205 Contact: Keri Streby, MD United States, Pennsylvania Children's Hospital of Philadelphia Not yet recruiting Philadelphia, Pennsylvania, United States, 19104-4318 Contact: Yael Mosse, MD 215-590-0965 mosse@chop.edu United States, Texas Cook Children's Healthcare System Not yet recruiting Fort Worth, Texas, United States, 76104 Contact: Meaghan Granger, MD 682-885-4007 mgranger@cookchildrens.org United States, Washington Seattle Children's Hospital Not yet recruiting Seattle, Washington, United States, 98105 Contact: Navin Pinto, MD 206-987-5783 收起 << |
NCT00096525 | Kidney Cancer | Phase 2 | Completed | - | United States, New York ... 展开 >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 收起 << |
NCT00784927 | - | Completed | - | - | |
NCT01091831 | Multiple Myeloma | Phase 3 | Active, not recruiting | July 2019 | Italy ... 展开 >> Division of Hematology, Molinette Hospital Torino, Italy, 10126 收起 << |
NCT01450215 | Multiple Myeloma | Phase 2 | Completed | - | Sweden ... 展开 >> Karolinska Inst. Stockholm, Sweden, S-141 86 Karolinska Institute Stockholm, Sweden, S-141 86 收起 << |
NCT00884546 | Advanced Cancer, Various, NOS | Phase 1 | Completed | - | United States, California ... 展开 >> City Of Hope National Medical Center Duarte, California, United States, 91010 Moores Ucsd Cancer Center La Jolla, California, United States, 92093 Local Institution Los Angeles, California, United States, 90048 United States, Maryland The Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21231 United States, Michigan Local Institution Detroit, Michigan, United States, 48201 United States, New Jersey John Theurer Cancer Center Hackensack, New Jersey, United States, 07601 United States, Texas Oncology Consultants, Pa Houston, Texas, United States, 77024 Cancer Therapy And Research Center San Antonio, Texas, United States, 78229 收起 << |
NCT00044018 | Multiple Myeloma | Phase 2 | Completed | - | United States, Florida ... 展开 >> H Lee Moffit Cancer Center Tampa, Florida, United States, 33612 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55902 United States, New York St Vincent's Cancer Center New York, New York, United States, 10011 收起 << |
NCT00907452 | Myeloma | Not Applicable | Unknown | - | France ... 展开 >> CH ALBI Albi, France CHRU Angers Angers, France CH Côte basque Bayonne, France CH Blois Blois, France BORDEAUX Bordeaux, France Chalons sur Saone Chalons sur Saone, France CHU Dijon Dijon, France Ch Dunkerque Dunkerque, France Chu Grenoble Grenoble, France CHD Vendée La Roche Sur Yon, France CHRU Lille Lille, France CHU LYON Lyon, France LYON SUD Lyon, France Ipc Marseille Marseille, France CHR METZ Metz, France CH Mulhouse Mulhouse, France Chu Nancy Nancy, France Chu Nantes Nantes, France Centre Antoine LACASSAGNE Nice, France Institut Curie Paris, France Chu Poitiers Poitiers, France Chu Rennes Rennes, France CH Yves Le Foll St Brieuc, France René Huguenin St CLOUD, France Chu Toulouse Toulouse, France Chu Tours Tours, France 收起 << |
NCT00899431 | Chronic Lymphocytic Leukemia | Phase 2 | Active, not recruiting | May 2019 | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01559935 | Multiple Myeloma | Phase 2 | Active, not recruiting | March 2022 | United States, New York ... 展开 >> Weill Cornell Medical College New York, New York, United States, 10021 收起 << |
NCT03591744 | Plasma Cell Leukemia | Phase 1 | Not yet recruiting | October 25, 2019 | United States, California ... 展开 >> City of Hope Medical Center Not yet recruiting Duarte, California, United States, 91010 Contact: Amrita Y. Krishnan, MD 626-256-4673 akrishnan@coh.org Principal Investigator: Amrita Y. Krishnan, MD United States, Minnesota Mayo Clinic Not yet recruiting Rochester, Minnesota, United States, 55905 Contact: Shaji K. Kumar 507-284-2511 kumar.shaji@mayo.edu Principal Investigator: Shaji K. Kumar United States, Missouri Siteman Cancer Center at Washington University Not yet recruiting Saint Louis, Missouri, United States, 63110 Contact: Ravi Vij 314-454-8323 rvij@wustl.edu Principal Investigator: Ravi Vij United States, North Carolina Carolinas Medical Center/Levine Cancer Institute Not yet recruiting Charlotte, North Carolina, United States, 28203 Contact: Saad Z. Usmani 980-442-2000 saad.usmani@carolinashealthcare.org Principal Investigator: Saad Z. Usmani United States, Tennessee Sarah Cannon Cancer Center Not yet recruiting Nashville, Tennessee, United States, 37203 Contact: Jesus G. Berdeja 615-329-7274 jberdeja@tnonc.com Principal Investigator: Jesus G. Berdeja 收起 << |
NCT00482261 | Multiple Myeloma | Phase 2 | Unknown | September 2013 | Australia, Victoria ... 展开 >> Peter MacCallum Cancer Centre Melbourne, Victoria, Australia, 3002 收起 << |
NCT02863458 | - | Not yet recruiting | September 30, 2020 | United States, Ohio ... 展开 >> Cleveland Clinic Recruiting Cleveland, Ohio, United States, 44195 收起 << | |
NCT01303965 | Multiple Myeloma | Phase 1 Phase 2 | Terminated(Slow accrual) | - | United States, Indiana ... 展开 >> Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 收起 << |
NCT01856192 | Ann Arbor Stage II Diffuse Lar... 展开 >>ge B-Cell Lymphoma Ann Arbor Stage III Diffuse Large B-Cell Lymphoma Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma CD20 Positive 收起 << | Phase 2 | Active, not recruiting | - | - |
NCT01303965 | - | Terminated(Slow accrual) | - | - | |
NCT00609869 | Lymphocytic Leukemia ... 展开 >> Mantle Cell Lymphoma 收起 << | Phase 2 | Completed | - | United States, Florida ... 展开 >> Center for Cancer Care & Research/Watson Lakeland, Florida, United States, 33805 H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 收起 << |
NCT01559935 | - | Active, not recruiting | - | - | |
NCT00609869 | - | Completed | - | - | |
NCT00065156 | - | Completed | - | - | |
NCT01904643 | Adult Acute Megakaryoblastic L... 展开 >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia 收起 << | Phase 1 | Terminated(Accrual factor) | - | United States, California ... 展开 >> Stanford University, School of Medicine Stanford, California, United States, 94305 收起 << |
NCT01400685 | Chronic Lymphocytic Leukemia ... 展开 >> Small Lymphocytic Lymphoma B Chronic Lymphocytic Leukemia 收起 << | Phase 1 | Completed | - | United States, Massachusetts ... 展开 >> Massachusetts General Hospital Boston, Massachusetts, United States, 02214 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 收起 << |
NCT00717756 | Liver Cancer | Phase 2 | Completed | - | United States, New York ... 展开 >> Montefiore Medical Center Bronx, New York, United States, 10467 United States, Rhode Island Memorial Hospital of Rhode island Pawtucket, Rhode Island, United States, 02860 Lifespan Hospitals Providence, Rhode Island, United States, 02903 收起 << |
NCT00065156 | Myelodysplastic Syndromes | Phase 2 | Completed | - | - |
NCT01408199 | Cutaneous Lupus | Phase 4 | Completed | - | Spain ... 展开 >> Vall D'Hebron Hospital Barcelona, Spain, 08035 收起 << |
NCT01246076 | Myelodysplastic Syndromes | Phase 2 | Completed | - | United States, Arizona ... 展开 >> Mayo Clinic Scottsdale AZ Scottsdale, Arizona, United States United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110 收起 << |
NCT00717756 | - | Completed | - | - | |
NCT01246076 | - | Completed | - | - | |
NCT00109772 | Complex Regional Pain Syndrome... 展开 >>, Type I 收起 << | Phase 2 | Terminated(Interim analysis sh... 展开 >>owed the primary outcome was not reached) 收起 << | - | - |
NCT00840931 | Leukemia | Phase 1 | Active, not recruiting | June 2019 | United States, Florida ... 展开 >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 收起 << |
NCT00109772 | - | Terminated(Interim analysis sh... 展开 >>owed the primary outcome was not reached) 收起 << | - | - | |
NCT00988208 | Prostate Cancer | Phase 3 | Completed | - | - |
NCT01178814 | Myelodysplastic Syndrome | Phase 2 | Unknown | September 2016 | United States, New York ... 展开 >> Columbia University Medical Center New York, New York, United States, 10032 收起 << |
NCT00883623 | Primary Amyloidosis | Phase 2 | Completed | - | Germany ... 展开 >> University Clinic Heidelberg Heidelberg, Germany, 69120 收起 << |
NCT01788189 | B-cell Lymphoma | Phase 1 Phase 2 | Recruiting | June 2019 | Germany ... 展开 >> Klinik für Hämatologie, Universitätsklinikum Essen Recruiting Essen, Germany, 45147 Contact: Ulrich Dührsen, Prof. Dr. med. +49-201-723 ext 2417 ulrich.duehrsen@uk-essen.de Principal Investigator: Ulrich Dührsen, Prof. Dr. med. 收起 << |
NCT00774345 | B-cell Chronic Lymphocytic Leu... 展开 >>kemia 收起 << | Phase 3 | Active, not recruiting | October 27, 2020 | - |
NCT03113695 | Richter's Syndrome ... 展开 >> CLL 收起 << | Phase 1 | Recruiting | August 2020 | United States, California ... 展开 >> University of California, San Diego Recruiting La Jolla, California, United States, 92093 Contact: Thomas Kipps, MD, PhD tkipps@ucsd.edu Principal Investigator: Thomas Kipps, MD, PhD 收起 << |
NCT03015896 | Grade 3a Follicular Lymphoma ... 展开 >> Recurrent Burkitt Lymphoma Recurrent Diffuse Large B-Cell Lymphoma Recurrent Follicular Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Lymphoplasmacytic Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Waldenstrom Macroglobulinemia Refractory Burkitt Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Follicular Lymphoma Refractory Lymphoplasmacytic Lymphoma Refractory Mantle Cell Lymphoma 收起 << | Phase 1 Phase 2 | Recruiting | April 30, 2020 | United States, Ohio ... 展开 >> Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Kami J. Maddocks, MD 614-293-3196 Kami.maddocks@osumc.edu Principal Investigator: Kami J. Maddocks, MD 收起 << |
NCT00988208 | - | Completed | - | - | |
NCT00910910 | B-Cell Chronic Lymphocytic Leu... 展开 >>kemia 收起 << | Phase 3 | Active, not recruiting | April 30, 2018 | - |
NCT00412581 | Melanoma | Phase 1 | Completed | - | United States, Texas ... 展开 >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01127542 | Chronic Lymphocytic Leukaemia | Phase 2 | Terminated(Potential safety is... 展开 >>sue of second primary malignancies in patients treated with lenalidomide.) 收起 << | - | United Kingdom ... 展开 >> The Royal Bournemouth Hospital Bournemouth, Dorset, United Kingdom, BH7 7DW Heart of England NHS Foundation Trust Birmingham, United Kingdom, B9 5SS Addenbrooke's Hospital Cambridge, United Kingdom, CB2 0QQ University Hospital of Wales Cardiff, United Kingdom, CF14 4XW St James's University Hospital Leeds, United Kingdom, LS9 7TF The Royal Liverpool and Broadgreen University Hospital Liverpool, United Kingdom, L7 8XP King's College Hospital London, United Kingdom, SE5 9RS The Christie NHS Foundation Trust Manchester, United Kingdom, M20 4BX Mid Yorkshire Hospitals NHS Trust Wakefield, United Kingdom, WF1 4DG 收起 << |
NCT00684242 | Advanced Cancer ... 展开 >> Pain 收起 << | Phase 2 | Terminated(Low accrual.) | - | United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT00684242 | - | Terminated(Low accrual.) | - | - | |
NCT01222195 | - | Terminated(Low accrual.) | - | - | |
NCT00910910 | - | Active, not recruiting | - | - | |
NCT00179621 | Myelodysplastic Syndromes | Phase 3 | Completed | - | - |
NCT02917941 | Relapsed and/or Refractory Mul... 展开 >>tiple Myeloma 收起 << | Phase 2 | Active, not recruiting | August 4, 2019 | Japan ... 展开 >> Nagoya, Aichi, Japan Narita, Chiba, Japan Shibukawa, Gunma, Japan Fukuyama, Hiroshima, Japan Kobe, Hyogo, Japan Ibaraki, Ibaragi, Japan Sagamihara, Kanagawa, Japan Sendai, Miyagi, Japan Ikoma, Nara, Japan Sunto, Shizuoka, Japan Utsunomiya, Tochigi, Japan Bunkyo-ku, Tokyo, Japan Koto-ku, Tokyo, Japan Shibuya-ku, Tokyo, Japan Shinjuku-ku, Tokyo, Japan Tachikawa, Tokyo, Japan Chiba, Japan Fukuoka, Japan Niigata, Japan Okayama, Japan Osaka, Japan 收起 << |
NCT00689936 | Multiple Myeloma | Phase 3 | Completed | - | - |
NCT00689936 | - | Completed | - | - | |
NCT01222195 | Leukemia | Phase 2 | Terminated(Low accrual.) | - | United States, Texas ... 展开 >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01886859 | B-Cell Prolymphocytic Leukemia... 展开 >> Recurrent Chronic Lymphocytic Leukemia Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Small Lymphocytic Lymphoma 收起 << | Phase 1 | Active, not recruiting | December 31, 2020 | United States, California ... 展开 >> Stanford Cancer Institute Palo Alto Palo Alto, California, United States, 94304 United States, Colorado University of Colorado Hospital Aurora, Colorado, United States, 80045 United States, Ohio Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 收起 << |
NCT00430365 | Myeloma | Phase 3 | Active, not recruiting | September 2020 | - |
NCT02659293 | Multiple Myeloma | Phase 3 | Recruiting | May 2020 | United States, Illinois ... 展开 >> University of Chicago Recruiting Chicago, Illinois, United States, 60637 Contact: Jennifer Nam 773-702-7716 jnam@medicine.bsd.uchicago.edu Principal Investigator: Andrzej Jakubowiak, M.D. United States, Michigan Wayne State University - Karmanos Cacner Institute Recruiting Detroit, Michigan, United States, 48201 Contact: Abhinav Deol, MD 313-576-8093 Poland Polish Myeloma Consortium Recruiting Poznań, Poland Contact: Dominik Dytfeld, dr n. med. dytfeld@me.com 收起 << |
NCT02992522 | B-Cell Lymphoma, Unclassifiabl... 展开 >>e, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma Grade 1 Follicular Lymphoma Grade 2 Follicular Lymphoma Grade 3a Follicular Lymphoma Recurrent Burkitt Lymphoma Recurrent Diffuse Large B-Cell Lymphoma Recurrent Follicular Lymphoma Recurrent Marginal Zone Lymphoma Refractory Burkitt Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Follicular Lymphoma Transformed Recurrent Non-Hodgkin Lymphoma 收起 << | Phase 1 | Recruiting | January 31, 2021 | United States, Ohio ... 展开 >> Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Beth A. Christian, MD 614-293-7807 beth.christian@osumc.edu Principal Investigator: Beth A. Christian, MD 收起 << |
NCT01419795 | - | Terminated(Low accrual) | - | - | |
NCT01419795 | Adult Nasal Type Extranodal NK... 展开 >>/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Cutaneous B-cell Non-Hodgkin Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Nodal Marginal Zone B-cell Lymphoma Noncutaneous Extranodal Lymphoma Peripheral T-cell Lymphoma Prolymphocytic Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Small Intestine Lymphoma Splenic Marginal Zone Lymphoma T-cell Large Granular Lymphocyte Leukemia Testicular Lymphoma Waldenström Macroglobulinemia 收起 << | Phase 2 | Terminated(Low accrual) | - | United States, Washington ... 展开 >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 收起 << |
NCT00179621 | - | Completed | - | - | |
NCT00891384 | Multiple Myeloma | Phase 3 | Completed | - | Germany ... 展开 >> Medizinische Klinik, Abteilung Innere Medizin Heidelberg, Baden-Württemberg, Germany, 69120 Clinic of Justus-Liebig-University, Medical Clinic for Hematology and Medical Oncology Giessen, Hessen, Germany, 35385 Departement of Hematology, Oncology and Clinical Immunology Duesseldorf, Northwest, Germany, 40225 St. Johannes Hospital, Medical Clinic II Duisburg, Northwest, Germany, 47166 Bone Marrow Transplantation Unit, University Hospital Hamburg-Eppendorf Hamburg, Germany, 20246 收起 << |
NCT00735930 | Anemia Chroni... 展开 >>c Lymphocytic Leukemia Prolymphocytic Leukemia Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Thrombocytopenia 收起 << | Phase 1 | Completed | - | United States, Ohio ... 展开 >> Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 收起 << |
NCT00765245 | Lymphoma | Phase 2 | Completed | - | United States, North Carolina ... 展开 >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 United States, Tennessee Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States, 37064 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 收起 << |
NCT01358734 | - | Completed | - | - | |
NCT00765245 | - | Completed | - | - | |
NCT00109005 | Melanoma | Phase 2 | Completed | - | United States, Maryland ... 展开 >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 收起 << |
NCT00109005 | - | Completed | - | - | |
NCT01927718 | Myeloma | Not Applicable | Terminated(Poor Response Rate) | - | United States, Texas ... 展开 >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 收起 << |
NCT01358734 | Acute Myeloid Leukemia ... 展开 >> Acute Myelogenous Leukemia 收起 << | Phase 2 | Completed | - | - |
NCT02521714 | Healthy Volunteers | Phase 1 | Completed | - | United States, Florida ... 展开 >> Covance-Daytona Beach Daytona Beach, Florida, United States, 32117 收起 << |
NCT00179647 | Multiple Myeloma | Phase 3 | Completed | - | - |
NCT00179647 | - | Completed | - | - |
尊敬的 Ambeed 客户您好,
请您选择所在区域,我们将转接对应客服为您服务!